Study ID;Patient ID;Sample ID;Diagnosis Age;American Joint Committee on Cancer Metastasis Stage Code;Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code;Neoplasm Disease Stage American Joint Committee on Cancer Code;American Joint Committee on Cancer Publication Version Type;American Joint Committee on Cancer Tumor Stage Code;Brachytherapy first reference point administered total dose;Cancer Type;Cancer Type Detailed;Cent17 Copy Number;Birth from Initial Pathologic Diagnosis Date;Days to Sample Collection.;Death from Initial Pathologic Diagnosis Date;Last Alive Less Initial Pathologic Diagnosis Date Calculated Day Value;Days to Last Followup;Disease Free (Months);Disease Free Status;Disease code;ER positivity scale other;ER positivity scale used;ER Status By IHC;ER Status IHC Percent Positive;Ethnicity Category;First surgical procedure other;Form completion date;Fraction Genome Altered;HER2 and cent17 cells count;HER2 and cent17 scale other;HER2 cent17 ratio;HER2 copy number;HER2 fish method;HER2 fish status;HER2 ihc percent positive;HER2 ihc score;HER2 positivity method text;HER2 positivity scale other;Neoplasm Histologic Type Name;Tumor Other Histologic Subtype;Neoadjuvant Therapy Type Administered Prior To Resection Text;Prior Cancer Diagnosis Occurence;ICD-10 Classification;International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code;International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code;IHC-HER2;IHC Score;Informed consent verified;Year Cancer Initial Diagnosis;Is FFPE;Primary Lymph Node Presentation Assessment Ind-3;Positive Finding Lymph Node Hematoxylin and Eosin Staining Microscopy Count;Positive Finding Lymph Node Keratin Immunohistochemistry Staining Method Count;Lymph Node(s) Examined Number;Margin status reexcision;Menopause Status;Metastatic Site;Metastatic Site Other;Metastatic tumor indicator;First Pathologic Diagnosis Biospecimen Acquisition Method Type;First Pathologic Diagnosis Biospecimen Acquisition Other Method Type;Micromet detection by ihc;Mutation Count;New Neoplasm Event Post Initial Therapy Indicator;Nte cent 17 HER2 ratio;Nte er ihc intensity score;Nte er status;Nte er status ihc positive;Nte HER2 fish status;Nte HER2 positivity ihc score;Nte HER2 status;Nte HER2 status ihc positive;Nte pr ihc intensity score;Nte pr status by ihc;Nte pr status ihc positive;Oct embedded;Oncotree Code;Overall Survival (Months);Overall Survival Status;Other Patient ID;Other Sample ID;Pathology Report File Name;Disease Surgical Margin Status;Adjuvant Postoperative Pharmaceutical Therapy Administered Indicator;Primary Tumor Site;Project code;Tissue Prospective Collection Indicator;PR positivity define method;PR positivity ihc intensity score;PR positivity scale other;PR positivity scale used;PR status by ihc;PR status ihc percent positive;Race Category;Did patient start adjuvant postoperative radiotherapy?;Tissue Retrospective Collection Indicator;Number of Samples Per Patient;Sample Type;Sex;Somatic Status;Staging System;Staging System_1;Surgery for positive margins;Surgery for positive margins other;Surgical procedure first;Tissue Source Site;TMB (nonsynonymous);Person Neoplasm Status;Tumor Disease Anatomic Site
brca_tcga_pub2015;TCGA-A1-A0SB;TCGA-A1-A0SB-01;70;M0;N0;Stage I;6th;T1c;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-25833;764;NA;0;259;8.51;0:DiseaseFree;NA;NA;NA;Positive;70-79%;NOT HISPANIC OR LATINO;NA;6/30/11;8;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Other, specify;NA;No;No;C50.9;1/03/8200;C50.9;Negative;NA;YES;2008;NO;YES;0;NA;2;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Fine needle aspiration biopsy;NA;NA;18;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;BRCA;851;0:LIVING;0045349c-69d9-4306-a403-c9c1fa836644;f66358d4-9319-4c23-983d-ab5056daacf1;TCGA-A1-A0SB.BEC7EEA9-6DEA-4402-A3A1-07EF33D58174.pdf;Negative;NA;Left;NA;NO;NA;NA;NA;NA;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Lumpectomy;A1;6;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A1-A0SD;TCGA-A1-A0SD-01;59;M0;N0;Stage IIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-21793;1697;NA;0;437;14.36;0:DiseaseFree;NA;NA;NA;Positive;90-99%;NOT HISPANIC OR LATINO;NA;9/7/11;2474;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2005;NO;YES;0;0;3;Negative;NA;NA;NA;NA;Core needle biopsy;NA;NA;30;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;1436;0:LIVING;c462e422-eb8d-4daf-9897-2a9c6cbd783a;81f193d9-ad19-43c2-b89f-54003a8d133e;TCGA-A1-A0SD.DD89D265-9E20-49C2-93BD-666BE7D5E41B.pdf;Positive;NA;Left;NA;NO;NA;NA;NA;NA;Positive;90-99%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;Lumpectomy;NA;Lumpectomy;A1;1;NA;Breast
brca_tcga_pub2015;TCGA-A1-A0SE;TCGA-A1-A0SE-01;56;M0;N0 (i-);Stage I;6th;T1c;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;2;-20717;1672;NA;0;1321;43.4;0:DiseaseFree;NA;NA;NA;Positive;80-89%;NOT HISPANIC OR LATINO;NA;12/6/10;2134;NA;NA;1;2;NA;Negative;NA;1;NA;NA;Mixed Histology (please specify);invasive ductal and lobular carcinoma;No;No;C50.9;1/03/8522;C50.9;Negative;3;YES;2005;NO;NA;0;NA;8;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NA;Core needle biopsy;NA;NA;21;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;ILC;434;0:LIVING;c397e6c2-ba3a-4f5e-a258-c140611192fe;2fd1998c-1ea4-42eb-84b9-db352da9cf25;TCGA-A1-A0SE.CFF567FC-8867-4CA4-85AE-81A7D30095E7.pdf;Negative;NA;Left Upper Outer Quadrant;NA;NO;NA;3+;NA;NA;Positive;90-99%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Modified Radical Mastectomy;A1;7;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A1-A0SF;TCGA-A1-A0SF-01;54;M0;N0;Stage IIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-19731;1648;NA;0;1463;48.06;0:DiseaseFree;NA;NA;NA;Positive;90-99%;NOT HISPANIC OR LATINO;NA;5/24/11;2015;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2006;NO;YES;0;NA;2;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Fine needle aspiration biopsy;NA;NA;38;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;4806;0:LIVING;4b620966-b4c7-4615-bf58-ca9d3226b9bd;f4d51ca6-89a6-4571-ae8d-0fad7dde4452;TCGA-A1-A0SF.1617B36B-4EFB-445E-95BC-E63B129AAAE7.pdf;Negative;NA;Left;NA;NO;NA;NA;NA;NA;Positive;90-99%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Modified Radical Mastectomy;A1;1266666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A1-A0SH;TCGA-A1-A0SH-01;39;M0;N0 (i-);Stage IIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;1.8;-14595;1305;NA;0;1437;47.21;0:DiseaseFree;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;12/6/10;1789;NA;NA;1.4;2.5;NA;Negative;NA;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;2006;NO;NA;0;NA;2;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NA;Fine needle aspiration biopsy;NA;NA;78;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;MDLC;4721;0:LIVING;a6a863d9-b39d-4965-b47f-79a1bcf3c976;08044da0-8cb7-4bf7-bbb6-b80be4fddd8c;TCGA-A1-A0SH.1FB1255E-D9EC-4FE9-BE96-F81271FCCFB6.pdf;Negative;NA;Left Upper Inner Quadrant;NA;NO;NA;NA;NA;NA;Positive;90-99%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Lumpectomy;A1;26;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A1-A0SI;TCGA-A1-A0SI-01;52;M0;N1a;Stage IIB;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-19250;1267;NA;0;635;20.86;0:DiseaseFree;NA;NA;NA;Positive;50-59%;NOT HISPANIC OR LATINO;NA;6/30/11;3313;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2007;NO;YES;1;NA;23;NA;NA;NA;NA;NO;Fine needle aspiration biopsy;NA;NA;168;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;2086;0:LIVING;16368c32-2118-4fcf-8693-6c89995e49d8;c5181ae5-bd05-459f-920d-26bd31bd9088;TCGA-A1-A0SI.4CD6BDB7-9629-41C6-8514-7661E3D33A66.pdf;Negative;NA;Right;NA;NO;NA;NA;NA;NA;Positive;10-19%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Lumpectomy;A1;5566666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A1-A0SJ;TCGA-A1-A0SJ-01;39;M0;N1a;Stage IIIA;6th;T3;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;4;-14383;1399;NA;0;416;13.67;0:DiseaseFree;NA;NA;NA;Positive;70-79%;NOT HISPANIC OR LATINO;NA;12/6/10;4600;NA;NA;1;5;NA;Negative;NA;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;2006;NO;NA;3;NA;19;NA;NA;NA;NA;NA;Core needle biopsy;NA;NA;30;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;1367;0:LIVING;a2db9dd1-44d5-48b5-817c-a21a85fadb21;9ec60572-39e4-4a0d-b157-cf0ec726fb1d;TCGA-A1-A0SJ.0C0EEC9F-A715-4769-B58C-99D06C3C91F3.pdf;Negative;NA;Left;NA;NO;NA;NA;NA;NA;Positive;10-19%;BLACK OR AFRICAN AMERICAN;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Modified Radical Mastectomy;A1;1;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A1-A0SK;TCGA-A1-A0SK-01;54;M0;N0 (i-);Stage IIA;6th;T2;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-20048;1164;967;0;NA;NA;NA;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;12/6/10;4163;NA;NA;NA;NA;NA;NA;NA;0;NA;NA;Other, specify;NA;No;No;C50.9;1/03/8013;C50.9;Negative;NA;YES;2007;NO;NA;0;NA;4;Negative;Indeterminate (neither Pre or Postmenopausal);NA;NA;NA;Excisional Biopsy;NA;NA;101;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;BRCA;3177;1:DECEASED;a5b44d66-c162-46b5-9df2-86305f0385c5;dbd8fda0-bdf2-40f0-80b6-daef5ebf9c97;TCGA-A1-A0SK.13302EC6-6511-42FE-AA8B-C875B5384FFE.pdf;Positive;NA;Right Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Negative;NA;ASIAN;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;Other;surgical resection;Lumpectomy;A1;3366666667;NA;Breast
brca_tcga_pub2015;TCGA-A1-A0SM;TCGA-A1-A0SM-01;77;M0;N0 (i-);Stage IIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;2;-28198;1115;NA;0;242;7.95;0:DiseaseFree;NA;NA;NA;Positive;20-29%;NOT HISPANIC OR LATINO;NA;12/6/10;1807;NA;NA;11;21;NA;Positive;NA;3;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;NA;YES;2007;NO;NA;0;NA;3;NA;NA;NA;NA;NA;Core needle biopsy;NA;NA;22;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;795;0:LIVING;784de7ac-8424-42eb-83d4-a1bebaa42b97;289f5433-4834-401f-9361-efc8e883e630;TCGA-A1-A0SM.4F047F5B-EF3A-4590-8E7A-D90A52860324.pdf;Negative;NA;Left;NA;NO;NA;NA;NA;NA;Negative;NA;WHITE;NA;YES;1;Primary;Male;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Modified Radical Mastectomy;A1;733333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A1-A0SN;TCGA-A1-A0SN-01;50;MX;N1;Stage IIA;6th;T1c;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-18401;1091;NA;0;1196;39.29;0:DiseaseFree;NA;NA;NA;Positive;90-99%;NOT HISPANIC OR LATINO;NA;5/23/11;5518;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;NA;YES;2007;NO;YES;4;NA;13;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NA;46;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;3929;0:LIVING;0dc337fa-da8b-42c4-b9a7-fb76d81c161f;62d2a36e-feb1-4084-8111-7ea38a4e3049;TCGA-A1-A0SN.D0269758-EFAE-4EBA-8CCF-4A6CF4D4B35A.pdf;Negative;NA;Left;NA;NO;NA;NA;NA;NA;Positive;60-69%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Lumpectomy;A1;1533333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A1-A0SP;TCGA-A1-A0SP-01;40;M0;N0 (i-);Stage IIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-14954;958;NA;0;584;19.19;0:DiseaseFree;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;12/6/10;3918;NA;NA;NA;NA;NA;NA;NA;0;NA;NA;Infiltrating Ductal Carcinoma;NA;NA;Yes;C50.9;1/03/8500;C50.9;Negative;NA;YES;2007;NO;NA;0;NA;3;NA;NA;NA;NA;NA;Fine needle aspiration biopsy;NA;NA;41;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;1919;0:LIVING;a9bb8159-32f0-454c-a946-b3286a52b9d5;c0c04ba3-7fdf-47f3-8750-a487639a76df;TCGA-A1-A0SP.01992912-611F-4AA8-8570-B062CBCCAF70.pdf;Negative;NA;Right;NA;NO;NA;NA;NA;NA;Negative;NA;NA;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Lumpectomy;A1;1366666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A1-A0SQ;TCGA-A1-A0SQ-01;45;MX;N1;Stage IIB;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-16458;967;NA;0;554;18.2;0:DiseaseFree;NA;NA;NA;Positive;90-99%;NOT HISPANIC OR LATINO;NA;6/30/11;1094;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2007;NO;YES;1;NA;15;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Core needle biopsy;NA;NA;26;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;182;0:LIVING;08de63a2-7b76-43c3-80dc-df748b1d81bc;58d073a2-68b8-4f48-ba5e-020258abef71;TCGA-A1-A0SQ.92EE56BF-AAA0-438E-9244-780DBB2D9835.pdf;Negative;NA;Left;NA;NO;NA;NA;NA;NA;Positive;90-99%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Modified Radical Mastectomy;A1;866666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A2-A04N;TCGA-A2-A04N-01;66;M0;N0 (i-);Stage IA;5th;T1c;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-24155;2850;NA;0;3153;143.04;0:DiseaseFree;NA;NA;NA;Positive;NA;HISPANIC OR LATINO;NA;1/27/11;862;NA;NA;1.2;NA;NA;Negative;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;2002;NO;NA;0;0;6;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Fine needle aspiration biopsy;NA;YES;37;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;BRCA;14304;0:LIVING;197428f7-bd77-4c5f-8119-87157b5c35b9;b8c9196c-182d-4522-b487-734f9a8f9a78;TCGA-A2-A04N.45B4B99C-80E6-4AF4-8692-F7EE19D0467A.pdf;Negative;NA;Right;NA;NO;NA;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;Other (specify);Sentinel lymph node biopsy plus non-sentinel lymph node biopsy;NA;NA;Lumpectomy;A2;1233333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A2-A04P;TCGA-A2-A04P-01;36;M0;N3c;Stage IIIC;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-13238;2623;548;0;NA;10.28;1:Recurred/Progressed;NA;NA;NA;Negative;<10%;NA;NA;8/26/10;6407;NA;NA;1.3;NA;NA;Negative;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;2003;NO;NA;18;0;20;Positive;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NA;Excisional Biopsy;NA;NO;102;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;18;1:DECEASED;ccd4a24b-d8cc-4686-9dee-c98b0c5a8d21;e4dee88b-58d0-4953-ad4a-a2df876f3c95;TCGA-A2-A04P.0E4B0EA9-14D1-4A82-814D-51CC2B9BA2B5.pdf;Positive;NA;Left;NA;NO;NA;NA;NA;NA;Negative;<10%;BLACK OR AFRICAN AMERICAN;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;Mastectomy NOS;NA;Lumpectomy;A2;34;WITH TUMOR;Breast
brca_tcga_pub2015;TCGA-A2-A04Q;TCGA-A2-A04Q-01;48;M0;N0 (i-);Stage IA;6th;T1;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-17660;2260;NA;0;2179;78.35;0:DiseaseFree;NA;NA;NA;Negative;<10%;NA;NA;8/10/10;853;NA;NA;1.4;NA;NA;Negative;NA;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;2004;NO;NA;0;0;3;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Other method, specify:;SKIN BIOPSY;YES;20;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;7835;0:LIVING;b5fba77b-1f50-4e71-95b2-566afba4bdd7;e17e273d-6f53-4419-9f0c-1e4e667c5257;TCGA-A2-A04Q.726B60CA-1B1C-440D-82FA-A4C978C4D484.pdf;Negative;NA;Right Upper Outer Quadrant|Right;NA;NO;NA;NA;NA;NA;Negative;<10%;WHITE;NA;YES;1;Primary;Female;Matched;Other (specify);SLN AND NON-SLN BX;NA;NA;Simple Mastectomy;A2;666666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A2-A04R;TCGA-A2-A04R-01;36;M0;N0 (i-);Stage IA;6th;T1;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-13483;2233;NA;0;2365;121.85;0:DiseaseFree;NA;NA;NA;Positive;60-69%;NOT HISPANIC OR LATINO;NA;10/8/10;2643;NA;NA;1.1;NA;NA;Negative;NA;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;2004;NO;NA;0;0;1;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NA;Core needle biopsy;NA;YES;70;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;12185;0:LIVING;f3a058b9-fb7f-4098-8f0e-83c2acfa1ed5;e29fc4e1-4c82-46d7-997c-be59470c7751;TCGA-A2-A04R.6A97C809-91BB-4E35-9E12-F5F2A58C9D35.pdf;Negative;NA;Left Upper Inner Quadrant;NA;NO;NA;NA;NA;NA;Positive;80-89%;BLACK OR AFRICAN AMERICAN;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Lumpectomy;A2;2333333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A2-A04T;TCGA-A2-A04T-01;62;M0;N0 (i-);Stage IIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-22707;1979;NA;0;1950;73.78;0:DiseaseFree;NA;NA;NA;Negative;<10%;NA;NA;8/9/10;6936;NA;NA;1.1;NA;NA;Negative;NA;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;2004;NO;NA;0;0;3;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;YES;81;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;7378;0:LIVING;b58ad350-5140-4fa8-bc2c-24bca8395f3a;6dd4870f-1ec2-484b-8703-6397d8e67daa;TCGA-A2-A04T.24D42292-B875-4FAF-8C3A-9834414C3A01.pdf;Negative;NA;Left Upper Inner Quadrant;NA;NO;NA;NA;NA;NA;Negative;<10%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Lumpectomy;A2;27;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A2-A04U;TCGA-A2-A04U-01;47;M0;N0 (i+);Stage IIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-17474;1924;NA;0;671;87.19;0:DiseaseFree;NA;NA;NA;Negative;<10%;NOT HISPANIC OR LATINO;NA;1/5/11;6677;NA;NA;2.2;NA;NA;Positive;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2004;NO;NA;0;1;3;NA;Peri (6-12 months since last menstrual period);NA;NA;NA;Core needle biopsy;NA;YES;47;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;8719;0:LIVING;1c3610f7-e0aa-48d7-9a27-0dbaf6e244f9;e1df2e78-ade5-4ff7-a636-95c79e23b942;TCGA-A2-A04U.B14456B1-4992-492D-AFB5-4F975F20A277.pdf;Negative;NA;Right;NA;NO;NA;NA;NA;NA;Negative;<10%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Simple Mastectomy;A2;16;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A2-A04V;TCGA-A2-A04V-01;39;M0;N0 (i-);Stage IIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-14250;1812;1920;0;NA;48.29;1:Recurred/Progressed;NA;STRONG;NA;Positive;90-99%;NOT HISPANIC OR LATINO;NA;8/10/10;1132;NA;NA;1.1;NA;NA;Negative;NA;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;2005;NO;NA;0;0;2;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NA;Core needle biopsy;NA;YES;28;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;6307;1:DECEASED;64f67506-f2df-4f0a-b7be-29b4949e986a;5dfab1d0-fed6-47b2-a47d-402e088361ad;TCGA-A2-A04V.7D84A145-19AF-48D0-A5D9-F5724068CB26.pdf;Negative;NA;Right Lower Outer Quadrant|Right;NA;NO;NA;NA;MODERATE;NA;Positive;10-19%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Simple Mastectomy;A2;933333333;WITH TUMOR;Breast
brca_tcga_pub2015;TCGA-A2-A04W;TCGA-A2-A04W-01;50;M0;N1mi;Stage IIB;6th;T2;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-18345;1630;NA;0;1918;101.91;0:DiseaseFree;NA;NA;NA;Negative;<10%;NOT HISPANIC OR LATINO;NA;1/5/11;1065;NA;NA;3.2;NA;NA;Positive;NA;NA;NA;NA;Other, specify;NA;No;No;C50.9;1/03/8401;C50.9;Positive;NA;YES;2005;NO;NA;1;NA;19;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NA;Core needle biopsy;NA;NO;102;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;BRCA;10191;0:LIVING;00807dae-9f4a-4fd1-aac2-82eb11bf2afb;699d9e14-0968-4773-b077-17db941f5c38;TCGA-A2-A04W.84CA9DDD-36CA-466E-A74C-C7FB03E7C9E4.pdf;Negative;NA;Right Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Negative;<10%;WHITE;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;A2;34;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A2-A04X;TCGA-A2-A04X-01;34;M0;N0 (i-);Stage IIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-12642;1390;NA;0;1349;55.39;0:DiseaseFree;NA;STRONG;NA;Positive;80-89%;NA;NA;8/9/10;2434;NA;NA;3.2;NA;NA;Positive;NA;3;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;NA;YES;2006;NO;NA;0;0;3;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NA;Core needle biopsy;NA;YES;23;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;5539;0:LIVING;733a2a0f-b37a-4b81-b49e-3c0f30d1eb37;abff5667-7ef4-46c1-ad34-ceabc27e7992;TCGA-A2-A04X.F114D078-5F03-47F8-82AE-B8A21C2F9D31.pdf;Negative;NA;Left;NA;NO;NA;NA;MODERATE;NA;Positive;50-59%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Simple Mastectomy;A2;766666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A2-A04Y;TCGA-A2-A04Y-01;53;M0;N1mi;Stage IIB;6th;T2;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-19533;756;NA;0;764;36.1;0:DiseaseFree;NA;Strong;NA;Positive;90-99%;NA;NA;8/9/10;1470;NA;NA;1.13;NA;NA;Negative;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2008;NO;NA;1;0;13;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;YES;49;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;BRCA;361;0:LIVING;9ce7ce09-4409-4fa3-9f78-b2b24716f860;7cd3890a-bac7-42d0-a615-4b0f862200b8;TCGA-A2-A04Y.E4F7064C-9D81-49B5-9992-898155B3F11E.pdf;Negative;NA;Right Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;10-19%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Simple Mastectomy;A2;1633333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A2-A0CK;TCGA-A2-A0CK-01;60;M0;N2a;Stage IIIA;5th;T3;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-22094;3080;NA;0;3820;44.81;1:Recurred/Progressed;NA;NA;3 Point Scale;Positive;40-49%;NOT HISPANIC OR LATINO;NA;5/21/12;1005;NA;NA;1.1;NA;NA;Negative;NA;NA;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Negative;2;YES;2001;NO;YES;4;NA;20;Negative;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Excisional Biopsy;NA;NO;14;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;ILC;13663;0:LIVING;5ACA16CA-4516-4E27-8249-6914029A7EBF;D22E0F16-8D28-467D-AB10-2DD72F7EAB42;TCGA-A2-A0CK.B065FC65-CD33-4878-AE2C-7E8C04F5ECAB.pdf;Positive;NA;Right;NA;NO;NA;3+;NA;3 Point Scale;Positive;80-89%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;Modified radical mastectomy;NA;Lumpectomy;A2;466666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A2-A0CL;TCGA-A2-A0CL-01;37;M0;N2a;Stage IIIA;6th;T3;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-13556;1552;NA;0;1827;99.05;0:DiseaseFree;NA;NA;NA;Positive;20-29%;NOT HISPANIC OR LATINO;NA;1/28/11;591;NA;NA;1.1;NA;NA;Negative;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2006;NO;NA;9;0;14;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NA;Core needle biopsy;NA;NO;37;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;9905;0:LIVING;5c8983f2-9788-4dfa-971c-3ec457b6166e;73cb9fe3-e820-42ef-af60-acbf07ed9f1d;TCGA-A2-A0CL.17950062-E052-4FC2-A437-A17669B4DD01.pdf;Positive;NA;Right Lower Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;<10%;BLACK OR AFRICAN AMERICAN;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;A2;1233333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A2-A0CM;TCGA-A2-A0CM-01;40;M0;N0 (i-);Stage IIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-14969;2546;754;0;NA;12.55;1:Recurred/Progressed;NA;NA;NA;Negative;<10%;NOT HISPANIC OR LATINO;NA;9/6/10;3928;NA;NA;NA;NA;NA;NA;<10%;0;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;0;YES;2003;NO;NA;0;0;1;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NA;Excisional Biopsy;NA;YES;50;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;2477;1:DECEASED;eb2dbb4f-66b6-4525-8323-431970f7a64e;ea7fb858-c17b-40d4-9a22-cbd9da614b65;TCGA-A2-A0CM.2972AB07-2C29-43B8-96DA-1386C5E248EB.pdf;Negative;NA;Left;NA;NO;NA;0;NA;NA;Negative;<10%;BLACK OR AFRICAN AMERICAN;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Simple Mastectomy;A2;1666666667;WITH TUMOR;Breast
brca_tcga_pub2015;TCGA-A2-A0CO;TCGA-A2-A0CO-01;85;M0;N0;Stage IIB;7th;T3;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-31404;2709;NA;0;3409;NA;NA;NA;NA;3 Point Scale;Positive;40-49%;NOT HISPANIC OR LATINO;NA;5/21/12;1329;NA;NA;1.1;NA;NA;Negative;NA;NA;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Negative;2;YES;2002;NO;YES;0;0;11;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;NO;23;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;ILC;11472;1:DECEASED;8E54232D-D8BB-4612-8B0E-4FEB076A60F9;9BC1887E-B3ED-4732-B8BC-EF4F4EA59258;TCGA-A2-A0CO.8C440009-E05E-4046-96AB-BAB211CB7D02.pdf;Positive;NA;Right;NA;NO;NA;2+;NA;3 Point Scale;Positive;20-29%;WHITE;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;A2;766666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A2-A0CP;TCGA-A2-A0CP-01;60;M0;N0 (i-);Stage IA;6th;T1c;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-22133;2445;NA;0;2495;92.41;0:DiseaseFree;NA;NA;NA;Positive;90-99%;NOT HISPANIC OR LATINO;NA;9/8/10;870;NA;NA;NA;NA;NA;Negative;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;2003;NO;NA;0;0;2;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;YES;78;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;9241;0:LIVING;fe15c48b-116d-461e-9b40-68514730fd18;80105f2a-438a-4d44-947d-3f5a50d6cab0;TCGA-A2-A0CP.DAB9A2B8-FCE7-4FF4-BAC4-4D2A04D7A43B.pdf;Negative;NA;Right;NA;NO;NA;NA;NA;NA;Positive;90-99%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Lumpectomy;A2;26;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A2-A0CQ;TCGA-A2-A0CQ-01;62;M0;N0 (i-);Stage IA;6th;T1;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-22810;2310;NA;0;2393;88.53;0:DiseaseFree;NA;NA;NA;Positive;90-99%;NOT HISPANIC OR LATINO;NA;8/10/10;1198;NA;NA;1.3;NA;NA;Negative;NA;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;2003;NO;NA;0;0;1;Negative;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;YES;32;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;8853;0:LIVING;ab34a9a2-d72d-4106-94fb-118844b1b60b;28d6a08d-f73d-4981-882c-aac092fdebb9;TCGA-A2-A0CQ.964DFAC8-91EC-4C0E-B499-3ED5F2D70096.pdf;Positive;NA;Right;NA;NO;NA;NA;NA;NA;Positive;90-99%;BLACK OR AFRICAN AMERICAN;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;Lumpectomy;NA;Lumpectomy;A2;1066666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A2-A0CR;TCGA-A2-A0CR-01;54;M0;N0;Stage IIB;7th;T3;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-20075;2191;NA;0;2955;107.85;0:DiseaseFree;NA;NA;3 Point Scale;Positive;60-69%;NOT HISPANIC OR LATINO;NA;6/5/12;0;NA;NA;1.2;NA;NA;Negative;NA;NA;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Negative;1;YES;2004;NO;YES;0;0;16;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;NO;103;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;ILC;10785;0:LIVING;4CF0F639-7940-48B6-8EA1-2A3494097CDB;7D3DEA42-F18F-4CF6-973D-EA2BAE39BA38;TCGA-A2-A0CR.A3167E2D-3588-41D4-99AA-6DCB660D55A4.pdf;Close;NA;Left Upper Inner Quadrant;NA;NO;NA;3+;NA;3 Point Scale;Positive;80-89%;ASIAN;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;A2;3433333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A2-A0CS;TCGA-A2-A0CS-01;73;M1;N3a;Stage IV;NA;T4b;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-26817;2030;NA;0;2298;NA;NA;NA;NA;NA;Positive;80-89%;NOT HISPANIC OR LATINO;NA;1/27/11;1967;NA;NA;1.3;NA;NA;Negative;NA;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;2004;NO;NA;12;0;15;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);Other, specify;Ovary;NA;Other method, specify:;Skin biopsy;NO;33;NA;1.09;NA;Positive;NA;Negative;NA;Negative;NA;NA;Positive;NA;VERDADERO;IDC;7714;1:DECEASED;d071c16b-7cee-45ed-8ec9-612418143815;54fffa7d-7d20-4ce4-8fe0-29372a6f3c82;TCGA-A2-A0CS.A985FB5C-9E91-40E1-864E-CEA887B3866D.pdf;Positive;NA;Left;NA;NO;NA;NA;NA;NA;Positive;80-89%;WHITE;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;A2;11;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A2-A0CT;TCGA-A2-A0CT-01;71;M0;N0 (i-);Stage IIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;NA;-25959;1931;NA;0;1918;75.2;0:DiseaseFree;NA;NA;NA;Positive;90-99%;NOT HISPANIC OR LATINO;NA;9/9/10;7056;NA;NA;1.3;NA;NA;Negative;NA;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;2005;NO;NA;0;0;2;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;YES;61;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;MDLC;752;0:LIVING;378778d2-b331-4867-a93b-c64028c8b4c7;3490858a-b2ef-4700-91ea-5e71c71cff67;TCGA-A2-A0CT.FDF38AA6-DC65-4043-8277-71BAE47902B1.pdf;Negative;NA;Right Upper Outer Quadrant;NA;NO;NA;0;NA;NA;Negative;<10%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Simple Mastectomy;A2;2033333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A2-A0CU;TCGA-A2-A0CU-01;73;M0;N0 (i+);Stage IIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-26823;1911;158;0;NA;NA;NA;NA;NA;NA;Positive;90-99%;NOT HISPANIC OR LATINO;NA;9/9/10;4388;NA;NA;1;NA;NA;Negative;NA;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;2005;NO;NA;0;1;1;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;YES;46;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;519;1:DECEASED;332423a7-8866-4ee3-b08f-3c8d7c16af80;df545b98-f81f-4e0d-a714-90b406f2a238;TCGA-A2-A0CU.D503E73D-8B94-46A0-A24F-93069A56DC7D.pdf;Close;NA;Right Lower Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;<10%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Simple Mastectomy;A2;1533333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A2-A0CV;TCGA-A2-A0CV-01;41;M0;N1a;Stage IIB;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-15289;1574;NA;0;1870;98.92;0:DiseaseFree;NA;NA;NA;Positive;90-99%;NOT HISPANIC OR LATINO;NA;1/28/11;6142;NA;NA;1.1;NA;NA;Negative;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2005;NO;NA;4;0;18;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NO;21;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;9892;0:LIVING;ad7fcc89-82a3-48aa-8461-581c1a857677;bb83d6d7-e5e4-49cb-a533-bdf2fb330bae;TCGA-A2-A0CV.FBDDD9EE-0A5C-4CAB-9EB3-48B6431A9A84.pdf;Negative;NA;Left Lower Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;90-99%;ASIAN;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;A2;7;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A2-A0CW;TCGA-A2-A0CW-01;67;M0;N1a;Stage IIB;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-24541;1533;NA;0;1750;107.85;0:DiseaseFree;NA;NA;NA;Positive;90-99%;NOT HISPANIC OR LATINO;NA;1/28/11;3083;NA;NA;0.5;NA;NA;Negative;NA;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;2006;NO;NA;2;0;19;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;YES;55;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;10785;0:LIVING;32efa6e8-6b19-480a-9d04-ace02e93318a;9cd3fc34-5380-4318-87fa-ccff0dbea879;TCGA-A2-A0CW.7D1C2CD8-9842-48AC-BB16-897E2A45B88D.pdf;Negative;NA;Right;NA;NO;NA;NA;NA;NA;Positive;10-19%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Lumpectomy;A2;1833333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A2-A0D0;TCGA-A2-A0D0-01;60;M0;N0 (i-);Stage IIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-22115;720;NA;0;643;67.28;0:DiseaseFree;NA;NA;NA;Negative;<10%;NOT HISPANIC OR LATINO;NA;9/16/10;7061;NA;NA;1.17;NA;NA;Negative;NA;0;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;0;YES;2008;NO;NA;0;0;8;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NO;64;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;6728;0:LIVING;324bcba2-f6a4-45a6-807c-215bdffcca21;7fd5702e-2d7b-4b79-b2d8-5ca4ca33cf65;TCGA-A2-A0D0.D8B44020-EC34-4788-B7FB-790B9C12D886.pdf;Negative;NA;Left Upper Outer Quadrant;NA;NO;NA;0;NA;NA;Negative;<10%;BLACK OR AFRICAN AMERICAN;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Simple Mastectomy;A2;2133333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A2-A0D2;TCGA-A2-A0D2-01;45;M0;N0 (i+);Stage IIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-16623;614;NA;0;761;33.74;0:DiseaseFree;NA;NA;NA;Negative;<10%;NOT HISPANIC OR LATINO;NA;9/16/10;5025;NA;NA;1.05;NA;NA;Negative;NA;0;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;0;YES;2008;NO;NA;0;4;5;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NA;Core needle biopsy;NA;YES;77;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;3374;0:LIVING;99e32c59-aa73-43fa-88c9-399ddadb2c72;72439e36-3c17-4a90-b3e1-8f6ccfd3dcd4;TCGA-A2-A0D2.B0DE3388-7826-40D3-ADEE-0B25FE201F4A.pdf;Negative;NA;Left Lower Outer Quadrant;NA;NO;NA;0;NA;NA;Negative;<10%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Simple Mastectomy;A2;2566666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A2-A0D3;TCGA-A2-A0D3-01;42;M0;N0 (i-);Stage IA;6th;T1c;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-15524;545;NA;0;736;61.53;0:DiseaseFree;NA;NA;NA;Positive;90-99%;NOT HISPANIC OR LATINO;NA;1/28/11;1108;NA;NA;1.41;NA;NA;Negative;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2008;NO;NA;0;0;1;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;YES;21;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;6153;0:LIVING;4a16429b-884f-4c95-8683-feeedf0d6a55;f71ea58f-a4b4-464c-a276-92747efcc0b9;TCGA-A2-A0D3.5C563F73-3793-4902-ACBB-82F432AED592.pdf;Negative;NA;Left Lower Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;90-99%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Simple Mastectomy;A2;7;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A2-A0D4;TCGA-A2-A0D4-01;37;M0;N1a;Stage IIB;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-13805;384;NA;0;496;25.2;0:DiseaseFree;NA;Intensity=moderate;NA;Positive;90-99%;NOT HISPANIC OR LATINO;NA;9/21/10;3856;NA;NA;1.14;NA;NA;Negative;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2009;NO;NA;1;0;23;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NA;Core needle biopsy;NA;NO;29;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;252;0:LIVING;75113445-d2d6-44a0-866c-c9175e6d214b;ace39ef3-1b5e-4ad2-a20d-62957e524281;TCGA-A2-A0D4.990F5885-8EDD-42A2-AEFE-9DEE3E95A0B1.pdf;Negative;NA;Left;NA;NO;NA;NA;Intensity=weak;NA;Positive;10-19%;BLACK OR AFRICAN AMERICAN;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Lumpectomy;A2;966666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A2-A0EM;TCGA-A2-A0EM-01;73;M0;N0 (i-);Stage IA;5th;T1;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-26845;2696;NA;0;2758;101.64;0:DiseaseFree;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;9/6/10;1025;NA;NA;1.3;NA;NA;Negative;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;2002;NO;NA;0;0;1;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;YES;27;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;BRCA;10164;0:LIVING;2fdfd287-d13c-4910-9788-73987d45908a;0d9139aa-d829-4ac9-8a65-822dcf79971c;TCGA-A2-A0EM.454CB5E9-3778-4666-9CED-913E08CB3615.pdf;Negative;NA;Right Upper Inner Quadrant;NA;NO;NA;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Lumpectomy;A2;9;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A2-A0EN;TCGA-A2-A0EN-01;70;M0;N0 (i+);Stage IIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-25771;2348;NA;0;4088;134.3;0:DiseaseFree;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;2/27/15;2206;NA;NA;1.4;NA;NA;Negative;NA;2;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Equivocal;NA;YES;2003;NO;NA;0;1;4;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Excisional Biopsy;NA;YES;30;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;ILC;1343;0:LIVING;5e670fec-8992-44bf-8657-f7f9a272306b;c59fa5bd-0b6d-41d5-83ef-7766f0241d70;TCGA-A2-A0EN.8169AA00-E396-4A3E-A91C-F67B1F0B8E3E.pdf;Negative;NA;Right;NA;NO;NA;NA;NA;NA;Positive;50-59%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Lumpectomy;A2;1;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A2-A0EO;TCGA-A2-A0EO-01;54;M0;N0 (i-);Stage IA;6th;T1;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-19880;2331;NA;0;2181;80.22;0:DiseaseFree;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;8/10/10;2512;NA;NA;1.6;NA;NA;Negative;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2003;NO;NA;0;0;3;NA;Peri (6-12 months since last menstrual period);NA;NA;NA;Core needle biopsy;NA;YES;30;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;8022;0:LIVING;bf88ddf5-a6d4-498c-bf7f-db9bfabff72d;bd7e34c8-d477-4caf-a44d-aa9a3a4bf7d4;TCGA-A2-A0EO.61BC91AE-CD06-432D-BCBA-6FAE2209C610.pdf;Close;NA;Left;NA;NO;NA;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Lumpectomy;A2;1;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A2-A0EP;TCGA-A2-A0EP-01;56;M0;N0 (i+);Stage I;6th;T1;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-20585;2198;NA;0;3021;118.36;0:DiseaseFree;NA;NA;3 Point Scale;Positive;80-89%;NOT HISPANIC OR LATINO;NA;8/16/12;0;NA;NA;1.3;NA;NA;Negative;NA;NA;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Negative;3;YES;2004;NO;YES;0;1;1;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;YES;6;NO;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;ILC;11836;0:LIVING;670F5022-5066-48F1-8472-5670129A1E0F;153D5E35-20A4-40F8-901A-D7208FA2D3D8;TCGA-A2-A0EP.F76120C1-B2B2-46EE-AAE1-57B05D258ED1.pdf;Negative;YES;Right Lower Inner Quadrant;NA;NO;NA;NA;NA;NA;Negative;NA;WHITE;NO;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Simple Mastectomy;A2;2;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A2-A0EQ;TCGA-A2-A0EQ-01;64;M0;N0 (i-);Stage IIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-23543;2038;NA;0;2053;79.7;0:DiseaseFree;NA;NA;NA;Negative;<10%;NOT HISPANIC OR LATINO;NA;8/11/10;2545;NA;NA;1.1;NA;NA;Negative;NA;3;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;0;YES;2004;NO;NA;0;0;2;Negative;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;YES;102;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;797;0:LIVING;2192c1db-4718-4254-ba42-3ae7f30ad5a8;63792ecf-4f55-4eb5-bfbc-78accb4f104a;TCGA-A2-A0EQ.60569C8B-7209-4A3F-A177-F337085E9146.pdf;Positive;NA;Left;NA;NO;NA;0;NA;NA;Negative;<10%;BLACK OR AFRICAN AMERICAN;NA;YES;1;Primary;Female;Matched;Other (specify);Sentinel lymph node and non-sentinel lymph node biopsy;Lumpectomy;NA;Lumpectomy;A2;34;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A2-A0ER;TCGA-A2-A0ER-01;63;M0;N1mi;Stage IB;6th;T1c;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-23021;1862;NA;0;1903;74.34;0:DiseaseFree;NA;NA;NA;Positive;90-99%;NOT HISPANIC OR LATINO;NA;8/13/10;756;NA;NA;1;NA;NA;Negative;NA;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;2005;NO;NA;1;0;14;Negative;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;YES;23;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;BRCA;7434;0:LIVING;7455d832-ad66-40df-85d7-3a7051c4498d;5c703f38-38a5-4543-a964-88cf1d5ba2f1;TCGA-A2-A0ER.A5D94D02-5423-4055-96E3-B5AA5799DC02.pdf;Positive;NA;Right Lower Inner Quadrant;NA;NO;NA;NA;NA;NA;Positive;80-89%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;Lumpectomy;NA;Lumpectomy;A2;766666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A2-A0ES;TCGA-A2-A0ES-01;52;M0;N0 (i-);Stage IIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;NA;-19160;756;NA;0;1001;71.94;0:DiseaseFree;NA;NA;NA;Positive;60-69%;NOT HISPANIC OR LATINO;NA;1/25/11;56;NA;NA;1.32;NA;NA;Negative;NA;1;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Negative;NA;YES;2008;NO;NA;0;0;1;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;YES;5;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;MDLC;7194;0:LIVING;a2934508-3daf-49e2-b14f-ed9b7693f96f;14e1cd4b-0d60-4202-981d-7e1e02a17006;TCGA-A2-A0ES.6860A718-FAAB-44A1-A3C1-E4A9EC1ECB05.pdf;Negative;NA;Left Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;10-19%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Simple Mastectomy;A2;166666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A2-A0ET;TCGA-A2-A0ET-01;58;M0;N2a;Stage IIIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-21464;674;NA;0;807;35.02;0:DiseaseFree;NA;Intensity=Strong;NA;Positive;90-99%;NOT HISPANIC OR LATINO;NA;9/20/10;5078;NA;NA;1.09;NA;NA;Negative;NA;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;2008;NO;NA;5;0;15;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NO;28;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;3502;0:LIVING;96f23d8a-be0f-4925-ba00-805dc293414c;a7e04cc7-3f4c-4986-a336-8083e5653754;TCGA-A2-A0ET.E9D3FFF1-5FB2-4F17-9C1D-D9775E3CC5AC.pdf;Negative;NA;Right Upper Outer Quadrant;NA;NO;NA;NA;Intensity=Strong;NA;Positive;70-79%;WHITE;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Lumpectomy;A2;933333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A2-A0EU;TCGA-A2-A0EU-01;79;M0;N0 (i-);Stage IA;6th;T1c;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-29144;644;NA;0;733;34.26;0:DiseaseFree;NA;Intensity=Strong;NA;Positive;90-99%;NOT HISPANIC OR LATINO;NA;8/11/10;5175;NA;NA;0.97;NA;NA;Negative;NA;0;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2008;NO;NA;0;0;1;Negative;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;YES;38;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;3426;0:LIVING;c0427237-b476-4af4-b664-7bd479922ea5;69dbb2ae-3f19-4c29-9c24-810ae60312f3;TCGA-A2-A0EU.42649B9A-29D4-4D05-A78C-AC801792ADEB.pdf;Positive;NA;Right Lower Outer Quadrant;NA;NO;NA;NA;Intensity=Strong;NA;Positive;90-99%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;Lumpectomy;NA;Lumpectomy;A2;1266666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A2-A0EV;TCGA-A2-A0EV-01;80;M0;N0 (i-);Stage IA;6th;T1c;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-29285;590;NA;0;545;31.8;0:DiseaseFree;NA;NA;NA;Positive;90-99%;NOT HISPANIC OR LATINO;NA;8/11/10;2086;NA;NA;1.4;NA;NA;Negative;<10%;0;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2008;NO;NA;0;0;6;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;YES;56;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;318;0:LIVING;7032ec9c-e96b-4642-a7b6-d0aee7a3add2;bf0f55ac-2f35-4f8b-a1d9-c4e283fc7365;TCGA-A2-A0EV.2A62DD22-EFE6-48CD-8BE6-59B08168F78A.pdf;Negative;NA;Left;NA;NO;NA;NA;NA;NA;Positive;90-99%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Lumpectomy;A2;1866666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A2-A0EW;TCGA-A2-A0EW-01;53;M0;N3a;Stage IIIC;6th;T1b;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-19413;542;NA;0;770;44.45;1:Recurred/Progressed;NA;NA;NA;Positive;90-99%;NOT HISPANIC OR LATINO;NA;1/5/11;724;NA;NA;1.33;NA;NA;Negative;NA;0;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Negative;NA;YES;2008;NO;NA;26;0;NA;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;YES;13;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;BRCA;6189;1:DECEASED;8d5fe6e8-d2cc-481f-a6a1-9cb6e7982cde;84ff236c-bc58-4797-9a34-da53eb1620dc;TCGA-A2-A0EW.2620E5E7-ED7D-4F04-A8AF-1499E9711E8A.pdf;Positive;NA;Right Lower Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;10-19%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Simple Mastectomy;A2;466666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A2-A0EX;TCGA-A2-A0EX-01;46;M0;N0 (i+);Stage IIB;6th;T3;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-16858;468;NA;0;550;24.7;0:DiseaseFree;NA;NA;NA;Positive;60-69%;NOT HISPANIC OR LATINO;NA;8/13/10;1003;NA;NA;1.22;NA;NA;Negative;NA;1;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Negative;NA;YES;2009;NO;NA;0;1;1;Negative;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;YES;25;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;ILC;247;0:LIVING;9d8702e1-1a36-4bca-85ab-5f11d58d7953;c8e05740-9d67-4e06-a30f-4298b6523a5a;TCGA-A2-A0EX.5B82545F-2636-4A8A-88DD-1B387DE678FF.pdf;Positive;NA;Left Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;90-99%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;Mastectomy NOS;NA;Lumpectomy;A2;833333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A2-A0EY;TCGA-A2-A0EY-01;62;M0;N1a;Stage IIB;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-22872;358;NA;0;485;63.24;0:DiseaseFree;NA;NA;NA;Positive;60-69%;NOT HISPANIC OR LATINO;NA;9/21/10;6388;NA;NA;7;NA;NA;Positive;NA;3;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;NA;YES;2009;NO;NA;1;0;23;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;YES;164;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;6324;0:LIVING;d67cd793-2931-429a-9084-2f3c4c8be7ad;2a3e4dbb-aaff-4b14-bbed-f2d7cf0f8fa3;TCGA-A2-A0EY.61462D57-DF98-4F89-BAEF-E8156A47E2DD.pdf;Negative;NA;Right Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Negative;<10%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Lumpectomy;A2;5466666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A2-A0ST;TCGA-A2-A0ST-01;62;M0;N1a;Stage IIA;6th;T1c;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-22922;2597;NA;0;2619;99.11;0:DiseaseFree;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;11/9/10;109;NA;NA;1.3;NA;NA;Negative;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;2003;NO;NA;3;0;9;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Excisional Biopsy;NA;YES;19;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;9911;0:LIVING;12d31787-e54d-4729-ace8-9141043c92b8;8da89b04-df25-4ed7-9d9a-e6c9478784e7;TCGA-A2-A0ST.1E8B978E-3D1B-46E8-80EE-3A11EE571CEC.pdf;Negative;NA;Right Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Lumpectomy;A2;633333333;NA;Breast
brca_tcga_pub2015;TCGA-A2-A0SU;TCGA-A2-A0SU-01;66;M0;N0 (i+);Stage IIA;NA;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-24219;1317;NA;0;1352;54.6;0:DiseaseFree;NA;NA;NA;Positive;90-99%;NOT HISPANIC OR LATINO;NA;11/17/10;1178;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2006;NO;NA;0;1;7;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;YES;20;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;546;0:LIVING;c632675e-e8af-43cd-8744-5be3754c1c14;46b0a695-f283-4623-a78b-954753e8ee62;TCGA-A2-A0SU.BC75790C-FBC7-4897-B228-762245C48740.pdf;Negative;NA;Left;NA;NO;NA;NA;NA;NA;Positive;<10%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Simple Mastectomy;A2;666666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A2-A0SV;TCGA-A2-A0SV-01;63;M1;N2a;Stage IV;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-23126;1513;825;0;NA;NA;NA;NA;NA;NA;Positive;90-99%;NOT HISPANIC OR LATINO;NA;11/15/10;3799;NA;NA;1;NA;NA;Negative;NA;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;2006;NO;NA;8;NA;9;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);Bone;NA;NA;Core needle biopsy;NA;NO;29;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;271;1:DECEASED;ad01259b-d858-40bc-a6ba-0bb06e996afb;7909743a-2bde-48c3-8254-3fbd57ac2e33;TCGA-A2-A0SV.161E2817-7DB2-46F8-BFEB-256DBBEFE633.pdf;Positive;NA;Right;NA;NO;NA;NA;NA;NA;Positive;10-19%;WHITE;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Simple Mastectomy;A2;966666667;WITH TUMOR;Breast
brca_tcga_pub2015;TCGA-A2-A0SW;TCGA-A2-A0SW-01;82;M1;N2;Stage IV;NA;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-30085;1337;1365;0;NA;21.45;1:Recurred/Progressed;NA;NA;NA;Positive;40-49%;NOT HISPANIC OR LATINO;NA;11/8/10;4298;60;NA;1.2;NA;"Enumerate 60 tumor cells; ratio HER2/Centromer 17 >= 2.1 is amplified";Negative;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;2006;NO;NA;4;NA;15;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);Liver;NA;NA;Core needle biopsy;NA;NO;48;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;4484;1:DECEASED;991e1427-3c01-423d-abfd-4584302ca72c;9113cf96-0feb-4e13-b1d5-0ddd12c2cab7;TCGA-A2-A0SW.8401DFCF-8793-461A-B17E-E6584CE2423B.pdf;Negative;NA;Right;NA;NO;NA;NA;NA;NA;Negative;<10%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Lumpectomy;A2;16;WITH TUMOR;Breast
brca_tcga_pub2015;TCGA-A2-A0SX;TCGA-A2-A0SX-01;48;M0;N0 (i-);Stage IA;6th;T1c;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-17774;1177;NA;0;1288;40.7;1:Recurred/Progressed;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;11/9/10;3822;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2007;NO;NA;0;0;1;Negative;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NA;Core needle biopsy;NA;YES;24;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;5039;0:LIVING;18d35983-ea6a-4b70-a209-9bef37595956;c0819744-0dad-4597-b9ac-9117497418a8;TCGA-A2-A0SX.63F76DB5-8433-4EFE-9054-6C04F065DF2D.pdf;Positive;NA;Left Upper Inner Quadrant;NA;NO;NA;NA;NA;NA;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;Lumpectomy;NA;Lumpectomy;A2;8;WITH TUMOR;Breast
brca_tcga_pub2015;TCGA-A2-A0SY;TCGA-A2-A0SY-01;62;M0;N1;Stage IIIA;NA;T3;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-22928;1083;NA;0;1154;44.25;0:DiseaseFree;NA;NA;NA;Positive;80-89%;NOT HISPANIC OR LATINO;NA;11/12/10;1043;60;NA;4.8;NA;"Enumerate 60 tumor cells; ratio HER2/Centromere 17 >= 2.1 is amplified";Positive;NA;NA;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;NA;NA;YES;2007;NO;NA;1;0;14;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;YES;104;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;ILC;4425;0:LIVING;dc696e3c-f448-468f-a576-f4429be0338a;759a1619-0432-4988-8a6f-5a0ef0956f87;TCGA-A2-A0SY.8E6902A6-A673-46CC-9AEB-3A71EF11099F.pdf;Negative;NA;Left Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;40-49%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Modified Radical Mastectomy;A2;35;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A2-A0T0;TCGA-A2-A0T0-01;59;M0;N1;Stage IIB;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-21575;268;NA;0;337;17.51;0:DiseaseFree;NA;NA;NA;Negative;<10%;NOT HISPANIC OR LATINO;NA;11/12/10;4533;NA;NA;NA;NA;NA;NA;<10%;0;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2009;NO;NA;2;NA;14;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NO;143;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;1751;0:LIVING;95c53f69-0f05-4348-822a-571f3d757001;e240d339-c042-42dc-b97a-d1effcac44b7;TCGA-A2-A0T0.6F5EBE67-0A25-4B20-A1F6-9CE6C4FF4096.pdf;Negative;NA;Left Lower Outer Quadrant;NA;NO;NA;NA;NA;NA;Negative;<10%;WHITE;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Lumpectomy;A2;48;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A2-A0T1;TCGA-A2-A0T1-01;55;M0;N3;Stage IIIC;NA;T3;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-20227;233;NA;0;323;17.12;0:DiseaseFree;NA;NA;NA;Negative;<10%;NOT HISPANIC OR LATINO;NA;11/12/10;1868;NA;NA;NA;NA;NA;NA;NA;3;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;NA;YES;2009;NO;NA;10;NA;10;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NO;15;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;1712;0:LIVING;02bed00f-bef7-4fb7-b243-540354990e45;c90925f3-2126-478f-b0d4-f3b2c50cfbf9;TCGA-A2-A0T1.7546B7FB-1976-4994-AFB7-6270382D44D7.pdf;Negative;NA;Right Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Negative;<10%;AMERICAN INDIAN OR ALASKA NATIVE;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Lumpectomy;A2;5;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A2-A0T2;TCGA-A2-A0T2-01;66;M1;N3;Stage IV;NA;T3;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-24235;261;255;0;NA;NA;NA;NA;NA;NA;Negative;<10%;NOT HISPANIC OR LATINO;NA;11/12/10;9463;NA;NA;NA;NA;NA;NA;NA;0;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2009;NO;NA;10;NA;14;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);Liver;Abdomen;NA;Core needle biopsy;NA;NO;44;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;838;1:DECEASED;128d198e-9b22-427c-90db-3714455f3a17;eeb8b594-1bba-4af3-be80-682e261965b4;TCGA-A2-A0T2.0DCD80E1-173E-4A1B-BDD8-74C7D12C1313.pdf;Close;NA;Right;NA;NO;NA;NA;NA;NA;Negative;<10%;WHITE;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;A2;1466666667;WITH TUMOR;Breast
brca_tcga_pub2015;TCGA-A2-A0T3;TCGA-A2-A0T3-01;37;M0;N1mi;Stage IB;7th;T1c;NA;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;2.3;-13680;303;NA;0;456;49.8;0:DiseaseFree;NA;NA;3 Point Scale;Positive;90-99%;NOT HISPANIC OR LATINO;NA;2/21/11;5528;556;NA;1.4;3.2;NA;Negative;NA;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;3;YES;2009;NO;YES;2;0;13;Negative;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Core needle biopsy;NA;YES;28;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;MDLC;498;0:LIVING;058dcb78-bed1-40c3-a6c2-a0cc40065531;78f8b01e-292f-4131-a3ef-4f9faec7913a;TCGA-A2-A0T3.E339A88E-3B39-465A-9545-FBA4F79727CC.pdf;Positive;NA;Right Upper Outer Quadrant;NA;NO;NA;3+;NA;3 Point Scale;Positive;90-99%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;Other;Margin resection;Lumpectomy;A2;933333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A2-A0T4;TCGA-A2-A0T4-01;62;M0;N0 (i-);Stage IIA;NA;T2;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-22849;303;NA;0;395;20.5;0:DiseaseFree;NA;NA;NA;Positive;90-99%;NOT HISPANIC OR LATINO;NA;11/17/10;2209;NA;NA;1.1;NA;NA;Negative;NA;2;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Equivocal;3;YES;2009;NO;NA;0;0;2;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;YES;28;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;ILC;205;0:LIVING;b0f8d698-a30e-4d8d-b0a2-a5a01fac8406;36ccb542-78a6-4960-8d49-fa02e08fd36f;TCGA-A2-A0T4.5B685F7F-917D-41BA-A7AB-D0E15D457BC5.pdf;Negative;NA;Right Upper Inner Quadrant;NA;NO;NA;2+;NA;NA;Positive;60-69%;WHITE;NA;YES;1;Primary;Female;Matched;Other (specify);SLN and non-SLN biopsy;NA;NA;Simple Mastectomy;A2;966666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A2-A0T5;TCGA-A2-A0T5-01;39;M0;N0 (i-);Stage IIA;NA;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-14503;263;NA;0;321;17.44;0:DiseaseFree;NA;NA;NA;Positive;90-99%;NOT HISPANIC OR LATINO;NA;11/9/10;1153;NA;NA;1.3;NA;NA;Negative;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2009;NO;NA;0;0;4;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NA;Core needle biopsy;NA;YES;1086;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;1744;0:LIVING;36d77496-99f8-4911-ba7c-89fae32662aa;bbf837cc-d336-45bc-9024-a018a667f8ec;TCGA-A2-A0T5.7B1E6EEB-3B61-4CE8-B695-ED11C2EF169F.pdf;Negative;NA;Left;NA;NO;NA;NA;NA;NA;Positive;90-99%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Simple Mastectomy;A2;3616666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A2-A0T6;TCGA-A2-A0T6-01;50;M0;N0 (i-);Stage IIB;NA;T3;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-18334;343;NA;0;344;18.89;0:DiseaseFree;NA;NA;NA;Positive;90-99%;NOT HISPANIC OR LATINO;NA;11/17/10;1161;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Negative;3;YES;2009;NO;NA;0;0;3;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NA;Core needle biopsy;NA;YES;94;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;ILC;1889;0:LIVING;08306ede-e74b-4be9-b768-7fd98647b6ac;f05204c8-8301-4117-b826-b5fa194d28d2;TCGA-A2-A0T6.377F7050-F900-4345-A326-568F00050BC3.pdf;Negative;NA;Left;NA;NO;NA;3+;NA;NA;Positive;90-99%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Simple Mastectomy;A2;3133333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A2-A0T7;TCGA-A2-A0T7-01;51;M0;N0 (i+);Stage IIA;NA;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-18756;280;NA;0;397;20.73;0:DiseaseFree;NA;NA;NA;Positive;90-99%;NOT HISPANIC OR LATINO;NA;11/17/10;3425;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;2;YES;2009;NO;NA;0;1;2;Negative;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NA;Core needle biopsy;NA;YES;24;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;2073;0:LIVING;43d5632e-7272-4aad-9496-7f5a99671223;dd8ebcff-9598-45db-b762-7ef446159e52;TCGA-A2-A0T7.383EC600-FBF3-4F91-8FAC-41E3DDE6589E.pdf;Positive;NA;Right Upper Inner Quadrant;NA;NO;NA;2+;NA;NA;Positive;70-79%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;Other;Skin excision;Modified Radical Mastectomy;A2;8;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A2-A0YC;TCGA-A2-A0YC-01;59;M0;N1mi;Stage IIB;NA;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-21685;673;NA;0;644;26.22;1:Recurred/Progressed;NA;NA;NA;Positive;90-99%;NOT HISPANIC OR LATINO;NA;12/8/10;1110;60;NA;1.18;NA;"Enumerate 60 tumor cells; ratio of HER2/Centromere 17 >= 2.1 is amplified";Negative;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;2008;NO;NA;1;0;3;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;YES;18;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;3252;0:LIVING;a1872011-b928-4189-ac02-e87506c20bca;00d38274-8ed5-46af-9a69-91d968a050ab;TCGA-A2-A0YC.9BAD4BD4-A54B-4115-A00E-6AA88F344FE1.pdf;Close;NA;Right Upper Inner Quadrant;NA;NO;NA;NA;NA;NA;Positive;90-99%;WHITE;NA;YES;1;Primary;Female;Matched;Other (specify);Sentinel lymph node biopsy x 2 and 1 non-sentinel lymph node biopsy;NA;NA;Lumpectomy;A2;6;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A2-A0YD;TCGA-A2-A0YD-01;63;M0;N0 (i+);Stage IIB;NA;T3;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-23021;572;NA;0;550;25.26;0:DiseaseFree;NA;NA;NA;Positive;90-99%;NOT HISPANIC OR LATINO;NA;12/8/10;935;60;NA;1.04;NA;"Enumerate 60 tumor cells; ratio of HER2/Centromere 17 >= 2.1 is amplified";Negative;NA;NA;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;NA;NA;YES;2009;NO;NA;0;1;2;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;YES;65;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;ILC;2526;0:LIVING;2c6adb12-380d-4710-a7e6-93d5a0e53289;08add75d-f706-458a-a6a8-41da7e07af19;TCGA-A2-A0YD.10DA3573-BD53-4579-AD90-E770CEF08498.pdf;Negative;NA;Left Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;80-89%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Simple Mastectomy;A2;2166666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A2-A0YF;TCGA-A2-A0YF-01;67;M0;N0 (i+);Stage I;6th;T1b;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-24660;343;NA;0;289;50.43;0:DiseaseFree;NA;NA;NA;Positive;90-99%;NOT HISPANIC OR LATINO;NA;12/2/10;1229;NA;NA;NA;NA;NA;NA;<10%;0;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;3;YES;2009;NO;NA;0;1;1;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;YES;17;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;5043;0:LIVING;ae8c77fe-e6c8-44d5-8265-4a38c637bbef;2b721ce6-b620-4216-9846-c82543880bb3;TCGA-A2-A0YF.C4C7D190-F0EC-4A70-8136-534EA3419217.pdf;Negative;NA;Right;NA;NO;NA;0;NA;NA;Negative;<10%;BLACK OR AFRICAN AMERICAN;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Simple Mastectomy;A2;566666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A2-A0YG;TCGA-A2-A0YG-01;63;M0;N3a;Stage IIIC;NA;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-23058;329;NA;0;404;21.88;0:DiseaseFree;NA;NA;NA;Positive;90-99%;NOT HISPANIC OR LATINO;NA;1/3/11;3672;NA;NA;NA;NA;NA;NA;NA;3;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;3;YES;2009;NO;NA;14;NA;18;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NO;45;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;2188;0:LIVING;c0892598-1f7b-4f23-9cd8-731f797753d5;5006c942-bc9a-41cb-8674-2341b4e66230;TCGA-A2-A0YG.B3D6A0F7-5E3C-4921-8399-6458E5222CC5.pdf;Negative;NA;Left Upper Outer Quadrant;NA;NO;NA;2+;NA;NA;Positive;<10%;WHITE;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Lumpectomy;A2;15;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A2-A0YH;TCGA-A2-A0YH-01;53;M0;N2a;Stage IIIA;NA;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-19596;321;NA;0;379;21.65;0:DiseaseFree;NA;NA;NA;Positive;80-89%;NOT HISPANIC OR LATINO;NA;12/14/10;3154;NA;NA;NA;NA;NA;NA;<10%;0;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;3;YES;2009;NO;NA;5;NA;28;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NO;66;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;2165;0:LIVING;298d33da-15af-48cb-b30f-eaf54e7baa43;835ef481-0c0c-4621-9111-e23d63ca9d7c;TCGA-A2-A0YH.0C344CD7-6FAB-462B-9A8E-75B720F2D626.pdf;Negative;NA;Left Lower Outer Quadrant;NA;NO;NA;3+;NA;NA;Positive;70-79%;WHITE;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Lumpectomy;A2;22;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A2-A0YI;TCGA-A2-A0YI-01;62;M0;N0 (i+);Stage I;6th;T1c;NA;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;NA;-22961;303;NA;0;358;49.44;0:DiseaseFree;NA;NA;NA;Positive;90-99%;NOT HISPANIC OR LATINO;NA;12/14/10;1891;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8522;C50.9;Negative;3;YES;2009;NO;NA;0;1;3;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;YES;10;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;MDLC;4944;0:LIVING;72cd1b17-d349-4551-83f7-3062ce9db865;f549267b-0932-45f0-b7e6-c4a42cac50c8;TCGA-A2-A0YI.CEFD12BB-1AF7-400D-8A84-49650DFDD8A5.pdf;Negative;NA;Right Upper Outer Quadrant;NA;NO;NA;2+;NA;NA;Positive;60-69%;WHITE;NA;YES;1;Primary;Female;Matched;Other (specify);Sentinel Lymph node biopsy and one non-sentinel lymph node biopsy;NA;NA;Lumpectomy;A2;366666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A2-A0YK;TCGA-A2-A0YK-01;61;M0;N0 (i-);Stage IIA;NA;T2;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-22625;280;NA;0;334;19.32;0:DiseaseFree;NA;NA;NA;Positive;90-99%;NOT HISPANIC OR LATINO;NA;12/28/10;1055;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Negative;3;YES;2009;NO;NA;0;0;3;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;YES;209;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;ILC;1932;0:LIVING;8f34cb4c-5798-47a0-89a1-f0ee26a8ae93;35276e2e-eb29-47be-88ab-3822b82153ea;TCGA-A2-A0YK.C3B5F075-864A-4D8B-B0CB-1B1FA28ACF4F.pdf;Close;NA;Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant;NA;NO;NA;NA;NA;NA;Negative;<10%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Simple Mastectomy;A2;6966666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A2-A0YL;TCGA-A2-A0YL-01;48;M0;N2a;Stage IIIA;NA;T3;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-17702;205;NA;0;268;48.42;0:DiseaseFree;NA;NA;NA;Positive;70-79%;NOT HISPANIC OR LATINO;NA;12/27/10;1036;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Negative;3;YES;2010;NO;NA;4;0;29;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NA;Core needle biopsy;NA;YES;16;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;ILC;4842;0:LIVING;b205c89f-af62-4186-acad-ed23d243fa98;905c8468-92b3-4e58-8445-6692775c7fde;TCGA-A2-A0YL.AB083371-A2AB-4F57-8FBF-0DB2C91CEDDE.pdf;Negative;NA;Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant;NA;NO;NA;3+;NA;NA;Positive;90-99%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Simple Mastectomy;A2;533333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A2-A0YM;TCGA-A2-A0YM-01;67;M0;N0 (i-);Stage IIA;NA;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-24831;691;NA;0;662;31.7;0:DiseaseFree;NA;NA;NA;Negative;<10%;NOT HISPANIC OR LATINO;NA;12/8/10;4340;60;NA;1.08;NA;"Enumerate 60 tumor cells; ratio of HER2/Centromere >=2.1 is amplified";Negative;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;2008;NO;NA;0;0;5;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;YES;65;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;317;0:LIVING;5cbf0aea-ebb4-4005-bdd5-14ef2dc6826c;27ac43e4-c348-4f83-97f5-cc0f4a87b670;TCGA-A2-A0YM.E1D8F2CB-25F1-49E0-92D3-132DCA8FD533.pdf;Negative;NA;Left Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Negative;<10%;WHITE;NA;YES;1;Primary;Female;Matched;Other (specify);Sentinel lymph node biopsy and non-sentinel lymph node biopsy;NA;NA;Lumpectomy;A2;22;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A2-A0YT;TCGA-A2-A0YT-01;56;M0;N2a;Stage IIIB;NA;T4b;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-20482;884;723;0;NA;NA;NA;NA;NA;NA;Positive;90-99%;NOT HISPANIC OR LATINO;NA;12/10/10;5755;60;NA;1.3;NA;"Enumerate 60 tumor cells; Ratio of HER2/Centromere 17 >=2.1 is amplified";Negative;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;Yes;No;C50.9;1/03/8500;C50.9;NA;NA;YES;2008;NO;NA;5;NA;5;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NO;45;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;2375;1:DECEASED;14b95463-2108-4921-afc2-e29eef52b18f;0fcd1ba3-8461-4533-9952-2831daf6a4db;TCGA-A2-A0YT.1C420F6B-8720-4CB0-9FB3-86A0EC05FBBD.pdf;Negative;NA;Left Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Negative;<10%;WHITE;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;A2;15;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A2-A1FV;TCGA-A2-A1FV-01;74;M0;N0 (i+);Stage IIB;7th;T3;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-27287;372;NA;0;461;23.46;0:DiseaseFree;NA;Strong;NA;Positive;90-99%;NOT HISPANIC OR LATINO;NA;5/26/11;3999;NA;NA;0.92;NA;NA;Negative;NA;1;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Negative;NA;YES;2010;NO;YES;0;1;2;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;YES;40;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;ILC;2346;0:LIVING;cd0c96a4-6414-4efb-879b-7408b62ed5b6;1624f434-259b-4782-afe1-7ac3d13d7807;TCGA-A2-A1FV.074223E9-5E1C-47E8-BE40-1C4442CAE9F0.pdf;Negative;NA;Left;NA;YES;NA;NA;Strong;NA;Positive;<10%;WHITE;NA;NO;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Simple Mastectomy;A2;1333333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A2-A1FW;TCGA-A2-A1FW-01;62;M0;N2a;Stage IIIA;7th;T3;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-22779;198;NA;0;221;17.35;0:DiseaseFree;NA;NA;NA;Positive;90-99%;NOT HISPANIC OR LATINO;NA;5/11/11;6055;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2010;NO;YES;5;NA;19;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;NO;60;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;BRCA;1735;0:LIVING;54883111-d475-4515-ba3f-fece8a71e79e;0dfe13f0-e1f5-4f7e-95b5-e88f9d9e920a;TCGA-A2-A1FW.849E9FA7-3420-427B-A310-3346CFA9F0CC.pdf;Negative;NA;Right Upper Outer Quadrant;NA;YES;NA;NA;NA;NA;Negative;NA;WHITE;NA;NO;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Modified Radical Mastectomy;A2;2;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A2-A1FX;TCGA-A2-A1FX-01;61;M0;N2a;Stage IIIA;6th;T3;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;160;-22344;937;NA;0;935;60.68;0:DiseaseFree;NA;NA;NA;Positive;70-79%;NOT HISPANIC OR LATINO;NA;5/12/11;4239;60;NA;1.1;185;NA;Negative;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;2008;NO;YES;6;NA;24;Negative;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;NO;21;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;BRCA;6068;0:LIVING;ac6d3ba9-f84f-4657-aa85-4d66fb7c09da;71e87611-903b-4b9d-a506-87e58914dc81;TCGA-A2-A1FX.EAFC71A1-D6FC-46EA-BC47-D054C497D705.pdf;Positive;NA;Right Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;60-69%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;Mastectomy NOS;NA;Lumpectomy;A2;7;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A2-A1FZ;TCGA-A2-A1FZ-01;63;M0;N0 (i-);Stage IIA;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-23055;335;NA;0;410;22.44;0:DiseaseFree;NA;NA;3 Point Scale;Positive;90-99%;NOT HISPANIC OR LATINO;NA;4/21/11;1009;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;3;YES;2010;NO;YES;0;0;3;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;YES;29;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;2244;0:LIVING;805bfe39-3695-43c2-93e4-d66d0559b89f;d5d86fc3-a720-43b7-8125-160f3af04de0;TCGA-A2-A1FZ.F93E326D-F4E0-4000-8A67-AA19C4D3637A.pdf;Negative;NA;Right;NA;YES;NA;3+;NA;3 Point Scale;Positive;90-99%;WHITE;NA;NO;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Simple Mastectomy;A2;966666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A2-A1G0;TCGA-A2-A1G0-01;49;M0;N1a;Stage IIB;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-18002;315;NA;0;380;20.24;0:DiseaseFree;NA;NA;3 Point Scale;Positive;90-99%;NOT HISPANIC OR LATINO;NA;4/21/11;1485;NA;NA;1.2;NA;NA;Negative;NA;2;NA;NA;Other, specify;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;3;YES;2010;NO;YES;2;NA;19;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Core needle biopsy;NA;NO;27;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;2024;0:LIVING;2e538802-2a31-4774-89a8-c6e4381a887d;3596c171-86d4-48ae-80a5-847c874d4860;TCGA-A2-A1G0.DA82E751-09C3-466E-A63A-38368D8A2C7C.pdf;Negative;NA;Left Upper Inner Quadrant;NA;YES;NA;3+;NA;3 Point Scale;Positive;90-99%;WHITE;NA;NO;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Simple Mastectomy;A2;9;NA;Breast
brca_tcga_pub2015;TCGA-A2-A1G1;TCGA-A2-A1G1-01;85;M0;N1;Stage IIB;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;51;-31223;338;NA;0;371;19.19;0:DiseaseFree;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;5/12/11;1756;30;NA;16.3;816;NA;Positive;NA;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;2010;NO;YES;1;NA;13;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;NO;27;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;1919;0:LIVING;75b5529b-565a-4eba-918a-910b2f441d32;159debac-79e0-4727-940c-020e120f8347;TCGA-A2-A1G1.E2E6CA22-AFE4-4B8F-90AC-32639687A590.pdf;Negative;NA;Right Upper Outer Quadrant;NA;YES;NA;NA;NA;NA;Negative;NA;WHITE;NA;NO;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Lumpectomy;A2;933333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A2-A1G4;TCGA-A2-A1G4-01;71;M0;N1a;Stage IIIA;7th;T3;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-25966;310;NA;0;372;19.55;0:DiseaseFree;NA;NA;3 Point Scale;Positive;90-99%;NOT HISPANIC OR LATINO;NA;4/22/11;1531;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;Yes;C50.9;1/03/8500;C50.9;Negative;3;YES;2010;NO;YES;2;NA;15;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;NO;41;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;1955;0:LIVING;e3b555aa-7f0a-49c6-9b13-182c61a144c1;81243c1f-affa-4985-ba0e-1f19db52db73;TCGA-A2-A1G4.5AD3B697-F097-496C-978B-F73BDA5394A7.pdf;Negative;NA;Right Lower Outer Quadrant;NA;YES;NA;3+;NA;3 Point Scale;Positive;90-99%;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;A2;1366666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A2-A1G6;TCGA-A2-A1G6-01;50;M0;N2a;Stage IIIA;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-18514;229;NA;0;132;16.46;0:DiseaseFree;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;4/22/11;1;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2010;NO;YES;4;NA;9;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Core needle biopsy;NA;NO;4;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;1646;0:LIVING;295cf595-4a29-46a3-a0c5-e5f08f947031;e957973b-0b41-484f-9f16-a112bed3107e;TCGA-A2-A1G6.02B4C31E-38F0-4AF3-8DAD-527D5F27C11A.pdf;Negative;NA;Right;NA;YES;NA;NA;NA;NA;Negative;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;A2;133333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A2-A259;TCGA-A2-A259-01;70;M0;N0 (i-);Stage I;6th;T1c;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;125;-25666;1238;NA;0;1286;52.43;0:DiseaseFree;NA;Strong using Weak, Moderate and Strong;3 Point Scale;Positive;90-99%;NOT HISPANIC OR LATINO;NA;6/20/11;1071;60;NA;1.1;132;NA;Negative;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2007;NO;YES;0;0;2;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;YES;17;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;5243;0:LIVING;3fc3755d-a3f8-4e2c-813f-ff124f2a75c1;eb2de640-6c2a-4c8a-87c3-80f9fbdc3d9b;TCGA-A2-A259.33569E07-D7BF-491B-A352-CEEA81556800.pdf;Close;NA;Left;NA;NO;NA;NA;Strong using Weak, Moderate and Strong;3 Point Scale;Positive;80-89%;BLACK OR AFRICAN AMERICAN;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Lumpectomy;A2;566666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A2-A25A;TCGA-A2-A25A-01;44;M0;N0 (i-);Stage IIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-16084;2927;NA;0;2968;107.62;0:DiseaseFree;NA;NA;NA;Positive;<10%;NOT HISPANIC OR LATINO;NA;6/21/11;1189;NA;NA;1.1;NA;NA;Negative;NA;2;NA;NA;Infiltrating Lobular Carcinoma;NA;No;Yes;C50.9;1/03/8520;C50.9;Equivocal;NA;YES;2003;NO;YES;0;0;14;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Core needle biopsy;NA;YES;102;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;ILC;10762;0:LIVING;aaea5f9c-b35b-47f8-93cb-bdc7b81844ff;57e65074-4dc7-4f55-9638-8d123702305c;TCGA-A2-A25A.3971CA42-F1B0-4D85-9AD3-210B98E76A9C.pdf;Negative;NA;Left Upper Inner Quadrant;NA;NO;NA;NA;NA;NA;Positive;<10%;WHITE;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Simple Mastectomy;A2;34;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A2-A25B;TCGA-A2-A25B-01;39;M0;N1;Stage IIB;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-14454;183;NA;0;258;42.38;1:Recurred/Progressed;NA;NA;NA;Positive;90-99%;NOT HISPANIC OR LATINO;NA;7/15/11;4302;NA;NA;0.93;NA;NA;Negative;NA;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;2010;NO;YES;2;NA;8;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Core needle biopsy;NA;NO;71;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;4241;0:LIVING;eadf8482-e60e-4307-adb7-d5c3b9fa6cae;2c619641-7849-4837-ab92-0da80342b3e9;TCGA-A2-A25B.FCE29F34-5D13-4A21-A950-A8577C957C10.pdf;Close;NA;Left Upper Outer Quadrant;NA;YES;NA;NA;NA;NA;Positive;10-19%;BLACK OR AFRICAN AMERICAN;NA;NO;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Simple Mastectomy;A2;2366666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A2-A25C;TCGA-A2-A25C-01;50;M0;N1a;Stage IIB;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-18508;215;NA;0;285;17.18;0:DiseaseFree;NA;NA;3 Point Scale;Positive;90-99%;NOT HISPANIC OR LATINO;NA;7/15/11;3264;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;3;YES;2010;NO;YES;3;NA;14;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Core needle biopsy;NA;NO;23;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;1718;0:LIVING;7aedb46a-48ec-4e0e-8baa-c9ea4c4a7cf1;9d657232-b6b4-4100-833c-5f94059a9ba7;TCGA-A2-A25C.1D4CA1BA-B534-4CEA-ABA5-EF9B31694204.pdf;Negative;NA;Left Lower Outer Quadrant;NA;YES;NA;2+;NA;3 Point Scale;Positive;20-29%;WHITE;NA;NO;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Simple Mastectomy;A2;766666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A2-A25D;TCGA-A2-A25D-01;90;M0;N3a;Stage IIIC;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;118;-32872;224;NA;0;243;18.13;0:DiseaseFree;NA;Moderate using the scale of Weak, Moderate, Strong;NA;Positive;70-79%;NOT HISPANIC OR LATINO;NA;6/21/11;2363;60;NA;1.22;145;NA;Negative;NA;1;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Negative;NA;YES;2010;NO;YES;22;NA;24;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;NO;43;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;ILC;1813;0:LIVING;3b963d72-ba5c-467b-83c9-fbdb462510a3;eda0ff5c-84cf-44cb-888f-0aab17441dfa;TCGA-A2-A25D.BE63B06A-E3E0-4E00-9B9F-5E7DE8852E07.pdf;Positive;NA;Right Upper Outer Quadrant;NA;YES;NA;NA;NA;NA;Negative;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Lumpectomy;A2;1433333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A2-A25E;TCGA-A2-A25E-01;34;M0;N2a;Stage IIIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;NA;-12601;2441;NA;0;2511;98.19;1:Recurred/Progressed;NA;Moderate using scale of Weak, Moderate, Strong;NA;Positive;80-89%;NOT HISPANIC OR LATINO;NA;7/21/11;3373;NA;NA;2.1;NA;NA;Equivocal;NA;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;2004;NO;YES;6;NA;10;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Excisional Biopsy;NA;NO;56;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;MDLC;10526;0:LIVING;ba89cb4f-cd63-47b1-9550-76fdaff89f2e;8da9c00e-1ec3-4657-9511-a2a00b8961cb;TCGA-A2-A25E.B81555D4-78D9-4235-AABE-F852CA6F15B5.pdf;Negative;NA;Left Upper Outer Quadrant;NA;NO;NA;NA;Strong, using scale of Weak, Moderate and Strong;NA;Positive;60-69%;BLACK OR AFRICAN AMERICAN;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;A2;1866666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A2-A25F;TCGA-A2-A25F-01;66;M0;N0 (i-);Stage IIA;7th;T2;NA;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;NA;-24319;86;NA;0;114;10.58;0:DiseaseFree;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;7/26/11;21;NA;NA;NA;NA;NA;NA;<10%;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2011;NO;YES;0;0;2;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;YES;15;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;MDLC;1058;0:LIVING;c836951b-3ffb-4e20-8504-0eccb7d50dd4;d8b4969f-428d-4bf3-bbd8-883c72e8a934;TCGA-A2-A25F.AC60F5BB-9371-4F69-BAA0-099AD7FC2A0B.pdf;Negative;NA;Right Upper Outer Quadrant;NA;YES;NA;NA;NA;NA;Positive;<10%;WHITE;NA;NO;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Lumpectomy;A2;5;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A2-A3KC;TCGA-A2-A3KC-01;55;M0;N1a;Stage IIB;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;1.9;-20401;299;NA;0;363;36.2;0:DiseaseFree;NA;NA;3 Point Scale;Positive;90-99%;NOT HISPANIC OR LATINO;NA;3/14/12;1404;20;NA;1;1.8;NA;Negative;NA;2;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Equivocal;3;YES;2011;NO;YES;2;0;19;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Core needle biopsy;NA;NO;22;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;ILC;362;0:LIVING;2D29A4AC-98E7-4663-9DD6-5681BC32AC2E;8318A9A4-E78E-4DB8-97C7-2CC733D0C512;TCGA-A2-A3KC.593AF241-8F84-4BA0-8878-7C1CE72A460B.pdf;Negative;NA;Right Lower Outer Quadrant;NA;YES;NA;3+;NA;3 Point Scale;Positive;90-99%;BLACK OR AFRICAN AMERICAN;NA;NO;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Simple Mastectomy;A2;766666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A2-A3KD;TCGA-A2-A3KD-01;47;M0;N1mi;Stage IIIA;7th;T3;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-17372;700;NA;0;804;39.62;0:DiseaseFree;NA;Strong;3 Point Scale;Positive;90-99%;NOT HISPANIC OR LATINO;NA;4/2/12;2021;NA;NA;1.2;NA;NA;Negative;NA;1;NA;NA;Mucinous Carcinoma;NA;No;No;C50.9;1/03/8480;C50.9;Negative;NA;YES;2010;NO;YES;1;1;19;Close;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Core needle biopsy;NA;YES;9;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;BRCA;3962;0:LIVING;BB026999-0AAB-4232-96D7-2C93B6C9691D;401D075C-D443-4592-8C03-E675CAAD2B50;TCGA-A2-A3KD.3E4717BA-E9AE-45F9-9696-F8928D9FCECC.pdf;Positive;NA;Right Upper Outer Quadrant;NA;YES;NA;NA;Strong;3 Point Scale;Positive;70-79%;WHITE;NA;NO;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;Mastectomy NOS;NA;Lumpectomy;A2;266666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A2-A3XS;TCGA-A2-A3XS-01;62;M0;N2a;Stage IIIA;6th;T1;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-23000;3355;1032;0;NA;22.4;1:Recurred/Progressed;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;8/15/12;5445;NA;NA;1.3;NA;NA;Negative;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;2003;NO;YES;9;0;19;Negative;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;YES;Core needle biopsy;NA;YES;21;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;BRCA;339;1:DECEASED;A78B04B4-2380-4803-963E-E4E633CD69AB;66E4ECF2-AF70-46C8-BE47-783E8E3EDECD;TCGA-A2-A3XS.DD5295D4-3896-4AA5-AF75-30AEA45D1652.pdf;Positive;NA;Left Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Negative;NA;BLACK OR AFRICAN AMERICAN;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;Mastectomy NOS;NA;Lumpectomy;A2;7;WITH TUMOR;Breast
brca_tcga_pub2015;TCGA-A2-A3XT;TCGA-A2-A3XT-01;45;M0;N1a;Stage IIB;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-16649;2164;NA;0;2238;91;0:DiseaseFree;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;8/17/12;4752;NA;NA;1.13;NA;NA;Negative;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2006;NO;YES;1;NA;13;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NA;Excisional Biopsy;NA;NO;71;NO;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;91;0:LIVING;C72CB184-462D-4009-9CDB-848782FF8A76;B599719F-F028-45EB-8464-ECF9AD60179F;TCGA-A2-A3XT.A614B6B7-256F-4148-8941-6145B2D9B8B5.pdf;Negative;YES;Left;NA;NO;NA;NA;NA;NA;Negative;NA;BLACK OR AFRICAN AMERICAN;YES;YES;1;Primary;Female;Matched;Other (specify);FNA plus axillary lymph node dissection;NA;NA;Modified Radical Mastectomy;A2;2333333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A2-A3XU;TCGA-A2-A3XU-01;35;M0;N1mi;Stage IIB;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;1.5;-13046;2089;912;0;NA;21.91;1:Recurred/Progressed;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;8/29/12;3244;60;NA;1.1;1.66;NA;Negative;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;2006;NO;YES;3;0;12;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Excisional Biopsy;NA;NO;19;YES;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;2996;1:DECEASED;A8E7D8A4-BBF0-496B-B387-8E014CFDCEA6;6FAE8A0E-A96A-4895-B40D-C1EB491F0F3E;TCGA-A2-A3XU.5018EC57-96C6-4D63-B708-45559B4D8527.pdf;Negative;YES;Left;NA;NO;NA;NA;NA;NA;Negative;NA;BLACK OR AFRICAN AMERICAN;YES;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Lumpectomy;A2;633333333;WITH TUMOR;Breast
brca_tcga_pub2015;TCGA-A2-A3XV;TCGA-A2-A3XV-01;46;M0;N0;Stage IIA;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;1.7;-16971;344;NA;0;428;32.72;0:DiseaseFree;NA;NA;3 Point Scale;Positive;<10%;NOT HISPANIC OR LATINO;NA;8/24/12;1244;60;NA;2.6;4.5;NA;Positive;NA;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;1;YES;2011;NO;YES;0;0;4;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NA;Core needle biopsy;NA;YES;41;NO;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;3272;0:LIVING;189E1F27-7738-413A-A4D4-97D41D592A13;91D2288C-0D88-4A49-A0E4-0A7D2A95CCC6;TCGA-A2-A3XV.405B9D03-6200-4DFA-A7D1-C622D3A48AEA.pdf;Negative;YES;Right;NA;YES;NA;NA;NA;NA;Negative;NA;BLACK OR AFRICAN AMERICAN;YES;NO;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Lumpectomy;A2;1366666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A2-A3XW;TCGA-A2-A3XW-01;42;M0;N1a;Stage IIB;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-15670;1148;NA;0;1209;56.24;0:DiseaseFree;NA;NA;3 Point Scale;Positive;90-99%;NOT HISPANIC OR LATINO;NA;8/15/12;11;NA;NA;1.31;NA;NA;Negative;<10%;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;2;YES;2009;NO;YES;3;0;18;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Core needle biopsy;NA;YES;3;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;5624;0:LIVING;C02699B5-580A-4D55-971E-F4692B2CCE57;9D306F32-10BF-4EF7-AC97-91DC07D8EB4A;TCGA-A2-A3XW.A4621FE7-E898-40BA-B45E-3DC9EF607F37.pdf;Negative;NA;Right;NA;YES;NA;NA;NA;NA;Negative;NA;BLACK OR AFRICAN AMERICAN;NA;NO;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Simple Mastectomy;A2;1;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A2-A3XX;TCGA-A2-A3XX-01;49;M0;N0;Stage IIA;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-17981;1143;NA;0;1168;NA;NA;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;8/15/12;5550;NA;NA;1.25;NA;NA;Negative;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2009;NO;YES;0;0;1;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;YES;34;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;4727;1:DECEASED;53886143-C1C6-40E9-88E6-E4E5E0271FC8;0A1F4A81-38C6-407A-A33B-716A0F9A6B4D;TCGA-A2-A3XX.770EEADF-19CD-4AB9-A7FA-1A05EE17984C.pdf;Negative;NA;Left Lower Outer Quadrant;NA;YES;NA;NA;NA;NA;Negative;NA;BLACK OR AFRICAN AMERICAN;NA;NO;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Simple Mastectomy;A2;1133333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A2-A3XY;TCGA-A2-A3XY-01;49;M0;N1a;Stage IIB;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-18059;703;NA;0;786;35.22;1:Recurred/Progressed;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;8/14/12;1367;NA;NA;1.13;NA;NA;Negative;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2010;NO;YES;3;NA;16;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;NO;42;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;3591;1:DECEASED;DEBA32E4-0E68-4711-941B-3B63BD965AFB;DA7FE5E0-6AE0-47F0-9B32-FB6B80C4BE38;TCGA-A2-A3XY.EC1BB6E8-6897-4E70-80A6-5A4E4B9C4E1F.pdf;Negative;NA;Left Upper Outer Quadrant;NA;YES;NA;NA;NA;NA;Negative;NA;BLACK OR AFRICAN AMERICAN;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;A2;1366666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A2-A3XZ;TCGA-A2-A3XZ-01;46;M0;N0;Stage I;6th;T1c;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-16978;909;NA;0;973;50.33;0:DiseaseFree;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;8/21/12;1157;NA;NA;NA;NA;NA;NA;NA;3;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;NA;YES;2009;NO;YES;0;0;3;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NA;Core needle biopsy;NA;YES;36;NO;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;5033;0:LIVING;FE7F74B8-20F4-4471-91DC-4CCA8C68E5C0;6B746708-F6EF-45CD-B877-AFA1949D1D78;TCGA-A2-A3XZ.A7B6FCF6-1B81-40B5-AD92-54681CBC8FE0.pdf;Negative;YES;Left Upper Inner Quadrant|Left Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Negative;NA;BLACK OR AFRICAN AMERICAN;NO;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Simple Mastectomy;A2;1233333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A2-A3Y0;TCGA-A2-A3Y0-01;57;M0;N1a;Stage IIB;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-21024;845;NA;0;859;50.79;0:DiseaseFree;NA;NA;3 Point Scale;Positive;90-99%;NOT HISPANIC OR LATINO;NA;8/24/12;4308;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;3;YES;2010;NO;YES;1;0;39;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NO;145;NO;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;5079;0:LIVING;174850B4-5EC2-462B-A890-89BD1716B3C2;CAA2D510-9024-4D7D-B0EF-80FA4BE1E2EE;TCGA-A2-A3Y0.0FEAEEBA-A72C-4207-AC21-6AF5B5ED1AFC.pdf;Close;YES;Left Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Negative;NA;BLACK OR AFRICAN AMERICAN;NO;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;A2;4866666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A2-A4RW;TCGA-A2-A4RW-01;49;M0;N3a;Stage IIIC;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-18060;567;NA;0;222;7.29;0:DiseaseFree;NA;NA;3 Point Scale;Positive;80-89%;NOT HISPANIC OR LATINO;NA;2/27/13;3425;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Negative;3;YES;2011;NO;YES;27;0;27;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NA;Core needle biopsy;NA;NO;96;NO;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;ILC;729;0:LIVING;0D146997-CFDC-4587-888C-E876FC455C80;0201CF15-D073-447F-B96E-ECA0800B8CFF;TCGA-A2-A4RW.C1D4D6BB-AF86-4208-A729-C61365941217.pdf;Negative;NA;Right|Right Upper Outer Quadrant;NA;YES;NA;3+;NA;3 Point Scale;Positive;90-99%;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;A2;3233333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A2-A4RX;TCGA-A2-A4RX-01;67;M0;N0;Stage IIA;7th;T2;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-24779;210;NA;0;274;24.38;0:DiseaseFree;NA;NA;3 Point Scale;Positive;<10%;NOT HISPANIC OR LATINO;NA;2/28/13;3733;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Metaplastic Carcinoma;NA;No;No;C50.9;1/03/8575;C50.9;Negative;1;YES;2012;NO;YES;0;0;3;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;YES;16;NO;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;BRCA;2438;0:LIVING;D111C4AB-B39A-4A7C-8D8E-CB342BC10627;5C016B5F-9E0B-4B33-90A0-D8B833DE27D3;TCGA-A2-A4RX.CA88491F-5572-4B0D-8E3D-D536E3CE5069.pdf;Negative;NA;Right Lower Outer Quadrant;NA;YES;NA;2+;NA;3 Point Scale;Positive;<10%;BLACK OR AFRICAN AMERICAN;NA;NO;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Simple Mastectomy;A2;533333333;NA;Breast
brca_tcga_pub2015;TCGA-A2-A4RY;TCGA-A2-A4RY-01;46;M0;N3a;Stage IIIC;7th;T3;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-17157;149;NA;0;268;21.29;0:DiseaseFree;NA;NA;3 Point Scale;Positive;90-99%;NOT HISPANIC OR LATINO;NA;2/26/13;40;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Negative;2;YES;2012;NO;YES;18;0;30;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NA;Core needle biopsy;NA;NO;16;NO;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;ILC;2129;0:LIVING;5A53EC47-E63F-44A2-8078-87659544FB04;6A6B6B80-65C6-413D-94ED-07F13E48D62C;TCGA-A2-A4RY.2D6815B5-7704-4D67-93D1-78EDD924F131.pdf;Negative;YES;Right;NA;YES;NA;3+;NA;3 Point Scale;Positive;90-99%;WHITE;YES;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;A2;533333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A2-A4S0;TCGA-A2-A4S0-01;77;M0;N0;Stage IIA;7th;T2;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-28416;159;NA;0;271;23.19;0:DiseaseFree;NA;NA;3 Point Scale;Positive;90-99%;NOT HISPANIC OR LATINO;NA;2/26/13;1;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Mucinous Carcinoma;NA;No;No;C50.9;1/03/8480;C50.9;Negative;3;YES;2012;NO;YES;0;0;1;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;YES;8;NO;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;BRCA;2319;0:LIVING;A53DD490-E0BA-419A-90C6-B905E241A8E5;74EC0A11-F4F7-4F19-93F9-48674394A885;TCGA-A2-A4S0.0118D9AE-B923-4EEF-BBBC-82D559763FF9.pdf;Negative;NO;Right Upper Outer Quadrant;NA;YES;NA;2+;NA;3 Point Scale;Positive;90-99%;WHITE;NO;NO;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Simple Mastectomy;A2;266666667;NA;Breast
brca_tcga_pub2015;TCGA-A2-A4S2;TCGA-A2-A4S2-01;62;M0;N2;Stage IIIA;7th;T3;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-22936;112;NA;0;205;21.12;0:DiseaseFree;NA;NA;3 Point Scale;Positive;90-99%;NOT HISPANIC OR LATINO;NA;2/28/13;3280;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8524;C50.9;Negative;2;YES;2012;NO;YES;5;0;10;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NO;34;NO;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;ILC;2112;0:LIVING;9DDC014D-9A8B-407B-845F-452A73F08E5E;E958EA52-21BC-43CE-9A24-72ACDA04E48D;TCGA-A2-A4S2.4A5630FF-0ADC-4E69-B22A-02F1F34F61F9.pdf;Negative;YES;Right;NA;YES;NA;2+;NA;3 Point Scale;Positive;90-99%;WHITE;NO;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;A2;1133333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A2-A4S3;TCGA-A2-A4S3-01;59;M0;N1a;Stage IIB;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-21762;147;NA;0;104;21.88;0:DiseaseFree;NA;NA;NA;Positive;90-99%;NOT HISPANIC OR LATINO;NA;2/28/13;4494;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2012;NO;YES;2;0;15;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NO;56;NO;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;2188;0:LIVING;418C11E8-2670-48D5-BBF5-95B46BFF1201;03EB5BA8-0307-49B0-AA05-003007D79107;TCGA-A2-A4S3.351D8E38-6E04-4F54-8CB1-975AEB7DB552.pdf;Negative;NA;Left Upper Outer Quadrant;NA;YES;NA;NA;NA;NA;Positive;90-99%;BLACK OR AFRICAN AMERICAN;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;A2;1833333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A7-A0CD;TCGA-A7-A0CD-01;66;M0;N0;Stage I;6th;T1;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;4;-24242;157;NA;0;171;38.27;0:DiseaseFree;NA;NA;NA;Positive;90-99%;NOT HISPANIC OR LATINO;NA;10/5/10;5843;279;NA;1.2;4.6;PathVysion HER-2 DNA Probe Kit;Negative;NA;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;Yes;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;2009;NO;NA;0;NA;2;NA;Indeterminate (neither Pre or Postmenopausal);NA;NA;NA;Core needle biopsy;NA;NO;26;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;3827;0:LIVING;09765b0a-94f6-47d2-af56-93368084ac3a;69886602-a4f1-4ad4-ba56-a0e031c2e295;TCGA-A7-A0CD.DEB67EB8-155C-4ACF-B3D4-595E4CBE2E5C.pdf;Negative;NA;Left;NA;YES;NA;NA;NA;NA;Positive;70-79%;WHITE;NA;NO;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Lumpectomy;A7;866666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A7-A0CE;TCGA-A7-A0CE-01;57;M0;N0 (i-);Stage IIA;NA;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;2.9;-20863;129;NA;0;254;35.28;0:DiseaseFree;NA;NA;NA;Negative;<10%;NOT HISPANIC OR LATINO;NA;10/4/10;4998;389;Vysis AutoVysion System;1.1;3.2;PathVysion;Negative;NA;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;2009;NO;NA;0;0;1;NA;Indeterminate (neither Pre or Postmenopausal);NA;NA;NA;Core needle biopsy;NA;YES;96;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;3528;0:LIVING;9d95a65b-e41d-4f93-92d4-99dce29ff40d;9dc315ce-3b76-4754-b103-2c2580cde4ab;TCGA-A7-A0CE.8A853D7F-979F-4112-9659-1FDE84EF5102.pdf;Negative;NA;Left;NA;YES;NA;NA;NA;NA;Negative;<10%;WHITE;NA;NO;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Lumpectomy;A7;32;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A7-A0CG;TCGA-A7-A0CG-01;78;M0;N0 (i-);Stage IIA;NA;T2;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-28596;93;NA;0;167;34.26;0:DiseaseFree;NA;NA;NA;Positive;90-99%;NOT HISPANIC OR LATINO;NA;10/7/10;1221;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Mixed Histology (please specify);Mixed infiltrating lobular and grade 1 ductal carcinoma;No;No;C50.9;1/03/8522;C50.9;Negative;NA;YES;2010;NO;NA;0;0;5;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;YES;37;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;ILC;3426;0:LIVING;67eef990-5ff4-45d1-843d-d22d7848f130;f2deda2c-63c8-4b4f-a725-381f00298cd0;TCGA-A7-A0CG.2BE28F5D-2DBB-476F-9AFF-6B2103ECF0CE.pdf;Close;NA;Right Upper Outer Quadrant|Right;NA;YES;NA;NA;NA;NA;Negative;<10%;WHITE;NA;NO;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Lumpectomy;A7;1233333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A7-A0CH;TCGA-A7-A0CH-01;79;M0;N0 (i-);Stage IIA;NA;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-29104;121;NA;0;162;35.45;0:DiseaseFree;NA;NA;NA;NA;NA;NOT HISPANIC OR LATINO;NA;10/4/10;627;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;2009;NO;NA;0;0;2;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;YES;34;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;3545;0:LIVING;9de678e5-67ed-4453-a98b-7ac351d5d0f1;1a9f7284-9770-4936-9fa4-500698184680;TCGA-A7-A0CH.F70DA7E5-2AB3-487F-8B2C-72EEE91E58E0.pdf;Negative;NA;Left Upper Outer Quadrant|Left;NA;YES;NA;NA;NA;NA;NA;NA;WHITE;NA;NO;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Simple Mastectomy;A7;1133333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A7-A0CJ;TCGA-A7-A0CJ-01;57;M0;N0 (i-);Stage IIA;NA;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-21014;36;NA;0;189;30.58;0:DiseaseFree;NA;NA;NA;Positive;90-99%;NOT HISPANIC OR LATINO;NA;10/7/10;5648;NA;NA;NA;NA;NA;NA;<10%;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2010;NO;NA;0;0;1;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;YES;46;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;3058;0:LIVING;d69e59a8-b10b-46f5-b859-b6c178d90506;5c28c3b3-1dfe-46ac-83f6-dd5cdb47d813;TCGA-A7-A0CJ.019F390D-7479-4CDC-8C82-45A27910E782.pdf;Positive;NA;Left;NA;YES;NA;NA;NA;NA;Positive;70-79%;WHITE;NA;NO;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;Other;Re-excision of the inferior margin;Lumpectomy;A7;1533333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A7-A0D9;TCGA-A7-A0D9-01;37;M0;N0 (i-);Stage IIA;NA;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-13836;173;NA;0;160;37.42;0:DiseaseFree;NA;NA;NA;Positive;90-99%;NOT HISPANIC OR LATINO;NA;10/4/10;1867;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2009;NO;NA;0;0;1;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NA;Core needle biopsy;NA;YES;27;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;3742;0:LIVING;17baef7c-d97d-4b98-ab53-503ef856523d;c144ae50-ed29-4e27-bbee-fa81e79ac7db;TCGA-A7-A0D9.7D5763F7-7284-4AF5-BBFC-5D8B5CB7F495.pdf;Negative;NA;Left Upper Outer Quadrant|Left;NA;YES;NA;NA;NA;NA;Negative;<10%;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Simple Mastectomy;A7;9;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A7-A0DA;TCGA-A7-A0DA-01;62;M0;N0 (i-);Stage IIA;NA;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-22708;177;NA;0;373;35.64;0:DiseaseFree;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;1/10/11;7563;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2009;NO;NA;0;NA;1;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NA;127;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;3564;0:LIVING;3afa1e93-1df8-4e4c-aaa4-557463f4bb77;4f441e61-6bea-4a12-841d-def270804bbe;TCGA-A7-A0DA.69AC5937-3FFD-40FB-9922-79DB3CED7510.pdf;Negative;NA;Left Lower Outer Quadrant;NA;YES;NA;NA;NA;NA;Negative;NA;WHITE;NA;NO;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Lumpectomy;A7;4233333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A7-A0DB;TCGA-A7-A0DB-01;56;M0;N0 (i-);Stage IIA;NA;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-20570;167;NA;0;141;33.08;0:DiseaseFree;FPPP;NA;NA;Positive;90-99%;NOT HISPANIC OR LATINO;NA;10/4/10;3296;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2009;NO;NA;0;0;4;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;YES;63;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;3308;0:LIVING;f130f376-5801-40f9-975d-a7e2f7b5670d;e8cb34ed-67cb-48b7-83cd-621a1224e781;TCGA-A7-A0DB.511CB4C5-FCEE-4EC4-98A4-4DD32ECA83C3.pdf;Close;NA;Right;TCGA;YES;NA;NA;NA;NA;Positive;60-69%;WHITE;NA;NO;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Simple Mastectomy;A7;21;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A7-A13D;TCGA-A7-A13D-01;46;M0;N0 (i-);Stage IIA;NA;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;1.8;-17070;240;NA;0;267;31.7;0:DiseaseFree;FPPP;NA;NA;Negative;<10%;NOT HISPANIC OR LATINO;NA;2/23/11;7824;197;NA;1.1;1.9;PathVysion HER-2 DNA Probe Kit;Negative;NA;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;2010;NO;NA;0;NA;4;Negative;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NO;96;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;317;0:LIVING;8785012f-f73e-4d68-87cf-1d804af32782;79fc9ed3-4e96-4c0e-869e-1756cbdabb39;TCGA-A7-A13D.6F3784B2-4A75-447C-9EAE-F146461C737E.pdf;Close;NA;Right Upper Outer Quadrant;TCGA;YES;NA;NA;NA;NA;Positive;<10%;BLACK OR AFRICAN AMERICAN;NA;NO;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;Lumpectomy;NA;Lumpectomy;A7;32;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A7-A13E;TCGA-A7-A13E-01;62;MX;N1;Stage IIB;NA;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;3;-22690;220;NA;0;287;18.27;1:Recurred/Progressed;FPPP;NA;NA;Positive;20-29%;NOT HISPANIC OR LATINO;NA;2/28/11;6513;561;NA;1.1;3.2;PathVysion HER-2 DNA Probe Kit;Negative;NA;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;2010;NO;NA;2;NA;12;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NO;130;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;2017;1:DECEASED;8c7e74e0-71ef-49b8-9217-94b8ef740ef9;8a790c78-8ad4-4e0b-9728-0e24cadc1f98;TCGA-A7-A13E.2180850C-CC8D-4376-B2EE-1ADC3F5B3EC1.pdf;Negative;NA;Left Upper Outer Quadrant;TCGA;YES;NA;NA;NA;NA;Negative;<10%;WHITE;NA;NO;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Lumpectomy;A7;4333333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A7-A13F;TCGA-A7-A13F-01;44;M0;N1a;Stage IIIA;NA;T3;NA;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;2.8;-16363;121;NA;0;196;25.13;0:DiseaseFree;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;3/2/11;2607;403;NA;1.1;3;PathVysion HER-2 DNA Probe Kit;Negative;NA;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;2010;NO;NA;3;NA;11;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NA;Core needle biopsy;NA;NO;32;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;MDLC;2513;0:LIVING;2cf68894-168b-458b-af4f-53cad72989a8;b36c8878-bab6-4f61-9a4e-4dcfca21391e;TCGA-A7-A13F.D64FFDC0-38BB-456E-9621-AF89B79D0C68.pdf;Negative;NA;Right Upper Outer Quadrant;NA;YES;NA;NA;NA;NA;Positive;NA;WHITE;NA;NO;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Modified Radical Mastectomy;A7;1066666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A7-A13G;TCGA-A7-A13G-01;79;MX;N0;Stage IIA;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-28969;69;NA;0;208;19.25;1:Recurred/Progressed;NA;NA;NA;Positive;90-99%;NOT HISPANIC OR LATINO;NA;5/16/11;1150;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;Yes;C50.9;1/03/8500;C50.9;Negative;NA;YES;2010;NO;YES;0;NA;1;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;NO;20;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;2359;0:LIVING;6cd9baf5-bbe0-4c1e-a87f-c53b3af22890;6a1c2fdb-18ce-40ec-af79-191b489f39a7;TCGA-A7-A13G.50782829-35B6-4A61-A3CE-F105A31EDB42.pdf;Negative;NA;Left;NA;YES;NA;NA;NA;NA;Positive;50-59%;WHITE;NA;NO;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Simple Mastectomy;A7;666666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A7-A13H;TCGA-A7-A13H-01;61;MX;N1a;Stage IIB;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;2.7;-22643;62;NA;0;551;26.12;1:Recurred/Progressed;NA;NA;NA;Positive;80-89%;NOT HISPANIC OR LATINO;NA;6/22/12;1215;371;NA;2.2;3.2;Pathvysion HER2 DNA Probe Kit;Negative;NA;2;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Equivocal;NA;YES;2010;NO;YES;2;2;12;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;YES;26;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;ILC;2953;0:LIVING;2E243F0E-9D7D-4CB0-9678-70607F90430A;5AE24B78-4C64-4A08-BD13-3D58182215AD;TCGA-A7-A13H.642B4B50-E227-4484-904E-E629F7F9DBC1.pdf;Negative;NA;Right;NA;YES;NA;NA;NA;NA;Positive;30-39%;WHITE;NA;NO;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Simple Mastectomy;A7;866666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A7-A26E;TCGA-A7-A26E-01;71;MX;N1a;Stage IIIA;7th;T3;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-26274;372;NA;0;421;31.34;0:DiseaseFree;FPPP;NA;3 Point Scale;Positive;90-99%;NOT HISPANIC OR LATINO;NA;7/28/11;1074;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Lobular Carcinoma;NA;No;Yes;C50.9;1/03/8520;C50.9;Negative;NA;YES;2010;NO;YES;0;NA;16;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;NO;40;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;ILC;3134;0:LIVING;011b9b2d-ebe5-42bf-9662-d922faccc7a1;d6023f30-0d07-4839-98d1-0b22b366cc51;TCGA-A7-A26E.EA830A26-3DF5-4731-AD0A-F20A61D58817.pdf;Negative;NA;Left;TCGA;YES;NA;NA;NA;3 Point Scale;Positive;20-29%;WHITE;NA;NO;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Simple Mastectomy;A7;1333333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A7-A26F;TCGA-A7-A26F-01;55;M0;N0;Stage IA;7th;T1;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;1.8;-20210;173;NA;0;257;24.24;0:DiseaseFree;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;8/8/11;3177;330;NA;1.1;1.9;PathVysion HER-2 DNA probe kit.;Negative;NA;2;NA;NA;Other, specify;NA;No;Yes;C50.9;1/03/8575;C50.9;Equivocal;NA;YES;2010;NO;YES;0;NA;1;Negative;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Fine needle aspiration biopsy;NA;NO;67;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;BRCA;2424;0:LIVING;3b7b9c1e-a84c-47ed-983c-9e4b00cbf01a;0edccd9b-72e9-4c69-899e-4bba4dbacb40;TCGA-A7-A26F.46A75AD3-BAD1-4A16-873E-0099BD10FA8C.pdf;Close;NA;Left;NA;YES;NA;NA;NA;NA;Negative;NA;WHITE;NA;NO;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Lumpectomy;A7;2233333333;NA;Breast
brca_tcga_pub2015;TCGA-A7-A26G;TCGA-A7-A26G-01;50;M0;N0 (i+);Stage IIA;7th;T2;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-18362;161;NA;0;210;23.72;0:DiseaseFree;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;Total Mastectomy;8/10/11;2490;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Other, specify;NA;No;No;C50.9;1/03/8575;C50.9;Negative;NA;YES;2010;NO;YES;0;NA;2;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Core needle biopsy;NA;NO;49;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;BRCA;2372;0:LIVING;5ed024e8-d05e-4c65-9441-eda9930ccc82;f0cf4acd-6b09-4538-b58c-e86c623b6c71;TCGA-A7-A26G.6BE810A6-3D30-4F75-89B7-00C866553165.pdf;Negative;NA;Right;NA;YES;NA;NA;NA;NA;Negative;NA;BLACK OR AFRICAN AMERICAN;NA;NO;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Other;A7;1633333333;NA;Breast
brca_tcga_pub2015;TCGA-A7-A26H;TCGA-A7-A26H-01;72;M0;N1a;Stage IIA;7th;T1;NA;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;2.2;-26423;79;NA;0;65;10.22;1:Recurred/Progressed;NA;NA;NA;Positive;90-99%;NOT HISPANIC OR LATINO;Bilateral Mastectomy;8/4/11;2219;20;NA;2.6;5.8;PathVysion Her-2 DNA;Positive;NA;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;Yes;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;2011;NO;YES;0;1;5;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;NO;92;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;MDLC;2378;0:LIVING;dddd8e2f-e540-418a-b02e-698d18a12c14;7de9f347-2a8b-4647-bd46-011d74fc48fc;TCGA-A7-A26H.1159E2EF-6407-4D90-8ED6-7AB04CF4FB32.pdf;Negative;NA;Left;NA;YES;NA;NA;NA;NA;Negative;NA;WHITE;NA;NO;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Other;A7;3066666667;NA;Breast
brca_tcga_pub2015;TCGA-A7-A26I;TCGA-A7-A26I-01;65;M0;N0;Stage IIA;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;2;-23948;40;NA;0;122;21.71;0:DiseaseFree;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;7/29/11;6589;229;NA;1.1;2.2;Path Vysion HER-2 DNA probe kit;Negative;NA;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;Yes;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;2011;NO;YES;0;NA;2;Negative;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Fine needle aspiration biopsy;NA;NO;35;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;2171;0:LIVING;b2ecbc0f-2c30-4200-8d5e-7b95424bcadb;e2b02d95-df95-48ad-b26f-3eb15201969d;TCGA-A7-A26I.CCE33A95-774E-4242-B2A1-05FF002ED1D9.pdf;Close;NA;Left;NA;YES;NA;NA;NA;NA;Negative;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;Other;Re-Excision of Superior Margin;Lumpectomy;A7;1166666667;NA;Breast
brca_tcga_pub2015;TCGA-A7-A26J;TCGA-A7-A26J-01;49;M0;N0;Stage IIA;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-17930;54;NA;0;68;20.6;0:DiseaseFree;FPPP;NA;3 Point Scale;Positive;90-99%;NOT HISPANIC OR LATINO;NA;7/28/11;3921;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2011;NO;YES;0;NA;4;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Core needle biopsy;NA;NO;131;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;206;0:LIVING;6cb6f179-defd-4661-af0a-c353b74c0c49;31a140ce-bcb7-46b4-8105-626c9db1e183;TCGA-A7-A26J.5CC0C09F-70F6-458A-B8E6-18BDC074BE74.pdf;Negative;NA;Left;TCGA;YES;NA;NA;NA;3 Point Scale;Positive;70-79%;WHITE;NA;NO;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Simple Mastectomy;A7;4366666667;WITH TUMOR;Breast
brca_tcga_pub2015;TCGA-A7-A2KD;TCGA-A7-A2KD-01;53;MX;N2a;Stage IIIA;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-19563;141;NA;0;182;22.31;0:DiseaseFree;NA;NA;3 Point Scale;Positive;90-99%;NOT HISPANIC OR LATINO;NA;10/11/11;3760;NA;NA;NA;NA;NA;NA;NA;3;NA;NA;Infiltrating Ductal Carcinoma;NA;No;Yes;C50.9;1/03/8500;C50.9;Positive;3;YES;2011;NO;YES;8;0;10;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NO;27;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;2231;0:LIVING;92654F8D-5137-4FFD-AAA3-5AE38EB88226;C685196B-C3CF-49FA-AAE4-F6CCBE04779F;TCGA-A7-A2KD.3C301346-4594-4071-A754-04F8B3BE894C.pdf;Negative;NA;Right;NA;YES;NA;3+;NA;3 Point Scale;Positive;90-99%;BLACK OR AFRICAN AMERICAN;NA;NO;1;Primary;Female;Matched;No axillary staging;NA;NA;NA;Modified Radical Mastectomy;A7;9;NA;Breast
brca_tcga_pub2015;TCGA-A7-A3IY;TCGA-A7-A3IY-01;71;M0;N0;Stage I;7th;T1c;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-26042;143;NA;0;151;11.33;0:DiseaseFree;NA;NA;NA;Positive;90-99%;NOT HISPANIC OR LATINO;NA;3/19/12;79;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Mucinous Carcinoma;NA;No;No;C50.9;1/03/8480;C50.9;Negative;NA;YES;2011;NO;YES;0;NA;1;Negative;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;NO;14;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;BRCA;1133;0:LIVING;6B4E0262-F589-4532-B578-9F2D76C19D90;FC56BE13-C3DD-4DD9-8C34-DC6C7F9D1E16;TCGA-A7-A3IY.63F5F3D8-6393-4DA7-BB74-7D587199D7FD.pdf;Close;NA;Right Upper Outer Quadrant;NA;YES;NA;NA;NA;NA;Positive;90-99%;WHITE;NA;NO;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;Lumpectomy;NA;Lumpectomy;A7;466666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A7-A3IZ;TCGA-A7-A3IZ-01;62;M0;N0 (i+);Stage IIA;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;3;-22997;86;NA;0;148;10.58;0:DiseaseFree;NA;NA;NA;Positive;90-99%;NOT HISPANIC OR LATINO;NA;3/12/12;1728;569;NA;1;3;PathVysion HER-2 DNA probe kit.;Negative;NA;2;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Equivocal;NA;YES;2011;NO;YES;NA;1;1;Negative;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;YES;68;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;ILC;1058;0:LIVING;15FF4B02-BB69-4D24-8A07-B82F428E428D;8BA93AD6-932D-42C9-8268-DDDA46802057;TCGA-A7-A3IZ.90F83655-038B-412C-91BD-84CC3A4201D4.pdf;Positive;NA;Right;NA;YES;NA;NA;NA;NA;Negative;<10%;WHITE;NA;NO;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;Other;Reexcision;Lumpectomy;A7;2266666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A7-A3J0;TCGA-A7-A3J0-01;62;M0;N0;Stage IIA;7th;T2;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-22672;78;NA;0;76;10.28;0:DiseaseFree;NA;NA;NA;Positive;90-99%;NOT HISPANIC OR LATINO;NA;3/13/12;2240;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Mucinous Carcinoma;NA;No;No;C50.9;1/03/8480;C50.9;Negative;NA;YES;2011;NO;YES;0;NA;2;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;NO;28;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;BRCA;1028;0:LIVING;DA70CF7E-0E61-4C72-B4C5-C408569D11B8;025EAC6D-539E-4E43-A6F7-4A2D2DEF571D;TCGA-A7-A3J0.A5AED5F0-A144-4615-AF78-539B8523D15F.pdf;Negative;NA;Right;NA;YES;NA;NA;NA;NA;Positive;90-99%;WHITE;NA;NO;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Lumpectomy;A7;933333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A7-A3J1;TCGA-A7-A3J1-01;63;MX;N0;Stage IA;7th;T1c;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-23209;49;NA;0;75;11.27;0:DiseaseFree;NA;NA;NA;Positive;90-99%;NOT HISPANIC OR LATINO;NA;3/12/12;2148;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Lobular Carcinoma;NA;No;Yes;C50.9;1/03/8520;C50.9;Negative;NA;YES;2011;NO;YES;0;NA;1;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;NA;18;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;ILC;1127;0:LIVING;8F9AD301-6699-4078-A80D-886E40894AF7;112C8CDD-A187-4D9F-8C71-400848804D32;TCGA-A7-A3J1.D8EFFB62-6A23-4033-8144-24B751DECB08.pdf;Negative;NA;Left;NA;YES;NA;NA;NA;NA;Positive;<10%;WHITE;NA;NO;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Lumpectomy;A7;6;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A7-A3RF;TCGA-A7-A3RF-01;79;M0;N0;Stage IIA;7th;T2;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-29184;61;NA;0;54;6.31;1:Recurred/Progressed;NA;NA;NA;Positive;90-99%;NOT HISPANIC OR LATINO;NA;5/3/12;23;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Mucinous Carcinoma;NA;No;No;C50.9;1/03/8480;C50.9;Negative;NA;YES;2012;NO;YES;0;NA;2;Negative;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NO;46;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;BRCA;134;0:LIVING;7451AF3C-ACC0-4D79-8429-6B8BE96911D8;2868849C-2BA4-42DE-AEF2-028BF68F4CB3;TCGA-A7-A3RF.4AF67A51-97C1-4D58-9E60-03FDFFACD38A.pdf;Positive;NA;Left Upper Outer Quadrant;NA;YES;NA;NA;NA;NA;Positive;30-39%;WHITE;NA;NO;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;Other;Left breast reexcision;Lumpectomy;A7;1533333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A7-A425;TCGA-A7-A425-01;70;MX;N3a;Stage IIIC;7th;T3;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;2.5;-25678;198;NA;0;293;14.55;1:Recurred/Progressed;NA;NA;3 Point Scale;Positive;90-99%;NOT HISPANIC OR LATINO;NA;11/5/12;1447;228;NA;1.1;2.8;Pathvysion HER-2 DNA Probe Kit;Negative;30-39%;3;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Indeterminate;3;YES;2012;NO;YES;12;NA;19;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;YES;36;NO;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;BRCA;1468;0:LIVING;A8F5C479-8685-4E2D-BB60-63F1CC651083;51FB2284-4C63-49D7-9E38-C7D213AB43A6;TCGA-A7-A425.F969E3E4-0053-44E9-85BC-BEFDBD62C512.pdf;Negative;YES;Right;NA;YES;NA;2+;NA;3 Point Scale;Positive;70-79%;WHITE;YES;NO;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Modified Radical Mastectomy;A7;12;NA;Breast
brca_tcga_pub2015;TCGA-A7-A426;TCGA-A7-A426-01;50;MX;N3a;Stage IIIC;7th;T3;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-18296;132;NA;0;229;11.96;0:DiseaseFree;NA;NA;3 Point Scale;Positive;70-79%;NOT HISPANIC OR LATINO;NA;11/5/12;1708;NA;NA;NA;NA;NA;NA;<10%;NA;NA;NA;Infiltrating Lobular Carcinoma;NA;No;Yes;C50.9;1/03/8520;C50.9;Negative;2;YES;2012;NO;YES;13;NA;20;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NA;Core needle biopsy;NA;YES;28;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;ILC;1196;0:LIVING;D48E9F25-F083-4F88-A92D-C12D9F765BA6;3374057F-4159-464C-B6C3-276BB12A8902;TCGA-A7-A426.B644AEB6-7D46-4D4D-BA00-D42BCDDCB164.pdf;Negative;YES;Right;NA;YES;NA;3+;NA;3 Point Scale;Positive;70-79%;WHITE;YES;NO;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Simple Mastectomy;A7;933333333;NA;Breast
brca_tcga_pub2015;TCGA-A7-A4SA;TCGA-A7-A4SA-01;40;M0;N1a;Stage IIB;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-14906;127;NA;0;241;14.91;0:DiseaseFree;NA;NA;3 Point Scale;Positive;80-89%;NOT HISPANIC OR LATINO;NA;2/19/13;3754;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Negative;NA;YES;2012;NO;YES;1;0;10;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NA;Core needle biopsy;NA;YES;55;NO;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;ILC;1491;0:LIVING;A2EFE7E1-ACA3-440F-825F-ED621EDCA69F;040438CF-A4BA-4F06-B562-73C79738F53E;TCGA-A7-A4SA.2649764C-9566-49DB-B8E9-B4B86DBB763C.pdf;Negative;YES;Left Lower Outer Quadrant;NA;YES;NA;NA;NA;NA;Negative;NA;WHITE;NO;NO;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Simple Mastectomy;A7;1833333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A7-A4SB;TCGA-A7-A4SB-01;56;M0;N1mi;Stage IIIA;7th;T3;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-20539;75;NA;0;200;13.73;0:DiseaseFree;NA;NA;3 Point Scale;Positive;70-79%;NOT HISPANIC OR LATINO;NA;2/20/13;5065;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Negative;NA;YES;2012;NO;YES;0;1;2;Negative;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;YES;33;NO;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;ILC;1373;0:LIVING;A947A945-4721-45CC-BC45-13B8EA41C10E;87845B6D-D3A0-43BF-82CF-A9429759E353;TCGA-A7-A4SB.03B39A59-0068-4276-8340-7B97A1395E68.pdf;Positive;YES;Right Upper Outer Quadrant;NA;YES;NA;NA;NA;3 Point Scale;Positive;50-59%;WHITE;YES;NO;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;Other;Right Breast reexcision;Lumpectomy;A7;11;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A7-A4SD;TCGA-A7-A4SD-01;52;M0;N0;Stage IIA;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;5;-19131;63;NA;0;168;14.49;0:DiseaseFree;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;2/19/13;3712;20;NA;1.3;6.4;PathVysion HER-2 DNA Probe Kit;Negative;NA;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;2012;NO;YES;0;0;6;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;YES;42;NO;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;1449;0:LIVING;8C09F413-E938-4F2E-A414-84F0E7FCFE41;EFE1592D-EF98-40DF-B31E-545BAEF69207;TCGA-A7-A4SD.563D1ED2-1A8B-4D90-BD42-AC3790D04913.pdf;Negative;YES;Right;NA;YES;NA;NA;NA;NA;Negative;NA;BLACK OR AFRICAN AMERICAN;NO;NO;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Simple Mastectomy;A7;14;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A7-A4SE;TCGA-A7-A4SE-01;54;M0;N0;Stage IIA;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-20080;306;NA;0;371;21.16;0:DiseaseFree;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;2/22/13;7743;NA;NA;NA;NA;NA;NA;<10%;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2011;NO;YES;0;0;3;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;YES;87;NO;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;2116;0:LIVING;DBF6F981-15CC-40AD-91AC-A66360405FBD;3440B3EB-511E-4904-873D-7A05D88FE879;TCGA-A7-A4SE.C0C49D41-AA66-435B-9312-FAD8E2DC3305.pdf;Negative;YES;Left;NA;YES;NA;NA;NA;NA;Negative;NA;BLACK OR AFRICAN AMERICAN;NO;NO;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Lumpectomy;A7;2933333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A7-A4SF;TCGA-A7-A4SF-01;54;M0;N0;Stage IIA;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-19985;245;NA;0;369;17.9;0:DiseaseFree;NA;NA;3 Point Scale;Positive;90-99%;NOT HISPANIC OR LATINO;NA;2/25/13;5960;NA;NA;NA;NA;NA;NA;NA;3;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;NA;YES;2012;NO;YES;0;0;2;Positive;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;YES;55;NO;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;179;0:LIVING;D81594D9-DD6A-45C3-8BAD-61960611D78D;2C9BB39C-A023-4B44-B8CD-A454E8B60B28;TCGA-A7-A4SF.C1B1FAA6-EB15-43BB-B3A3-D11511C76060.pdf;Positive;YES;Right;NA;YES;NA;NA;NA;NA;Negative;NA;BLACK OR AFRICAN AMERICAN;YES;NO;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;Other;Right Breast Reexcision;Lumpectomy;A7;1833333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A7-A5ZV;TCGA-A7-A5ZV-01;62;M0;N0;Stage IIA;7th;T2;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;2.5;-22966;154;NA;0;210;12.09;0:DiseaseFree;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;5/14/13;5955;40;NA;1.5;3.8;PathVysion HER-2 DNA Probe Kit;Negative;NA;2;NA;NA;Infiltrating Carcinoma NOS;NA;No;No;C50.9;1/03/8010;C50.9;Equivocal;NA;YES;2012;NO;YES;0;NA;2;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NO;149;NO;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;BRCA;1209;0:LIVING;0EC70E40-07DF-461D-8FF9-351240A0D454;B9EEEAF9-5A04-4F93-B2FB-897377BD57F4;TCGA-A7-A5ZV.FA5CF5A2-F44A-4303-9200-32250FAEF374.pdf;Negative;YES;Left;NA;YES;NA;NA;NA;NA;Negative;NA;BLACK OR AFRICAN AMERICAN;NO;NO;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Lumpectomy;A7;4966666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A7-A5ZW;TCGA-A7-A5ZW-01;47;M0;N1a;Stage IIA;7th;T1c;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-17529;77;NA;0;134;10.71;0:DiseaseFree;NA;NA;3 Point Scale;Positive;90-99%;NOT HISPANIC OR LATINO;NA;5/13/13;489;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2012;NO;YES;1;NA;1;NA;Peri (6-12 months since last menstrual period);NA;NA;NA;Core needle biopsy;NA;NO;22;NO;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;BRCA;1071;0:LIVING;523E24A2-51B9-4658-BE2F-42E5FCCEBB17;CB7C50BF-C1DF-4B2D-939D-CBE1A4B7B667;TCGA-A7-A5ZW.A56585F9-9651-472B-BF53-C708A686EB7D.pdf;Negative;YES;Right Upper Outer Quadrant;NA;YES;NA;NA;NA;3 Point Scale;Positive;80-89%;BLACK OR AFRICAN AMERICAN;NO;NO;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Lumpectomy;A7;766666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A7-A5ZX;TCGA-A7-A5ZX-01;48;M0;N3a;Stage IIIC;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-17683;76;NA;0;132;11.04;0:DiseaseFree;NA;NA;3 Point Scale;Positive;NA;NOT HISPANIC OR LATINO;Bilateral skin sparing Mastectomy and Bilateral breast reconstruction with tissue expanders.;5/13/13;684;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Lobular Carcinoma;NA;No;Yes;C50.9;1/03/8520;C50.9;Negative;NA;YES;2012;NO;YES;21;NA;24;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NA;Core needle biopsy;NA;YES;29;NO;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;ILC;1104;0:LIVING;BA80DB4E-D899-4DA4-AE49-5263D98E1530;BC4EF13B-1AB7-4929-953D-45592691394F;TCGA-A7-A5ZX.A8834D03-81F5-43BC-A4AB-F215C89CB095.pdf;NA;YES;Left;NA;YES;NA;NA;NA;3 Point Scale;Positive;NA;WHITE;NO;NO;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Other;A7;966666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A8-A06N;TCGA-A8-A06N-01;66;M0;N0;Stage IIIB;6th;T4b;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-24288;241;NA;0;0;0;0:DiseaseFree;NA;NA;NA;Positive;NA;NA;Surgical Resection;5/27/11;5584;NA;NA;NA;NA;NA;Negative;NA;0;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2009;NO;NA;NA;NA;NA;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;NA;NA;NA;34;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;0;0:LIVING;3a711140-1b89-4611-9992-3861e3d0e01a;600df455-fdf4-4955-8d65-236b7b112693;TCGA-A8-A06N.2F0333BC-E9BB-4903-B3E2-8AE241DDDF84.pdf;Negative;NA;Left;NA;NO;NA;NA;NA;NA;Negative;NA;NA;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;A8;1133333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A8-A06O;TCGA-A8-A06O-01;60;M0;N0;Stage I;6th;T1c;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-22157;272;NA;0;396;13.01;0:DiseaseFree;NA;NA;NA;Positive;NA;NA;Surgical Resection;5/27/11;3914;NA;NA;NA;NA;NA;Negative;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2009;NO;NA;NA;NA;NA;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;NA;NA;NA;63;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;1301;0:LIVING;69054195-9e93-49e5-b820-69b0091cc2d4;3ee32152-2834-4137-a6e8-254f3cca6b6e;TCGA-A8-A06O.EB9B8904-F6CC-451F-8628-50CC71F1F7C3.pdf;Negative;NA;Left;NA;NO;NA;NA;NA;NA;Positive;NA;NA;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;A8;21;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A8-A06P;TCGA-A8-A06P-01;63;M0;N2a;Stage IIIA;6th;T1c;NA;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;NA;-23011;241;NA;0;396;13.01;0:DiseaseFree;NA;NA;NA;Positive;NA;NA;Surgical Resection;5/27/11;945;NA;NA;NA;NA;NA;Negative;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2009;NO;NA;NA;NA;NA;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;NA;NA;NA;39;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;MDLC;1301;0:LIVING;5f90d955-bbb0-4b44-a5ac-ba6fda9ca0fb;bdcd6720-fcbf-4c64-8703-b8932472ad19;TCGA-A8-A06P.AADFAF8B-92B8-4292-96A3-912D55EB9C31.pdf;Negative;NA;Right;NA;NO;NA;NA;NA;NA;Positive;NA;NA;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;A8;13;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A8-A06Q;TCGA-A8-A06Q-01;63;M0;N2;Stage IIIA;5th;T3;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-23164;1184;NA;0;31;1.02;0:DiseaseFree;NA;NA;NA;Positive;NA;NA;Surgical Resection;5/27/11;6549;NA;NA;NA;NA;NA;Negative;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2007;NO;NA;NA;NA;NA;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;NA;NA;NA;187;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;102;0:LIVING;281f70c5-876f-44b3-84fb-f2302f85e74c;a03cd506-47aa-4333-a9a4-fa1a6815ac75;TCGA-A8-A06Q.8FE77EF7-C83A-431F-B3BA-D93B5ECC70AF.pdf;Negative;NA;Left Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;NA;NA;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;A8;6233333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A8-A06R;TCGA-A8-A06R-01;69;M0;N1a;Stage IIB;5th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-25477;1184;NA;0;547;17.97;0:DiseaseFree;NA;NA;NA;Positive;NA;NA;Surgical Resection;5/27/11;5927;NA;NA;NA;NA;NA;Positive;NA;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;NA;YES;2007;NO;NA;NA;NA;NA;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;NA;NA;NA;58;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;1797;0:LIVING;f3ba71f9-25f3-4784-bf2d-3aa522a0cba8;7fa91f3b-34db-41ba-8447-d745eebac2db;TCGA-A8-A06R.B6B7939C-63AF-4B52-B494-AA09A9C03871.pdf;Negative;NA;Right Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Negative;NA;NA;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;A8;1933333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A8-A06T;TCGA-A8-A06T-01;75;M0;N1a;Stage IIIA;6th;T3;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-27393;941;NA;0;1249;53.02;0:DiseaseFree;NA;NA;NA;Positive;NA;NA;Surgical Resection;5/27/11;7708;NA;NA;NA;NA;NA;Positive;NA;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;Yes;C50.9;1/03/8500;C50.9;Positive;NA;YES;2007;NO;NA;NA;NA;NA;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;NA;NA;NA;26;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;5302;0:LIVING;2c04a2f5-321e-4dea-8e00-268325da65cb;7b80a02f-c065-4ec2-95fc-05baf0aa3926;TCGA-A8-A06T.5D888D65-685F-4598-884F-AD057DE5FD1D.pdf;Negative;NA;Left Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;NA;NA;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;A8;866666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A8-A06U;TCGA-A8-A06U-01;80;M0;N1a;Stage IIB;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-29525;759;883;0;NA;NA;NA;NA;NA;NA;Positive;NA;NA;Surgical Resection;5/27/11;6192;NA;NA;NA;NA;NA;Positive;NA;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;Yes;C50.9;1/03/8500;C50.9;Positive;NA;YES;2008;NO;NA;NA;NA;NA;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;NA;NA;NA;58;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;2901;1:DECEASED;6bc4c56d-aac5-49a2-9913-9538d06d898f;d1224e18-6c94-45f7-afb0-d4321150cc8f;TCGA-A8-A06U.A314FB55-F20A-4485-965D-D7894D070A16.pdf;Negative;NA;Right Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;NA;NA;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;A8;1933333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A8-A06Y;TCGA-A8-A06Y-01;66;M0;N0;Stage IIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-24442;667;NA;0;791;25.99;1:Recurred/Progressed;NA;NA;NA;Positive;NA;NA;Surgical Resection;5/27/11;3042;NA;NA;NA;NA;NA;Negative;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2008;NO;NA;NA;NA;NA;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;NA;NA;NA;25;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;2599;0:LIVING;515b1400-e896-4f2a-81bd-70895441a0bd;dac9090c-fae9-4d99-b5d7-fc3c8b6a201a;TCGA-A8-A06Y.5664F531-9D45-4302-A455-63E46B5EDD26.pdf;Negative;NA;Left Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;NA;NA;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;A8;833333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A8-A06Z;TCGA-A8-A06Z-01;84;M0;N0;Stage IIB;6th;T3;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-30984;1003;NA;0;31;1.02;0:DiseaseFree;NA;NA;NA;Positive;NA;NA;Surgical Resection;5/27/11;7074;NA;NA;NA;NA;NA;Negative;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2007;NO;NA;NA;NA;NA;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;NA;NA;NA;54;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;102;0:LIVING;2399caeb-ead2-4003-af38-809db4ac2e2b;993d2cba-b4f8-4a46-994b-b97bb9f10d34;TCGA-A8-A06Z.956F45E5-A8C6-4A4A-9D1F-D31912180584.pdf;NA;NA;Right Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;NA;NA;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;A8;18;NA;Breast
brca_tcga_pub2015;TCGA-A8-A075;TCGA-A8-A075-01;42;M0;N1a;Stage IIB;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-15369;394;NA;0;518;17.02;0:DiseaseFree;NA;NA;NA;Positive;NA;NA;Surgical Resection;5/27/11;5033;NA;NA;NA;NA;NA;Positive;NA;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;NA;YES;2009;NO;NA;NA;NA;NA;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NA;NA;NA;NA;63;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;1702;0:LIVING;7861a5f2-8910-4bcb-9c34-f79c5acd6e21;d3263082-946d-4420-8a63-8d67eeee09c5;TCGA-A8-A075.6643B290-5D7A-4649-B57D-47A5BA4E8D31.pdf;Negative;NA;Left Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;NA;NA;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;A8;2066666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A8-A076;TCGA-A8-A076-01;66;M0;N0;Stage IIA;5th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-24230;1518;NA;0;1642;53.94;0:DiseaseFree;NA;NA;NA;Positive;NA;NA;Surgical Resection;5/27/11;5527;NA;NA;NA;NA;NA;Positive;NA;3;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;NA;YES;2006;NO;NA;NA;NA;NA;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;NA;NA;NA;48;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;5394;0:LIVING;23dabeef-8e3c-44bc-9a12-a9522d17be5c;750932d7-0e9d-44e0-bc5a-6031ca4b0448;TCGA-A8-A076.DD669244-34D8-4725-A52C-F3AAF59852F9.pdf;Negative;NA;Left Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;NA;NA;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;A8;16;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A8-A079;TCGA-A8-A079-01;69;M0;N3;Stage IIIB;5th;T4b;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-25294;1033;NA;0;274;9;0:DiseaseFree;NA;NA;NA;Positive;NA;NA;Surgical Resection;5/27/11;3639;NA;NA;NA;NA;NA;Negative;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2007;NO;NA;NA;NA;NA;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;NA;NA;NA;49;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;9;0:LIVING;31c31cce-1b4d-4f12-922f-84f389403170;ce2a0734-ea41-4e2c-87dd-516f6e5b83d6;TCGA-A8-A079.81ADDBAB-C02F-4DA8-9429-76293FB42E42.pdf;Negative;NA;Left Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;NA;NA;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;A8;1633333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A8-A07B;TCGA-A8-A07B-01;69;M0;N0;Stage IIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;NA;-25475;880;NA;0;1004;42.97;0:DiseaseFree;NA;NA;NA;Positive;NA;NA;Surgical Resection;5/27/11;3844;NA;NA;NA;NA;NA;Positive;NA;3;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;NA;YES;2007;NO;NA;NA;NA;NA;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;NA;NA;NA;55;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;MDLC;4297;0:LIVING;b43e41af-1d82-4b5f-b8f1-add0510e6b86;685fa2ea-3dff-450a-8ea6-e97dfe9000a4;TCGA-A8-A07B.F24A752C-1AAE-4C70-B6D4-DD0E8C89D9AA.pdf;Negative;NA;Left Lower Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;NA;NA;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;A8;1833333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A8-A07E;TCGA-A8-A07E-01;81;MX;N3a;Stage X;6th;T4b;NA;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;NA;-29800;545;NA;0;608;19.97;0:DiseaseFree;NA;NA;NA;Positive;NA;NA;Surgical Resection;5/27/11;2136;NA;NA;NA;NA;NA;Negative;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;Yes;C50.9;1/03/8500;C50.9;Negative;NA;YES;2008;NO;NA;NA;NA;NA;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;NA;NA;NA;68;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;MDLC;1997;0:LIVING;853456d8-2367-404e-abc9-020fe8bbd209;059a543a-4408-4c82-96ef-eae1cc126763;TCGA-A8-A07E.E20AC0FF-43C4-49EA-9E33-764E553933B7.pdf;Negative;NA;Left Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;NA;NA;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;A8;2266666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A8-A07F;TCGA-A8-A07F-01;65;M0;N1a;Stage IIB;6th;T2;NA;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;NA;-23742;453;NA;0;577;18.96;0:DiseaseFree;NA;NA;NA;Positive;NA;NA;Surgical Resection;5/27/11;6103;NA;NA;NA;NA;NA;Negative;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2009;NO;NA;NA;NA;NA;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;NA;NA;NA;25;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;MDLC;1896;0:LIVING;5d688049-f271-40ef-813a-d37240ffe21c;f411d1ba-697f-4759-afb1-89eaa56e6da7;TCGA-A8-A07F.D1456192-83E7-4FC8-B783-90D615830156.pdf;Negative;NA;Left Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;NA;NA;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;A8;833333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A8-A07G;TCGA-A8-A07G-01;65;M0;N1a;Stage IIA;6th;T1c;NA;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;NA;-23926;453;NA;0;577;18.96;0:DiseaseFree;NA;NA;NA;Positive;NA;NA;Surgical Resection;5/27/11;2875;NA;NA;NA;NA;NA;Negative;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2009;NO;NA;NA;NA;NA;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;NA;NA;NA;48;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;MDLC;1896;0:LIVING;8cf8b620-7ab6-4b6e-84bc-ff5a83f381fa;32ed93a7-250a-4fd4-81a8-6d94a6bc9f33;TCGA-A8-A07G.1ED901DF-BCDC-44C8-A7DF-AB895ECA0952.pdf;Negative;NA;Right Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;NA;NA;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;A8;16;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A8-A07I;TCGA-A8-A07I-01;69;M0;N2a;Stage IIIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-25263;302;NA;0;426;13.99;0:DiseaseFree;NA;NA;NA;Positive;NA;NA;Surgical Resection;5/27/11;2446;NA;NA;NA;NA;NA;Positive;NA;3;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;NA;YES;2009;NO;NA;NA;NA;NA;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;NA;NA;NA;39;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;1399;0:LIVING;566792ae-f853-4a47-856d-f02cdcfcb18a;0d2e50fa-daef-45a3-97b2-5d71ab03cfbf;TCGA-A8-A07I.5DA3A8E1-7EE6-45EC-89EC-69423E2B866B.pdf;Negative;NA;Left Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Negative;NA;NA;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;A8;13;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A8-A07J;TCGA-A8-A07J-01;35;M0;N1a;Stage IIB;6th;T2;NA;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;NA;-12965;241;NA;0;365;11.99;0:DiseaseFree;NA;NA;NA;Positive;NA;NA;Surgical Resection;5/27/11;1612;NA;NA;NA;NA;NA;Negative;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2009;NO;NA;NA;NA;NA;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NA;NA;NA;NA;37;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;MDLC;1199;0:LIVING;316625b8-a217-4829-90d1-dfd9cb7e4bc3;e7008896-7348-4b14-a443-d9da1352c80e;TCGA-A8-A07J.2243F29C-191C-4D33-8483-09BB3AD36598.pdf;Negative;NA;Right Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;NA;NA;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;A8;1233333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A8-A07L;TCGA-A8-A07L-01;58;M0;N1a;Stage IIIA;6th;T3;NA;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;NA;-21428;394;NA;0;518;32.03;0:DiseaseFree;NA;NA;NA;Positive;NA;NA;Surgical Resection;5/27/11;4588;NA;NA;NA;NA;NA;Negative;NA;0;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2009;NO;NA;NA;NA;NA;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;NA;NA;NA;89;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;MDLC;3203;0:LIVING;e89a9deb-6321-4e61-b412-b4993d4277dd;e5bfc024-9ee5-4e37-97ee-45e695489f8d;TCGA-A8-A07L.5D93AE27-79A0-4809-AE7C-54814CED0851.pdf;Negative;NA;Right Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;NA;NA;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;A8;2933333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A8-A07O;TCGA-A8-A07O-01;51;M0;N0;Stage IIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-18870;180;NA;0;304;9.99;0:DiseaseFree;NA;NA;NA;Negative;NA;NA;Surgical Resection;5/27/11;3136;NA;NA;NA;NA;NA;Negative;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2009;NO;NA;NA;NA;NA;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;NA;NA;NA;38;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;999;0:LIVING;cf9db1af-17f0-490e-8139-142bd704763a;2d80cd9e-8906-4fc9-9645-b3c137d71dc7;TCGA-A8-A07O.9ECA4450-A550-44DE-B2E5-FD1CFF02A9FE.pdf;Negative;NA;Right Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Negative;NA;NA;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;A8;1266666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A8-A07P;TCGA-A8-A07P-01;68;M0;N1;Stage IIB;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-24929;210;NA;0;334;10.97;0:DiseaseFree;NA;NA;NA;Positive;NA;NA;Surgical Resection;5/27/11;2830;NA;NA;NA;NA;NA;Positive;NA;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;NA;YES;2009;NO;NA;NA;NA;NA;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;NA;NA;NA;44;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;1097;0:LIVING;8cccf160-93e9-48a5-9b8b-54aa50153142;b16578d4-4d04-430d-8f9c-168ec0288cf1;TCGA-A8-A07P.6C7D956E-1247-4663-9ED5-D406AE6E2959.pdf;Negative;NA;Left Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;NA;NA;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;A8;1466666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A8-A07R;TCGA-A8-A07R-01;80;M0;N3a;Stage IIIC;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-29251;149;NA;0;273;8.97;0:DiseaseFree;NA;NA;NA;Negative;NA;NA;Surgical Resection;5/27/11;7041;NA;NA;NA;NA;NA;NA;NA;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;NA;YES;2009;NO;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;372;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;897;0:LIVING;72e486b8-a866-4916-b2e4-8b4bb5dcd92d;02a0a874-6d4e-4e56-8d74-7952c912fed2;TCGA-A8-A07R.FD75D315-EED7-4350-A890-8FB94648E9FC.pdf;Positive;NA;Left Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Negative;NA;NA;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;A8;1236666667;NA;Breast
brca_tcga_pub2015;TCGA-A8-A07U;TCGA-A8-A07U-01;66;M0;N2a;Stage IIIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-24411;210;NA;0;303;24.97;0:DiseaseFree;NA;NA;NA;Negative;NA;NA;Surgical Resection;5/27/11;901;NA;NA;NA;NA;NA;Negative;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2009;NO;NA;NA;NA;NA;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;NA;NA;NA;44;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;2497;0:LIVING;59bf0ce4-715a-4017-bccb-c59916e78324;7bd968be-14ae-4a63-96d5-814d16072818;TCGA-A8-A07U.1E7788D8-B5FC-473A-8A10-79910443799A.pdf;Negative;NA;Right Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;NA;NA;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;A8;1466666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A8-A07W;TCGA-A8-A07W-01;76;M1;NX;Stage IV;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-27942;180;NA;0;304;9.99;0:DiseaseFree;NA;NA;NA;Positive;NA;NA;Surgical Resection;5/25/11;4787;NA;NA;NA;NA;NA;Negative;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2009;NO;NA;NA;NA;NA;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;NA;NA;NA;71;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;999;0:LIVING;01263518-5f7c-49dc-8d7e-84b0c03a6a63;5d1a5545-6934-41e5-b41b-8e0ee88e6ec6;TCGA-A8-A07W.C39563FD-CD7F-47C6-A257-5CB70A01C67C.pdf;Positive;NA;Left Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;NA;NA;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;A8;2366666667;WITH TUMOR;Breast
brca_tcga_pub2015;TCGA-A8-A081;TCGA-A8-A081-01;80;M0;N0;Stage IIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-29555;637;NA;0;0;0;0:DiseaseFree;NA;NA;NA;Positive;NA;NA;Surgical Resection;5/27/11;6450;NA;NA;NA;NA;NA;Negative;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2008;NO;NA;NA;NA;NA;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;NA;NA;NA;76;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;0;0:LIVING;9d876f05-5080-4c4e-9bf5-45f631d381e5;050ec96b-f110-429e-a138-4a41b38a24ae;TCGA-A8-A081.DE25BF82-5F7A-489B-BFC1-9386C44E7D62.pdf;Negative;NA;Right;NA;NO;NA;NA;NA;NA;Positive;NA;NA;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;A8;2533333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A8-A082;TCGA-A8-A082-01;58;M0;N1a;Stage IIB;6th;T2;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-21338;606;NA;0;549;18.04;0:DiseaseFree;NA;NA;NA;Positive;NA;NA;Surgical Resection;5/27/11;1231;NA;NA;NA;NA;NA;Negative;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2008;NO;NA;NA;NA;NA;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;NA;NA;NA;20;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;BRCA;1804;0:LIVING;5e4187c9-98f8-4bdb-a8da-6a914e96f47a;24eaa7eb-502d-4c9a-b390-507b51c53f96;TCGA-A8-A082.3E967C4F-B916-4A80-A9A1-A5E94F02322C.pdf;Negative;NA;Right;NA;NO;NA;NA;NA;NA;Positive;NA;NA;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;A8;666666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A8-A083;TCGA-A8-A083-01;67;M0;N0;Stage IIB;6th;T3;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-24746;575;NA;0;0;0;0:DiseaseFree;NA;NA;NA;Positive;NA;NA;Surgical Resection;5/27/11;1819;NA;NA;NA;NA;NA;Negative;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2008;NO;NA;NA;NA;NA;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;NA;NA;NA;31;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;BRCA;0;0:LIVING;afb9418e-91eb-4db1-aacf-12bd946c9ba0;90b93fd6-b94d-4a98-ad7d-dba3428cbb25;TCGA-A8-A083.AF0A2220-DEEC-44C8-B15C-B6442D5B7517.pdf;Negative;NA;Left;NA;NO;NA;NA;NA;NA;Positive;NA;NA;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;A8;1033333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A8-A084;TCGA-A8-A084-01;81;M0;N1a;Stage IIB;5th;T2;NA;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;NA;-29858;1033;NA;0;458;15.05;0:DiseaseFree;NA;NA;NA;Positive;NA;NA;Surgical resection;5/27/11;4237;NA;NA;NA;NA;NA;Negative;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;Yes;Yes;C50.9;1/03/8500;C50.9;Negative;NA;YES;2007;NO;NA;NA;NA;NA;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;NA;NA;NA;62;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;MDLC;1505;0:LIVING;3dbe99d1-e3b8-4ee2-b6a8-2e2e12c6fbe9;3b3eab6c-c039-4c2b-ae4c-18b043d3d810;TCGA-A8-A084.6A49B3F9-6B43-4D74-A28B-C83BFE61EC7B.pdf;Positive;NA;Left;NA;NO;NA;NA;NA;NA;Negative;NA;NA;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;A8;2066666667;WITH TUMOR;Breast
brca_tcga_pub2015;TCGA-A8-A085;TCGA-A8-A085-01;44;M0;N1a;Stage IIB;6th;T2;NA;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;NA;-16377;788;NA;0;1124;36.93;0:DiseaseFree;NA;NA;NA;Positive;NA;NA;Surgical Resection;5/27/11;2398;NA;NA;NA;NA;NA;Negative;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2008;NO;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;59;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;MDLC;3693;0:LIVING;3c08aabd-d5b5-4bbe-857c-38a7527b2163;0dba8c12-0f21-4489-8639-47c156ddfa5f;TCGA-A8-A085.64F84FF4-A477-4E1E-B4BB-E5614517229E.pdf;Negative;NA;Left;NA;NO;NA;NA;NA;NA;Positive;NA;NA;NA;YES;1;Primary;Male;Matched;NA;NA;NA;NA;Other;A8;1933333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A8-A086;TCGA-A8-A086-01;59;M0;N1a;Stage IIA;6th;T1c;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-21731;272;NA;0;396;13.01;0:DiseaseFree;NA;NA;NA;Positive;NA;NA;Surgical Resection;5/27/11;2758;NA;NA;NA;NA;NA;Negative;NA;0;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2009;NO;NA;NA;NA;NA;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;NA;NA;NA;18;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;1301;0:LIVING;f9eb88f7-9293-46bf-ace4-a746e4ff80dc;0b2e3720-4a7e-44cd-9e38-7d883f559c1c;TCGA-A8-A086.D4E86E20-B75E-4CDA-83F2-22C481D4B9E8.pdf;Negative;NA;Right;NA;NO;NA;NA;NA;NA;Positive;NA;NA;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;A8;6;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A8-A08B;TCGA-A8-A08B-01;52;M0;N0;Stage IIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-19114;759;NA;0;702;37.98;0:DiseaseFree;NA;NA;NA;Positive;NA;NA;Surgical Resection;5/27/11;3997;NA;NA;NA;NA;NA;Positive;NA;3;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;NA;YES;2008;NO;NA;NA;NA;NA;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NA;NA;NA;NA;27;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;3798;0:LIVING;d8d7a6c2-6427-4f47-968c-6c3affba4617;1964addf-c524-4c72-b596-009235bad133;TCGA-A8-A08B.2261B407-340D-4BB3-94BC-F06096FBDA80.pdf;Negative;NA;Right Upper Inner Quadrant;NA;NO;NA;NA;NA;NA;Negative;NA;NA;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;A8;9;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A8-A08G;TCGA-A8-A08G-01;41;M0;N0;Stage IIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-14976;422;NA;0;607;19.94;0:DiseaseFree;NA;NA;NA;Positive;NA;NA;Surgical Resection;5/27/11;5338;NA;NA;NA;NA;NA;Positive;NA;3;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;NA;YES;2009;NO;NA;NA;NA;NA;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NA;NA;NA;NA;35;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;1994;0:LIVING;719082cc-1ebe-4a51-a659-85a59db1d77d;ea93b70f-c0b6-4063-86a8-cac7d5d99c77;TCGA-A8-A08G.6DCA5C2C-F28A-409D-9623-24AB748FB4E7.pdf;Negative;NA;Left Upper Inner Quadrant;NA;NO;NA;NA;NA;NA;Positive;NA;NA;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;A8;1166666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A8-A08H;TCGA-A8-A08H-01;66;M0;N0;Stage IIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-24137;1184;NA;0;0;0;0:DiseaseFree;NA;NA;NA;Positive;NA;NA;Surgical Resection;5/27/11;0;NA;NA;NA;NA;NA;Positive;NA;3;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;NA;YES;2007;NO;NA;NA;NA;NA;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;NA;NA;NA;55;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;0;0:LIVING;db8d38ab-cc61-49ee-863d-40060112f2af;298e1da3-0691-4675-931e-4a36f2ca858d;TCGA-A8-A08H.33188769-D86E-41AD-A74D-31A7C2DD08B7.pdf;Negative;NA;Left Upper Inner Quadrant;NA;NO;NA;NA;NA;NA;Positive;NA;NA;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;A8;1833333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A8-A08I;TCGA-A8-A08I-01;53;M0;N0;Stage IIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-19389;241;NA;0;365;11.99;0:DiseaseFree;NA;NA;NA;Positive;NA;NA;Surgical Resection;5/27/11;6372;NA;NA;NA;NA;NA;Negative;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2009;NO;NA;NA;NA;NA;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;NA;NA;NA;34;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;1199;0:LIVING;7acf33e7-c386-45fd-8c9a-469600378687;6d462341-cb4a-47bf-8c1b-2ffd6cf5e9ed;TCGA-A8-A08I.F2077079-D683-4D18-94B9-84C760674AF6.pdf;Negative;NA;Right Upper Inner Quadrant;NA;NO;NA;NA;NA;NA;Positive;NA;NA;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;A8;1133333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A8-A08J;TCGA-A8-A08J-01;52;M1;N3;Stage IV;6th;T4b;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-19266;1733;1127;0;NA;NA;NA;NA;NA;NA;Positive;NA;NA;Surgical Resection;5/27/11;4491;NA;NA;NA;NA;NA;Negative;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8541;C50.9;Negative;NA;YES;2005;NO;NA;NA;NA;NA;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;NA;NA;NA;35;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;3702;1:DECEASED;68177e92-4784-45d9-af14-4ce0c00eae74;4c54a99b-a820-4602-9b39-deaca98034a5;TCGA-A8-A08J.C1D59BA7-FC3E-46EA-B095-3B6DF42892B0.pdf;Positive;NA;Right;NA;NO;NA;NA;NA;NA;Negative;NA;NA;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;A8;1166666667;WITH TUMOR;Breast
brca_tcga_pub2015;TCGA-A8-A08L;TCGA-A8-A08L-01;89;M0;N2a;Stage IIIA;6th;T3;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-32842;698;304;0;NA;NA;NA;NA;NA;NA;Positive;NA;NA;Surgical Resection;5/27/11;5383;NA;NA;NA;NA;NA;Negative;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2008;NO;NA;NA;NA;NA;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;NA;NA;NA;181;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;999;1:DECEASED;8bd68696-5eeb-46d7-9dc6-c39c849029a4;c385c7fc-0e3e-4fc8-87c1-6db442e5606f;TCGA-A8-A08L.BC0E0F93-B183-44E8-B551-EA463B2FBCE4.pdf;Negative;NA;Left;NA;NO;NA;NA;NA;NA;Negative;NA;NA;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;A8;6033333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A8-A08O;TCGA-A8-A08O-01;45;M1;N3a;Stage IV;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-16681;819;NA;0;943;25.03;1:Recurred/Progressed;NA;NA;NA;Positive;NA;NA;Surgical Resection;5/27/11;6432;NA;NA;NA;NA;NA;Negative;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2008;NO;NA;NA;NA;NA;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NA;NA;NA;NA;21;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;3098;0:LIVING;5f5964a8-8e07-4620-98f0-93d162dbc31e;6c05cfbf-4858-45d1-b5b8-d943a542d196;TCGA-A8-A08O.2F102533-4B6B-4411-9080-3697ED3099EA.pdf;Positive;NA;Right;NA;NO;NA;NA;NA;NA;Positive;NA;NA;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;A8;7;WITH TUMOR;Breast
brca_tcga_pub2015;TCGA-A8-A08R;TCGA-A8-A08R-01;52;M0;N1a;Stage IIB;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-19298;728;NA;0;30;0.99;0:DiseaseFree;NA;NA;NA;Negative;NA;NA;Surgical Resection;5/27/11;5152;NA;NA;NA;NA;NA;Negative;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2008;NO;NA;NA;NA;NA;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;NA;NA;NA;141;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;99;0:LIVING;6412854a-f874-469e-9d1f-8bd3ae5bd41d;0dd8e6c7-9b41-4489-924f-bddf7d189eb3;TCGA-A8-A08R.FC0C1BF3-74C3-4DFC-B9B5-2FD1728E287A.pdf;Negative;NA;Left;NA;NO;NA;NA;NA;NA;Negative;NA;NA;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;A8;47;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A8-A08S;TCGA-A8-A08S-01;71;M0;N1;Stage IIA;6th;T1c;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-25994;637;NA;0;580;32.98;0:DiseaseFree;NA;NA;NA;Positive;NA;NA;Surgical resection;5/27/11;4019;NA;NA;NA;NA;NA;Positive;NA;3;NA;NA;Infiltrating Ductal Carcinoma;NA;Yes;Yes;C50.9;1/03/8500;C50.9;Positive;NA;YES;2008;NO;NA;NA;NA;NA;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;NA;NA;NA;47;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;3298;0:LIVING;2779fa01-ac93-4e80-a997-3385f72172c3;960d194f-fe39-42a0-831d-5c031cf93544;TCGA-A8-A08S.0D293DF8-374D-4681-9B2A-ACC98601AA25.pdf;Negative;NA;Left;NA;NO;NA;NA;NA;NA;Positive;NA;NA;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;A8;1566666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A8-A08T;TCGA-A8-A08T-01;64;M1;N1a;Stage IV;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-23560;2767;NA;0;2830;84;1:Recurred/Progressed;NA;NA;NA;Positive;NA;NA;Surgical Resection;5/27/11;2105;NA;NA;NA;NA;NA;Positive;NA;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;NA;YES;2002;NO;NA;NA;NA;NA;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;NA;NA;NA;41;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;11199;1:DECEASED;32bc7cc4-d185-4594-bbee-4b96410be512;4ab5f84d-7ba2-49e2-862b-48ff8cff3c34;TCGA-A8-A08T.5780D50C-5BF0-4392-BC9B-894D1369866A.pdf;Positive;NA;Right;NA;NO;NA;NA;NA;NA;Positive;NA;NA;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;A8;1366666667;WITH TUMOR;Breast
brca_tcga_pub2015;TCGA-A8-A08X;TCGA-A8-A08X-01;43;M0;N3a;Stage IIIC;6th;T4d;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-15705;941;NA;0;1034;12.02;1:Recurred/Progressed;NA;NA;NA;Negative;NA;NA;Surgical Resection;5/27/11;3454;NA;NA;NA;NA;NA;Positive;NA;3;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;NA;YES;2007;NO;NA;NA;NA;NA;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NA;NA;NA;NA;18;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;4297;0:LIVING;f5539207-6534-4edc-a5a5-7666b5d16ba4;32b46b33-43d1-4663-bebd-f31673f18a16;TCGA-A8-A08X.CA911D90-5DDA-49F1-993F-68FCA77A8558.pdf;Negative;NA;Left;NA;NO;NA;NA;NA;NA;Negative;NA;NA;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;A8;6;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A8-A08Z;TCGA-A8-A08Z-01;76;M0;N3a;NA;6th;T4b;NA;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;NA;-28003;2036;NA;0;1217;39.98;0:DiseaseFree;NA;NA;NA;Positive;NA;NA;Surgical Resection;5/27/11;1054;NA;NA;NA;NA;NA;Negative;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2004;NO;NA;NA;NA;NA;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;NA;NA;NA;27;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;MDLC;3998;0:LIVING;d7808cbc-4b8c-467b-b2c3-f48d05b9ecab;5af3de3e-4376-41ab-ae28-4ea9a95dce2d;TCGA-A8-A08Z.DA7BD84B-C00E-40A0-9AE2-33FCE7995696.pdf;Negative;NA;Left;NA;NO;NA;NA;NA;NA;Positive;NA;NA;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;A8;9;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A8-A090;TCGA-A8-A090-01;74;M0;N0;Stage IIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;NA;-27121;667;NA;0;0;0;0:DiseaseFree;NA;NA;NA;Positive;NA;NA;Surgical Resection;5/27/11;2863;NA;NA;NA;NA;NA;Positive;NA;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;NA;YES;2008;NO;NA;NA;NA;NA;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;NA;NA;NA;31;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;MDLC;0;0:LIVING;f4b69043-4a67-48e3-a4d1-72a21ae2d175;5ebda262-2b64-4495-afec-38d3fa616d9a;TCGA-A8-A090.549E825B-F206-4FF9-835B-2FBE51C7B831.pdf;Negative;NA;Right;NA;NO;NA;NA;NA;NA;Positive;NA;NA;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;A8;1033333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A8-A091;TCGA-A8-A091-01;61;M0;N0;Stage IIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-22554;637;NA;0;580;7.98;1:Recurred/Progressed;NA;NA;NA;Positive;NA;NA;Surgical Resection;5/27/11;3068;NA;NA;NA;NA;NA;Negative;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;Yes;C50.9;1/03/8500;C50.9;Negative;NA;YES;2008;NO;NA;NA;NA;NA;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;NA;NA;NA;24;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;3298;0:LIVING;f39edd06-1016-4e8e-a42e-12f7e699ddc5;f26df76e-66bc-4e25-8a27-41b6147dc67b;TCGA-A8-A091.FECA34F6-CEF7-4A6D-AA7E-F88542EAF6F7.pdf;Negative;NA;Right;NA;NO;NA;NA;NA;NA;Negative;NA;NA;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;A8;8;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A8-A092;TCGA-A8-A092-01;48;M0;N2a;Stage IIIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-17807;575;NA;0;487;30.95;0:DiseaseFree;NA;NA;NA;Positive;NA;NA;Surgical Resection;5/27/11;5728;NA;NA;NA;NA;NA;Negative;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2008;NO;NA;NA;NA;NA;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NA;NA;NA;NA;71;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;3095;0:LIVING;38a8b734-9acc-42f9-b5b7-e51b0dfc6504;8b5c7e4d-a220-4499-9e38-7deacc1776a2;TCGA-A8-A092.93D66EAD-B7D3-4688-8EC9-75C4380619D9.pdf;Negative;NA;Left;NA;NO;NA;NA;NA;NA;Positive;NA;NA;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;A8;2366666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A8-A093;TCGA-A8-A093-01;61;M0;N0;Stage IIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-22373;422;NA;0;546;17.94;0:DiseaseFree;NA;NA;NA;Positive;NA;NA;Surgical resection;5/27/11;4219;NA;NA;NA;NA;NA;Negative;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;Yes;C50.9;1/03/8500;C50.9;Negative;NA;YES;2009;NO;NA;NA;NA;NA;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;NA;NA;NA;81;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;1794;0:LIVING;02f5ae33-a563-4ecb-9e33-dfa500a44931;7b2cc917-cd91-486b-bb9b-4c57cf4e86e0;TCGA-A8-A093.9DCF000D-D996-49A6-950A-0CD1E90CC6C7.pdf;Negative;NA;Right;NA;NO;NA;NA;NA;NA;Positive;NA;NA;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;A8;2733333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A8-A094;TCGA-A8-A094-01;75;M0;N0;Stage IIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-27729;363;NA;0;0;0;0:DiseaseFree;NA;NA;NA;Positive;NA;NA;Surgical Resection;5/27/11;4871;NA;NA;NA;NA;NA;Negative;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2009;NO;NA;NA;NA;NA;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;NA;NA;NA;160;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;0;0:LIVING;993103b1-e5a1-4c33-8629-be53ebc41d64;a36231aa-f304-4bbf-aa86-b9547916c097;TCGA-A8-A094.85288EC6-0BDC-4955-8B88-1DEECBF0E235.pdf;Negative;NA;Left;NA;NO;NA;NA;NA;NA;Negative;NA;NA;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;A8;5333333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A8-A095;TCGA-A8-A095-01;45;M0;N0;Stage I;6th;T1c;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-16742;1153;NA;0;1277;41.95;0:DiseaseFree;NA;NA;NA;Positive;NA;NA;Surgical Resection;5/27/11;741;NA;NA;NA;NA;NA;Negative;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2007;NO;NA;NA;NA;NA;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NA;NA;NA;NA;103;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;4195;0:LIVING;29df128d-ace2-40cf-88ee-3f6f2170f159;2223917e-5ff9-4726-99be-c73b19522265;TCGA-A8-A095.41A41A7F-E4DD-4D3A-B97D-B4657CA211E1.pdf;Negative;NA;Left;NA;NO;NA;NA;NA;NA;Positive;NA;NA;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;A8;3433333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A8-A096;TCGA-A8-A096-01;73;M0;N0;Stage IIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-26723;394;NA;0;0;0;0:DiseaseFree;NA;NA;NA;Positive;NA;NA;Surgical Resection;5/27/11;683;NA;NA;NA;NA;NA;Negative;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2009;NO;NA;NA;NA;NA;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;NA;NA;NA;29;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;0;0:LIVING;d7cac141-9269-4733-83ce-e1bc0b503254;cc620a1f-7955-43f8-aa30-12e244f89f1b;TCGA-A8-A096.91BFC77A-E56F-49F0-A294-A5EE9F266FB6.pdf;Negative;NA;Right;NA;NO;NA;NA;NA;NA;Positive;NA;NA;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;A8;966666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A8-A097;TCGA-A8-A097-01;65;M0;N1;Stage IIB;6th;T2;NA;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;NA;-23741;241;NA;0;365;11.99;0:DiseaseFree;NA;NA;NA;Positive;NA;NA;Surgical Resection;5/27/11;3867;NA;NA;NA;NA;NA;Positive;NA;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;NA;YES;2009;NO;NA;NA;NA;NA;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;NA;NA;NA;108;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;MDLC;1199;0:LIVING;dcfd0b1d-5707-44a6-b225-5e8f7cea5ca1;8deb20df-b01a-40d8-a398-5dbb14786792;TCGA-A8-A097.5B867CB6-F94D-435D-83E3-0ADB814B8077.pdf;Negative;NA;Left;NA;NO;NA;NA;NA;NA;Positive;NA;NA;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;A8;36;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A8-A099;TCGA-A8-A099-01;76;MX;N3a;Stage X;6th;T4b;NA;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;NA;-28063;180;NA;0;304;9.99;0:DiseaseFree;NA;NA;NA;Positive;NA;NA;Surgical Resection;5/27/11;1923;NA;NA;NA;NA;NA;Positive;NA;3;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;NA;YES;2009;NO;NA;NA;NA;NA;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;NA;NA;NA;24;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;MDLC;999;0:LIVING;e98b69bc-766a-485f-b5e8-9166b8d457b3;582b2af4-08e5-44d8-996d-d00db1e98413;TCGA-A8-A099.34499A83-DFCE-4DB8-BAA0-A7590AF8BC07.pdf;NA;NA;Right;NA;NO;NA;NA;NA;NA;Positive;NA;NA;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;A8;8;NA;Breast
brca_tcga_pub2015;TCGA-A8-A09A;TCGA-A8-A09A-01;40;M0;NX;Stage X;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-14883;180;NA;0;304;9.99;0:DiseaseFree;NA;NA;NA;Positive;NA;NA;Surgical Resection;5/27/11;4260;NA;NA;NA;NA;NA;Negative;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2009;NO;NA;NA;NA;NA;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NA;NA;NA;NA;103;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;999;0:LIVING;b205bba0-1870-4458-9088-8817e20389fe;035ceab2-5468-41d5-9adf-f669225be543;TCGA-A8-A09A.5A6E0F10-758E-4DC1-A5C7-57D5DF9B25EF.pdf;Positive;NA;Left;NA;NO;NA;NA;NA;NA;Positive;NA;NA;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;A8;3433333333;WITH TUMOR;Breast
brca_tcga_pub2015;TCGA-A8-A09B;TCGA-A8-A09B-01;58;M0;N1a;Stage IIIB;6th;T4b;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-21520;210;NA;0;365;11.99;0:DiseaseFree;NA;NA;NA;Positive;NA;NA;Surgical Resection;5/27/11;5104;NA;NA;NA;NA;NA;Negative;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2009;NO;NA;NA;NA;NA;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;NA;NA;NA;34;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;1199;0:LIVING;3828b534-908e-4953-a3fb-07d01cf49c7d;250c0ab4-ef0f-4340-a86d-628b98f8acca;TCGA-A8-A09B.5D439E4F-F1B7-41F7-BF1D-1F6E93D6427D.pdf;Negative;NA;Left;NA;NO;NA;NA;NA;NA;Positive;NA;NA;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;A8;1133333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A8-A09C;TCGA-A8-A09C-01;69;MX;N0;Stage X;6th;T2;NA;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;NA;-25355;180;NA;0;31;1.02;0:DiseaseFree;NA;NA;NA;Positive;NA;NA;Surgical resection;5/27/11;4981;NA;NA;NA;NA;NA;Negative;NA;0;NA;NA;Infiltrating Ductal Carcinoma;NA;No;Yes;C50.9;1/03/8500;C50.9;Negative;NA;YES;2009;NO;NA;NA;NA;NA;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;NA;NA;NA;20;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;MDLC;102;0:LIVING;80f3f48a-cc21-415c-b181-c77e7ba1c563;0856c285-b57f-47ac-be8b-865dc2ddb58f;TCGA-A8-A09C.1E002C47-CEC6-491C-9E67-B289687D5B66.pdf;NA;NA;Right;NA;NO;NA;NA;NA;NA;Positive;NA;NA;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;A8;666666667;NA;Breast
brca_tcga_pub2015;TCGA-A8-A09D;TCGA-A8-A09D-01;47;M0;N1;Stage IIB;5th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-17440;1033;NA;0;396;50;0:DiseaseFree;NA;NA;NA;Positive;NA;NA;Surgical Resection;5/27/11;2338;NA;NA;NA;NA;NA;Negative;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2007;NO;NA;NA;NA;NA;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;NA;NA;NA;33;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;50;0:LIVING;36449392-de76-4ee9-bc09-627a07e18727;ac9318f5-9e1f-4340-8da6-3815fff8bff5;TCGA-A8-A09D.C4A1A482-6AE5-4807-BA05-C73AC0898546.pdf;Negative;NA;Right Lower Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;NA;NA;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;A8;11;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A8-A09G;TCGA-A8-A09G-01;79;M0;N3a;Stage IIIC;6th;T3;NA;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;NA;-29006;759;NA;0;0;0;0:DiseaseFree;NA;NA;NA;Positive;NA;NA;Surgical Resection;5/27/11;2213;NA;NA;NA;NA;NA;Positive;NA;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;NA;YES;2008;NO;NA;NA;NA;NA;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;NA;NA;NA;211;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;MDLC;0;0:LIVING;3927f736-3b5c-48c8-9d9e-83669ec44770;084b2d8f-96a8-41f1-844d-20004cd665e7;TCGA-A8-A09G.2728DB14-66D5-4E67-B9B6-63D93DBF509C.pdf;Negative;NA;Right Lower Outer Quadrant;NA;NO;NA;NA;NA;NA;Negative;NA;NA;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;A8;7033333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A8-A09I;TCGA-A8-A09I-01;84;M0;N0;Stage IIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-30711;698;NA;0;1006;45.04;0:DiseaseFree;NA;NA;NA;Positive;NA;NA;Surgical Resection;5/27/11;3571;NA;NA;NA;NA;NA;Positive;NA;3;NA;NA;Infiltrating Ductal Carcinoma;NA;No;Yes;C50.9;1/03/8500;C50.9;Positive;NA;YES;2008;NO;NA;NA;NA;NA;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;NA;NA;NA;112;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;4504;0:LIVING;1557183c-aedd-4df6-b98a-3654667f7b69;a09a99f9-33e3-45d5-bfc2-f57ce149a527;TCGA-A8-A09I.AF12859A-D67A-488D-8BC2-ED28698F2ACA.pdf;Negative;NA;Right Lower Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;NA;NA;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;A8;3733333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A8-A09K;TCGA-A8-A09K-01;68;M0;N1;Stage IIA;6th;T1c;NA;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;NA;-24960;788;NA;0;912;29.96;0:DiseaseFree;NA;NA;NA;Positive;NA;NA;Surgical resection;5/27/11;5029;NA;NA;NA;NA;NA;Negative;NA;0;NA;NA;Infiltrating Ductal Carcinoma;NA;Yes;Yes;C50.9;1/03/8500;C50.9;Negative;NA;YES;2008;NO;NA;NA;NA;NA;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;NA;NA;NA;37;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;MDLC;2996;0:LIVING;6f959c92-b79f-4f84-9ee5-d07d3212d52d;6871927f-1488-4366-8545-439557a377aa;TCGA-A8-A09K.56C24ABB-CF1D-447F-A5A8-B762C4B01566.pdf;Negative;NA;Left Lower Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;NA;NA;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;A8;1266666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A8-A09M;TCGA-A8-A09M-01;75;M0;N3a;Stage IIIC;6th;T2;NA;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;NA;-27455;333;NA;0;457;33.05;0:DiseaseFree;NA;NA;NA;Positive;NA;NA;Surgical Resection;5/27/11;4565;NA;NA;NA;NA;NA;Negative;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2009;NO;NA;NA;NA;NA;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;NA;NA;NA;90;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;MDLC;3305;0:LIVING;626b4ff0-2188-4a14-aac8-6703c624917f;6d1ce13f-530e-433f-b2a3-f30793b0b003;TCGA-A8-A09M.EBBF2A70-2773-40FA-823A-E608ABFEF591.pdf;Negative;NA;Right Lower Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;NA;NA;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;A8;3;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A8-A09N;TCGA-A8-A09N-01;57;M0;N3a;Stage IIIC;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-21002;1276;NA;0;31;1.02;0:DiseaseFree;NA;NA;NA;Positive;NA;NA;Surgical Resection;5/27/11;6977;NA;NA;NA;NA;NA;Positive;NA;3;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;NA;YES;2006;NO;NA;NA;NA;NA;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;NA;NA;NA;57;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;102;0:LIVING;33919e92-4ea9-47e5-a6f4-36e51845d50f;03115606-c46f-40ef-a95f-cdc1c174797d;TCGA-A8-A09N.F5A97F05-4B5C-4B10-BF10-5DDE7D412BCF.pdf;Negative;NA;Right Lower Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;NA;NA;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;A8;19;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A8-A09Q;TCGA-A8-A09Q-01;83;M0;N2a;Stage IIIB;6th;T4b;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-30528;637;NA;0;761;25;0:DiseaseFree;NA;NA;NA;Positive;NA;NA;Surgical Resection;5/27/11;5959;NA;NA;NA;NA;NA;Negative;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2008;NO;NA;NA;NA;NA;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;NA;NA;NA;87;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;25;0:LIVING;09c2bc35-c21f-4aa4-ac30-0d8db02ad811;6f8b48ba-ef24-4d33-a0c3-bc900a6c8cd2;TCGA-A8-A09Q.46C0AB7B-82FC-4D06-9F26-22AEC8BEEDA7.pdf;Positive;NA;Left Lower Inner Quadrant;NA;NO;NA;NA;NA;NA;Positive;NA;NA;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;A8;2933333333;WITH TUMOR;Breast
brca_tcga_pub2015;TCGA-A8-A09R;TCGA-A8-A09R-01;82;M0;N1;Stage IIB;6th;T2;NA;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;NA;-30196;149;NA;0;273;8.97;0:DiseaseFree;NA;NA;NA;Positive;NA;NA;Surgical Resection;5/27/11;4749;NA;NA;NA;NA;NA;Negative;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2009;NO;NA;NA;NA;NA;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;NA;NA;NA;51;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;MDLC;897;0:LIVING;cb0a2055-2168-4454-8755-47dd613db36f;3ed5e5ce-12c3-4d15-9414-0b76f874e43c;TCGA-A8-A09R.5E615F92-6FD0-48C7-AC37-78526974BCFC.pdf;Negative;NA;Left Lower Inner Quadrant;NA;NO;NA;NA;NA;NA;Positive;NA;NA;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;A8;17;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A8-A09T;TCGA-A8-A09T-01;68;MX;N0;NA;6th;T1c;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-25110;394;NA;0;579;19.02;0:DiseaseFree;NA;NA;NA;Positive;NA;NA;Surgical Resection;5/27/11;930;NA;NA;NA;NA;NA;Negative;NA;NA;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Negative;NA;YES;2009;NO;NA;NA;NA;NA;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;NA;NA;NA;23;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;BRCA;1902;0:LIVING;0adf59c6-581a-475d-a2f4-40aa40060b5b;8df411bb-1d82-4470-84ff-e2d335698d42;TCGA-A8-A09T.C616E97C-8352-4FED-9E83-558318216FB6.pdf;Negative;NA;Left;NA;NO;NA;NA;NA;NA;Positive;NA;NA;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;A8;766666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A8-A09X;TCGA-A8-A09X-01;62;M0;N3a;Stage IIIC;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-22858;302;426;0;NA;NA;NA;NA;NA;NA;Negative;NA;NA;Surgical Resection;5/27/11;1791;NA;NA;NA;NA;NA;Negative;NA;1;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Negative;NA;YES;2009;NO;NA;NA;NA;NA;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;NA;NA;NA;50;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;ILC;1399;1:DECEASED;27b05b15-a44b-45ed-a6e3-e7d1ca488ea9;5a9087b1-d001-4fcc-b061-f59e7026e711;TCGA-A8-A09X.F72703A2-2C57-459A-9015-94BD3D302491.pdf;NA;NA;Left Upper Inner Quadrant;NA;NO;NA;NA;NA;NA;Negative;NA;NA;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;A8;1666666667;NA;Breast
brca_tcga_pub2015;TCGA-A8-A09Z;TCGA-A8-A09Z-01;83;M0;N0;Stage IIB;6th;T3;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-30590;728;NA;0;0;0;0:DiseaseFree;NA;NA;NA;Positive;NA;NA;Surgical Resection;5/27/11;1205;NA;NA;NA;NA;NA;Negative;NA;1;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Negative;NA;YES;2008;NO;NA;NA;NA;NA;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;NA;NA;NA;1078;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;ILC;0;0:LIVING;81e7a3d3-be70-4834-8018-4d2cc077a4e6;600a6f89-e714-4258-b4e7-33240123bfc6;TCGA-A8-A09Z.DF890966-D14E-4EDF-B6E3-E10E40BA5B5D.pdf;Positive;NA;Right;NA;NO;NA;NA;NA;NA;Negative;NA;NA;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;A8;3593333333;WITH TUMOR;Breast
brca_tcga_pub2015;TCGA-A8-A0A1;TCGA-A8-A0A1-01;84;M0;N0;Stage IIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-30742;241;NA;0;365;11.99;0:DiseaseFree;NA;NA;NA;Positive;NA;NA;Surgical Resection;5/27/11;1170;NA;NA;NA;NA;NA;Negative;NA;NA;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Negative;NA;YES;2009;NO;NA;NA;NA;NA;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;NA;NA;NA;35;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;ILC;1199;0:LIVING;3efa245d-177d-4ef9-94f7-f554c54e345e;7d53f59e-5ae6-4325-9054-c9b1eac7983d;TCGA-A8-A0A1.3BC6CE69-2641-4B6D-85DF-E8FE838015D0.pdf;Negative;NA;Right;NA;NO;NA;NA;NA;NA;Positive;NA;NA;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;A8;1166666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A8-A0A2;TCGA-A8-A0A2-01;66;M0;N0;Stage IIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-24380;394;NA;0;579;19.02;0:DiseaseFree;NA;NA;NA;Positive;NA;NA;Surgical Resection;5/27/11;3321;NA;NA;NA;NA;NA;Negative;NA;0;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Negative;NA;YES;2009;NO;NA;NA;NA;NA;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;NA;NA;NA;23;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;ILC;1902;0:LIVING;34d5a193-85e5-4399-8a9b-e92858eafdfe;9ae522c2-0fbf-493c-b3c7-a6ccd685c787;TCGA-A8-A0A2.6443B16E-E6D9-4A1D-B950-BEEC7BAEDBBE.pdf;Negative;NA;Right Lower Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;NA;NA;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;A8;766666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A8-A0A4;TCGA-A8-A0A4-01;73;M0;N0;Stage IIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-26693;272;NA;0;396;13.01;0:DiseaseFree;NA;NA;NA;Positive;NA;NA;Surgical Resection;5/27/11;2609;NA;NA;NA;NA;NA;Negative;NA;NA;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Negative;NA;YES;2009;NO;NA;NA;NA;NA;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;NA;NA;NA;25;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;ILC;1301;0:LIVING;2cb8c866-9296-4c70-a3ea-f9a9b707895c;e315f3f0-664e-47fb-9f3a-c55b3eda826a;TCGA-A8-A0A4.25F8F043-2CD0-4344-9B4A-5BBB691B5BF9.pdf;Negative;NA;Left;NA;NO;NA;NA;NA;NA;Positive;NA;NA;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;A8;833333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A8-A0A7;TCGA-A8-A0A7-01;57;M0;N1a;Stage IIB;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-20940;302;NA;0;30;0.99;0:DiseaseFree;NA;NA;NA;Negative;NA;NA;Surgical Resection;5/27/11;491;NA;NA;NA;NA;NA;Positive;NA;3;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Positive;NA;YES;2009;NO;NA;NA;NA;NA;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;NA;NA;NA;119;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;ILC;99;0:LIVING;995fdab7-7284-4d33-befa-ec22aa7c6479;ea748969-579b-43dd-b2cd-1b0ac46b64ea;TCGA-A8-A0A7.E306BE26-0358-4BE4-AEF6-AD42CC0DA020.pdf;Negative;NA;Right Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Negative;NA;NA;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;A8;3966666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A8-A0A9;TCGA-A8-A0A9-01;80;M0;N0;Stage IIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-29370;272;NA;0;396;27;0:DiseaseFree;NA;NA;NA;Positive;NA;NA;Surgical Resection;5/27/11;4832;NA;NA;NA;NA;NA;Negative;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2009;NO;NA;NA;NA;NA;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;NA;NA;NA;45;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;27;0:LIVING;7b605fb6-d077-401e-b870-b87ddf505f82;35f3fabc-9939-43a2-8491-c3813a970d13;TCGA-A8-A0A9.8612388B-3680-4BD8-986C-E7ABE9F92F91.pdf;Negative;NA;Left Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;NA;NA;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;A8;15;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-A8-A0AD;TCGA-A8-A0AD-01;83;M0;N0;Stage I;6th;T1c;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-30407;1033;NA;0;1157;38.01;0:DiseaseFree;NA;NA;NA;Positive;NA;NA;Surgical Resection;5/27/11;1633;NA;NA;NA;NA;NA;Negative;NA;1;NA;NA;Mixed Histology (please specify);lobular/ductal;No;No;C50.9;1/03/8522;C50.9;Negative;NA;YES;2007;NO;NA;NA;NA;NA;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;NA;NA;NA;27;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;BRCA;3801;0:LIVING;af5453a9-cf1f-40de-aec4-0e0710908fb7;392933ed-ca0e-458d-b0b1-6ccfe71df1c3;TCGA-A8-A0AD.BD2AE048-BE93-4421-AD3E-BE6F9646484F.pdf;Negative;NA;Right Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;NA;NA;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;A8;9;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-AC-A23C;TCGA-AC-A23C-01;62;MX;N1;Stage IIB;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-22751;198;NA;0;29;19.22;0:DiseaseFree;NA;NA;NA;Positive;90-99%;NA;NA;7/14/11;1676;NA;NA;NA;NA;NA;Positive;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;NA;YES;2010;NO;YES;1;NA;1;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;NA;101;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;1922;0:LIVING;dfd0b7ba-c7d3-498e-b455-346301865452;9cbd4bd6-244b-4274-a230-a7bd02e79571;TCGA-AC-A23C.926E93B6-EF7C-4F13-824D-13D08B7F7938.pdf;Negative;NA;Left;NA;NO;NA;NA;NA;NA;Positive;50-59%;WHITE;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Modified Radical Mastectomy;AC;3333333333;NA;Breast
brca_tcga_pub2015;TCGA-AC-A23E;TCGA-AC-A23E-01;50;MX;N1;Stage IIB;7th;T2;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-18500;158;NA;0;72;22.93;0:DiseaseFree;NA;NA;NA;Positive;30-39%;NA;NA;7/18/11;1121;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;2010;NO;YES;1;NA;2;NA;NA;NA;NA;NO;Core needle biopsy;NA;NA;15;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;BRCA;2293;0:LIVING;e7bae6e7-f779-449d-92b9-66996041e00d;d490330a-de38-478f-9504-a69260ab3967;TCGA-AC-A23E.C976ACED-7FF8-4287-9D68-C6FD17895FC0.pdf;Negative;NA;Right;NA;NA;NA;NA;NA;NA;Positive;80-89%;WHITE;NA;NA;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Modified Radical Mastectomy;AC;5;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-AC-A23G;TCGA-AC-A23G-01;76;MX;N1;Stage IIA;6th;T1c;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-27934;1590;NA;0;330;73.85;0:DiseaseFree;NA;NA;NA;Positive;90-99%;NA;Right Total Mastectomy and Sentinel Node Biopsy;7/14/11;984;NA;NA;NA;NA;NA;Positive;NA;NA;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Positive;NA;YES;2006;NO;YES;2;NA;8;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;NA;22;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;ILC;7385;0:LIVING;A721DAC6-0126-476C-B2D4-2DBF7406454B;05BF18CD-2346-4EF9-B6DF-58AA8A67E8A5;TCGA-AC-A23G.810663DD-1718-4FD6-B9C2-77B4C091B3F1.pdf;Negative;NA;Right Upper Inner Quadrant;NA;NO;NA;NA;NA;NA;Positive;80-89%;WHITE;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;AC;733333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-AC-A23H;TCGA-AC-A23H-01;90;M0;NX;Stage IIA;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-32873;478;NA;0;81;NA;NA;NA;NA;NA;Positive;10-19%;NOT HISPANIC OR LATINO;NA;7/13/11;2724;NA;NA;NA;NA;NA;Positive;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;NA;YES;2009;NO;NO;NA;NA;NA;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;NA;3860;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;572;1:DECEASED;7dcf550c-90ce-4f63-aecd-0e46897e2a3e;d7e3b628-d5fd-4e79-9c4a-6409330fb8a7;TCGA-AC-A23H.A7C7D409-D086-4A9B-8C8F-E7E231D5891D.pdf;Negative;NA;Right Upper Inner Quadrant|Right Lower Inner Quadrant;NA;NO;NA;NA;NA;NA;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Simple Mastectomy;AC;1284333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-AC-A2B8;TCGA-AC-A2B8-01;84;M0;N0 (i-);Stage IIB;7th;T3;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-31003;101;NA;0;45;21.48;1:Recurred/Progressed;NA;NA;NA;Positive;90-99%;NOT HISPANIC OR LATINO;NA;9/12/11;1088;NA;NA;NA;NA;NA;Negative;NA;NA;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Negative;NA;YES;2011;NO;YES;0;0;1;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;NA;86;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;ILC;2224;0:LIVING;6E126B73-D3E8-4641-A128-306F3B313E40;FABFEC99-220B-4A94-A8FE-01DFD71487F6;TCGA-AC-A2B8.3D878253-22B3-4A53-AE54-C0D95E085DB1.pdf;Negative;NA;Right;NA;YES;NA;NA;NA;NA;Positive;90-99%;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Simple Mastectomy;AC;2866666667;NA;Breast
brca_tcga_pub2015;TCGA-AC-A2BK;TCGA-AC-A2BK-01;78;MX;N2a;Stage IIIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-28625;1717;NA;0;1172;73;0:DiseaseFree;NA;NA;NA;Negative;NA;NA;NA;9/16/11;5065;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2006;NO;YES;6;NA;23;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;NO;74;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;73;0:LIVING;6FA2A667-9C36-4526-8A58-1975E863A806;B85BE663-EDBA-4E1E-A10C-D0297744A0E9;TCGA-AC-A2BK.3E54B0CE-8863-4728-BC95-A47C1869F52A.pdf;Negative;NA;Left Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Negative;NA;BLACK OR AFRICAN AMERICAN;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;AC;2466666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-AC-A2BM;TCGA-AC-A2BM-01;41;MX;N1a;Stage IIB;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-15212;2164;NA;0;1162;99.28;0:DiseaseFree;NA;NA;NA;Positive;60-69%;NA;NA;9/12/11;3919;NA;NA;NA;NA;NA;Negative;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;2005;NO;YES;1;1;13;NA;NA;NA;NA;NO;Tumor resection;NA;YES;20;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;9928;0:LIVING;8159FF7B-89F4-411A-9B9C-491F1CB3EB34;8D65B4EE-183B-4767-9091-DEC23A17AF93;TCGA-AC-A2BM.9F00B6F4-EE91-4A18-B533-127E39EF8554.pdf;Negative;NA;Left Upper Inner Quadrant;NA;NO;NA;NA;NA;NA;Positive;10-19%;BLACK OR AFRICAN AMERICAN;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Modified Radical Mastectomy;AC;666666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-AC-A2FB;TCGA-AC-A2FB-01;65;MX;N0;Stage IIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-23851;576;NA;0;44;40.54;0:DiseaseFree;NA;NA;3 Point Scale;Positive;90-99%;NOT HISPANIC OR LATINO;NA;9/20/11;24;NA;NA;NA;NA;NA;NA;10-19%;3;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Positive;2;YES;2009;NO;YES;0;NA;1;NA;NA;NA;NA;NO;Core needle biopsy;NA;NO;15;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;ILC;4054;0:LIVING;02BBB632-0F7F-439D-B8F0-C86A06237424;7E2ED541-38EE-473F-AC5D-3CAE6F5D9A56;TCGA-AC-A2FB.F6CFE506-16BA-475A-A81F-1AC4B2EFE24A.pdf;Negative;NA;Left Upper Inner Quadrant;NA;NO;NA;3+;NA;3 Point Scale;Positive;<10%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Simple Mastectomy;AC;5;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-AC-A2FE;TCGA-AC-A2FE-01;62;MX;N3a;Stage IIIC;6th;T3;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-22746;2228;NA;0;791;82;1:Recurred/Progressed;NA;NA;NA;Positive;60-69%;NOT HISPANIC OR LATINO;NA;12/3/12;1862;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;NA;NA;YES;2005;NO;YES;18;NA;18;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Fine needle aspiration biopsy;NA;NO;24;YES;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;ILC;866;1:DECEASED;F6EEBD4B-B63A-4A9C-92D3-0D954A8A6655;9439BB31-588C-433B-A7A5-787D8B496F57;TCGA-AC-A2FE.F694CBD6-880D-40C7-AB17-D0AD02B7F06B.pdf;Negative;YES;Right Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;<10%;WHITE;YES;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Modified Radical Mastectomy;AC;8;WITH TUMOR;Breast
brca_tcga_pub2015;TCGA-AC-A2FF;TCGA-AC-A2FF-01;40;MX;N1;Stage IIB;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;;1904;NA;0;1686;90.64;0:DiseaseFree;NA;NA;NA;Positive;30-39%;NOT HISPANIC OR LATINO;NA;9/23/11;11;NA;NA;1.7;NA;NA;Negative;NA;NA;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;NA;NA;YES;2006;NO;YES;3;0;7;NA;NA;NA;NA;NO;Core needle biopsy;NA;YES;15;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;ILC;9064;0:LIVING;3CA67CD0-81DA-4F68-A9FA-F1A8C013C28D;62D4D442-98A0-4540-B22A-4ACF1FBFC40B;TCGA-AC-A2FF.E6897E14-465A-486A-A6AD-FCFED21629F2.pdf;Negative;NA;Right;NA;NO;NA;NA;NA;NA;Positive;70-79%;ASIAN;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Lumpectomy;AC;5;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-AC-A2FG;TCGA-AC-A2FG-01;79;MX;N1a;Stage IIB;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-29211;1517;NA;0;1125;60.87;0:DiseaseFree;NA;NA;NA;Positive;90-99%;NA;NA;9/21/11;788;NA;NA;NA;NA;NA;Negative;NA;NA;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;NA;NA;YES;2007;NO;YES;1;1;11;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;YES;38;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;ILC;6087;0:LIVING;39CDA4C9-E1C8-44C2-BAB7-F5849C12F879;891365B0-3BB1-4F7C-B351-6191B18EE9D7;TCGA-AC-A2FG.C1ABCD83-40EA-4FF7-BEB6-69679589E8E7.pdf;Negative;NA;Left Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Modified Radical Mastectomy;AC;1266666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-AC-A2FK;TCGA-AC-A2FK-01;45;M0;N3a;Stage IIIC;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-16627;1833;NA;0;1180;87.06;0:DiseaseFree;NA;NA;NA;Positive;90-99%;HISPANIC OR LATINO;NA;9/13/11;0;NA;NA;NA;NA;NA;Negative;NA;NA;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;NA;NA;YES;2006;NO;YES;3;NA;3;NA;NA;NA;NA;NO;Core needle biopsy;NA;NA;1;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;ILC;8706;0:LIVING;79126E88-9CF8-45FF-BF91-A98DA3B304D7;5D7A6563-6E74-48CB-A6A9-6D860759DDAC;TCGA-AC-A2FK.1CF3FA64-EAE6-4A18-9B51-F5980A885371.pdf;Negative;NA;Left Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;90-99%;WHITE;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Modified Radical Mastectomy;AC;33333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-AC-A2FM;TCGA-AC-A2FM-01;87;M0;N1mi;Stage IIB;6th;T2;NA;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;NA;-31805;2606;792;0;NA;25.62;1:Recurred/Progressed;NA;NA;NA;NA;NA;NOT HISPANIC OR LATINO;NA;2/22/12;4843;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;NA;NA;YES;2004;NO;YES;0;0;2;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;YES;Core needle biopsy;NA;YES;39;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;MDLC;2602;1:DECEASED;B6B1DC9A-91F4-4B0A-AFD5-62C9A90C0D5E;8E391BEC-541C-49DC-A0A8-5ECE5F268F1F;TCGA-AC-A2FM.83BA3E82-E8E4-4A70-ADEE-A1360940EECE.pdf;Negative;NA;Right Upper Inner Quadrant;NA;NO;NA;NA;NA;NA;NA;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Modified Radical Mastectomy;AC;13;WITH TUMOR;Breast
brca_tcga_pub2015;TCGA-AC-A2FO;TCGA-AC-A2FO-01;65;MX;N1;Stage IIB;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-23928;2051;NA;0;1542;74.08;0:DiseaseFree;NA;NA;NA;Positive;90-99%;NOT HISPANIC OR LATINO;NA;9/21/11;1185;NA;NA;NA;NA;NA;Indeterminate;NA;NA;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Negative;NA;YES;2005;NO;YES;2;NA;10;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;NO;22;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;ILC;7408;0:LIVING;F5D4C2D3-CC69-4B38-8551-0917E3622A68;6AB6C7D7-A0B5-4830-94A3-F16BC11EF953;TCGA-AC-A2FO.5A7EB73F-E681-46CC-B2D6-C87EEAB0AC99.pdf;Negative;NA;Left Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;Other (specify);Sentinel lymph node plus Level I and Level II lymph nodes;NA;NA;Simple Mastectomy;AC;733333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-AC-A2QH;TCGA-AC-A2QH-01;58;MX;N0;Stage IIB;7th;T3;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-21488;108;NA;0;31;33.02;0:DiseaseFree;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;10/18/11;4092;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Metaplastic Carcinoma;NA;No;No;C50.9;1/03/8575;C50.9;Negative;NA;YES;2011;NO;YES;0;0;22;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;YES;59;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;BRCA;3302;0:LIVING;67C5F371-3FA9-47C5-8B15-C2DD9ACC8519;FD735DC5-2EC3-43BD-B1B1-8FA811BE0633;TCGA-AC-A2QH.C2A0E948-2B9E-4E49-90C4-57CE4C4A95B3.pdf;Negative;NA;Right Upper Outer Quadrant;NA;YES;NA;NA;NA;NA;Negative;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;AC;1966666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-AC-A2QI;TCGA-AC-A2QI-01;76;MX;N1a;Stage IIIA;7th;T3;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-27865;91;NA;0;28;19.32;0:DiseaseFree;NA;NA;NA;Positive;90-99%;NOT HISPANIC OR LATINO;Total Mastectomy;10/18/11;938;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Negative;NA;YES;2011;NO;YES;2;NA;2;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;NA;60;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;ILC;1932;0:LIVING;C57835BE-77AB-4CF5-9B23-62C11A7B2EAF;08F10BB1-6DD4-4F36-86A3-1801F9762187;TCGA-AC-A2QI.5CF85AF1-D227-430C-99CD-C2A524CFFA29.pdf;Negative;NA;Right;NA;YES;NA;NA;NA;NA;Negative;NA;WHITE;NA;NO;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Other;AC;2;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-AC-A2QJ;TCGA-AC-A2QJ-01;48;M0;N0;Stage IIIB;7th;T4b;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-17569;160;NA;0;69;7.79;1:Recurred/Progressed;NA;NA;NA;Negative;NA;HISPANIC OR LATINO;Mastectomy;10/18/11;1854;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Metaplastic Carcinoma;NA;No;No;C50.9;1/03/8575;C50.9;Negative;NA;YES;2011;NO;YES;0;NA;2;NA;Peri (6-12 months since last menstrual period);NA;NA;NO;Core needle biopsy;NA;NO;33;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;BRCA;1465;1:DECEASED;D9FD2724-7DB0-4AF3-AC14-217BDFA5203F;A3AFBB9F-F611-4BF7-A7F7-8DB59022F66F;TCGA-AC-A2QJ.E422C6E8-084F-42B8-84E7-4EF387F098C7.pdf;Negative;NA;Left Upper Outer Quadrant|Left Lower Outer Quadrant;NA;YES;NA;NA;NA;NA;Negative;NA;WHITE;NA;NO;1;Primary;Female;Matched;Other (specify);Sentinel lymph node and axillary lymph node biopsy;NA;NA;Other;AC;11;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-AC-A3BB;TCGA-AC-A3BB-01;46;MX;N2a;Stage IIIA;7th;T3;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-16983;106;NA;0;30;32.42;0:DiseaseFree;NA;NA;NA;Positive;90-99%;NOT HISPANIC OR LATINO;NA;2/3/12;1171;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Negative;NA;YES;2011;NO;NA;5;NA;14;NA;NA;NA;NA;NO;Core needle biopsy;NA;NA;72;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;ILC;3242;0:LIVING;048549CF-D0A5-4743-A0A1-2004F7CC2B08;2FA19AF2-6FA0-4164-A0BB-8524D6085D80;TCGA-AC-A3BB.4D864947-076C-4A66-940D-682E75E525A2.pdf;Negative;NA;Right Upper Outer Quadrant;NA;YES;NA;NA;NA;NA;Positive;90-99%;BLACK OR AFRICAN AMERICAN;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;AC;2366666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-AC-A3EH;TCGA-AC-A3EH-01;79;M0;N3;Stage IIIC;7th;T3;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-29014;67;NA;0;17;NA;NA;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;9/24/12;3579;NA;NA;NA;NA;NA;Negative;NA;NA;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8022;C50.9;Negative;NA;YES;2011;NO;YES;12;NA;12;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Excisional Biopsy;NA;NO;37;NO;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;ILC;647;1:DECEASED;FAC173A8-1613-4BD4-87BA-83A2CFE8A37D;075393F6-0404-410E-9FD5-7C2C63D3FA84;TCGA-AC-A3EH.3094774B-B764-4D60-BFF3-48FEF39F4BEA.pdf;Negative;NA;Right;NA;YES;NA;NA;NA;NA;Negative;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;AC;1233333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-AC-A3HN;TCGA-AC-A3HN-01;87;MX;N1a;Stage IIB;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-32061;97;NA;0;21;16.29;0:DiseaseFree;NA;NA;3 Point Scale;Positive;90-99%;NOT HISPANIC OR LATINO;NA;4/13/12;1499;NA;NA;NA;NA;NA;NA;<10%;NA;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Negative;3;YES;2011;NO;YES;2;0;3;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;YES;15;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;ILC;1629;0:LIVING;E37AE674-A107-4EB3-94D8-B86B0035A9F7;96E71B7B-D32B-48BC-858D-20F7C8B7812D;TCGA-AC-A3HN.F0308FC8-D8B4-487F-A072-05E66D01842A.pdf;Negative;NA;Left Upper Inner Quadrant;NA;YES;NA;1+;NA;3 Point Scale;Positive;<10%;WHITE;NA;NO;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Simple Mastectomy;AC;5;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-AC-A3OD;TCGA-AC-A3OD-01;68;MX;N1mi;Stage IIB;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-25186;63;NA;0;35;14.82;0:DiseaseFree;NA;NA;NA;Positive;90-99%;NOT HISPANIC OR LATINO;NA;4/19/12;2670;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Negative;NA;YES;2011;NO;YES;1;NA;3;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;YES;20;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;ILC;1482;0:LIVING;F2622CDB-AC92-42B3-A1CA-67E133C3DD4A;42C7E92B-6820-4562-9E32-A424A99A6CBA;TCGA-AC-A3OD.9F7E2B98-29E7-465F-AE12-33D78FDFD71A.pdf;Negative;NA;Left;NA;YES;NA;NA;NA;NA;Positive;90-99%;WHITE;NA;NO;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Modified Radical Mastectomy;AC;666666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-AC-A3QP;TCGA-AC-A3QP-01;79;MX;N1mi;Stage IIB;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;2.2;-29113;184;NA;0;286;22.17;0:DiseaseFree;NA;NA;NA;Positive;70-79%;NOT HISPANIC OR LATINO;NA;7/5/12;716;30;NA;1.2;2.6;NA;Negative;NA;2;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Equivocal;NA;YES;2011;NO;YES;1;1;2;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;NA;24;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;ILC;2217;0:LIVING;6F4C8D30-47FB-47DF-9EB7-4E5881E3711E;A14E7E3D-0593-4D69-B17B-E79DFB065A0F;TCGA-AC-A3QP.14E2FC4E-7205-4929-81B5-7FF3006F08AD.pdf;Negative;NA;Right;NA;YES;NA;NA;NA;NA;Positive;90-99%;WHITE;NA;NO;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Lumpectomy;AC;833333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-AC-A3TM;TCGA-AC-A3TM-01;50;M0;N1mi;Stage IIIA;7th;T3;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;1.9;-18535;136;NA;0;93;25.03;0:DiseaseFree;NA;NA;NA;Positive;90-99%;NOT HISPANIC OR LATINO;NA;8/1/12;1223;60;NA;1.9;3.3;NA;Equivocal;NA;2;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Equivocal;NA;YES;2011;NO;YES;0;2;4;NA;Peri (6-12 months since last menstrual period);NA;NA;NO;Core needle biopsy;NA;YES;39;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;2503;0:LIVING;67C73260-A242-4BBA-87C5-D2302556DFF7;4EE0389F-33EC-4A69-BC02-1C458D812CB2;TCGA-AC-A3TM.87DB9AD3-7640-4A78-B401-D5562D03BA76.pdf;Negative;NA;Right;NA;YES;NA;NA;NA;NA;Positive;90-99%;WHITE;NA;NO;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Simple Mastectomy;AC;13;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-AC-A3TN;TCGA-AC-A3TN-01;75;MX;N0;Stage IIB;7th;T3;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-27421;78;NA;0;34;14.98;0:DiseaseFree;NA;NA;NA;Positive;90-99%;NOT HISPANIC OR LATINO;NA;8/1/12;710;NA;NA;NA;NA;NA;Indeterminate;NA;NA;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Positive;NA;YES;2012;NO;YES;0;NA;2;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Other method, specify:;NA;NA;77;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;ILC;1498;0:LIVING;81B70C58-4A12-448C-A594-2ADE44F6A0AE;70E344F1-A29C-42C7-9FE8-DA9219D45158;TCGA-AC-A3TN.1A0D203A-BC4B-441F-97F6-D1FF7E959262.pdf;Negative;NA;Right;NA;YES;NA;NA;NA;NA;Positive;80-89%;WHITE;NA;NO;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Simple Mastectomy;AC;26;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-AC-A3W5;TCGA-AC-A3W5-01;65;MX;N0;Stage IIA;7th;T2;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-24029;120;NA;0;55;16.56;0:DiseaseFree;NA;NA;NA;Positive;50-59%;NOT HISPANIC OR LATINO;NA;9/24/12;3754;NA;NA;NA;NA;NA;Positive;NA;NA;NA;NA;Infiltrating Lobular Carcinoma;NA;No;Yes;C50.9;1/03/8520;C50.9;NA;NA;YES;2011;NO;YES;0;0;3;NA;NA;NA;NA;NA;Core needle biopsy;NA;YES;109;NO;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;BRCA;1656;0:LIVING;4C313E5B-4DC3-408E-8E92-22427F74743E;083F4985-57C0-4931-BA8A-00F565430DA9;TCGA-AC-A3W5.CA0CD57E-DA92-463E-A004-D554825A22D6.pdf;Close;NA;Right;NA;YES;NA;NA;NA;NA;Positive;30-39%;BLACK OR AFRICAN AMERICAN;NA;NO;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Lumpectomy;AC;3666666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-AC-A3W6;TCGA-AC-A3W6-01;90;MX;N1;Stage IIIA;7th;T3;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-32872;101;NA;0;51;19.78;0:DiseaseFree;NA;NA;3 Point Scale;Positive;90-99%;NOT HISPANIC OR LATINO;NA;9/24/12;1051;NA;NA;NA;NA;NA;NA;NA;3;NA;NA;Infiltrating Lobular Carcinoma;NA;No;Yes;C50.9;1/03/8520;C50.9;Negative;1;YES;2012;NO;YES;3;3;3;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;YES;170;NO;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;ILC;1978;0:LIVING;1B4CFAD1-E353-4411-97B6-2B7B9309E95E;314E66DF-0ADC-4B7F-98E0-A32929192C71;TCGA-AC-A3W6.B52E150F-5B34-482A-84E7-1739B9AC09B7.pdf;Negative;NA;Right;NA;YES;NA;1+;NA;3 Point Scale;Positive;20-29%;WHITE;NA;NO;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Modified Radical Mastectomy;AC;5666666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-AC-A3W7;TCGA-AC-A3W7-01;66;MX;N1a;Stage IIB;7th;T2;NA;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;NA;-24327;65;NA;0;192;15.47;0:DiseaseFree;NA;NA;NA;Positive;90-99%;NOT HISPANIC OR LATINO;NA;10/17/12;1454;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Negative;NA;YES;2012;NO;YES;1;NA;2;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NO;54;NO;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;MDLC;1547;0:LIVING;2481A671-760B-428C-968D-42E25FD42AC5;ECE8AB6E-9A67-440A-8F3E-C80F3820474F;TCGA-AC-A3W7.3B77A3E1-AB8F-47B2-A5CC-A3B593A055CE.pdf;Negative;NA;Right Upper Outer Quadrant;NA;YES;NA;NA;NA;NA;Negative;<10%;WHITE;NA;NO;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Simple Mastectomy;AC;18;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-AC-A3YI;TCGA-AC-A3YI-01;74;MX;N3a;Stage IIIC;7th;T1c;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-27143;87;NA;0;47;23.23;0:DiseaseFree;NA;NA;NA;Positive;90-99%;NOT HISPANIC OR LATINO;NA;10/8/12;325;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Positive;NA;YES;2012;NO;YES;12;NA;13;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NO;19;NO;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;ILC;2323;0:LIVING;A45D296E-EFC0-479E-B2F6-BAD834668CDF;EA7490BF-06AC-43E0-BB61-A2756D027836;TCGA-AC-A3YI.52CEF542-0F5B-4660-8746-2CF4A27B214E.pdf;Negative;NA;Right;NA;YES;NA;NA;NA;NA;Positive;20-29%;WHITE;NA;NO;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Lumpectomy;AC;633333333;NA;Breast
brca_tcga_pub2015;TCGA-AC-A5XS;TCGA-AC-A5XS-01;74;MX;N0;Stage IIA;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-27160;127;NA;0;47;19.32;0:DiseaseFree;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;7/15/13;2478;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Lobular Carcinoma;NA;No;Yes;C50.9;1/03/8520;C50.9;Negative;NA;YES;2012;NO;YES;0;NA;8;NA;NA;NA;NA;NA;Core needle biopsy;NA;NO;388;NO;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;ILC;1932;0:LIVING;D9627184-B972-4E00-8C11-B0B946AC357A;3D137341-F9A3-4CF0-8F26-ACAD49FA113E;TCGA-AC-A5XS.C4F259BA-7C00-4326-ACB2-924C4AE33E87.pdf;Negative;NA;Left Upper Inner Quadrant;NA;YES;NA;NA;NA;NA;Positive;NA;WHITE;NA;NO;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Simple Mastectomy;AC;1293333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-AC-A62Y;TCGA-AC-A62Y-01;79;MX;N1;Stage IIB;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-28876;112;NA;0;55;17.41;0:DiseaseFree;NA;NA;3 Point Scale;Positive;90-99%;NOT HISPANIC OR LATINO;NA;9/19/13;4145;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Negative;NA;YES;2012;NO;YES;1;NA;1;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NO;56;NO;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;ILC;1741;0:LIVING;05AF737D-89AA-49B6-97B2-28B8AC8BD2CF;A76BC38A-9EEF-4E6C-B021-F940FF5137B8;TCGA-AC-A62Y.83BCCC3C-0384-45CD-84B4-67E2EDE822EE.pdf;Positive;NA;Right;NA;YES;NA;NA;NA;3 Point Scale;Positive;80-89%;WHITE;NA;NO;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Modified Radical Mastectomy;AC;1866666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-AN-A04D;TCGA-AN-A04D-01;58;M0;N1;Stage IIB;NA;T2;Allred (Biocare);Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-21426;676;NA;0;52;1.71;0:DiseaseFree;NA;0;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;12/20/10;3686;NA;NA;NA;NA;NA;NA;NA;0;Dako Hercept Test;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;0;YES;2008;NO;NA;2;0;15;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Tumor resection;NA;NO;79;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;171;0:LIVING;49717f75-0f2d-4e1c-9a12-f1cd7877b80a;cbf66244-42c8-4df6-aca7-932e77bb5e0e;TCGA-AN-A04D.A3CB59DE-5893-4FA2-B4D5-EDA612480E76.pdf;Positive;NA;Left Upper Outer Quadrant;NA;NO;Allred (Biocare);0;0;NA;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;No axillary staging;NA;Modified radical mastectomy;NA;Simple Mastectomy;AN;2666666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-AN-A0AJ;TCGA-AN-A0AJ-01;79;M0;N0;Stage IIB;NA;T3;dextran coated charcoal;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-29131;63;NA;0;244;9.95;0:DiseaseFree;NA;230;NA;Positive;80-89%;NOT HISPANIC OR LATINO;NA;12/20/10;6855;NA;NA;NA;NA;NA;NA;90-99%;3;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8522;C50.9;Positive;3;YES;2010;NO;NA;0;0;9;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Tumor resection;NA;NO;65;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;995;0:LIVING;9646160a-f1f9-437b-8c7d-efb0b57bfb97;1c0714ec-70a9-4902-bd98-8b0fb002c084;TCGA-AN-A0AJ.6E2365F3-0875-4949-8409-7E26BBCDE700.pdf;Negative;NA;Left Upper Outer Quadrant;NA;NO;dextran coated charcoal;2+;120;NA;Positive;40-49%;WHITE;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;AN;2166666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-AN-A0AK;TCGA-AN-A0AK-01;76;M0;N0;Stage IIA;NA;T2;dextran coated charcoal;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-27977;58;NA;0;224;7.36;0:DiseaseFree;NA;230;NA;Positive;80-89%;NOT HISPANIC OR LATINO;NA;12/21/10;2818;NA;NA;NA;NA;NA;NA;70-79%;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;3;YES;2010;NO;NA;0;0;11;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Tumor resection;NA;NO;1053;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;736;0:LIVING;9e894662-b718-40f8-8899-b5e036cfbd76;fe23a254-a0a4-452c-a2ba-685f66738a86;TCGA-AN-A0AK.12683FCC-4828-4D9A-9B35-E4B7295CC417.pdf;Negative;NA;Left Upper Outer Quadrant;NA;NO;dextran coated charcoal;0;NA;NA;Negative;<10%;WHITE;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;AN;3513333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-AN-A0AL;TCGA-AN-A0AL-01;41;M0;N0;Stage IIIB;7th;T4;dextran coated charcoal;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-15286;49;NA;0;198;7.46;0:DiseaseFree;NA;NA;NA;Negative;<10%;NOT HISPANIC OR LATINO;NA;12/21/10;4407;NA;NA;NA;NA;NA;NA;<10%;0;dextran coated charcoal;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;0;YES;2010;NO;NA;0;0;5;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NA;Tumor resection;NA;NO;72;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;746;0:LIVING;3e9f93c0-aa79-4b4c-bd6c-b3325912362a;5b9560c4-0632-479a-835f-67d373e59206;TCGA-AN-A0AL.20F4DBD9-02FA-4FFD-AEF5-234910D31263.pdf;Negative;NA;Left Lower Outer Quadrant;NA;NO;dextran coated charcoal;0;NA;NA;Negative;<10%;WHITE;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;AN;24;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-AN-A0AM;TCGA-AN-A0AM-01;56;M0;N0;Stage IIA;NA;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-20713;47;NA;0;5;0.16;0:DiseaseFree;NA;205;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;12/28/10;2787;NA;NA;NA;NA;NA;NA;NA;NA;NA;0;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2010;NO;NA;0;0;20;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Tumor resection;NA;NO;57;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;16;0:LIVING;00a2d166-78c9-4687-a195-3d6315c27574;2e4b5ba3-ccc8-40f6-80ac-edaea1685204;TCGA-AN-A0AM.7189A8A8-EB8B-4795-B7FE-725CCC4B7FA7.pdf;Negative;NA;Left Upper Outer Quadrant;NA;NO;NA;NA;0;NA;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;No axillary staging;NA;NA;NA;Modified Radical Mastectomy;AN;19;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-AN-A0AS;TCGA-AN-A0AS-01;70;M0;N2;Stage IIIA;NA;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-25658;33;NA;0;10;0.33;0:DiseaseFree;NA;190;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;12/28/10;2493;NA;NA;NA;NA;NA;NA;NA;0;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2010;NO;NA;4;0;9;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Tumor resection;NA;NO;42;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;33;0:LIVING;7c2a8440-0206-4039-8474-8d62f6c7de0c;9d772786-6ac9-4e52-9899-023ffa7247d2;TCGA-AN-A0AS.0D1ACC76-910E-4243-A229-5F76B5A3299A.pdf;Negative;NA;Left Upper Outer Quadrant;NA;NO;NA;0;0;NA;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;No axillary staging;NA;NA;NA;Modified Radical Mastectomy;AN;14;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-AN-A0AT;TCGA-AN-A0AT-01;62;M0;N0;Stage IIA;NA;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-22798;28;NA;0;10;0.33;0:DiseaseFree;NA;0;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;12/28/10;4552;NA;NA;NA;NA;NA;NA;NA;NA;NA;0;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2010;NO;NA;0;0;10;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Tumor resection;NA;NO;98;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;33;0:LIVING;05506f4c-e701-4a9d-ae06-97f066aade43;b2905a3f-810b-4e74-af5c-42d513d91746;TCGA-AN-A0AT.3E8F2012-A457-4358-9C8B-23292374A743.pdf;Negative;NA;Right Upper Inner Quadrant;NA;NO;NA;NA;0;NA;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;No axillary staging;NA;NA;NA;Modified Radical Mastectomy;AN;3266666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-AN-A0FF;TCGA-AN-A0FF-01;32;M0;N0;Stage IA;NA;T1b;dextran coated charcoal;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-11929;75;NA;0;172;5.65;0:DiseaseFree;NA;NA;NA;Positive;90-99%;NOT HISPANIC OR LATINO;NA;12/27/10;1509;NA;NA;NA;NA;NA;NA;<10%;0;dextran coated charcoal;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;3;YES;2010;NO;NA;0;0;14;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NA;Tumor resection;NA;NO;23;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;565;0:LIVING;d5cab7f5-e4f1-40ee-a0c8-4c8004c1c9a0;d78ecfd3-1a99-47e6-bb5f-a13c57148a76;TCGA-AN-A0FF.9B4BA15D-A071-4213-AD2C-075A04ED48CD.pdf;Negative;NA;Left Upper Outer Quadrant;NA;NO;dextran coated charcoal;3+;NA;NA;Positive;90-99%;WHITE;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;AN;766666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-AN-A0FJ;TCGA-AN-A0FJ-01;59;M1;N2;Stage IV;NA;T2;dextran coated charcoal;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-21910;70;NA;0;242;7.95;0:DiseaseFree;NA;NA;NA;Positive;10-19%;NOT HISPANIC OR LATINO;NA;12/27/10;6191;NA;NA;NA;NA;NA;NA;40-49%;1;dextran coated charcoal;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;1;YES;2010;NO;NA;8;0;14;NA;Peri (6-12 months since last menstrual period);NA;NA;NA;Tumor resection;NA;NO;71;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;795;0:LIVING;546248b0-22a0-4b70-a437-76fb0a238a0d;d09d5a48-2dc0-4d0f-8b20-d1f11a08143b;TCGA-AN-A0FJ.59163BD6-41E8-4489-81F0-036484447886.pdf;Negative;NA;Left Upper Outer Quadrant;NA;NO;dextran coated charcoal;0;NA;NA;Negative;<10%;WHITE;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;AN;24;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-AN-A0FK;TCGA-AN-A0FK-01;88;M0;N0;Stage IIIB;NA;T4;dextran coated charcoal;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-32462;69;NA;0;213;7;0:DiseaseFree;NA;230;NA;Positive;90-99%;NOT HISPANIC OR LATINO;NA;12/20/10;5521;NA;NA;NA;NA;NA;NA;20-29%;1;dextran coated charcoal;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;3;YES;2010;NO;NA;0;0;7;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Tumor resection;NA;NO;34;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;7;0:LIVING;2f4cbedf-ed7e-45a2-bf34-f1d1e696bdde;27b748ba-fef9-4eaa-96b6-a8ad31b5c478;TCGA-AN-A0FK.5F5FF3CA-2DBB-4DE1-9190-1FE36E2B5ACB.pdf;Negative;NA;Right Lower Outer Quadrant;NA;NO;dextran coated charcoal;3+;230;NA;Positive;90-99%;WHITE;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;AN;1133333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-AN-A0FL;TCGA-AN-A0FL-01;62;M0;N0;Stage IIA;NA;T2;dextran coated charcoal;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-22805;69;NA;0;231;7.59;0:DiseaseFree;NA;NA;NA;Negative;<10%;NOT HISPANIC OR LATINO;NA;12/28/10;5381;NA;NA;NA;NA;NA;NA;20-29%;1;dextran coated charcoal;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;1;YES;2010;NO;NA;0;0;8;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Tumor resection;NA;NO;149;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;BRCA;759;0:LIVING;baf1207d-7d1a-4cad-ba58-62c26be2415e;2f2d2e05-c6ea-4f29-8bed-040bd9c46911;TCGA-AN-A0FL.049A2CA6-951A-452F-963A-F54FE87ECA31.pdf;Negative;NA;Left Upper Inner Quadrant;NA;NO;dextran coated charcoal;1+;NA;NA;Negative;<10%;WHITE;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;AN;5;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-AN-A0FN;TCGA-AN-A0FN-01;61;M0;N0;Stage IA;7th;T1c;dextran coated charcoal;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;NA;-22629;57;NA;0;218;7.16;0:DiseaseFree;NA;250;NA;Positive;90-99%;NOT HISPANIC OR LATINO;NA;12/28/10;4;NA;NA;NA;NA;NA;NA;20-29%;1;dextran coated charcoal;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;3;YES;2010;NO;NA;0;0;10;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Tumor resection;NA;NO;31;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;MDLC;716;0:LIVING;c2a742fe-3e8b-4210-85a6-7191a1123609;c7da9758-e55a-4ed7-984f-cd86e2f6ea20;TCGA-AN-A0FN.6B53F577-5EB6-4AF5-9773-3654D3432BE4.pdf;Negative;NA;Right Lower Outer Quadrant;NA;NO;dextran coated charcoal;1+;NA;NA;Positive;10-19%;WHITE;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;AN;1033333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-AN-A0FS;TCGA-AN-A0FS-01;55;M0;N0;Stage IA;7th;T1c;dextran coated charcoal;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;NA;-20352;44;NA;0;191;6.9;0:DiseaseFree;NA;230;NA;Positive;90-99%;NOT HISPANIC OR LATINO;NA;12/20/10;1049;NA;NA;NA;NA;NA;NA;20-29%;1;dextran coated charcoal;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;3;YES;2010;NO;NA;0;0;14;NA;Peri (6-12 months since last menstrual period);NA;NA;NA;Tumor resection;NA;NO;47;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;MDLC;69;0:LIVING;10c9be1e-2cc0-45e4-8d2c-c013ea63ef05;181ff04b-8315-4069-a4cc-e102796ecde4;TCGA-AN-A0FS.3CD1D537-29E4-479B-99FA-26D27E192948.pdf;Negative;NA;Right Lower Outer Quadrant;NA;NO;dextran coated charcoal;0;NA;NA;Negative;<10%;WHITE;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;AN;1566666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-AN-A0FT;TCGA-AN-A0FT-01;63;M0;N1;Stage IIB;NA;T2;dextran coated charcoal;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-23300;44;NA;0;183;7.03;0:DiseaseFree;NA;230;NA;Positive;90-99%;NOT HISPANIC OR LATINO;NA;12/28/10;5805;NA;NA;NA;NA;NA;NA;90-99%;3;dextran coated charcoal;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;NA;YES;2010;NO;NA;1;0;7;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Tumor resection;NA;NO;74;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;BRCA;703;0:LIVING;baf5e81f-2322-41ec-9053-b9559a7993bc;071f43e9-e416-453b-a519-c197c5aaf1d1;TCGA-AN-A0FT.338D5387-0CFB-4D91-944F-1F054C21C769.pdf;Negative;NA;Right Lower Outer Quadrant;NA;NO;dextran coated charcoal;3+;NA;NA;Positive;90-99%;WHITE;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;AN;2466666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-AN-A0FV;TCGA-AN-A0FV-01;58;M0;N0;Stage IIA;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-21479;42;NA;0;10;0.33;0:DiseaseFree;NA;0;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;12/28/10;5399;NA;NA;NA;NA;NA;NA;NA;3;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;NA;YES;2010;NO;NA;0;0;12;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Tumor resection;NA;NO;65;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;33;0:LIVING;2e8e70f2-c781-44c2-8f12-1f8c2f536aa3;8046edc0-e5f9-42ec-85f2-6cc66596633f;TCGA-AN-A0FV.5AEE90E0-A9A1-4944-AD6A-2675764D869D.pdf;Negative;NA;Right Upper Outer Quadrant;NA;NO;NA;NA;0;NA;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;No axillary staging;NA;NA;NA;Modified Radical Mastectomy;AN;2166666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-AN-A0FW;TCGA-AN-A0FW-01;67;M0;N2;Stage IIIA;NA;T2;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-24692;41;NA;0;11;0.36;0:DiseaseFree;NA;180;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;12/28/10;1949;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2010;NO;NA;2;0;14;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Tumor resection;NA;NO;98;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;BRCA;36;0:LIVING;e112b452-8850-4353-bfed-0dbdc243290b;a4910543-8bfd-4cd9-9eab-cf16aead9537;TCGA-AN-A0FW.03BD8920-CA01-4818-BBD7-925DDD3F6908.pdf;Negative;NA;Left Upper Outer Quadrant;NA;NO;NA;NA;10;NA;Indeterminate;NA;WHITE;NA;YES;1;Primary;Female;Matched;No axillary staging;NA;NA;NA;Modified Radical Mastectomy;AN;3266666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-AN-A0FX;TCGA-AN-A0FX-01;52;M0;N0;Stage IIA;NA;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-19309;34;NA;0;10;0.33;0:DiseaseFree;NA;0;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;11/28/10;5402;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;NA;YES;2010;NO;NA;0;0;12;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Tumor resection;NA;NO;131;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;33;0:LIVING;13b860c3-8048-4dc9-9eb0-7480bc660837;78feb5be-f9d1-4cc6-baba-274136b9487c;TCGA-AN-A0FX.0CC079D3-EB90-47B5-B554-599A67C9E12A.pdf;Negative;NA;Left Upper Outer Quadrant;NA;NO;NA;NA;0;NA;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;No axillary staging;NA;NA;NA;Modified Radical Mastectomy;AN;4366666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-AN-A0FY;TCGA-AN-A0FY-01;55;M0;N0;Stage IA;7th;T1c;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-20347;34;NA;0;10;0.33;0:DiseaseFree;NA;80;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;12/29/10;3500;NA;NA;NA;NA;NA;NA;NA;0;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2010;NO;NA;0;0;11;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Tumor resection;NA;NO;60;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;33;0:LIVING;de75d0b9-0f47-4732-8df5-05c350cfcd32;76c09917-15f9-4908-ab22-ea1401abcb3b;TCGA-AN-A0FY.6C520037-2A9B-41CB-8362-97FFCA2AA6E2.pdf;Negative;NA;Left Upper Outer Quadrant;NA;NO;NA;NA;110;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;No axillary staging;NA;NA;NA;Modified Radical Mastectomy;AN;2;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-AN-A0FZ;TCGA-AN-A0FZ-01;45;M0;N2;Stage IIIA;NA;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-16533;34;NA;0;10;0.33;0:DiseaseFree;NA;120;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;12/29/10;4504;NA;NA;NA;NA;NA;NA;NA;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;NA;YES;2010;NO;NA;1;0;14;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NA;Tumor resection;NA;NO;43;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;33;0:LIVING;8240c4ae-f878-4882-aa07-7857c7ac52cf;199c6271-b0af-489c-99b8-fc76e7e66cf2;TCGA-AN-A0FZ.8CC70CDC-01EC-4E2B-84C1-F1C946602CCE.pdf;Negative;NA;Left Upper Outer Quadrant;NA;NO;NA;NA;0;NA;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;No axillary staging;NA;NA;NA;Modified Radical Mastectomy;AN;1433333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-AN-A0XU;TCGA-AN-A0XU-01;54;M0;N0;Stage IIA;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-20052;106;NA;0;10;0.33;0:DiseaseFree;NA;0;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;3/28/11;4834;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2010;NO;YES;0;NA;16;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Tumor resection;NA;NA;94;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;33;0:LIVING;a1da9db1-db11-4f4d-a249-c738db81b87e;ee368eb1-55e1-471e-b88b-bab896e37b5c;TCGA-AN-A0XU.8216B837-DCF3-4E7F-A72A-212655F394F0.pdf;Negative;NA;Left Upper Outer Quadrant;NA;NO;NA;NA;0;NA;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;NA;AN;3133333333;NA;Breast
brca_tcga_pub2015;TCGA-AO-A128;TCGA-AO-A128-01;61;M0;N0 (i-);Stage IIA;NA;T2;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;49;-22340;2960;NA;0;2877;106.7;0:DiseaseFree;NA;NA;NA;Negative;<10%;NOT HISPANIC OR LATINO;NA;12/7/10;1548;30;NA;1;52;>=2.0 Positive;Negative;<10%;0;3+ Positive;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2002;NO;NA;0;0;15;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Fine needle aspiration biopsy;NA;YES;861;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;BRCA;1067;0:LIVING;016caf42-4e19-4444-ab5d-6cf1e76c4afa;163000c7-0633-4d89-a84f-f487517248db;TCGA-AO-A128.03526CFD-0C3E-4ACB-AB26-3E0B0ED0ADA2.pdf;Negative;NA;Right Lower Outer Quadrant|Right;NA;NO;NA;NA;NA;NA;Negative;<10%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Lumpectomy;AO;2866666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-AO-A1KO;TCGA-AO-A1KO-01;46;M0;N0 (i+);Stage IIB;6th;T3;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-16817;832;NA;0;448;20.43;0:DiseaseFree;NA;NA;4 Point Scale;Positive;90-99%;NOT HISPANIC OR LATINO;NA;4/1/11;0;NA;NA;NA;NA;NA;NA;<10%;1;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Negative;4;YES;2008;NO;YES;0;1;19;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Excisional Biopsy;NA;YES;28;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;ILC;2043;0:LIVING;c25898b4-eb33-42f4-bf3f-bf532a929e7d;f4544809-7b92-40bc-b121-0db70c8af314;TCGA-AO-A1KO.15FB8CBD-85EF-45BE-8065-9F4E922D457E.pdf;Negative;NA;Left Upper Outer Quadrant|Left Lower Outer Quadrant|Left;NA;NO;NA;4+;NA;4 Point Scale;Positive;90-99%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Simple Mastectomy;AO;933333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-AO-A1KP;TCGA-AO-A1KP-01;77;M0;N1;Stage IIA;6th;T1;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-28247;2604;NA;0;2513;97.01;0:DiseaseFree;NA;NA;4 Point Scale;Positive;80-89%;NOT HISPANIC OR LATINO;NA;4/1/11;1817;NA;NA;1.3;NA;>=2.0 Positive;Negative;<10%;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;4;YES;2003;NO;YES;0;1;9;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;YES;20;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;9701;0:LIVING;3aaabc62-f5a4-4025-9b29-5adf82c86c84;b8718131-47af-4eec-b601-12fa3969ca44;TCGA-AO-A1KP.467172CC-6EA1-435D-BDC1-D65FBF8EA0E8.pdf;Negative;NA;Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left;NA;NO;NA;4+;NA;4 Point Scale;Positive;40-49%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Simple Mastectomy;AO;666666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-AO-A1KR;TCGA-AO-A1KR-01;51;M0;N0;Stage IIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-18900;1932;NA;0;2141;82.56;0:DiseaseFree;NA;NA;4 Point Scale;Negative;NA;NOT HISPANIC OR LATINO;NA;9/15/11;4509;NA;NA;NA;1;NA;Negative;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2005;NO;YES;0;0;4;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Core needle biopsy;NA;YES;57;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;8256;0:LIVING;b7f74ae1-6f58-447c-be50-a7666eb19d9a;00a59c97-91b4-413e-8d9e-674753997221;TCGA-AO-A1KR.FF188295-E139-4AEE-8EE8-364536F2BBE8.pdf;Negative;NA;Right Upper Inner Quadrant;NA;NO;NA;NA;NA;3 Point Scale;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Simple Mastectomy;AO;1933333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-AO-A1KS;TCGA-AO-A1KS-01;69;M0;N0 (i-);Stage IIA;7th;T2;NA;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;3.2;-25230;147;NA;0;16;11.5;0:DiseaseFree;NA;NA;4 Point Scale;Positive;90-99%;NOT HISPANIC OR LATINO;NA;4/1/11;4859;40;NA;1;3.2;Positive >2.2;Negative;10-19%;2;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Equivocal;4;YES;2010;NO;YES;0;0;5;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;YES;34;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;MDLC;115;0:LIVING;bb8d42d3-ad65-4d88-ae1d-f9aadfc7962d;76f4bdbc-58c8-4424-865b-c6531d908dc3;TCGA-AO-A1KS.0FB93D92-81F6-4241-9094-4AABF70E6A0F.pdf;Negative;NA;Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left;NA;NO;NA;2+;NA;4 Point Scale;Positive;90-99%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Lumpectomy;AO;1133333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-AO-A1KT;TCGA-AO-A1KT-01;78;M0;N1;Stage IIA;6th;T1;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;1.7;-28660;617;NA;0;541;17.77;0:DiseaseFree;NA;NA;4 Point Scale;Positive;90-99%;NOT HISPANIC OR LATINO;NA;4/1/11;3513;40;NA;1.4;2.4;>2.2 Positive;Negative;10-19%;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;NA;C50.9;1/03/8500;C50.9;Equivocal;4;YES;2009;NO;YES;1;1;5;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;YES;34;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;1777;0:LIVING;1f8f87cb-8a0b-474c-97fb-c71b4fd88d97;15c2deaa-1162-4ee8-b698-179bfd67a78d;TCGA-AO-A1KT.D9432167-0F2E-4377-9DB4-EA4E59A6C9B9.pdf;Negative;NA;Left Upper Outer Quadrant|Left;NA;NO;NA;4+;NA;4 Point Scale;Positive;40-49%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Lumpectomy;AO;1133333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-AQ-A04H;TCGA-AQ-A04H-01;61;MX;N2a;Stage IIIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;NA;-22539;365;NA;0;439;24.77;0:DiseaseFree;NA;>10%;NA;Positive;90-99%;NOT HISPANIC OR LATINO;NA;12/15/10;4203;30;NA;3.2;NA;NA;Positive;NA;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Indeterminate;NA;YES;2009;NO;NA;4;NA;15;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NO;63;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;MDLC;2477;0:LIVING;83f943c7-3975-4b4f-985d-9c057741793b;21438c0b-398e-4fe6-bd2f-cfae83292341;TCGA-AQ-A04H.D40D0424-E1DA-4AEF-AD00-126038E80218.pdf;Negative;NA;Left Lower Inner Quadrant;NA;NO;NA;NA;>10%;NA;Positive;20-29%;WHITE;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;AQ;21;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-AQ-A04J;TCGA-AQ-A04J-01;45;M0;N0 (i+);Stage IIA;NA;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-16615;118;NA;0;160;26.91;0:DiseaseFree;NA;NA;NA;Negative;<10%;NOT HISPANIC OR LATINO;NA;10/15/10;3431;NA;NA;NA;NA;NA;NA;<10%;0;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;0;YES;2009;NO;NA;0;0;20;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NA;Core needle biopsy;NA;NO;51;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;2691;0:LIVING;9938ce5c-e74e-446e-a932-f096f85cc3b1;09d6f42c-5e9f-4adc-bd8c-e5dca597fc01;TCGA-AQ-A04J.71CEC5F6-16E5-46E1-A91B-B5E0F699B231.pdf;Negative;NA;Right Upper Outer Quadrant;NA;NO;NA;0;NA;NA;Negative;<10%;WHITE;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Simple Mastectomy;AQ;17;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-AQ-A04L;TCGA-AQ-A04L-01;48;MX;N0 (i-);Stage IIA;5th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-17759;3403;NA;0;3359;129.99;0:DiseaseFree;NA;NA;NA;Positive;60-69%;NOT HISPANIC OR LATINO;NA;12/15/10;5876;NA;NA;NA;NA;NA;NA;NA;3;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;2;YES;2001;NO;NA;0;NA;2;NA;Peri (6-12 months since last menstrual period);NA;NA;NA;Fine needle aspiration biopsy;NA;NO;33;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;12999;0:LIVING;78582fbc-dcc7-48ae-9f95-5271c9bc5b72;da0ed50a-e7d6-4a78-8bb6-cfd80f6e2ff6;TCGA-AQ-A04L.40B58A7A-2A05-4AAF-B1D4-B418E4A56115.pdf;Negative;NA;Right;NA;NO;NA;NA;NA;NA;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Modified Radical Mastectomy;AQ;11;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-AQ-A0Y5;TCGA-AQ-A0Y5-01;70;MX;N2a;Stage IIIA;7th;T2;NA;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;NA;-25793;212;172;0;NA;NA;NA;NA;NA;NA;Positive;70-79%;NOT HISPANIC OR LATINO;NA;4/7/11;4961;NA;NA;3.8;NA;NA;Positive;NA;2;NA;NA;Infiltrating Ductal Carcinoma;NA;Yes;Yes;C50.9;1/03/8500;C50.9;Positive;NA;YES;2010;NO;YES;5;NA;17;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;NO;38;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;MDLC;565;1:DECEASED;d0b78f3f-a198-437a-ab8c-204345d3b75d;f5675b71-ed1b-4fdb-be07-d627dc98ed88;TCGA-AQ-A0Y5.5BC01981-366E-44EC-A986-087DB7904E5C.pdf;Negative;NA;Right;NA;YES;NA;NA;NA;NA;Positive;40-49%;WHITE;NA;NO;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Modified Radical Mastectomy;AQ;1233333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-AQ-A1H2;TCGA-AQ-A1H2-01;84;MX;N2a;Stage IIIA;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-30958;156;NA;0;230;15.6;0:DiseaseFree;NA;NA;NA;Positive;90-99%;NOT HISPANIC OR LATINO;NA;4/20/11;3295;NA;NA;2.7;NA;NA;Positive;NA;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Indeterminate;NA;YES;2010;NO;YES;13;NA;19;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;NO;25;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;156;0:LIVING;4d120899-9a80-4736-b097-285e9e261bcb;26b0cf7a-584f-46e5-8f83-b6b5f7d542ba;TCGA-AQ-A1H2.1B5FA34B-E3B4-4D4B-AF0A-1C90016CC532.pdf;Negative;NA;Right Upper Outer Quadrant;NA;YES;NA;NA;NA;NA;Positive;10-19%;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;AQ;833333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-AQ-A1H3;TCGA-AQ-A1H3-01;49;MX;N3a;Stage IIIC;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-18177;94;NA;0;162;32.49;0:DiseaseFree;NA;NA;NA;Positive;90-99%;NOT HISPANIC OR LATINO;NA;4/20/11;2038;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2010;NO;YES;14;NA;23;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Core needle biopsy;NA;NO;31;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;3249;0:LIVING;82ec33dd-e783-4c74-9a87-797a699e11df;09191482-34de-4130-afbe-dd47d481d539;TCGA-AQ-A1H3.6EB1A616-E99C-4AF6-9C0A-0FDC521A79CD.pdf;Negative;NA;Right Upper Outer Quadrant;NA;YES;NA;NA;NA;NA;Positive;80-89%;WHITE;NA;NO;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Modified Radical Mastectomy;AQ;1033333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-AQ-A54N;TCGA-AQ-A54N-01;51;M0;N0;Stage IIA;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-18741;639;NA;0;78;2.56;0:DiseaseFree;NA;NA;NA;Negative;NA;HISPANIC OR LATINO;NA;2/26/13;6816;NA;NA;1.1;NA;NA;Negative;NA;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;Yes;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;2011;NO;YES;0;0;1;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;YES;70;NO;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;256;0:LIVING;58090433-D8D1-4499-A235-810C3E9D5B74;79A531B5-1BF5-442B-BEF7-72B9FC628F5F;TCGA-AQ-A54N.9BF0E34A-F78C-4BFD-AC4C-926FA1D60342.pdf;Negative;NO;Left Lower Inner Quadrant;NA;YES;NA;NA;NA;NA;Negative;NA;BLACK OR AFRICAN AMERICAN;NO;NO;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Lumpectomy;AQ;2333333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-AQ-A54O;TCGA-AQ-A54O-01;51;M0;N0;Stage IIA;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-18694;617;NA;0;665;32.88;0:DiseaseFree;NA;NA;NA;Positive;90-99%;NOT HISPANIC OR LATINO;NA;2/26/13;4149;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;Yes;C50.9;1/03/8500;C50.9;Negative;NA;YES;2011;NO;YES;0;0;14;NA;NA;NA;NA;NA;Fine needle aspiration biopsy;NA;YES;24;NO;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;3288;0:LIVING;35CA5E2A-861A-4DD2-A4CE-D294CF080DA3;E7BB0755-D706-480D-989D-108B3E817973;TCGA-AQ-A54O.B3884493-D0D2-445C-B9BB-BC475021EBA4.pdf;Negative;YES;Right Upper Outer Quadrant;NA;YES;NA;NA;NA;NA;Positive;70-79%;BLACK OR AFRICAN AMERICAN;NO;NO;1;Primary;Male;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Simple Mastectomy;AQ;8;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-AR-A0TS;TCGA-AR-A0TS-01;46;M0;N1;Stage IIB;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-17141;1549;NA;0;1138;84.03;0:DiseaseFree;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;3/8/11;895;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2006;NO;NA;2;NA;16;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NA;Core needle biopsy;NA;YES;48;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;8403;0:LIVING;972447aa-4332-47e7-bddd-2eb699dbb664;2ca5fbc4-80ab-42ff-b277-36f4217ee38a;TCGA-AR-A0TS.39A0AD32-D372-422F-94F2-173F963C7AAB.pdf;Negative;NA;Right;NA;NO;NA;0;NA;NA;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Lumpectomy;AR;16;NA;Breast
brca_tcga_pub2015;TCGA-AR-A0TX;TCGA-AR-A0TX-01;64;M0;N1;Stage IIA;NA;T1;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-23653;1976;NA;0;15;64.78;0:DiseaseFree;NA;NA;NA;Positive;<10%;NA;Wide local excision;3/10/11;2237;NA;NA;NA;NA;NA;NA;NA;3;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;NA;YES;2005;NO;NA;3;NA;25;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NO;258;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;BRCA;6478;0:LIVING;c364e81c-eb1e-4870-ab37-9c661f5f2e3d;d5adaf35-04b1-4198-b308-f4720b3d6417;TCGA-AR-A0TX.4FC34715-9004-4F53-B914-F0004AEA88C8.pdf;Negative;NA;Left Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;NA;NA;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Other;AR;86;NA;Breast
brca_tcga_pub2015;TCGA-AR-A0TY;TCGA-AR-A0TY-01;54;M0;N0;Stage IIA;NA;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-19836;2141;1699;0;NA;17.87;1:Recurred/Progressed;NA;NA;NA;Positive;10-19%;NOT HISPANIC OR LATINO;NA;3/10/11;3607;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2004;NO;NA;0;NA;15;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;YES;109;NA;NA;NA;Positive;NA;NA;1+;NA;NA;NA;Negative;NA;VERDADERO;IDC;5581;1:DECEASED;da1c58a7-c6bd-47d9-95c2-8d2ac70e20e4;2147c985-f4f4-441a-9142-9b76e6131435;TCGA-AR-A0TY.12A4A731-1ADF-4D36-88F3-16C9642484F3.pdf;Negative;NA;Right Upper Outer Quadrant;NA;NO;NA;0;NA;NA;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Simple Mastectomy;AR;3633333333;NA;Breast
brca_tcga_pub2015;TCGA-AR-A0U2;TCGA-AR-A0U2-01;47;M0;N2;Stage IIIA;NA;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-17390;2395;2551;0;NA;52.86;1:Recurred/Progressed;NA;NA;NA;Positive;10-19%;NOT HISPANIC OR LATINO;NA;2/24/11;6621;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2004;NO;NA;4;0;16;Negative;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);Bone|Liver;NA;NA;Incisional Biopsy;NA;NO;52;NA;2.47;NA;Positive;70-79%;Negative;2+;Negative;NA;NA;Negative;NA;VERDADERO;IDC;838;1:DECEASED;9ad603dc-3fd0-44f5-ae4e-64eeb1ae8d6d;7c8b0e74-bd47-4c5c-99de-8484eca2b1ad;TCGA-AR-A0U2.51F69645-9564-4257-A86E-3A574C27034F.pdf;Negative;NA;Left Lower Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;AR;1733333333;WITH TUMOR;Breast
brca_tcga_pub2015;TCGA-AR-A0U3;TCGA-AR-A0U3-01;59;M0;N1;Stage IIB;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-21755;2413;NA;0;2317;134.03;0:DiseaseFree;NA;NA;NA;Positive;10-19%;HISPANIC OR LATINO;Wide local excision;2/25/11;5081;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2004;NO;NA;1;NA;4;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NO;29;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;13403;0:LIVING;c5f00132-1c6b-4337-af6f-596c652665cc;a439dcc3-4377-449d-983e-f34f8e5741e3;TCGA-AR-A0U3.ED2D1BA8-8FEB-43E1-9174-91F9D59565F9.pdf;Negative;NA;Left Upper Inner Quadrant|Left Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Other;AR;966666667;NA;Breast
brca_tcga_pub2015;TCGA-AR-A1AH;TCGA-AR-A1AH-01;51;M0;N1;Stage IIB;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-18991;2368;NA;0;2298;37.32;1:Recurred/Progressed;NA;NA;NA;Positive;10-19%;NOT HISPANIC OR LATINO;Total Mastectomy;6/13/11;9025;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2004;NO;YES;1;NA;9;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NA;71;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;12507;0:LIVING;a6e11b30-3ae8-4dd1-b04c-a730c6a79746;65ce036f-a8ed-4e83-818c-b54c95529a2e;TCGA-AR-A1AH.75F29A17-B6AF-43B9-BE12-3ABF850F23BA.pdf;Negative;NA;Right Upper Inner Quadrant;NA;NO;NA;NA;NA;NA;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Other;AR;2366666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-AR-A1AI;TCGA-AR-A1AI-01;47;M0;N0;Stage IIA;6th;T2;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-17229;1939;NA;0;1881;19.32;1:Recurred/Progressed;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;6/15/11;4681;NA;NA;NA;NA;NA;Negative;NA;2;NA;NA;Medullary Carcinoma;NA;No;No;C50.9;1/03/8510;C50.9;Equivocal;NA;YES;2005;NO;YES;0;NA;5;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Fine needle aspiration biopsy;NA;YES;71;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;BRCA;10828;0:LIVING;9848307d-1bd5-40c1-b655-a33297aaf74f;2e78b083-64df-4f0e-95ae-783209aee124;TCGA-AR-A1AI.F5CAE962-5347-46FA-86EE-169121BED547.pdf;Negative;NA;Left Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Simple Mastectomy;AR;2366666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-AR-A1AJ;TCGA-AR-A1AJ-01;83;M0;N0;Stage I;6th;T1;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-30489;1828;NA;0;1605;100.92;0:DiseaseFree;NA;NA;NA;Positive;10-19%;NOT HISPANIC OR LATINO;Wide local excision;6/13/11;657;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2005;NO;YES;0;NA;8;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;YES;25;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;10092;0:LIVING;23e7a78a-1d56-4ad1-9bb4-72ec0178aff2;17bb7144-07ec-49d0-8345-2a5b4ceeeaec;TCGA-AR-A1AJ.0DEAC35F-8B73-4A9F-B7FA-2F501B736B0E.pdf;Negative;NA;Right;NA;NO;NA;NA;NA;NA;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Other;AR;833333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-AR-A1AK;TCGA-AR-A1AK-01;70;M0;N0;Stage I;6th;T1;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-25825;1744;NA;0;1559;103.78;0:DiseaseFree;NA;NA;NA;Positive;10-19%;NOT HISPANIC OR LATINO;NA;6/15/11;2941;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Negative;NA;YES;2006;NO;YES;0;NA;5;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;YES;57;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;ILC;10378;0:LIVING;94b03e1d-50ec-4680-bffd-7086d1536ff2;fe0ddcfc-f6e9-460d-b8e6-5187ffe8eb4f;TCGA-AR-A1AK.F4DBFC71-9CD0-41C3-9F20-77FA0605D4A8.pdf;Negative;NA;Right;NA;NO;NA;NA;NA;NA;Positive;10-19%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Simple Mastectomy;AR;19;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-AR-A1AL;TCGA-AR-A1AL-01;60;M0;N1;Stage IIIA;6th;T3;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-22023;1528;NA;0;1485;97.6;0:DiseaseFree;NA;NA;NA;Positive;70-79%;NOT HISPANIC OR LATINO;NA;6/15/11;817;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Negative;NA;YES;2006;NO;YES;3;NA;15;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;YES;22;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;ILC;976;0:LIVING;1f99e4d4-4e8b-4cc1-a129-227a2a82780e;a7945d1c-35ca-4c95-98c6-ccb6e6d2b39c;TCGA-AR-A1AL.E3D44C6B-4497-4212-8CA1-AC9444B4CC54.pdf;Negative;NA;Left Upper Inner Quadrant|Left Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;70-79%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Simple Mastectomy;AR;733333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-AR-A1AM;TCGA-AR-A1AM-01;52;M0;N1;Stage IIIA;6th;T3;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-19123;1506;NA;0;1903;98.26;0:DiseaseFree;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;11/20/12;1216;NA;NA;NA;NA;NA;Negative;NA;2;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Equivocal;NA;YES;2006;NO;YES;1;NA;12;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NA;25;NO;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;ILC;9826;0:LIVING;EBD1512A-4865-4193-97B3-F599D555759A;7153D60A-43D2-4A9A-BD8D-C15CD0BD9D75;TCGA-AR-A1AM.10C43124-3C21-443C-8268-23BF8A4D317E.pdf;Negative;YES;Right Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;NA;WHITE;NO;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Simple Mastectomy;AR;833333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-AR-A1AN;TCGA-AR-A1AN-01;46;M0;N0;Stage IIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-16974;1463;NA;0;1330;95.93;0:DiseaseFree;NA;NA;NA;Positive;70-79%;HISPANIC OR LATINO;Wide Local Excision;6/14/11;3367;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2006;NO;YES;0;NA;5;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NA;Core needle biopsy;NA;YES;18;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;9593;0:LIVING;43029932-feb0-4658-97fa-645c1e775009;2dd17e3a-3034-4bb9-8a79-d0c89fa9ae21;TCGA-AR-A1AN.DA251274-7966-4F48-A02F-393ABBDAB4E9.pdf;Negative;NA;Right Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;70-79%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Other;AR;6;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-AR-A1AO;TCGA-AR-A1AO-01;47;M0;N1;Stage IIA;6th;T1;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-17332;1471;NA;0;1325;86.01;0:DiseaseFree;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;Wide local excision;6/13/11;2;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2006;NO;YES;2;NA;39;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NA;Core needle biopsy;NA;YES;22;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;BRCA;8601;0:LIVING;623befd6-0ca4-4a6c-9cf5-d9385c3b718f;5cedca81-7593-48c9-8bed-ebd294347ce7;TCGA-AR-A1AO.37EF1828-0A53-4358-97C7-A7849EC653AF.pdf;Negative;NA;Left Upper Inner Quadrant;NA;NO;NA;NA;NA;NA;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Other;AR;733333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-AR-A1AP;TCGA-AR-A1AP-01;80;M0;N0;Stage I;6th;T1;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-29406;1450;NA;0;1216;93.82;0:DiseaseFree;NA;NA;NA;Positive;70-79%;NOT HISPANIC OR LATINO;Wide local excision;6/13/11;2882;NA;NA;NA;NA;NA;Negative;NA;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;2007;NO;YES;0;NA;1;Negative;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;YES;37;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;BRCA;9382;0:LIVING;9495f029-9882-4c9b-a557-b3aec9e91698;550f24b0-a925-41d6-be27-96c827693611;TCGA-AR-A1AP.0BFF09DE-6F36-4F68-AC13-8BC16AA0DCBE.pdf;Positive;NA;Left Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;<10%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;Mastectomy NOS;NA;Other;AR;1233333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-AR-A1AQ;TCGA-AR-A1AQ-01;49;M0;N0;Stage IIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-18109;1424;NA;0;1310;99.24;0:DiseaseFree;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;Wide local excision;6/14/11;4982;NA;NA;NA;NA;NA;Negative;NA;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;2007;NO;YES;0;NA;6;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;YES;35;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;9924;0:LIVING;98e0b4de-52fc-4945-9bf5-11e29368f939;3c111956-7bcf-46a7-b64f-708ce11b9ff8;TCGA-AR-A1AQ.FC236604-AAE5-4394-9D39-270FFEFB635A.pdf;Negative;NA;Right Upper Inner Quadrant|Right Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Other;AR;1133333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-AR-A1AR;TCGA-AR-A1AR-01;50;M0;N2;Stage IIIA;6th;T1;NA;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;NA;-18482;1416;524;0;NA;12.71;1:Recurred/Progressed;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;6/28/11;4696;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;Yes;C50.9;1/03/8500;C50.9;Negative;NA;YES;2007;NO;NA;5;NA;14;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NA;48;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;MDLC;1721;1:DECEASED;eda6d2d5-4199-4f76-a45b-1d0401b4e54c;5fa9998b-deff-493e-8a8e-dc2422192a48;TCGA-AR-A1AR.747FB91B-F523-4FA0-91DD-6014EF55643D.pdf;Negative;NA;Left Lower Inner Quadrant;NA;NO;NA;NA;NA;NA;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Lumpectomy;AR;16;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-AR-A1AS;TCGA-AR-A1AS-01;54;M0;N1;Stage IIB;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-20028;1331;NA;0;1150;37.78;0:DiseaseFree;NA;NA;NA;Positive;70-79%;NA;Wide local excision;6/14/11;1378;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2007;NO;YES;1;NA;17;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NA;32;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;3778;0:LIVING;7d681cc6-689d-41c8-9e84-e13733089ec9;f6cc81c4-e7b6-462c-a97a-27c1ef62b958;TCGA-AR-A1AS.180AA688-0B63-4DD9-BA29-708E80FBC4C9.pdf;Negative;NA;Left Upper Inner Quadrant;NA;NO;NA;NA;NA;NA;Positive;70-79%;ASIAN;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Other;AR;1066666667;NA;Breast
brca_tcga_pub2015;TCGA-AR-A1AU;TCGA-AR-A1AU-01;39;M0;N2;Stage IIIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-14564;1317;NA;0;1409;94.22;0:DiseaseFree;NA;NA;NA;Positive;70-79%;NOT HISPANIC OR LATINO;Total Mastectomy;6/14/11;2156;NA;NA;NA;NA;NA;Negative;NA;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;2007;NO;YES;4;NA;37;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NA;Core needle biopsy;NA;NA;19;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;9422;0:LIVING;36220587-1c1c-4f92-b177-3b2155e7e273;cd002b40-3caf-429b-934f-64f4ada1731d;TCGA-AR-A1AU.5654FC27-47D3-4C7F-A0E7-A5B6140991C2.pdf;Negative;NA;Right Upper Inner Quadrant|Right Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;70-79%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Other;AR;633333333;NA;Breast
brca_tcga_pub2015;TCGA-AR-A1AV;TCGA-AR-A1AV-01;68;M0;N1;Stage IIB;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-24875;1233;NA;0;1295;61.24;0:DiseaseFree;NA;NA;NA;Positive;70-79%;HISPANIC OR LATINO;NA;6/14/11;1890;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2007;NO;YES;1;NA;25;NA;NA;NA;NA;NA;Core needle biopsy;NA;NA;40;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;6124;0:LIVING;daf62b56-6dd2-4ab7-adaa-f296bb86a0a5;bcb6b37b-62f7-40a9-bdb9-1b6479610dd6;TCGA-AR-A1AV.5AD5B38F-5CC1-4A2F-96E6-F344D8FE0149.pdf;Negative;NA;Left;NA;NO;NA;NA;NA;NA;Positive;70-79%;WHITE;NA;YES;1;Primary;Male;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;AR;1333333333;NA;Breast
brca_tcga_pub2015;TCGA-AR-A1AW;TCGA-AR-A1AW-01;65;M0;N0;Stage IIA;6th;T2;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-23855;1157;NA;0;1072;86.47;0:DiseaseFree;NA;NA;NA;Positive;70-79%;NOT HISPANIC OR LATINO;NA;6/14/11;1214;NA;NA;NA;NA;NA;Negative;NA;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;2007;NO;YES;0;NA;1;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Incisional Biopsy;NA;YES;23;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;BRCA;8647;0:LIVING;a12fd22a-7f84-4b6e-b6d8-012e38eb73d7;7cfe5395-8477-405a-8260-b3b3aaf46a42;TCGA-AR-A1AW.BB485405-199C-48C7-96D7-8C315DEA66B4.pdf;Negative;NA;Left Upper Inner Quadrant;NA;NO;NA;NA;NA;NA;Positive;70-79%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Lumpectomy;AR;8;NA;Breast
brca_tcga_pub2015;TCGA-AR-A1AX;TCGA-AR-A1AX-01;64;M0;N0;Stage I;6th;T1;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-23507;1140;NA;0;1103;86.37;0:DiseaseFree;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;Wide local excision;6/14/11;366;NA;NA;NA;NA;NA;NA;NA;3;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;NA;YES;2007;NO;YES;0;NA;8;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;YES;17;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;8637;0:LIVING;f72c1d69-da35-459f-8542-59bfd6c09c23;f3ac7557-714a-492c-a166-246ef7298952;TCGA-AR-A1AX.4FDBA110-6E14-428C-BF82-168AE28A14E4.pdf;Negative;NA;Left Upper Inner Quadrant|Left Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;70-79%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Other;AR;566666667;NA;Breast
brca_tcga_pub2015;TCGA-AR-A1AY;TCGA-AR-A1AY-01;65;M0;N0;Stage I;6th;T1;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-23927;1085;NA;0;615;33.71;0:DiseaseFree;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;Wide Local Excision;6/14/11;5101;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2008;NO;YES;0;NA;4;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;YES;48;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;3371;0:LIVING;5fd9552a-c742-4388-940d-295d1107ae00;81fc993e-8f5a-4b3b-bea3-4c4c2f5e4ef2;TCGA-AR-A1AY.01D97550-C616-4001-85A5-5502D35FA38E.pdf;Negative;NA;Left Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Other;AR;1633333333;NA;Breast
brca_tcga_pub2015;TCGA-AR-A24H;TCGA-AR-A24H-01;65;M0;N0;Stage IIA;5th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-24046;3641;NA;0;3333;160.78;0:DiseaseFree;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;Excision;8/29/11;4579;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Negative;NA;YES;2001;NO;YES;0;NA;4;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NA;117;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;ILC;16078;0:LIVING;6f89509c-f802-482e-b4da-94553aa76fe9;c7f97f19-47ae-48d3-a90a-0162d3975747;TCGA-AR-A24H.C373F2EE-C601-4E17-8E2D-D9BC6AC0301A.pdf;Negative;NA;Right Lower Inner Quadrant|Right Lower Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Other;AR;39;NA;Breast
brca_tcga_pub2015;TCGA-AR-A24K;TCGA-AR-A24K-01;46;M0;N0;Stage IIA;6th;T2;No value Given;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-16961;2325;NA;0;1548;50.85;0:DiseaseFree;NA;NA;NA;Positive;10-19%;NA;Wide local excision;8/12/11;2005;NA;NA;NA;NA;NA;Negative;NA;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;2004;NO;YES;0;NA;2;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NA;Core needle biopsy;NA;YES;28;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;5085;0:LIVING;599c3701-df7a-4a75-a347-fa9b510dd242;c9ec05fa-5548-4fe3-8c09-a32c9e599d90;TCGA-AR-A24K.BC7B3577-CA6C-41AD-98E2-89D357D29D37.pdf;Negative;NA;Left Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;10-19%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Other;AR;933333333;NA;Breast
brca_tcga_pub2015;TCGA-AR-A24L;TCGA-AR-A24L-01;26;M0;N1;Stage IIB;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-9706;2275;NA;0;2221;46.45;1:Recurred/Progressed;NA;NA;NA;Positive;10-19%;NOT HISPANIC OR LATINO;Wide local excision;8/12/11;3426;NA;NA;NA;NA;NA;Negative;NA;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;2005;NO;YES;2;NA;12;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NA;Core needle biopsy;NA;NA;41;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;9415;1:DECEASED;de646f6a-6d50-4be2-b3cd-f17554b234df;f773ae1d-0ad9-42dd-9675-c8b7287fec85;TCGA-AR-A24L.BF82AD23-B40E-459F-83EC-590D392664FD.pdf;Negative;NA;Right;NA;NO;NA;NA;NA;NA;Positive;10-19%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Other;AR;1366666667;NA;Breast
brca_tcga_pub2015;TCGA-AR-A24M;TCGA-AR-A24M-01;38;M0;N2;Stage IIIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-14119;2245;NA;0;1991;120.24;0:DiseaseFree;NA;NA;NA;Positive;10-19%;NOT HISPANIC OR LATINO;Wide local excision;8/12/11;1579;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Mixed Histology (please specify);Mixed invasive ductal and invasive lobular;No;No;C50.9;1/03/8522;C50.9;Negative;NA;YES;2005;NO;YES;4;NA;28;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NA;Core needle biopsy;NA;NA;15;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;12024;0:LIVING;aa30ac3d-4216-45dd-a314-1ae192fafcb2;5754d368-87b9-40e5-9a56-bd48ad9a80e3;TCGA-AR-A24M.56DFBCCE-A9D9-4F08-AC7E-33998F3439B2.pdf;Negative;NA;Left Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;10-19%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Other;AR;5;NA;Breast
brca_tcga_pub2015;TCGA-AR-A24N;TCGA-AR-A24N-01;54;M0;N0;Stage I;6th;T1;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-19989;2219;NA;0;2074;99.7;0:DiseaseFree;NA;NA;NA;Positive;10-19%;NOT HISPANIC OR LATINO;NA;8/16/11;1106;NA;NA;NA;NA;NA;Negative;NA;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;2005;NO;YES;0;NA;4;NA;Peri (6-12 months since last menstrual period);NA;NA;NA;Core needle biopsy;NA;YES;33;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;997;0:LIVING;30047d32-0833-4aca-98d1-3b9ab7122863;dcc31bf1-9890-4fb1-9677-b5fb77e1fc37;TCGA-AR-A24N.AAF32BB7-716A-4C0E-AE7E-04F6A5BF5628.pdf;Negative;NA;Left Upper Inner Quadrant;NA;NO;NA;NA;NA;NA;Positive;10-19%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Simple Mastectomy;AR;11;NA;Breast
brca_tcga_pub2015;TCGA-AR-A24O;TCGA-AR-A24O-01;43;M0;N2;Stage IIIA;6th;T3;NA;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;NA;-15977;2213;NA;0;1998;84.13;1:Recurred/Progressed;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;8/16/11;332;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Mixed Histology (please specify);Lobular carcinoma with ductal features;No;No;C50.9;1/03/8522;C50.9;Negative;NA;YES;2005;NO;YES;7;NA;19;Negative;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NA;Incisional Biopsy;NA;NA;18;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;MDLC;1185;0:LIVING;125b0a9a-6cbe-4207-9178-e7ff03487e87;146bd11a-e66a-4d8d-990a-9f1199cdf255;TCGA-AR-A24O.887F0E3A-DC70-4CD4-AAAF-3C613195D895.pdf;Positive;NA;Left;NA;NO;NA;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;NA;NA;Mastectomy NOS;NA;Modified Radical Mastectomy;AR;6;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-AR-A24P;TCGA-AR-A24P-01;47;M0;N0;Stage I;6th;T1;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-17490;2161;NA;0;26;2.76;0:DiseaseFree;NA;NA;NA;Positive;10-19%;NOT HISPANIC OR LATINO;Wide local excision;8/16/11;1587;NA;NA;NA;NA;NA;Negative;NA;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;2005;NO;YES;0;NA;3;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;YES;25;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;276;0:LIVING;d1fd8ed2-be13-4272-b31e-df86911db3b1;d12bd5fd-838e-491b-8949-6a22f78194ad;TCGA-AR-A24P.0BF7CB67-49F1-42EA-8B41-988BD7E0DE61.pdf;Negative;NA;Left Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;10-19%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Other;AR;833333333;NA;Breast
brca_tcga_pub2015;TCGA-AR-A24Q;TCGA-AR-A24Q-01;49;M0;N0;Stage IIB;6th;T3;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-18084;1932;NA;0;2009;104.2;0:DiseaseFree;NA;NA;NA;Positive;<10%;NA;NA;8/30/11;6640;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2006;NO;YES;0;NA;2;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NA;126;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;1042;0:LIVING;28e9048a-e540-42de-a1f4-4ef894fccc4c;9ff22b6b-ec23-41f5-a887-a59da1639858;TCGA-AR-A24Q.CCE8E855-2582-4214-B9B1-25F0431065CB.pdf;Negative;NA;Left Upper Inner Quadrant;NA;NO;NA;NA;NA;NA;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Simple Mastectomy;AR;4233333333;NA;Breast
brca_tcga_pub2015;TCGA-AR-A24R;TCGA-AR-A24R-01;45;M0;N2;Stage IIIA;6th;T1;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-16642;1913;NA;0;1746;112.68;0:DiseaseFree;NA;NA;NA;Positive;10-19%;NOT HISPANIC OR LATINO;Wide local excision;8/26/11;3412;NA;NA;NA;NA;NA;Negative;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2006;NO;YES;6;NA;28;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NA;Core needle biopsy;NA;NA;21;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;11268;0:LIVING;db62d9c7-8343-4771-84fc-146d2e307bb8;7f15f76b-305d-43f7-8d02-34cd0f76340e;TCGA-AR-A24R.C3259BD1-1A2A-40C4-A106-FA2EF0201811.pdf;Negative;NA;Right Upper Inner Quadrant|Right Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;10-19%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Other;AR;7;NA;Breast
brca_tcga_pub2015;TCGA-AR-A24S;TCGA-AR-A24S-01;61;M0;N0;Stage I;6th;T1;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-22587;1812;NA;0;1888;97.77;0:DiseaseFree;NA;NA;NA;Positive;70-79%;NOT HISPANIC OR LATINO;Wide local excision;8/30/11;3411;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2006;NO;YES;0;NA;4;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;YES;36;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;9777;0:LIVING;074e8b06-3929-4896-9263-3b80ad6a355b;d79df987-e362-43f5-acbd-b19522bace7d;TCGA-AR-A24S.C0A8A457-8790-4745-BD5D-AFBE55254A1C.pdf;Negative;NA;Right Lower Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Other;AR;12;NA;Breast
brca_tcga_pub2015;TCGA-AR-A24T;TCGA-AR-A24T-01;46;M0;N3;Stage IIIC;6th;T3;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-17135;1786;NA;0;1620;105.19;0:DiseaseFree;NA;NA;NA;Positive;10-19%;NOT HISPANIC OR LATINO;NA;8/30/11;2168;NA;NA;NA;NA;NA;Negative;NA;2;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Equivocal;NA;YES;2006;NO;YES;15;NA;17;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NA;Core needle biopsy;NA;NA;22;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;ILC;10519;0:LIVING;9e3de467-fb0d-4021-89f8-b34968a7c7bc;3cf5c205-2a3b-4f17-8e56-2078e88f615c;TCGA-AR-A24T.226031B3-D9C2-4343-B3F7-4E0C36B901E7.pdf;Negative;NA;Right Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;10-19%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Simple Mastectomy;AR;733333333;NA;Breast
brca_tcga_pub2015;TCGA-AR-A2LE;TCGA-AR-A2LE-01;69;M0;N0;Stage I;5th;T1;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-25499;3755;NA;0;3913;138.07;1:Recurred/Progressed;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;Excision;1/12/12;725;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;NA;NA;YES;2001;NO;YES;0;NA;2;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;YES;243;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;ILC;16629;0:LIVING;E3FCBF94-D3EF-4A37-AA45-5297F96AF9EB;E53D7A9A-3DB0-4A24-8DC1-6DC80428CD24;TCGA-AR-A2LE.95DC80AB-C070-4613-8C11-A124AEDF9754.pdf;Negative;NA;Right;NA;NO;NA;NA;NA;NA;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Other;AR;81;NA;Breast
brca_tcga_pub2015;TCGA-AR-A2LH;TCGA-AR-A2LH-01;55;M0;N3;Stage III;6th;T3;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-20288;1661;616;0;NA;14.26;1:Recurred/Progressed;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;1/12/12;0;NA;NA;NA;NA;NA;Negative;NA;2;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Equivocal;NA;YES;2007;NO;YES;29;NA;39;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);Bone|Liver;NA;YES;Core needle biopsy;NA;NA;43;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;ILC;2024;1:DECEASED;376FFE63-EFD7-42AF-90E1-261255B28BB7;22FF97E9-F168-48BB-9B61-6F50ABA08D27;TCGA-AR-A2LH.4E3FDA72-93E1-4961-B1DE-5BFDAC7E947D.pdf;Negative;NA;Right Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Modified Radical Mastectomy;AR;1433333333;NA;Breast
brca_tcga_pub2015;TCGA-AR-A2LJ;TCGA-AR-A2LJ-01;40;MX;N1;Stage IIIA;6th;T3;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-14723;1382;NA;0;1359;86.47;0:DiseaseFree;NA;NA;NA;Positive;70-79%;NOT HISPANIC OR LATINO;Total Mastectomy;1/12/12;874;NA;NA;NA;NA;NA;Positive;NA;3;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Positive;NA;YES;2007;NO;YES;1;NA;18;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Core needle biopsy;NA;YES;13;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;ILC;8647;0:LIVING;738E1ACC-1F0C-4A96-9C8A-222727EF5AF8;FCA8DA49-849B-4790-A956-DB7EE97C39E9;TCGA-AR-A2LJ.5411AC07-09E4-40C3-844F-2DFAA216D947.pdf;Negative;NA;Left;NA;NO;NA;NA;NA;NA;Positive;70-79%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Other;AR;433333333;NA;Breast
brca_tcga_pub2015;TCGA-AR-A2LK;TCGA-AR-A2LK-01;62;M0;N2;Stage III;6th;T3;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-22800;1340;NA;0;1304;42.84;1:Recurred/Progressed;NA;NA;NA;Positive;70-79%;NOT HISPANIC OR LATINO;Wide local excision;1/25/12;6563;NA;NA;NA;NA;NA;Negative;NA;1;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Equivocal;NA;YES;2007;NO;YES;5;NA;18;Negative;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;NA;31;NA;NA;NA;Positive;NA;NA;NA;Negative;NA;NA;Positive;NA;VERDADERO;ILC;5417;1:DECEASED;1B703058-E596-45BC-80FE-8B98D545C2E2;D6F5C34A-0F5C-4AED-977A-74A1E5D50915;TCGA-AR-A2LK.73FFBADB-37C0-4F17-8C95-F8DC94EF1AD3.pdf;Positive;NA;Right Upper Outer Quadrant|Right Lower Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;Mastectomy NOS;NA;Other;AR;1033333333;NA;Breast
brca_tcga_pub2015;TCGA-AR-A2LM;TCGA-AR-A2LM-01;49;M0;N1;Stage II;6th;T1;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-18053;1339;NA;0;1218;63.57;0:DiseaseFree;NA;NA;NA;Positive;70-79%;NOT HISPANIC OR LATINO;NA;1/12/12;1000;NA;NA;NA;NA;NA;Negative;NA;NA;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;NA;NA;YES;2007;NO;YES;1;NA;3;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Core needle biopsy;NA;YES;13;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;ILC;6357;0:LIVING;0BF6E772-1AA1-4F54-9A50-C1414E2F22F3;9EBE5223-7566-4026-83AE-812283A8AAEB;TCGA-AR-A2LM.F868DC95-23CA-4DFC-BAA3-FBF5BF6F45A9.pdf;Negative;NA;Right;NA;NO;NA;NA;NA;NA;Positive;70-79%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Simple Mastectomy;AR;433333333;NA;Breast
brca_tcga_pub2015;TCGA-AR-A2LN;TCGA-AR-A2LN-01;65;M0;N0;Stage IIA;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-23992;513;NA;0;520;38.14;0:DiseaseFree;NA;NA;NA;Positive;70-79%;NOT HISPANIC OR LATINO;Mastectomy;1/12/12;982;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Negative;NA;YES;2010;NO;YES;0;NA;2;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;NA;32;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;ILC;3814;0:LIVING;A076F135-BE82-40FA-8516-285ED355C965;3F9D6A98-182C-4297-85C5-02CE3B1A3500;TCGA-AR-A2LN.128D4F7D-017D-459F-9664-AF509AE4555E.pdf;Negative;NA;Right Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;70-79%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Other;AR;1066666667;NA;Breast
brca_tcga_pub2015;TCGA-AR-A2LO;TCGA-AR-A2LO-01;46;M0;N1;Stage IIB;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-17080;486;NA;0;633;39.36;0:DiseaseFree;NA;NA;NA;Positive;70-79%;NOT HISPANIC OR LATINO;NA;1/12/12;2232;NA;NA;NA;NA;NA;Negative;NA;2;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Equivocal;NA;YES;2010;NO;YES;1;NA;16;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Core needle biopsy;NA;NA;12;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;ILC;3936;0:LIVING;AD0FA961-C085-4F38-B3DB-5FC0CBF6B64F;A189A276-126A-4357-8AEA-9AC6A791A1C5;TCGA-AR-A2LO.E5B6771D-450A-49AD-AEBC-7FC056BFCDBE.pdf;Negative;NA;Left Lower Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Simple Mastectomy;AR;4;NA;Breast
brca_tcga_pub2015;TCGA-AR-A2LQ;TCGA-AR-A2LQ-01;59;M0;N0;Stage IIB;7th;T3;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-21865;449;NA;0;516;40.51;0:DiseaseFree;NA;NA;NA;Positive;70-79%;NOT HISPANIC OR LATINO;NA;1/12/12;0;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Negative;NA;YES;2010;NO;YES;0;NA;3;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;NA;12;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;ILC;4051;0:LIVING;4229E432-6AC5-49D2-B58A-E8713DDB79BD;E4F422A0-1142-4BF2-B848-B681295B370E;TCGA-AR-A2LQ.C3537961-4636-4BD1-BC89-892580B36E43.pdf;Negative;NA;Right Upper Inner Quadrant|Right Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;<10%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Simple Mastectomy;AR;4;NA;Breast
brca_tcga_pub2015;TCGA-B6-A0I2;TCGA-B6-A0I2-01;45;M0;N0 (i-);Stage IA;4th;T1c;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-16702;5305;NA;0;3827;143.27;0:DiseaseFree;NA;NA;NA;NA;NA;NOT HISPANIC OR LATINO;NA;11/2/10;8535;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;1995;NO;NA;0;NA;8;NA;Indeterminate (neither Pre or Postmenopausal);NA;NA;NA;Excisional Biopsy;NA;NO;44;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;14327;0:LIVING;328dfcb0-b5ae-43f2-bc87-dad0ab3df9e7;47436ce0-438f-475b-ac0d-1972d0c5285e;TCGA-B6-A0I2.CA834E5F-30DC-46CF-AF33-AD11226FC09E.pdf;NA;NA;Left Upper Outer Quadrant|Left;NA;NO;NA;NA;NA;NA;NA;NA;WHITE;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;NA;B6;1466666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-B6-A0I5;TCGA-B6-A0I5-01;49;M0;N1b;Stage IIB;3rd;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-18038;7820;NA;0;4550;281.08;0:DiseaseFree;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;biopsy;11/2/10;2451;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;1988;NO;NA;5;NA;13;NA;Indeterminate (neither Pre or Postmenopausal);NA;NA;NA;Other method, specify:;biopsy, NOS;NO;20;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;28108;0:LIVING;1a18974d-967c-4727-b42e-12ae7be66589;ca3c9a05-88b7-4d99-abd5-fc557e3929a0;TCGA-B6-A0I5.FA43414D-3757-43CC-8949-77F82DF4FA4D.pdf;Negative;NA;Right Lower Inner Quadrant;NA;NO;NA;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Other;B6;666666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-B6-A0I9;TCGA-B6-A0I9-01;62;M1;NX;Stage IV;3rd;T3;IHC;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-22798;6687;362;0;NA;NA;NA;NA;NA;NA;Indeterminate;NA;NOT HISPANIC OR LATINO;NA;11/2/10;4950;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;1992;NO;NA;NA;NA;NA;NA;Indeterminate (neither Pre or Postmenopausal);Bone;NA;NA;Other method, specify:;Biopsy, NOS;NO;69;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;1189;1:DECEASED;44954053-0b93-4577-a436-42777e442300;43f2cdb0-e5f0-4586-808a-fc0ef3313aa0;TCGA-B6-A0I9.291884D2-FDFD-4C98-BA19-1A0824ABB68F.pdf;NA;NA;Left Lower Outer Quadrant|Left;NA;NO;IHC;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;No axillary staging;NA;NA;NA;NA;B6;23;WITH TUMOR;Breast
brca_tcga_pub2015;TCGA-B6-A0IA;TCGA-B6-A0IA-01;51;M0;N0 (i-);Stage IIA;NA;T2;IHC;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-18748;6664;NA;0;6719;275.66;0:DiseaseFree;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;Excisional biopsy;11/2/10;2386;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Other, specify;NA;No;No;C50.9;1/03/8523;C50.9;NA;NA;YES;1992;NO;NA;0;NA;15;NA;Indeterminate (neither Pre or Postmenopausal);NA;NA;NA;Other method, specify:;Biopsy, NOS;NO;41;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;BRCA;27566;0:LIVING;0807435a-e75e-4e04-8e45-ed0cd49a841a;ef8c35b3-bdab-4a7e-b5ab-a0a99f4db803;TCGA-B6-A0IA.55F3F917-E441-4C10-A3E3-0645A4E8374E.pdf;Negative;NA;Right;NA;NO;IHC;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Other;B6;1366666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-B6-A0IB;TCGA-B6-A0IB-01;64;M1;N3;Stage IV;3rd;T3;IHC;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-23646;6660;3941;0;NA;89.26;1:Recurred/Progressed;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;11/2/10;5461;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;1992;NO;NA;8;NA;15;NA;Indeterminate (neither Pre or Postmenopausal);Other, specify;Skin;NA;Other method, specify:;Biopsy, NOS;NO;61;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;12947;1:DECEASED;157ec9e0-ca6e-4da1-9233-f976cf0db433;e405d22f-86a6-4141-ae74-7098d0fdedfd;TCGA-B6-A0IB.CFC4801B-04BD-4FFC-911A-7B88E2FA4B49.pdf;Negative;NA;Right Upper Inner Quadrant|Right;NA;NO;IHC;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;B6;2033333333;WITH TUMOR;Breast
brca_tcga_pub2015;TCGA-B6-A0IC;TCGA-B6-A0IC-01;90;MX;NX;Stage X;3rd;T2;IHC;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-32872;6475;1542;0;NA;NA;NA;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;Excisional biopsy;11/2/10;787;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Other, specify;NA;No;No;C50.9;1/03/8503;C50.9;NA;NA;YES;1992;NO;NA;NA;NA;NA;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Fine needle aspiration biopsy;NA;NO;35;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;BRCA;5066;1:DECEASED;b804f7ae-da8f-4414-be11-f880f1859160;81bebbeb-bdb8-43f4-8113-b8f53425b725;TCGA-B6-A0IC.8AABC46F-03C7-4FBF-AC20-2C862E303A8B.pdf;Negative;NA;Right;NA;NO;IHC;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;No axillary staging;NA;NA;NA;Other;B6;1166666667;NA;Breast
brca_tcga_pub2015;TCGA-B6-A0IE;TCGA-B6-A0IE-01;38;M0;N1b;Stage IIIA;4th;T3;Image Analysis;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-13982;5557;1993;0;NA;27.4;1:Recurred/Progressed;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;Wide re-excisional biopsy;11/2/10;3490;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Mixed Histology (please specify);Lobular/Ductal;No;No;C50.9;1/03/8520;C50.9;NA;NA;YES;1995;NO;NA;6;NA;24;Negative;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NA;Incisional Biopsy;NA;NO;29;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;ILC;6547;1:DECEASED;3f834fa7-6d7b-4b85-98c0-5c55d55b6c95;95f2fd0c-9121-47bf-b2c1-dd9ed667a146;TCGA-B6-A0IE.DFCA9C6E-710E-4645-9CFC-A908AAD583F3.pdf;Close;NA;Left Upper Outer Quadrant|Left;NA;NO;Image Analysis;NA;NA;NA;Negative;NA;BLACK OR AFRICAN AMERICAN;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Other;B6;966666667;WITH TUMOR;Breast
brca_tcga_pub2015;TCGA-B6-A0IG;TCGA-B6-A0IG-01;50;M0;N1b;Stage IIB;4th;T2;Image Analysis;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-18433;5836;4456;0;NA;NA;NA;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;11/2/10;3174;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;1994;NO;NA;4;NA;16;NA;Indeterminate (neither Pre or Postmenopausal);NA;NA;NA;Other method, specify:;Biopsy, NOS;NO;41;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;14639;1:DECEASED;34ab0cb8-bf19-4cbb-b4eb-3c45ee5aa60b;4c3d691c-fdf7-46e3-977e-68500c4ac358;TCGA-B6-A0IG.4379DEE0-F7CB-4A73-8828-21EA0AA830F5.pdf;Negative;NA;Left;NA;NO;Image Analysis;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;B6;1366666667;WITH TUMOR;Breast
brca_tcga_pub2015;TCGA-B6-A0IH;TCGA-B6-A0IH-01;81;M0;N1b;Stage IIIA;4th;T3;Image Analysis;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-29907;5388;3418;0;NA;NA;NA;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;Excisional biopsy;3/15/11;1988;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;NA;NA;YES;1995;NO;YES;25;NA;27;Negative;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Fine needle aspiration biopsy;NA;NO;28;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;ILC;11229;1:DECEASED;2476dda9-da2a-4242-9642-b92b8b9b1c79;5ac66414-2c9e-45d0-837a-f620898a86e0;TCGA-B6-A0IH.12C64846-1CB3-42E4-B307-54C7AD12F530.pdf;Positive;NA;Left Upper Outer Quadrant|Left;NA;NO;Image Analysis;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;Modified radical mastectomy;NA;Other;B6;933333333;NA;Breast
brca_tcga_pub2015;TCGA-B6-A0IJ;TCGA-B6-A0IJ-01;42;M0;N0 (i-);Stage IIB;NA;T3;Image Analysis;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-15625;5350;NA;0;5383;233.44;0:DiseaseFree;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;11/2/10;5979;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;1995;NO;NA;0;NA;27;NA;Indeterminate (neither Pre or Postmenopausal);NA;NA;NA;Excisional Biopsy;NA;NO;122;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;23344;0:LIVING;2c86c3ea-d926-4d39-a5ae-39ece4774287;9ef8142a-8627-4dcf-8c87-15b1bc2bfea2;TCGA-B6-A0IJ.F3BAF04C-35EE-450F-BFA8-E9DFE9F984FD.pdf;Negative;NA;Right Upper Outer Quadrant|Right;NA;NO;Image Analysis;NA;NA;NA;Positive;NA;BLACK OR AFRICAN AMERICAN;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;B6;4066666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-B6-A0IK;TCGA-B6-A0IK-01;63;M0;N1;Stage IIIB;4th;T4;Image Analysis;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-23150;5724;571;0;NA;16.06;1:Recurred/Progressed;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;11/2/10;3518;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;1994;NO;NA;1;NA;14;Negative;Indeterminate (neither Pre or Postmenopausal);NA;NA;NA;Other method, specify:;Biopsy, NOS;NO;120;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;1876;1:DECEASED;0491063c-14a7-4104-8002-1459126332f3;357e1eca-0f5c-49d6-b437-0ed0afe3b178;TCGA-B6-A0IK.3A38A97C-2CBB-4802-9528-A4BBD62AEA4A.pdf;Positive;NA;Left;NA;NO;Image Analysis;NA;NA;NA;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;NA;NA;Modified radical mastectomy;NA;Lumpectomy;B6;4;WITH TUMOR;Breast
brca_tcga_pub2015;TCGA-B6-A0IM;TCGA-B6-A0IM-01;75;M0;N0 (i-);Stage IIB;4th;T3;Image Analysis;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-27557;4754;NA;0;3836;NA;NA;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;11/2/10;2215;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Other, specify;NA;No;No;C50.9;1/03/8523;C50.9;NA;NA;YES;1997;NO;NA;0;NA;9;Negative;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Fine needle aspiration biopsy;NA;NO;40;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;BRCA;12723;1:DECEASED;5a4b7098-1f6a-49e9-b364-29d6d34f5bd5;74f23f3b-989c-441b-8715-505378d175e3;TCGA-B6-A0IM.4A86A028-C56D-455E-A5CD-47D8A34B5734.pdf;Positive;NA;Right Upper Outer Quadrant|Right;NA;NO;Image Analysis;NA;NA;NA;Positive;NA;BLACK OR AFRICAN AMERICAN;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;Modified radical mastectomy;NA;Lumpectomy;B6;1333333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-B6-A0IN;TCGA-B6-A0IN-01;45;MX;NX;Stage X;4th;T1c;Image Analysis;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-16705;5073;2573;0;NA;46.39;1:Recurred/Progressed;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;Excisional biopsy;11/2/10;2325;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Other, specify;NA;No;No;C50.9;1/03/8523;C50.9;NA;NA;YES;1996;NO;NA;NA;NA;NA;Negative;Indeterminate (neither Pre or Postmenopausal);NA;NA;NA;Fine needle aspiration biopsy;NA;NO;31;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;BRCA;8453;1:DECEASED;16a8d916-ad46-4690-b1a5-3b2b323f4336;75103265-c66d-4bd9-8ecf-cfcf66402918;TCGA-B6-A0IN.267F1EFD-AB89-4124-B803-00CC0E8E9CD2.pdf;Positive;NA;Right Upper Outer Quadrant|Right;NA;NO;Image Analysis;NA;NA;NA;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;No axillary staging;NA;Modified radical mastectomy;NA;Other;B6;1033333333;WITH TUMOR;Breast
brca_tcga_pub2015;TCGA-B6-A0IO;TCGA-B6-A0IO-01;66;M0;N0 (i-);Stage IIA;NA;T2;Image Analysis;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-24322;3278;NA;0;3350;165.64;0:DiseaseFree;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;11/2/10;3270;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;2001;NO;NA;0;NA;17;NA;Indeterminate (neither Pre or Postmenopausal);NA;NA;NA;Core needle biopsy;NA;NO;56;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;16564;0:LIVING;04af44fc-c487-4005-b3cb-cb64815824a2;476b6ab5-f108-4280-9d53-7eb75fe17e4a;TCGA-B6-A0IO.9B3F0B22-8442-4720-A21B-7EF12CBCD2CE.pdf;Negative;NA;Left;NA;NO;Image Analysis;NA;NA;NA;Indeterminate;NA;WHITE;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;B6;1866666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-B6-A0IP;TCGA-B6-A0IP-01;74;M0;N0 (i-);Stage IA;NA;T1c;IMAGE ANALYSIS;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-27047;4565;NA;0;3374;NA;NA;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;11/2/10;661;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;NA;NA;YES;1997;NO;YES;0;NA;16;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Fine needle aspiration biopsy;NA;NO;24;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;ILC;12898;1:DECEASED;1402082d-25c9-4148-8a1e-f58450b706bb;6b1c8010-d4fe-40e7-8e09-7a7dbdde6616;TCGA-B6-A0IP.6C91D49C-9738-4A4F-A480-E71CD8EE5268.pdf;Negative;NA;Left Upper Outer Quadrant;NA;NO;IMAGE ANALYSIS;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;B6;8;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-B6-A0IQ;TCGA-B6-A0IQ-01;40;M0;N1b;Stage IIIA;4th;T3;Image Analysis;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-14669;5238;NA;0;3872;140.77;0:DiseaseFree;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;11/2/10;5981;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;1996;NO;NA;1;NA;26;NA;Indeterminate (neither Pre or Postmenopausal);NA;NA;NA;Other method, specify:;Biopsy, NOS;NO;62;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;14077;0:LIVING;01eef340-598c-4205-a990-cec190ac2ca5;183a47b2-1b00-4a72-adeb-f35b55692ee1;TCGA-B6-A0IQ.0ED7357E-662C-4D65-82ED-29739919068F.pdf;Negative;NA;Left Upper Outer Quadrant|Left;NA;NO;Image Analysis;NA;NA;NA;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;B6;2033333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-B6-A0RE;TCGA-B6-A0RE-01;61;M0;N0 (i-);Stage X;NA;TX;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-22449;7492;NA;0;6435;255.49;0:DiseaseFree;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;11/2/10;5386;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;1989;NO;NA;0;NA;14;NA;Indeterminate (neither Pre or Postmenopausal);NA;NA;NA;Other method, specify:;NA;NO;93;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;25549;0:LIVING;08da7c4c-3067-4bcf-9d7a-78566df72e69;270be245-2239-4e96-a917-79cca40868ba;TCGA-B6-A0RE.5607C6CE-21D5-495E-9174-85F1E2E0CB9D.pdf;Negative;NA;Right Upper Outer Quadrant|Right;NA;NO;NA;NA;NA;NA;Negative;NA;BLACK OR AFRICAN AMERICAN;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;B6;31;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-B6-A0RG;TCGA-B6-A0RG-01;26;M0;N0 (i-);Stage IIB;4th;T3;IHC;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-9840;6869;NA;0;2082;68.4;0:DiseaseFree;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;11/2/10;3585;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;1991;NO;NA;0;NA;19;NA;Indeterminate (neither Pre or Postmenopausal);NA;NA;NA;Other method, specify:;Biopsy, NOS;NO;56;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;684;0:LIVING;9b13927c-7357-44fd-8385-92ae6a656b7d;b98aa84f-5144-4062-badc-32e89368d684;TCGA-B6-A0RG.0429FA9A-AD19-424C-94ED-1A902119E559.pdf;Negative;NA;Left;NA;NO;IHC;NA;NA;NA;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Lumpectomy;B6;1866666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-B6-A0RH;TCGA-B6-A0RH-01;51;M0;N0 (i-);Stage IIA;6th;T2;Immunohistochemistry;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-18759;6821;NA;0;5749;71.12;1:Recurred/Progressed;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;3/15/11;2783;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;1991;NO;YES;0;NA;23;Negative;Indeterminate (neither Pre or Postmenopausal);NA;NA;NA;Incisional Biopsy;NA;NO;34;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;21209;1:DECEASED;c3148e68-1739-4334-abda-1dcbc2166846;5559a7ea-5db7-4af8-b491-24bb9871b89d;TCGA-B6-A0RH.3801F39A-6F4B-40C0-9625-9E0818266819.pdf;Positive;NA;Left Lower Inner Quadrant;NA;NO;Immunohistochemistry;NA;NA;NA;Positive;NA;BLACK OR AFRICAN AMERICAN;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;B6;12;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-B6-A0RI;TCGA-B6-A0RI-01;44;M0;N1b;Stage IIIB;3rd;T4b;IHC;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-16138;6755;NA;0;6796;36.14;1:Recurred/Progressed;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;11/2/10;928;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;1992;NO;NA;6;NA;15;NA;Indeterminate (neither Pre or Postmenopausal);NA;NA;NA;Other method, specify:;Biopsy, NOS;NO;18;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;2341;0:LIVING;bfd55808-dddd-44c3-97d7-41600497b992;973ee776-e287-4568-a43d-7b16cc0094a9;TCGA-B6-A0RI.F2B21F52-74F4-44C5-9991-60EBCC4E43A6.pdf;Negative;NA;Right Upper Outer Quadrant|Right;NA;NO;IHC;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;B6;6;WITH TUMOR;Breast
brca_tcga_pub2015;TCGA-B6-A0RN;TCGA-B6-A0RN-01;60;M0;N0 (i-);Stage IA;NA;T1c;Image Analysis;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;NA;-22077;6286;NA;0;5261;263.07;0:DiseaseFree;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;11/2/10;741;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;1993;NO;NA;0;NA;19;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Other method, specify:;Biopsy, NOS;NO;28;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;MDLC;26307;0:LIVING;2199b7a1-bd47-4bb5-b36a-a3e291e3e259;3652a456-36ee-4746-b25d-a6303984b77f;TCGA-B6-A0RN.5F08632D-BC1D-4414-80C1-75F67F3A07AF.pdf;Negative;NA;Right Upper Inner Quadrant|Right;NA;NO;Image Analysis;NA;NA;NA;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;B6;933333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-B6-A0RO;TCGA-B6-A0RO-01;71;M0;N1a;Stage IIIB;4th;T4;Image Analysis;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-26269;6035;NA;0;4929;161.93;0:DiseaseFree;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;11/2/10;4705;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;1993;NO;NA;2;NA;17;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Other method, specify:;Biopsy, NOS;NO;34;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;16193;0:LIVING;0b172e29-6166-4863-803d-a0a010887c11;edf2dbbe-b055-4d90-bc41-72355621b99e;TCGA-B6-A0RO.EFA0354A-641D-4EC2-A1BE-4ACC7CE421DF.pdf;Negative;NA;Right;NA;NO;Image Analysis;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;B6;1133333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-B6-A0RP;TCGA-B6-A0RP-01;73;M0;N1b;NA;4th;T2;Image Analysis;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;NA;-26941;5890;3126;0;NA;91.56;1:Recurred/Progressed;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;11/2/10;4882;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Mixed Histology (please specify);ductal/lobular;No;No;C50.9;1/03/8522;C50.9;NA;NA;YES;1994;NO;NA;2;NA;15;Negative;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Other method, specify:;Biopsy, NOS;NO;20;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;MDLC;10269;1:DECEASED;451e1a67-47e6-4738-99d7-fb7771ef61a3;6f261668-4373-4bf7-940b-38acf79b97b5;TCGA-B6-A0RP.889D6E80-A656-49FA-9DFA-1674EB3877F6.pdf;Positive;NA;Left Upper Outer Quadrant|Left;NA;NO;Image Analysis;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;Modified radical mastectomy;NA;Lumpectomy;B6;666666667;NA;Breast
brca_tcga_pub2015;TCGA-B6-A0RQ;TCGA-B6-A0RQ-01;68;M0;N0 (i-);Stage IIB;4th;T3;Image Analysis;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-25010;5890;4267;0;NA;NA;NA;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;excisional biopsy;3/15/11;134;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;NA;NA;YES;1994;NO;YES;0;NA;14;Negative;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Fine needle aspiration biopsy;NA;NO;11;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;ILC;14018;1:DECEASED;caa9b533-24b4-4ecd-9159-c165de049f6a;d43f3908-db7e-4064-b245-9e7ae83a47cc;TCGA-B6-A0RQ.46B892B9-82C8-4305-BCB9-805F6F5FC90A.pdf;NA;NA;Right Upper Outer Quadrant|Right;NA;NO;Image Analysis;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Other;B6;366666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-B6-A0RT;TCGA-B6-A0RT-01;39;M0;N1;Stage IIIA;4th;T3;Image Analysis;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;NA;-14374;5047;NA;0;2721;89.39;0:DiseaseFree;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;11/3/10;237;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;1996;NO;NA;1;NA;23;NA;Indeterminate (neither Pre or Postmenopausal);NA;NA;NA;Fine needle aspiration biopsy;NA;NO;31;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;MDLC;8939;0:LIVING;4bf50455-9ab7-4521-a791-089f66d3b877;c2300b5b-43a7-43b8-8cd1-22ff7e89a21a;TCGA-B6-A0RT.64D53A4B-4735-4AD2-A413-520797F5F9CB.pdf;Close;NA;Right Upper Outer Quadrant|Right;NA;NO;Image Analysis;NA;NA;NA;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;B6;1033333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-B6-A0RU;TCGA-B6-A0RU-01;40;M0;N0 (i-);Stage IA;3rd;T1c;Image Analysis;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-14920;7290;NA;0;7067;101.05;1:Recurred/Progressed;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;Excisional biopsy;11/2/10;3834;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Other, specify;NA;No;No;C50.9;1/03/8523;C50.9;NA;NA;YES;1990;NO;NA;0;NA;15;NA;Indeterminate (neither Pre or Postmenopausal);NA;NA;NA;Tumor resection;NA;NO;41;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;BRCA;28269;0:LIVING;6956473b-92e5-4069-a26b-b48e280e76f2;c94232f8-2e37-46d0-b12a-b8e920e659d9;TCGA-B6-A0RU.39C689CA-F7BA-4554-BEC8-11F9C8142D9C.pdf;Negative;NA;Right;NA;NO;Image Analysis;NA;NA;NA;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Other;B6;1366666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-B6-A0RV;TCGA-B6-A0RV-01;42;M0;N2;Stage IIIA;4th;T3;Image Analysis;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-15507;5165;NA;0;4788;169.38;0:DiseaseFree;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;11/2/10;1644;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Mixed Histology (please specify);Lobular/Ductal;No;No;C50.9;1/03/8522;C50.9;NA;NA;YES;1996;NO;NA;5;NA;10;NA;Indeterminate (neither Pre or Postmenopausal);NA;NA;NA;Incisional Biopsy;NA;NO;35;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;ILC;16938;0:LIVING;cd3faa15-743c-476f-ab0d-f205b14126b6;8a0c0515-abdd-4e78-9205-bd8f80f60397;TCGA-B6-A0RV.FF5D000A-4600-4C42-8802-4BCD29F61CA6.pdf;Negative;NA;Right;NA;NO;Image Analysis;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;B6;1166666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-B6-A0WS;TCGA-B6-A0WS-01;58;MX;NX;Stage X;4th;T1c;Image Analysis;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-21230;5113;2965;0;NA;NA;NA;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;3/15/11;2277;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;1996;NO;NO;NA;NA;NA;NA;Indeterminate (neither Pre or Postmenopausal);NA;NA;NA;Fine needle aspiration biopsy;NA;NO;13;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;974;1:DECEASED;197741de-a098-4f04-bb37-8ea8b3bb39bc;5dc7e339-f508-4d0d-ae4e-016a5425aba4;TCGA-B6-A0WS.36AE47A6-B881-4C1D-8436-EB65783243CF.pdf;Positive;NA;Left Upper Outer Quadrant|Left;NA;NO;Image Analysis;NA;NA;NA;Positive;NA;BLACK OR AFRICAN AMERICAN;NA;YES;1;Primary;Female;Matched;No axillary staging;NA;NA;NA;Lumpectomy;B6;433333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-B6-A0WT;TCGA-B6-A0WT-01;61;M0;N1;Stage IIB;4th;T2;Image Analysis;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-22362;5606;NA;0;5396;126.87;1:Recurred/Progressed;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;12/14/10;1520;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;1995;NO;NA;1;NA;15;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Fine needle aspiration biopsy;NA;NO;17;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;18853;0:LIVING;d7195183-9fe4-4b17-bcfd-9367d2e539ce;1940c04b-a08a-4cce-9915-483656d5b4c3;TCGA-B6-A0WT.BACD800B-F320-472C-ACFF-175E9F525E9F.pdf;Negative;NA;Left Lower Inner Quadrant|Left;NA;NO;Image Analysis;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;B6;566666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-B6-A0WV;TCGA-B6-A0WV-01;67;M0;N1b;Stage IIB;4th;T2;Image Analysis;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-24803;5531;2417;0;NA;NA;NA;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;12/14/10;4345;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;1995;NO;NA;4;NA;7;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Incisional Biopsy;NA;NO;26;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;794;1:DECEASED;7588a286-6935-424a-bc5f-92e24c83eb37;9caf2f97-a056-4274-be21-cf06656116fa;TCGA-B6-A0WV.506BFD3B-240B-440E-B7A0-E596FC0B7F72.pdf;Negative;NA;Right;NA;NO;Image Analysis;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;B6;866666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-B6-A0WW;TCGA-B6-A0WW-01;58;MX;N1b;Stage X;4th;T2;Image Analysis;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-21479;4664;558;0;NA;14.68;1:Recurred/Progressed;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;12/14/10;3127;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;1997;NO;NA;5;NA;18;NA;Indeterminate (neither Pre or Postmenopausal);NA;NA;NA;Incisional Biopsy;NA;NO;30;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;1833;1:DECEASED;f02931f8-d72a-481d-b532-8b141dab115f;cbc8cfce-6c77-4b2e-90a1-198eaaba6fde;TCGA-B6-A0WW.F05F5886-DC5D-4685-B2BF-57A68A0BB7B9.pdf;Negative;NA;Right Upper Inner Quadrant|Right;NA;NO;Image Analysis;NA;NA;NA;Positive;NA;BLACK OR AFRICAN AMERICAN;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;B6;1;WITH TUMOR;Breast
brca_tcga_pub2015;TCGA-B6-A0WX;TCGA-B6-A0WX-01;40;M0;N1b;Stage IIIA;5th;T3;Image Analysis;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-14784;4476;639;0;NA;18.5;1:Recurred/Progressed;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;12/14/10;4622;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Other, specify;NA;No;No;C50.9;1/03/8520;C50.9;NA;NA;YES;1998;NO;NA;9;NA;21;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NA;Excisional Biopsy;NA;NO;25;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;BRCA;2099;1:DECEASED;a482fc4c-ff1d-46a0-a968-7df06422cc4b;7daa9124-2878-4708-ae74-28b17ef4898c;TCGA-B6-A0WX.EE5BB205-D59B-4FEF-8D8F-D5720EDEB075.pdf;Negative;NA;Left;NA;NO;Image Analysis;NA;NA;NA;Negative;NA;BLACK OR AFRICAN AMERICAN;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;B6;833333333;WITH TUMOR;Breast
brca_tcga_pub2015;TCGA-B6-A0WY;TCGA-B6-A0WY-01;40;M0;N1b;Stage IIIA;4th;T3;Image Analysis;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-14778;5294;3461;0;NA;66.06;1:Recurred/Progressed;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;12/14/10;836;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;1996;NO;NA;3;NA;21;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NA;Core needle biopsy;NA;NO;23;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;1137;1:DECEASED;f475d460-75cd-4fe9-aa54-c90be12b4ef8;ed3f6393-6955-41af-bb3a-7723b5dbe41e;TCGA-B6-A0WY.C0E92852-4146-468C-9713-2DE9C3316B9F.pdf;Negative;NA;Left Lower Inner Quadrant|Left;NA;NO;Image Analysis;NA;NA;NA;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Lumpectomy;B6;766666667;WITH TUMOR;Breast
brca_tcga_pub2015;TCGA-B6-A0WZ;TCGA-B6-A0WZ-01;50;M0;N1b;Stage II;4th;T2;Image Analysis;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-18584;5179;NA;0;3941;168.1;1:Recurred/Progressed;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;Fine Needle aspiration biopsy;12/14/10;2496;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;1996;NO;NA;11;NA;21;NA;Indeterminate (neither Pre or Postmenopausal);NA;NA;NA;Fine needle aspiration biopsy;NA;NO;41;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;2067;0:LIVING;08740d7f-5a5e-4dfa-bd48-7fbf228a7a28;5b94a116-7e70-41d4-8c6f-2bae44e591aa;TCGA-B6-A0WZ.B5B7CCDD-1ED2-437A-BDF0-684AF474A8A6.pdf;Negative;NA;Right Upper Inner Quadrant|Right;NA;NO;Image Analysis;NA;NA;NA;Positive;NA;BLACK OR AFRICAN AMERICAN;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Other;B6;1366666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-B6-A0X0;TCGA-B6-A0X0-01;54;M0;N0 (i-);Stage I;4th;T1c;Image Analysis;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-19802;5243;3945;0;NA;NA;NA;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;3/15/11;1143;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Other, specify;NA;No;No;C50.919;1/03/8201;C50.9;NA;NA;YES;1996;NO;YES;0;NA;31;NA;Indeterminate (neither Pre or Postmenopausal);NA;NA;NA;Fine needle aspiration biopsy;NA;NO;21;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;BRCA;1296;1:DECEASED;1e68e760-a4cf-4100-bf9c-e50fa8d126f6;14f380df-eda0-4593-b00f-43abc87e22d4;TCGA-B6-A0X0.84A8BA4A-35F0-46C4-BDB0-64C033AFD1A8.pdf;Negative;NA;Right Upper Outer Quadrant|Right;NA;NO;Image Analysis;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;B6;7;NA;Breast
brca_tcga_pub2015;TCGA-B6-A0X4;TCGA-B6-A0X4-01;62;M0;N1b;Stage IIB;4th;T2;Image Analysis;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-22688;5323;860;0;NA;23.52;1:Recurred/Progressed;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;12/14/10;305;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;1996;NO;NA;2;NA;21;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Incisional Biopsy;NA;NO;20;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;2825;1:DECEASED;4e42fdc5-2a8b-49e9-87ef-6db7a6692d08;45c3bd72-d260-4663-9091-5058e58f352d;TCGA-B6-A0X4.CA935E8D-ED8A-4485-BDC6-02C07CCE2EA5.pdf;Negative;NA;Left;NA;NO;Image Analysis;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;B6;633333333;WITH TUMOR;Breast
brca_tcga_pub2015;TCGA-B6-A0X5;TCGA-B6-A0X5-01;61;M0;N1b;Stage IIB;4th;T2;Image Analysis;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-22380;5600;2097;0;NA;44.12;1:Recurred/Progressed;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;12/14/10;827;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;1995;NO;NA;3;NA;14;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;NA;NA;NO;28;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;6889;1:DECEASED;4e6edfe6-adcb-4c12-8ff4-38a79f5887e8;e56e785d-f9b1-4afa-bc2d-b6cebf9e64cc;TCGA-B6-A0X5.29811BAC-AFD1-4951-BDF8-7B859941B634.pdf;Negative;NA;Left;NA;NO;Image Analysis;NA;NA;NA;Positive;NA;BLACK OR AFRICAN AMERICAN;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;B6;933333333;WITH TUMOR;Breast
brca_tcga_pub2015;TCGA-B6-A0X7;TCGA-B6-A0X7-01;62;MX;NX;Stage X;4th;T1c;Image Analysis;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-22723;6002;1781;0;NA;36.27;1:Recurred/Progressed;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;12/14/10;1698;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Mixed Histology (please specify);Ductal/Lobular;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;1994;NO;NA;NA;NA;0;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Excisional Biopsy;NA;NO;16;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;ILC;5851;1:DECEASED;5b9a5cd2-5ec8-48a0-b9f2-da9bede0b089;de27ccdd-56a4-44e9-89a3-ff0173026315;TCGA-B6-A0X7.0FB6BB0F-C3F9-43E6-8BDE-90D1DBA298CA.pdf;NA;NA;Right;NA;NO;Image Analysis;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;No axillary staging;NA;NA;NA;NA;B6;533333333;NA;Breast
brca_tcga_pub2015;TCGA-B6-A1KC;TCGA-B6-A1KC-01;67;M0;N1;Stage IIB;6th;T2;image cytometry;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-24791;2781;NA;0;1326;43.56;0:DiseaseFree;NA;49 fmol/mg protein;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;7/19/11;5293;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2003;NO;YES;1;NA;2;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;NO;27;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;4356;0:LIVING;1502c7d7-1535-4e56-9f34-30623acd50d5;0cc10a1e-a90a-4c55-87a2-a74d47474a4a;TCGA-B6-A1KC.E1FDF8EB-9D75-4629-9C78-6019DAF8190E.pdf;Negative;NA;Right Lower Outer Quadrant;NA;NO;image cytometry;NA;NA;NA;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Lumpectomy;B6;9;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-B6-A1KF;TCGA-B6-A1KF-01;68;M0;N1;Stage IIB;5th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-24891;4536;NA;0;3088;101.45;0:DiseaseFree;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;Excisional biopsy;7/19/11;5575;NA;NA;NA;NA;NA;NA;60-69%;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;1998;NO;YES;2;NA;14;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Fine needle aspiration biopsy;NA;NO;44;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;10145;0:LIVING;f30eb65f-fb44-4062-ac39-a38d072f655f;11678ad0-81ae-4420-8976-52f99c5d7d5d;TCGA-B6-A1KF.40EE8416-9DD8-457D-94AC-A871B5C62873.pdf;Negative;NA;Right Lower Outer Quadrant;NA;NO;NA;NA;NA;NA;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Other;B6;15;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-B6-A1KI;TCGA-B6-A1KI-01;63;M0;N0;Stage I;6th;T1c;image cytometry;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;3.1;-23031;2634;NA;0;1463;73.46;0:DiseaseFree;NA;288 fmol/mg;NA;Positive;NA;NOT HISPANIC OR LATINO;Excisional biospy;7/19/11;1086;60;NA;1.2;3.8;NA;Negative;90-99%;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;2003;NO;YES;0;NA;1;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;NO;17;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;7346;0:LIVING;1dafdd64-527d-4d46-bbdf-7a97774f881b;a6b12e25-7b2d-460c-876f-02a75a82d7d2;TCGA-B6-A1KI.C2711492-0BDD-487E-9C9B-CEF20BBE57C3.pdf;Negative;NA;Right Upper Inner Quadrant;NA;NO;image cytometry;NA;70 fmol/mg;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Other;B6;566666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-B6-A1KN;TCGA-B6-A1KN-01;57;M0;N1;Stage IIIB;5th;T4b;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-21183;4537;NA;0;3330;139.06;0:DiseaseFree;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;7/19/11;2858;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;1998;NO;YES;24;NA;30;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;NO;60;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;13906;0:LIVING;271404de-24e8-43f6-806b-fb510c1124c4;ca44a8bf-428e-48b5-ae58-614f9a3e0fd8;TCGA-B6-A1KN.72996825-1FFA-4C51-8DB0-DA74BCB595EB.pdf;Negative;NA;Right Upper Inner Quadrant;NA;NO;NA;NA;NA;NA;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;B6;2033333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-B6-A2IU;TCGA-B6-A2IU-01;62;M0;N0;Stage IIA;5th;T2;image cytometry;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-22905;4665;NA;0;4840;138.76;1:Recurred/Progressed;NA;NA;NA;Positive;NA;HISPANIC OR LATINO;NA;1/11/12;2248;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;NA;NA;YES;1998;NO;YES;0;NA;28;NA;Indeterminate (neither Pre or Postmenopausal);NA;NA;NA;Core needle biopsy;NA;NO;37;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;ILC;17004;0:LIVING;9857BE0C-AECA-4A43-90B1-0535BD08E086;571468B9-6FB4-40C6-8830-1FFAD5419B60;TCGA-B6-A2IU.EE769039-220E-4158-8999-09F17AFB4C46.pdf;Negative;NA;Right;NA;NO;image cytometry;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;B6;1233333333;NA;Breast
brca_tcga_pub2015;TCGA-BH-A0AU;TCGA-BH-A0AU-01;45;M0;N0;Stage IIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-16688;583;NA;0;746;62.88;0:DiseaseFree;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;left segmental mastectomy with sentinel node dissection;7/27/11;4255;NA;NA;NA;NA;NA;Negative;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;NA;YES;2008;NO;YES;0;NA;2;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Core needle biopsy;NA;NA;18;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;6288;0:LIVING;360d1d6d-cf3e-4c78-b36f-ef5e3160aa6b;9df5fb66-44da-4d92-899a-99c07cd23fff;TCGA-BH-A0AU.4C942A1D-53B2-43A6-9B96-5155CCDEEC34.pdf;Negative;NA;Left Upper Inner Quadrant;NA;NO;NA;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;BH;6;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A0AV;TCGA-BH-A0AV-01;52;M0;N0;Stage I;6th;T1c;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-19314;761;NA;0;1180;59.79;0:DiseaseFree;NA;NA;NA;Negative;NA;NA;Segmental mastectomy with left axillary lymph node dissection;8/2/11;6161;NA;NA;NA;NA;NA;Negative;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;2008;NO;YES;0;NA;2;NA;NA;NA;NA;NO;Core needle biopsy;NA;NA;54;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;5979;0:LIVING;790ff5db-b7f3-4946-aaed-305f66b1dd6a;dce6cac3-6c76-4574-b7a8-c7083b12f22e;TCGA-BH-A0AV.6DFA6F0F-09BC-4246-87B9-247207B74A39.pdf;Negative;NA;Left Upper Inner Quadrant;NA;NO;NA;NA;NA;NA;Negative;NA;BLACK OR AFRICAN AMERICAN;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;BH;18;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A0AW;TCGA-BH-A0AW-01;56;M0;N1a;Stage IIA;NA;T1c;ER Positive H-Score 95;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;NA;-20468;545;NA;0;622;20.43;0:DiseaseFree;NA;H-Score;NA;Positive;NA;NA;NA;11/3/10;2907;NA;NA;NA;NA;NA;NA;NA;3;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;NA;YES;2008;NO;NA;2;0;12;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NO;117;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;MDLC;2043;0:LIVING;c5891c7a-fd24-4891-8f51-373967e4a6dd;18bb30b2-6018-45af-9393-f7a8ea40fa04;TCGA-BH-A0AW.D1B30DA1-FF63-4FC7-AB8B-818331EE6D72.pdf;Negative;NA;Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left;NA;NO;PR Negative H-Score 0;NA;H-Score;NA;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Lumpectomy;BH;39;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A0AY;TCGA-BH-A0AY-01;62;M0;N0 (i-);Stage IIA;NA;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-22703;587;NA;0;777;25.53;0:DiseaseFree;NA;NA;NA;Positive;NA;NA;NA;11/3/10;2207;NA;NA;NA;NA;NA;NA;NA;0;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2008;NO;NA;0;NA;1;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NO;46;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;2553;0:LIVING;93ed6066-b567-4e1c-ab81-23370f9d3452;7f00169e-2572-4158-a453-ccec33cd2159;TCGA-BH-A0AY.06905BD3-4D17-4625-8631-46CA81D1B47B.pdf;Negative;NA;Left Lower Outer Quadrant|Left;NA;NO;NA;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Simple Mastectomy;BH;1533333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A0AZ;TCGA-BH-A0AZ-01;47;cM0 (i+);N1a;Stage IIIA;6th;T3;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-17465;575;NA;0;867;63.04;0:DiseaseFree;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;total mastectomy with sentinel lymph node biopsy with tissue reconstruction;7/27/11;2853;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2008;NO;YES;1;NA;13;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Core needle biopsy;NA;NA;47;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;6304;0:LIVING;518f231c-f5f9-4a39-a97b-7fd5666d3e50;aafc7bc4-1e57-4df9-9bad-a04a4d9edebd;TCGA-BH-A0AZ.6721193F-FE9D-4573-BF2A-ABAECF57DFD9.pdf;Negative;NA;Right;NA;NO;NA;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;BH;1566666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A0B0;TCGA-BH-A0B0-01;56;M0;N0;Stage I;6th;T1c;NA;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;NA;-20776;1223;NA;0;1428;81.37;0:DiseaseFree;NA;NA;NA;Positive;NA;NA;left segmental mastectomy with axillary sentinel lymph node biopsy;7/27/11;2342;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2006;NO;YES;0;NA;2;NA;Peri (6-12 months since last menstrual period);NA;NA;NO;Fine needle aspiration biopsy;NA;NA;39;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;MDLC;8137;0:LIVING;66af34ea-f471-4092-aff6-9ac9a5b75b11;b25afcbc-accf-4f14-acc3-2f8bb700e5d2;TCGA-BH-A0B0.EB09D890-879C-4874-AE3F-47E41C2C66FE.pdf;Negative;NA;Left Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;NA;BLACK OR AFRICAN AMERICAN;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;BH;13;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A0B3;TCGA-BH-A0B3-01;53;M0;N1a;Stage IIB;NA;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-19479;1030;NA;0;1203;39.52;0:DiseaseFree;NA;NA;NA;Negative;NA;NA;Segmental mastectomy;11/3/10;2146;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;0;YES;2007;NO;NA;2;NA;29;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NO;35;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;3952;0:LIVING;18eb4dfc-556f-4bf3-a411-4780209ed1e0;fc1f0ad4-8412-4143-8ebf-fa6592f396e9;TCGA-BH-A0B3.A6E2735B-AAD3-48D7-8289-306257CB5B6F.pdf;Negative;NA;Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right;NA;NO;NA;0;NA;NA;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Other;BH;1166666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A0B4;TCGA-BH-A0B4-01;65;M0;N2;Stage IIIA;NA;T2;NA;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;2;-23980;995;NA;0;1191;39.13;0:DiseaseFree;NA;NA;NA;Positive;80-89%;NA;NA;11/4/10;3681;40;NA;2.83;5.65;NA;Positive;NA;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;3;YES;2007;NO;NA;6;NA;10;NA;NA;NA;NA;NA;Core needle biopsy;NA;NO;55;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;MDLC;3913;0:LIVING;c710f4ab-fbd9-42ed-95d4-4e6d51207f38;481cdbff-1f84-4508-ad9f-21a61009d68a;TCGA-BH-A0B4.00C75246-4343-490D-9782-E6C0068C77B2.pdf;Negative;NA;Left;NA;NO;NA;3+;NA;NA;Positive;50-59%;WHITE;NA;YES;1;Primary;Male;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;BH;1833333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A0B5;TCGA-BH-A0B5-01;40;M0;N2a;Stage IIIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-14920;1008;NA;0;1471;70.17;0:DiseaseFree;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;8/2/11;2328;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Negative;NA;YES;2007;NO;YES;5;NA;24;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Fine needle aspiration biopsy;NA;NA;57;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;ILC;7017;0:LIVING;9da462b0-93c2-4305-89f6-7199a30399a7;a0de3018-8916-4e06-8ba1-beb1d218e30e;TCGA-BH-A0B5.F44C515D-5A58-4382-A147-4429A78D434F.pdf;Positive;NA;Left;NA;NO;NA;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Modified Radical Mastectomy;BH;19;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A0B6;TCGA-BH-A0B6-01;47;M0;N0;Stage I;6th;T1c;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-17346;1405;NA;0;1732;81.57;0:DiseaseFree;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;segmental mastectomy with sentinel lymph node biopsy;8/4/11;1574;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;Yes;Yes;C50.9;1/03/8500;C50.9;Positive;NA;YES;2006;NO;YES;0;NA;4;NA;NA;NA;NA;NO;Fine needle aspiration biopsy;NA;NA;591;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;8157;0:LIVING;FA4E082A-D213-412E-8D91-842A6F4BEF12;930B82A6-A039-4F8F-8487-B0ABB4FE7ABA;TCGA-BH-A0B6.06602AD0-AC4D-4674-B4B0-2D207C3E78DC.pdf;Negative;NA;Left Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;BH;197;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A0B7;TCGA-BH-A0B7-01;42;M0;N1a;Stage IIB;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-15593;1391;NA;0;1733;84.07;0:DiseaseFree;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;right total mastectomy with sentinel lymph node dissection right reconstruction with TRAMP;8/4/11;1253;NA;NA;NA;NA;NA;NA;NA;3;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;NA;YES;2006;NO;YES;1;NA;17;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Core needle biopsy;NA;NA;25;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;8407;0:LIVING;214a4507-d974-4b3e-8525-7408fccc6a0f;45c79141-a125-4305-b1b7-c838de1af8a3;TCGA-BH-A0B7.B5E5A3B8-108E-47D3-99DA-EC7A64B5FA9C.pdf;Negative;NA;Right;NA;NO;NA;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;BH;833333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A0B9;TCGA-BH-A0B9-01;44;M0;N0 (i-);Stage IA;NA;T1c;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-16310;1391;NA;0;1572;51.64;0:DiseaseFree;NA;NA;NA;Negative;NA;NA;Segmental mastectomy;11/4/10;3070;NA;NA;NA;NA;NA;NA;<10%;0;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;0;YES;2006;NO;NA;0;NA;1;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NA;Core needle biopsy;NA;NO;36;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;5164;0:LIVING;5a57dc25-d252-4b22-b192-4de630d7002f;8137ffee-bb4f-4e5f-b831-acfc9c5585a8;TCGA-BH-A0B9.EB00527B-1E37-420E-85E4-10063DB4BC1C.pdf;Negative;NA;Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right;NA;NO;NA;0;NA;NA;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Other;BH;12;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A0BA;TCGA-BH-A0BA-01;51;M0;N3a;Stage IIIC;NA;T3;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-18839;1266;NA;0;1132;37.19;0:DiseaseFree;NA;NA;NA;Positive;80-89%;NA;NA;11/4/10;8633;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Mixed Histology (please specify);Infiltrating ductal & lobular;No;No;C50.9;1/03/8522;C50.9;Negative;3;YES;2006;NO;NA;27;NA;27;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NA;Core needle biopsy;NA;NO;29;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;ILC;3719;0:LIVING;49dc3e68-6206-4f16-969f-a758cc7be8ed;992d3519-cd51-4f48-880c-81fef52be1bf;TCGA-BH-A0BA.142F03FE-5B60-416D-8DCD-EC34DB5495DB.pdf;Negative;NA;Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left;NA;NO;NA;1+;NA;NA;Positive;40-49%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Modified Radical Mastectomy;BH;966666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A0BC;TCGA-BH-A0BC-01;60;M0;N3;Stage IIIC;NA;T2;NA;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;NA;-21949;1098;NA;0;974;32;0:DiseaseFree;NA;NA;NA;Positive;90-99%;NA;Segmental mastectomy;11/4/10;1967;NA;NA;NA;NA;NA;NA;<10%;0;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;3;YES;2007;NO;NA;12;NA;18;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NO;26;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;MDLC;32;0:LIVING;327a2395-85c8-42e1-9638-8e037a1723ed;e586a2b3-1132-45db-9283-dc318653a09f;TCGA-BH-A0BC.9714A9F8-B507-43E6-9D56-1852F5D1F675.pdf;Negative;NA;Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right;NA;NO;NA;1+;NA;NA;Positive;30-39%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Other;BH;9;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A0BD;TCGA-BH-A0BD-01;47;M0;N1a;Stage IIA;6th;T1c;H-Score-190;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-17275;364;NA;0;554;18.2;0:DiseaseFree;NA;H-Score;NA;Positive;NA;NA;segmental mastectomy;11/4/10;1794;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2009;NO;NA;2;NA;9;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NA;Core needle biopsy;NA;NO;17;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;182;0:LIVING;b379bfb8-284e-4300-8325-85cfd6809cb8;832b8766-0e59-4ad4-b4c9-1e39b2ce4fb1;TCGA-BH-A0BD.CE70DD1E-BCA4-4F89-AA5B-D90FE18A36FF.pdf;Negative;NA;Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left;NA;NO;H-Score-230;NA;H-Score;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Other;BH;566666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A0BF;TCGA-BH-A0BF-01;56;M0;N1mi;Stage IIB;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-20691;413;NA;0;782;NA;NA;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;Total mastectomy with sentinel lymph node biopsy;8/5/11;2904;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2009;NO;YES;1;NA;3;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;NA;26;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;435;1:DECEASED;e6b79d7a-ed6b-459a-b040-d142616e7ab4;4dc7d403-3ea7-4d02-94a7-fb33511bab09;TCGA-BH-A0BF.0D76394C-40B4-4E74-8A80-FAE00E21FD10.pdf;Negative;NA;Right Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;BH;866666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A0BG;TCGA-BH-A0BG-01;73;M0;N0;Stage I;6th;T1;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-26988;798;NA;0;756;61.47;0:DiseaseFree;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;Segmental mastectomy with sentinel axillary lymph node biopsy;8/8/11;4262;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2008;NO;YES;0;NA;1;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;NA;34;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;6147;0:LIVING;4f608829-ffc4-4527-886e-6bc764ab29f5;4aa1d78b-37cc-43be-b4f7-ce677992024e;TCGA-BH-A0BG.CB0C2E8E-2D5D-492C-9C7E-0ECD0458425A.pdf;Negative;NA;Left Lower Outer Quadrant;NA;NO;NA;NA;NA;NA;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;BH;1133333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A0BJ;TCGA-BH-A0BJ-01;41;M0;N1a;Stage IIB;NA;T2;H-Score 300;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-15027;595;NA;0;660;21.68;0:DiseaseFree;NA;H Score;NA;Positive;90-99%;NA;Segmental mastectomy;11/8/10;4003;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;3;YES;2008;NO;NA;2;NA;18;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NA;Core needle biopsy;NA;NO;29;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;2168;0:LIVING;d6f911b5-e895-43f8-8f86-0ac2f1bc6fae;d1991ebd-1cd1-4c2d-ac99-2a6ecd3f90f1;TCGA-BH-A0BJ.A3CDF051-4162-47EC-BE8A-1519A5564518.pdf;Negative;NA;Left Upper Outer Quadrant|Left;NA;NO;H-Score 260;3+;H-Score;NA;Positive;70-79%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Other;BH;966666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A0BL;TCGA-BH-A0BL-01;35;M0;N0;Stage I;6th;T1c;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-12841;1135;NA;0;1340;74.84;0:DiseaseFree;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;Segmental mastectomy with sentinel lymph node biopsy;8/8/11;3435;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2007;NO;YES;0;NA;2;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Core needle biopsy;NA;NA;59;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;7484;0:LIVING;92b5de82-0221-4df1-8094-80f40c0bb4fa;e11dab7d-dc9c-416c-8200-ebdf8a64e3ea;TCGA-BH-A0BL.DD647293-3CEA-4845-A0B3-D7000CBAB4C0.pdf;Negative;NA;Right Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;BH;1966666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A0BM;TCGA-BH-A0BM-01;54;M0;N1a;Stage IIB;6th;T2;NA;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;NA;-20049;1080;NA;0;1117;61.63;0:DiseaseFree;NA;NA;NA;Positive;NA;NA;NA;11/8/10;936;NA;NA;NA;NA;NA;NA;<10%;0;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;3;YES;2007;NO;NA;3;NA;24;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NO;30;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;MDLC;6163;0:LIVING;c2aeee6c-ba10-4cf9-b560-c739580f7bf3;5423b7f8-d2bb-47c8-9af8-3d3e1276888c;TCGA-BH-A0BM.7F75F15A-2476-4FFD-97B3-313F06568E21.pdf;Negative;NA;Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right;NA;NO;NA;0;NA;NA;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Lumpectomy;BH;1;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A0BO;TCGA-BH-A0BO-01;54;M0;N0;Stage I;6th;T1b;NA;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;NA;-19767;1162;NA;0;1085;72.17;0:DiseaseFree;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;Segmental mastectomy with sentinel lymph node biopsy;8/9/11;180;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2007;NO;YES;0;NA;3;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Core needle biopsy;NA;NA;23;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;MDLC;7217;0:LIVING;26573441-eedb-4364-966c-e7f803deef19;b6702fc2-9794-466e-a2e3-a8407674d05f;TCGA-BH-A0BO.DDAB2FC2-D9F0-4D8F-A7FE-6C0B823E6823.pdf;Negative;NA;Left Upper Inner Quadrant;NA;NO;NA;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;BH;766666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A0BP;TCGA-BH-A0BP-01;76;M0;N0;Stage I;6th;T1c;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-27917;1217;NA;0;1481;NA;NA;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;Segmental mastectomy;8/9/11;6741;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2006;NO;YES;0;NA;3;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;NA;118;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;7543;1:DECEASED;f251cb6c-d18e-4691-9c82-24ed1ac0abf9;35b5f5a8-dd85-46d3-97cc-444060b2a11b;TCGA-BH-A0BP.2444E1FE-E0AB-4AA0-9081-967426B90EE6.pdf;Negative;NA;Left Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;BH;3933333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A0BQ;TCGA-BH-A0BQ-01;39;M0;N0;Stage I;6th;T1c;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-14494;1197;NA;0;827;56.14;1:Recurred/Progressed;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;Total mastectomy with retromammary lymph node excision;8/10/11;1009;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;NA;YES;2007;NO;YES;0;NA;2;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Core needle biopsy;NA;NA;19;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;7408;0:LIVING;b3bb8fd6-ee54-4813-b042-2bbe70115382;18dddb4e-11d6-4fe7-b44a-48342374a5b1;TCGA-BH-A0BQ.24245506-25BA-411D-8A43-52DB8F6B6037.pdf;Negative;NA;Left;NA;NO;NA;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;BH;633333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A0BR;TCGA-BH-A0BR-01;59;M0;N0;Stage I;6th;T1c;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-21622;1170;NA;0;1633;76.54;0:DiseaseFree;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;Segmental mastectomy with sentinel lymph node biopsy;8/10/11;4653;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2007;NO;YES;0;NA;3;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;NA;61;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;7654;0:LIVING;3ecb0147-276d-486c-9af0-ce437c24ba83;581cc2a6-e95c-46e1-8530-598a616e86be;TCGA-BH-A0BR.6122CE59-23C0-4205-91B5-B71E39C6EAB8.pdf;Negative;NA;Left Lower Inner Quadrant;NA;NO;NA;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;BH;2066666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A0BS;TCGA-BH-A0BS-01;55;M0;N1c;Stage IIIA;6th;T3;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-20374;1164;NA;0;1641;85.81;0:DiseaseFree;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;8/18/11;493;NA;NA;NA;NA;NA;Negative;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;2007;NO;YES;0;NA;11;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;NA;12;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;8581;0:LIVING;2b22db1d-54a1-4b9e-a86e-a174cf51d95c;2f125802-32af-40b6-b4c8-4018740ccee9;TCGA-BH-A0BS.A231BC51-EFA3-4FEB-A83F-C793FFF8E607.pdf;Negative;NA;Left;NA;NO;NA;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Simple Mastectomy;BH;4;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A0BV;TCGA-BH-A0BV-01;78;M0;N1a;Stage IIB;NA;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-28699;1328;NA;0;1519;49.9;0:DiseaseFree;NA;NA;NA;Positive;90-99%;NA;NA;11/9/10;1734;NA;NA;NA;NA;NA;NA;<10%;0;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;3;YES;2006;NO;NA;2;NA;25;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NO;29;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;499;0:LIVING;87f03d04-e651-4a6e-aea6-1c946aa46202;ce3c01d9-e8c7-4bd6-84f9-741f38b07267;TCGA-BH-A0BV.7C877EE0-B4BC-4B17-94AB-81B67C7B6DB3.pdf;Negative;NA;Right Upper Inner Quadrant|Right;NA;NO;NA;2+;NA;NA;Positive;50-59%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Modified Radical Mastectomy;BH;966666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A0BW;TCGA-BH-A0BW-01;71;M0;N0;Stage I;6th;T1c;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-25974;1344;NA;0;355;77.89;0:DiseaseFree;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;Segmental mastectomy;8/10/11;3953;NA;NA;NA;NA;NA;Negative;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;2006;NO;YES;0;NA;8;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;NA;83;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;7789;0:LIVING;5d1d00c6-fcae-479e-ae1e-de76efd41d98;dbeeddc1-d149-46f7-91ff-d057f8c6bffb;TCGA-BH-A0BW.14CE78F3-8FB4-476D-A09C-AE87F7919D77.pdf;Negative;NA;Left Lower Outer Quadrant;NA;NO;NA;NA;NA;NA;Negative;NA;BLACK OR AFRICAN AMERICAN;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;BH;2766666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A0BZ;TCGA-BH-A0BZ-01;59;M0;N1a;Stage IIIA;6th;T3;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-21856;1084;NA;0;1492;74.08;0:DiseaseFree;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;8/10/11;1500;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2007;NO;YES;1;NA;23;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Fine needle aspiration biopsy;NA;NA;208;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;BRCA;7408;0:LIVING;4a032bad-e726-48f2-8f39-e3acc109cc91;55906ee0-a385-4ec9-8515-90ab613eca35;TCGA-BH-A0BZ.1B56E5A6-35B8-4C60-8BC5-68716C946799.pdf;Negative;NA;Left;NA;NO;NA;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Modified Radical Mastectomy;BH;6933333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A0C0;TCGA-BH-A0C0-01;62;M0;N1a;Stage IIA;NA;T1c;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;2.65;-23006;1094;NA;0;1270;41.72;0:DiseaseFree;NA;NA;NA;Positive;90-99%;NA;Segmental mastectomy;11/8/10;3023;40;NA;4.7;12.45;NA;Positive;NA;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;3;YES;2007;NO;NA;1;NA;35;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NO;86;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;4172;0:LIVING;7875018b-91dc-4ab1-83b0-ee3883e2816e;c1898b32-a9c5-410b-a197-572b2a6a2d7a;TCGA-BH-A0C0.53DD68D0-C2BE-4EC2-907E-3F1F11D31052.pdf;Negative;NA;Left Upper Outer Quadrant|Left;NA;NO;NA;NA;NA;NA;Positive;60-69%;WHITE;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Other;BH;2866666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A0C1;TCGA-BH-A0C1-01;61;M0;N2a;Stage IIIA;6th;T3;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-22377;891;NA;0;1339;36.89;1:Recurred/Progressed;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;8/11/11;1678;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Negative;NA;YES;2007;NO;YES;8;NA;10;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;YES;Core needle biopsy;NA;NA;26;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;ILC;4635;1:DECEASED;d10a4887-373b-4726-a61d-126f950e4a06;A6B0528C-68D5-4E07-A3F3-5DC2E1A6B4F5;TCGA-BH-A0C1.1EC74EB3-9ECC-49B6-AE25-048A5F6A1D02.pdf;Negative;NA;Right;NA;NO;NA;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Modified Radical Mastectomy;BH;866666667;WITH TUMOR;Breast
brca_tcga_pub2015;TCGA-BH-A0C3;TCGA-BH-A0C3-01;47;M0;N0;Stage I;6th;T1c;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-17221;1335;NA;0;1464;87.84;1:Recurred/Progressed;NA;NA;NA;Positive;NA;NA;Segmental mastectomy with sentinel node biopsy;8/11/11;1667;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Mixed Histology (please specify);with ductal and lobular phenotypes;No;No;C50.9;1/03/8522;C50.9;Negative;NA;YES;2006;NO;YES;0;NA;4;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Core needle biopsy;NA;NA;11;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;ILC;8899;0:LIVING;7bcf6d42-eb8f-4aa2-825b-38671d4f9e3a;21ba28ff-89f6-4f02-a135-821efc4f42f8;TCGA-BH-A0C3.3A54CF6E-AFDB-4609-A827-77D75BB376A7.pdf;Negative;NA;Left;NA;NO;NA;NA;NA;NA;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;BH;366666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A0C7;TCGA-BH-A0C7-01;48;M0;N1mi;Stage IIB;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-17871;1338;NA;0;1305;90.9;0:DiseaseFree;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;8/11/11;3045;NA;NA;NA;NA;NA;Positive;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;2006;NO;YES;1;NA;18;NA;Peri (6-12 months since last menstrual period);NA;NA;NO;Core needle biopsy;NA;NA;35;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;909;0:LIVING;e1119732-3e97-4259-bc69-dc4269d9496d;BBD9EDD0-2251-4AB0-84F9-F6D8990D0CAB;TCGA-BH-A0C7.880F3DC6-4342-4232-A04E-A128F1A8201D.pdf;Negative;NA;Left;NA;NO;NA;NA;NA;NA;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Simple Mastectomy;BH;1166666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A0DD;TCGA-BH-A0DD-01;58;M0;N1a;Stage IIB;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-21386;1248;NA;0;1394;81.67;0:DiseaseFree;NA;NA;NA;Positive;NA;NA;NA;8/18/11;3503;NA;NA;NA;NA;NA;Positive;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;NA;YES;2006;NO;YES;0;NA;22;NA;NA;NA;NA;NO;Core needle biopsy;NA;NA;17;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;8167;0:LIVING;dba9beec-5e51-48c0-9229-0ee286a02a1a;b5d03f26-66ec-4861-9635-e0ee4a6e41c9;TCGA-BH-A0DD.35FFF2A4-7956-47AC-B6B8-1AA6775E332B.pdf;Negative;NA;Right;NA;NO;NA;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Male;Matched;NA;NA;NA;NA;Modified Radical Mastectomy;BH;533333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A0DE;TCGA-BH-A0DE-01;62;M0;N0;Stage IIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;NA;-22656;1130;NA;0;948;77.92;0:DiseaseFree;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;Segmental mastectomy with sentinel lymph node biopsy;8/11/11;1869;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2007;NO;YES;0;NA;2;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;NA;25;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;MDLC;7792;0:LIVING;7f0bbba1-9bc3-45db-bdda-eb3319bb15d2;c73178ad-f042-47ca-af89-343a647076b4;TCGA-BH-A0DE.E8EA922D-A851-4D36-B70D-372DE9352548.pdf;Negative;NA;Left Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;BH;833333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A0DG;TCGA-BH-A0DG-01;30;M0;N0;Stage IIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-11204;972;NA;0;713;67.05;0:DiseaseFree;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;Total mastectomy;8/2/11;1591;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2007;NO;YES;0;NA;3;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Core needle biopsy;NA;NA;30;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;6705;0:LIVING;0bc5744c-5fa3-45bb-87d0-70a02068b392;3f104cf7-8de8-4e77-8baa-bad1bbb493ac;TCGA-BH-A0DG.46B16DD0-68E6-4A7A-919B-758219D1E85C.pdf;Negative;NA;Right Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Negative;NA;BLACK OR AFRICAN AMERICAN;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;BH;1;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A0DH;TCGA-BH-A0DH-01;63;M0;N1a;Stage IIB;NA;T2;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-23366;968;NA;0;1156;37.98;0:DiseaseFree;NA;NA;NA;Positive;90-99%;NA;Segmental mastectomy;11/8/10;2305;NA;NA;NA;NA;NA;NA;<10%;0;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;3;YES;2007;NO;NA;3;NA;28;Negative;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NO;37;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;BRCA;3798;0:LIVING;491b6364-1223-474f-816f-e248c8c841e2;700477dc-5eb4-4efb-a301-12172a7469f7;TCGA-BH-A0DH.79B22278-2BA1-4904-BCA6-2B1368C77475.pdf;Positive;NA;Left Upper Outer Quadrant|Left;NA;NO;NA;3+;NA;NA;Positive;40-49%;WHITE;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;Mastectomy NOS;NA;Other;BH;1233333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A0DI;TCGA-BH-A0DI-01;63;M0;N1a;Stage IIB;6th;T2;NA;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;NA;-23327;267;NA;0;673;29.96;0:DiseaseFree;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;8/11/11;2622;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2009;NO;YES;3;NA;28;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;NA;28;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;MDLC;2996;0:LIVING;27ba717a-5cd8-440a-9345-4ae086f6efca;3f33a14d-7797-4ade-85f7-1dbec18f774f;TCGA-BH-A0DI.5B7CE4A4-E1D5-4D0B-B9B4-71B94E32D782.pdf;Negative;NA;Right;NA;NO;NA;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Modified Radical Mastectomy;BH;933333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A0DK;TCGA-BH-A0DK-01;49;M0;N0 (i-);Stage IIA;NA;T2;H-SCORE 260;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-18237;254;NA;0;423;13.9;0:DiseaseFree;NA;H-SCORE;NA;Positive;NA;NA;NA;11/8/10;2171;NA;NA;NA;NA;NA;NA;NA;0;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2009;NO;NA;0;NA;3;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NA;Excisional Biopsy;NA;NO;79;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;139;0:LIVING;f2bbfa9d-9a9d-4f46-9fde-378e4c44e2ad;1acae6e0-3100-4de8-a436-e15cdbe1322b;TCGA-BH-A0DK.1E3F22FC-3D82-4911-9C97-8CB87A3D131C.pdf;Negative;NA;Left Upper Outer Quadrant|Left;NA;NO;H-SCORE 120;NA;H-SCORE;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Simple Mastectomy;BH;2633333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A0DL;TCGA-BH-A0DL-01;64;M0;N0;Stage IIA;6th;T2;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-23628;1074;NA;0;1467;78.22;0:DiseaseFree;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;Segmental mastectomy with sentinel lymph node biopsy;8/11/11;2605;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Other, specify;NA;No;No;C50.9;1/03/8575;C50.9;Negative;NA;YES;2007;NO;YES;0;NA;3;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;NA;40;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;BRCA;7822;0:LIVING;ba39bfbc-5cac-4f6c-b55c-4eee3466ee93;20308c88-18f2-4373-9e93-1f1d589d97e2;TCGA-BH-A0DL.C96287D0-A60B-4BAA-ABA0-8AD4F48662DB.pdf;Negative;NA;Left;NA;NO;NA;NA;NA;NA;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;BH;1333333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A0DO;TCGA-BH-A0DO-01;78;M0;N0;Stage I;6th;T1c;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-28529;454;NA;0;525;54.01;0:DiseaseFree;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;8/11/11;1608;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;Yes;C50.9;1/03/8500;C50.9;Negative;NA;YES;2009;NO;YES;0;NA;2;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;NA;14;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;5401;0:LIVING;d3d4d709-ab34-4617-aa8c-51a3d0a3efe6;8b5d38fb-e9ad-445c-b5d5-f054a5eafeb1;TCGA-BH-A0DO.C75872B6-2260-41C3-9E21-91E4F52AD7EA.pdf;Negative;NA;Left Upper Inner Quadrant;NA;NO;NA;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Simple Mastectomy;BH;466666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A0DP;TCGA-BH-A0DP-01;60;M0;N0 (i-);Stage IIB;NA;T3;H-SCORE 280;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-22199;293;NA;0;476;15.64;0:DiseaseFree;NA;H-SCORE;NA;Positive;80-89%;NA;NA;11/9/10;2568;NA;NA;NA;NA;NA;NA;<10%;0;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Negative;3;YES;2009;NO;NA;0;NA;4;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NO;36;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;ILC;1564;0:LIVING;14267783-5624-4fe5-ba81-9d67f1017474;ffb838b0-db61-4dc9-aadc-41562f677f54;TCGA-BH-A0DP.F04188AB-51CE-4AA1-B72C-399BE7863235.pdf;Negative;NA;Right;NA;NO;H-SCORE 280;3+;H-SCORE;NA;Positive;80-89%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Simple Mastectomy;BH;12;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A0DQ;TCGA-BH-A0DQ-01;42;M0;N1;Stage IIB;NA;T2;H-SCORE 136;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-15533;190;NA;0;98;3.22;0:DiseaseFree;NA;H-SCORE;NA;Positive;60-69%;NA;Segmental mastectomy;11/9/10;2833;NA;NA;NA;NA;NA;NA;<10%;0;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;1;YES;2009;NO;NA;1;NA;25;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NA;Core needle biopsy;NA;NO;28;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;322;0:LIVING;a851ca14-7bbf-455b-a054-ec03979a4247;10285a0d-d8cc-4c20-a8a2-8891d9807599;TCGA-BH-A0DQ.D644B589-A6ED-4DCC-97D4-751E22AE3A7D.pdf;Negative;NA;Right Upper Inner Quadrant|Right;NA;NO;H-SCORE 140;1+;H-SCORE;NA;Positive;70-79%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Other;BH;933333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A0DS;TCGA-BH-A0DS-01;71;M0;N2a;Stage IIIA;7th;T2;H-SCORE 190;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-25944;79;NA;0;78;2.56;0:DiseaseFree;NA;H-SCORE;NA;Positive;70-79%;NA;Segmental mastectomy;11/9/10;3395;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;2;YES;2010;NO;NA;8;NA;14;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NO;34;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;256;0:LIVING;fb57c598-b45b-478a-9d34-ca1f050d5b7c;a99e45da-6933-4300-9c8a-e9d0f9e9c825;TCGA-BH-A0DS.E4CBDC29-63E2-4CF0-B02F-16CA9C69F26E.pdf;Negative;NA;Right Upper Inner Quadrant|Right Lower Inner Quadrant|Right;NA;NO;H-SCORE 162;2+;H-SCORE;NA;Positive;70-79%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Other;BH;1133333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A0DT;TCGA-BH-A0DT-01;41;M0;N1a;Stage IIA;6th;T1c;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-15078;1044;NA;0;1170;78.94;0:DiseaseFree;NA;NA;NA;Positive;NA;NA;Total mastectomy with sentinel lymoh node biopsy;8/11/11;1927;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2007;NO;YES;1;NA;18;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Core needle biopsy;NA;NA;13;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;7894;0:LIVING;74f31744-0aed-4633-beec-4e203315f0b7;eb11d414-2f0e-44a1-843c-ecacc7212e91;TCGA-BH-A0DT.C0AFC806-9F96-484F-BF40-89B26ABF8714.pdf;Negative;NA;Right;NA;NO;NA;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;BH;4;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A0DV;TCGA-BH-A0DV-01;54;M0;N2a;Stage IIIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;NA;-19781;975;NA;0;1374;67.81;0:DiseaseFree;NA;NA;NA;Positive;NA;NA;NA;8/2/11;82;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2007;NO;YES;9;NA;9;NA;Peri (6-12 months since last menstrual period);NA;NA;NO;Core needle biopsy;NA;NA;7;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;MDLC;6781;0:LIVING;96b9c7db-1be1-4b60-b47c-26b654c3d64c;b4c19f4e-c5bf-4c4f-bad8-9c18128c112d;TCGA-BH-A0DV.3A0E1EF6-B234-46EC-BD15-95B5FAB06D45.pdf;Negative;NA;Left Upper Inner Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left;NA;NO;NA;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Modified Radical Mastectomy;BH;233333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A0DX;TCGA-BH-A0DX-01;62;M0;N0;Stage I;6th;T1b;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-22833;997;NA;0;1442;70.83;0:DiseaseFree;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;Segmental mastectomy with sentinel lymph node biopsy;8/11/11;1997;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2007;NO;YES;0;NA;11;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;NA;55;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;7083;0:LIVING;035cb359-eac3-484a-9e88-3ddc739440a3;7b420e74-ed0d-416b-8355-9a80a61d6a4b;TCGA-BH-A0DX.EBAB36DE-A97F-4F8B-806C-EF182519933A.pdf;Negative;NA;Left Upper Inner Quadrant;NA;NO;NA;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;BH;1833333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A0DZ;TCGA-BH-A0DZ-01;43;M0;N1a;Stage IIB;NA;T2;H-SCORE 140;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-15980;308;NA;0;495;16.26;0:DiseaseFree;NA;H-SCORE;NA;Positive;50-59%;NA;NA;11/9/10;2130;NA;NA;NA;NA;NA;NA;30-39%;3;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;2;YES;2009;NO;NA;1;NA;5;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NA;Core needle biopsy;NA;NO;198;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;1626;0:LIVING;478eb8aa-50b8-4ce5-98e4-d518ede4b174;6093f268-1c3f-4fec-bde7-fc3721ecaf8e;TCGA-BH-A0DZ.16DE55CE-076E-43D3-84BD-332A79B95EFD.pdf;Negative;NA;Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right;NA;NO;H-SCORE 15;2+;H-SCORE;NA;Positive;<10%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Simple Mastectomy;BH;66;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A0E0;TCGA-BH-A0E0-01;38;M0;N3a;Stage IIIC;NA;T3;H-SCORE 0;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-14175;136;NA;0;134;4.4;0:DiseaseFree;NA;H-SCORE;NA;Negative;NA;NA;NA;11/9/10;6731;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;0;YES;2009;NO;NA;10;NA;21;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NA;Core needle biopsy;NA;NO;32;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;44;0:LIVING;20e8106b-1290-4735-abe4-7621e08e3dc8;662cc11c-da31-4e31-8e77-46011b38ea96;TCGA-BH-A0E0.975989FE-8785-42C1-8551-53661B7B16A1.pdf;Negative;NA;Left Upper Outer Quadrant|Left Lower Outer Quadrant|Left;NA;NO;H-SCORE 0;0;H-SCORE;NA;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;BH;1066666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A0E1;TCGA-BH-A0E1-01;52;M0;N1;Stage IIB;NA;T2;H-SCORE 180;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;1.67;-19192;301;NA;0;477;15.67;0:DiseaseFree;NA;H-SCORE;NA;Positive;70-79%;NA;NA;11/9/10;595;40;NA;1.69;2.81;NA;Negative;NA;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;2;YES;2009;NO;NA;2;NA;17;NA;Peri (6-12 months since last menstrual period);NA;NA;NA;Core needle biopsy;NA;NO;27;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;1567;0:LIVING;606fbc6a-b41b-441d-9401-51e54912bf5e;dcf7829e-abaa-435f-b41d-a2bcfde5d66a;TCGA-BH-A0E1.891F4C63-8207-4CB8-AB59-A970CC6F1A1A.pdf;Negative;NA;Left Upper Inner Quadrant|Left;NA;NO;H-SCORE 245;3+;H-SCORE;NA;Positive;50-59%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Simple Mastectomy;BH;9;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A0E2;TCGA-BH-A0E2-01;49;M0;N2a;Stage IIIA;NA;T2;H-SCORE 300;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-18152;210;NA;0;376;14.29;0:DiseaseFree;NA;H-SCORE;NA;Positive;90-99%;NA;NA;11/9/10;2837;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;3;YES;2009;NO;NA;4;NA;26;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NA;Core needle biopsy;NA;NO;33;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;1429;0:LIVING;8ace3b8c-f23e-48a9-a137-9e046bd9549b;4c70c0b1-1566-4e39-9dec-5050f62cd0a8;TCGA-BH-A0E2.29EDE507-90BA-4ABE-B3EF-559EBA4CCD56.pdf;Negative;NA;Right Upper Inner Quadrant|Right;NA;NO;H-SCORE 1;1+;H-SCORE;NA;Positive;<10%;BLACK OR AFRICAN AMERICAN;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;BH;11;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A0E6;TCGA-BH-A0E6-01;69;M0;N0 (i-);Stage IA;NA;T1c;H-SCORE 0;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;2.38;-25408;134;NA;0;293;9.63;0:DiseaseFree;NA;H-SCORE;NA;Negative;NA;NA;Segmental mastectomy;11/9/10;6170;40;NA;1.19;2.83;NA;Negative;NA;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;0;YES;2009;NO;NA;0;NA;1;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NO;49;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;963;0:LIVING;6c0066e3-96df-4870-bcd3-98cda64082e9;052e361c-9cf7-4a92-a77d-f3d70f9dec0b;TCGA-BH-A0E6.739E1733-3540-4E82-AC91-F511105DABD5.pdf;Negative;NA;Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left;NA;NO;H-SCORE 0;0;H-SCORE;NA;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Other;BH;1633333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A0E7;TCGA-BH-A0E7-01;79;M0;N1a;Stage IIB;NA;T2;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-29115;1259;NA;0;1363;44.78;0:DiseaseFree;NA;NA;NA;Positive;50-59%;NA;Segmental mastectomy;11/9/10;790;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;3;YES;2006;NO;NA;1;NA;17;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Excisional Biopsy;NA;NO;40;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;BRCA;4478;0:LIVING;d3b9d925-ae04-4721-8bfc-50b41225bc74;5c031f2a-0e98-4ab4-b8c5-3a296fda419d;TCGA-BH-A0E7.CE32A294-10FC-4DBA-A779-FAEEBE677D38.pdf;Negative;NA;Left Upper Outer Quadrant|Left;NA;NO;NA;3+;NA;NA;Positive;60-69%;WHITE;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Other;BH;1333333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A0E9;TCGA-BH-A0E9-01;53;M0;N1a;Stage IIB;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-19415;1357;NA;0;1405;81.77;0:DiseaseFree;NA;NA;NA;Positive;NA;NA;NA;8/11/11;2195;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Negative;NA;YES;2006;NO;YES;3;NA;12;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;NA;17;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;ILC;8177;0:LIVING;76ace6aa-0505-442c-978a-f889cf2d44bb;46f79f16-4d38-4a71-ad9e-24037054966c;TCGA-BH-A0E9.8FDACA3D-C172-4198-9BBB-8F9E5A5FF0D6.pdf;Negative;NA;Right;NA;NO;NA;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Modified Radical Mastectomy;BH;566666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A0EA;TCGA-BH-A0EA-01;72;M0;N1a;Stage IIA;6th;T1c;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-26548;567;991;0;NA;NA;NA;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;Total mastectomy with sentinel lymph node biopsy;8/11/11;603;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;Yes;C50.9;1/03/8500;C50.9;Negative;NA;YES;2008;NO;YES;2;NA;4;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;NA;21;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;3256;1:DECEASED;1f601832-eee3-48fb-acf5-80c4a454f26e;7f791228-dd77-4ab0-8227-d784a4c7fea1;TCGA-BH-A0EA.28231C7B-64EE-49AC-B7AB-9BADDDDCC17C.pdf;Negative;NA;Left;NA;NO;NA;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;BH;7;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A0EE;TCGA-BH-A0EE-01;68;M0;N0 (i-);Stage IIB;NA;T3;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-24850;946;NA;0;943;30.98;0:DiseaseFree;NA;NA;NA;Negative;NA;NA;NA;11/9/10;4417;NA;NA;NA;NA;NA;NA;30-39%;3;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;0;YES;2007;NO;NA;0;NA;1;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NO;79;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;BRCA;3098;0:LIVING;ca76c6fc-ff30-4833-884d-3a94fe53ff17;2ee13ed0-cb80-4375-a329-91ff9904bb7c;TCGA-BH-A0EE.B8664381-386A-44A2-AC3B-D69A4980A8EA.pdf;Negative;NA;Right Upper Inner Quadrant|Right;NA;NO;NA;0;NA;NA;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Simple Mastectomy;BH;2633333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A0EI;TCGA-BH-A0EI-01;51;M0;N1a;Stage IIA;6th;T1c;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-18741;541;NA;0;743;63.27;0:DiseaseFree;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;segmental mastectomy with right sentinel lymph node biopsy;8/11/11;1622;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2008;NO;YES;2;NA;2;NA;Peri (6-12 months since last menstrual period);NA;NA;NO;Core needle biopsy;NA;NA;15;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;6327;0:LIVING;22b35927-1c3f-4f98-ba42-deafc56b677a;4a4d5c63-8e41-487d-839a-f68f28ab9b82;TCGA-BH-A0EI.DFB21194-30C7-430E-A53C-C38345209B1F.pdf;Negative;NA;Right;NA;NO;NA;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;BH;5;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A0GY;TCGA-BH-A0GY-01;67;M0;N1;Stage IIA;NA;T2;H-Score 150;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-24493;745;NA;0;917;30.32;0:DiseaseFree;NA;H-Score;NA;Positive;40-49%;NA;Segmental mastectomy;11/10/10;2656;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;2;YES;2008;NO;NA;3;NA;26;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NO;38;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;3032;0:LIVING;7d9d3522-ec3b-4efe-8c8e-c0e675276ef5;a7e71eac-1768-4fc2-8eba-1576d22e0f43;TCGA-BH-A0GY.A997FF30-F112-48BE-8FF1-15F8266A5E62.pdf;Negative;NA;Left Lower Outer Quadrant|Left;NA;NO;H-Score 290;3+;H-Score;NA;Positive;90-99%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Other;BH;1266666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A0GZ;TCGA-BH-A0GZ-01;62;M0;N1a;Stage IIA;NA;T1c;H-SCORE 300;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;2.08;-22714;206;NA;0;328;10.78;0:DiseaseFree;NA;H-SCORE;NA;Positive;90-99%;NA;Segmental mastectomy;11/10/10;2724;40;NA;1.05;2.2;NA;Negative;NA;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;3;YES;2009;NO;NA;1;NA;14;Negative;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NO;28;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;1078;0:LIVING;27dfb9d4-3a2c-44bc-9acf-8f638d3f3004;1142b1cf-ebf3-485b-aae2-dcf4d8793212;TCGA-BH-A0GZ.C956B4B1-99E6-4823-886A-FA8FCD1E3E4D.pdf;Negative;NA;Left Upper Inner Quadrant|Left;NA;NO;H-SCORE 280;3+;H-SCORE;NA;Positive;80-89%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Other;BH;933333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A0H0;TCGA-BH-A0H0-01;69;M0;N0 (i-);Stage IA;NA;T1c;H-SCORE 190;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-25223;344;NA;0;461;15.14;0:DiseaseFree;NA;H-SCORE;NA;Positive;50-59%;NA;Segmental mastectomy;11/10/10;2534;NA;NA;NA;NA;NA;NA;<10%;0;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;2;YES;2009;NO;NA;0;NA;2;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NO;16;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;1514;0:LIVING;96457ebf-ae88-41f4-97e5-cdc3163418aa;93a3fc8a-1b50-4da3-9dbb-cf9f582fc22e;TCGA-BH-A0H0.94CF5704-1BE7-4CCC-870E-FB8527AC47E8.pdf;Negative;NA;Right Upper Outer Quadrant|Right;NA;NO;H-SCORE 7;2+;H-SCORE;NA;Positive;<10%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Other;BH;533333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A0H3;TCGA-BH-A0H3-01;46;M0;N0;Stage I;6th;T1c;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-17152;773;NA;0;1149;63.34;0:DiseaseFree;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;Left segmental mastectomy with axillary lymph node dissection;8/11/11;606;NA;NA;NA;NA;NA;Negative;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;2008;NO;YES;0;NA;2;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Core needle biopsy;NA;NA;17;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;6334;0:LIVING;6cdc0d53-f813-4101-81e5-9bee68270536;6f26754e-8132-4612-bf6c-9301302fec2d;TCGA-BH-A0H3.6D3F79A6-C55C-497F-9CCD-1C6D3ACE7492.pdf;Negative;NA;Left Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;BH;566666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A0H5;TCGA-BH-A0H5-01;45;M0;N0 (i-);Stage I;6th;T1c;NA;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;NA;-16719;815;NA;0;1080;53.22;0:DiseaseFree;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;Right total mastectomy with lymph node left axillary lymph node excision;8/12/11;0;NA;NA;NA;NA;NA;Negative;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;2008;NO;YES;0;NA;1;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;NA;40;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;MDLC;5322;0:LIVING;cab38ea8-4555-413c-b81e-4621aac4ef85;8cc4fd25-dd8b-4983-ac21-24f3cf3e51cd;TCGA-BH-A0H5.C350A3BE-1709-427D-8E1D-E0BBA480A56D.pdf;Negative;NA;Right Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;BH;1333333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A0H6;TCGA-BH-A0H6-01;82;M0;NX;Stage I;NA;T1b;H-SCORE 230;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-30125;583;NA;0;747;24.54;0:DiseaseFree;NA;H-SCORE;NA;Positive;50-59%;NA;Segmental mastectomy;11/10/10;982;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;2;YES;2008;NO;NA;0;0;0;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NO;14;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;BRCA;2454;0:LIVING;aeb6a3a6-b57a-4c53-90e6-e833777dd2a1;b2921c9d-c655-46f3-86e5-2fc2bed1ed33;TCGA-BH-A0H6.93292768-8C20-4551-8CA8-44AE0FFB487E.pdf;Negative;NA;Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right;NA;NO;H-SCORE 250;3+;H-SCORE;NA;Positive;60-69%;WHITE;NA;YES;1;Primary;Female;Matched;No axillary staging;NA;NA;NA;Other;BH;466666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A0H7;TCGA-BH-A0H7-01;65;M0;N2a;Stage IIIA;NA;T1c;H-SCORE 255;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-23972;542;NA;0;702;23.06;0:DiseaseFree;NA;H-SCORE;NA;Positive;70-79%;NA;NA;11/10/10;4407;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;3;YES;2008;NO;NA;6;NA;16;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NO;57;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;2306;0:LIVING;2021ed1f-dc75-4701-b8b8-1386466e4802;69bfa6ce-ed46-4321-a107-347c49d68951;TCGA-BH-A0H7.CC7D1177-1638-4A80-A3AA-266ADC260EC9.pdf;Negative;NA;Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right;NA;NO;H-SCORE 150;2+;H-SCORE;NA;Positive;30-39%;WHITE;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;BH;19;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A0H9;TCGA-BH-A0H9-01;69;M0;N0 (i-);Stage IIA;NA;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;2.98;-25289;1088;NA;0;1247;40.97;0:DiseaseFree;NA;NA;NA;Positive;90-99%;NA;Segmental mastectomy;11/17/10;3068;40;NA;1.5;3.43;NA;Negative;NA;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;3;YES;2007;NO;NA;0;NA;1;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NO;38;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;4097;0:LIVING;0f64edec-0f1f-4025-8a53-75f9534f7828;4a7c76a9-c3a2-4b57-a57a-de055152dcf8;TCGA-BH-A0H9.584E15EE-1C80-4507-8AD3-558DF06DBDF3.pdf;Negative;NA;Right Upper Outer Quadrant|Right;NA;NO;NA;1+;NA;NA;Positive;30-39%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Other;BH;1266666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A0HA;TCGA-BH-A0HA-01;31;M0;N0 (i-);Stage I;6th;T1c;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-11379;675;NA;0;856;52.92;0:DiseaseFree;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;bilateral total mastectomies with right sentinel node biopsy;8/2/11;838;NA;NA;NA;NA;NA;Negative;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;2008;NO;YES;0;NA;4;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Core needle biopsy;NA;NA;258;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;5292;0:LIVING;e666081b-caaf-4e8b-9446-807be71201a5;63baef92-6733-4791-b897-0abe9131a5f5;TCGA-BH-A0HA.E6C20D27-63E5-4FFF-96BF-E8BD71296925.pdf;Negative;NA;Right;NA;NO;NA;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;BH;8633333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A0HB;TCGA-BH-A0HB-01;55;M0;N0 (i-);Stage IA;NA;T1c;H-Score 300;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;2.13;-20448;739;NA;0;806;26.48;0:DiseaseFree;NA;H-Score;NA;Positive;90-99%;NA;Segmental mastectomy;11/10/10;2922;40;NA;1.21;2.58;NA;Negative;NA;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;3;YES;2008;NO;NA;0;NA;2;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NO;30;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;2648;0:LIVING;0c1023c0-d2ce-4940-8047-7642f1dc3965;19193b8f-1e1b-448c-b934-93f25e60d45b;TCGA-BH-A0HB.C7476B2B-0040-4013-8D30-06935E3FB897.pdf;Negative;NA;Right Upper Outer Quadrant|Right;NA;NO;H-Score 70;1+;H-Score;NA;Positive;30-39%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Other;BH;1;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A0HI;TCGA-BH-A0HI-01;78;M0;N0 (i-);Stage IA;NA;T1c;H-Score 240;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-28644;554;NA;0;620;20.37;0:DiseaseFree;NA;H-Score;NA;Positive;50-59%;NA;Segmental mastectomy;11/10/10;729;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;3;YES;2008;NO;NA;0;0;1;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;YES;28;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;2037;0:LIVING;e0375a8b-a135-4103-a59d-39063fcf4a6f;838f924a-989c-4642-ba15-d711df6ccb37;TCGA-BH-A0HI.EE9E0908-05D2-4F26-B3C2-2B40A48FEA6D.pdf;Negative;NA;Right Upper Inner Quadrant|Right Lower Inner Quadrant|Right;NA;NO;H-Score 160;1+;H-Score;NA;Positive;40-49%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Other;BH;933333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A0HK;TCGA-BH-A0HK-01;81;M0;N1;Stage IIB;NA;T2;H-SCORE 260;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-29751;35;NA;0;178;5.85;0:DiseaseFree;NA;H-SCORE;NA;Positive;70-79%;NA;NA;11/10/10;924;NA;NA;NA;NA;NA;NA;<10%;0;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;3;YES;2010;NO;NA;2;NA;17;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NO;90;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;ILC;585;0:LIVING;24334ac1-28a3-4b61-b590-3f51e375b247;8835b20e-9343-4266-a356-e0343c657130;TCGA-BH-A0HK.575F2EFD-2D8B-4140-9FCB-D8CB9EC14D09.pdf;Negative;NA;Right Upper Inner Quadrant|Right;NA;NO;H-SCORE 0;0;H-SCORE;NA;Negative;<10%;WHITE;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;BH;3;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A0HO;TCGA-BH-A0HO-01;48;M0;N1a;Stage IIA;NA;T1c;H-Score 200;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-17710;224;NA;0;76;2.5;0:DiseaseFree;NA;H-Score;NA;Positive;90-99%;NA;Segmental mastectomy;11/11/10;493;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;2;YES;2009;NO;NA;1;1;18;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NA;Core needle biopsy;NA;YES;19;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;25;0:LIVING;8332806e-f547-4aae-89af-6d5bec831fd2;02c8bf84-4816-49a9-b5d1-0edebb8627c7;TCGA-BH-A0HO.C9AD69EB-506A-4442-B1C2-C8F09B519CB2.pdf;Negative;NA;Right Upper Outer Quadrant|Right;NA;NO;H-Score 290;3+;H-Score;NA;Positive;90-99%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Other;BH;633333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A0HP;TCGA-BH-A0HP-01;65;M0;N2a;Stage IIIA;NA;T3;H-Score 280;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-23883;346;NA;0;414;13.6;0:DiseaseFree;NA;H-Score;NA;Positive;80-89%;NA;NA;11/11/10;1767;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Negative;3;YES;2009;NO;NA;8;NA;17;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NO;216;NA;NA;NA;Positive;NA;NA;NA;NA;NA;NA;Negative;NA;VERDADERO;ILC;136;0:LIVING;fcef8cb5-fb2c-4bfb-82cd-6b9f3145182c;c1e94fa4-ace1-4ee2-9cdc-ec7b13e6bc8a;TCGA-BH-A0HP.F13CE7B3-F275-4EEE-90A3-11B8B92FA431.pdf;Negative;NA;Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left;NA;NO;H-Score 0;0;H-Score;NA;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;BH;7166666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A0HQ;TCGA-BH-A0HQ-01;56;M0;N0 (i+);Stage IIA;NA;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-20719;962;NA;0;1121;36.83;0:DiseaseFree;NA;NA;NA;Positive;90-99%;NA;Segmental mastectomy;11/11/10;1281;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;3;YES;2007;NO;NA;0;NA;4;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;YES;30;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;3683;0:LIVING;f31c21b6-0f7f-435b-9e24-97c909755c36;ef48e806-e31c-4a11-afe8-dcc232357329;TCGA-BH-A0HQ.A76A272F-675E-4E56-8761-96B71419A012.pdf;Negative;NA;Left Upper Outer Quadrant|Left;NA;NO;NA;3+;NA;NA;Positive;90-99%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Other;BH;1;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A0HU;TCGA-BH-A0HU-01;52;M0;N0 (i-);Stage IA;NA;T1c;H-Score 140;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-19216;394;NA;0;392;12.88;0:DiseaseFree;NA;H-Score;NA;Positive;40-49%;NA;Segmental mastectomy;11/11/10;3924;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;2;YES;2009;NO;NA;0;NA;1;NA;Peri (6-12 months since last menstrual period);NA;NA;NA;Core needle biopsy;NA;NO;35;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;1288;0:LIVING;dc657ca8-98e8-4ec4-a513-1b848be0e85d;ba869eea-6e25-4afb-a0ad-73fda57a1d88;TCGA-BH-A0HU.1F35A542-2795-4B1F-A846-7097B442C2D9.pdf;Negative;NA;Right Upper Outer Quadrant|Right;NA;NO;H-Score 140;2+;H-Score;NA;Positive;40-49%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Other;BH;1166666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A0HW;TCGA-BH-A0HW-01;62;M0;N0 (i-);Stage IA;NA;T1c;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-22962;1591;NA;0;1561;51.28;0:DiseaseFree;NA;NA;NA;Positive;90-99%;NA;Segmental mastectomy;11/11/10;2300;NA;NA;1.6;NA;NA;Negative;NA;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;3;YES;2006;NO;NA;0;NA;2;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NO;33;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;BRCA;5128;0:LIVING;29fdc464-f216-4828-b456-829f71436e27;f76e87a9-4a50-48b4-9527-eac98c38800e;TCGA-BH-A0HW.8AC7EF1D-53EB-466B-9C45-A6A7E9DB9CCD.pdf;Negative;NA;Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left;NA;NO;NA;0;NA;NA;Negative;<10%;ASIAN;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Other;BH;11;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A0HX;TCGA-BH-A0HX-01;54;M0;N1a;Stage IIB;NA;T2;H-Score 270;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-19900;672;NA;0;829;27.23;0:DiseaseFree;NA;H-Score;NA;Positive;80-89%;NA;NA;11/11/10;5678;NA;NA;NA;NA;NA;NA;<10%;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;3;YES;2008;NO;NA;2;2;24;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;YES;49;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;2723;0:LIVING;3b01d064-8c00-4972-9f07-407eac8e7534;989c2df5-5183-4daa-a8da-fc9ab18a437c;TCGA-BH-A0HX.8C4FEB77-99B6-4C73-9751-508953A874DC.pdf;Negative;NA;Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left;NA;NO;H-Score 190;3+;H-Score;NA;Positive;50-59%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Simple Mastectomy;BH;1633333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A0HY;TCGA-BH-A0HY-01;60;M0;N0;Stage I;6th;T1c;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-22179;470;NA;0;868;50.76;0:DiseaseFree;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;Total mastectomy with left sentinel lymph node biospy;8/2/11;6304;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;NA;YES;2009;NO;YES;0;NA;3;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;NA;47;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;5076;0:LIVING;844ad251-3ee4-42f6-ad00-59a7a1670eea;38ac0df0-950e-4c55-9f8a-96fd3f837ee6;TCGA-BH-A0HY.E57B4989-102F-44FD-8FB2-0627143FA904.pdf;Negative;NA;Left;NA;NO;NA;NA;NA;NA;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;BH;1566666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A0RX;TCGA-BH-A0RX-01;59;M0;N0 (i-);Stage IIA;NA;T2;H-Score 0;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-21857;63;NA;0;170;5.58;0:DiseaseFree;NA;H-Score;NA;Negative;<10%;NA;Segmental mastectomy;11/11/10;950;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;0;YES;2010;NO;NA;0;NA;3;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NO;23;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;BRCA;558;0:LIVING;e828455d-4680-41b2-8a1c-1582e3790d62;b9c728ca-9ff2-4aa4-bd9d-6cb69a8d7e2c;TCGA-BH-A0RX.57359A9F-7E5A-4599-918C-A95DCF0D9479.pdf;Negative;NA;Left Upper Outer Quadrant|Left;NA;NO;H-Score 0;0;H-Score;NA;Negative;<10%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Other;BH;766666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A0W3;TCGA-BH-A0W3-01;58;M0;N1a;Stage IIA;7th;T1c;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-21369;85;NA;0;180;23.92;0:DiseaseFree;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;Segmental mastectomy;2/14/11;1333;NA;NA;NA;NA;NA;Negative;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;2010;NO;NA;1;1;4;NA;Indeterminate (neither Pre or Postmenopausal);NA;NA;NA;Core needle biopsy;NA;NA;14;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;2392;0:LIVING;3c612e12-6de8-44fa-a095-805c45474821;9ad80473-9148-45a7-ad6d-9936a899e022;TCGA-BH-A0W3.801A4E2F-E26E-424F-BF42-CD0D9CD62BCE.pdf;NA;NA;Left Upper Inner Quadrant;NA;NO;NA;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;BH;466666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A0W4;TCGA-BH-A0W4-01;46;M0;N0 (i-);Stage IIA;7th;T2;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-16911;119;NA;0;175;24.93;0:DiseaseFree;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;Total mastectomy;2/15/11;207;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2010;NO;NA;NA;NA;3;NA;NA;NA;NA;NA;Core needle biopsy;NA;NA;33;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;BRCA;2493;0:LIVING;0772cdbe-8b0d-452b-8df1-bd70d1306363;5a800052-150a-4273-9d5d-0ce48be4fd8a;TCGA-BH-A0W4.0C158269-A420-4E71-9E59-8775FB26084B.pdf;NA;NA;Left Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;BH;11;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A0W5;TCGA-BH-A0W5-01;77;M0;N1a;Stage IIA;6th;T1c;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-28304;906;NA;0;543;42.31;0:DiseaseFree;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;segmental mastectomy;2/15/11;719;NA;NA;NA;NA;NA;Equivocal;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;2008;NO;NA;1;1;11;NA;NA;NA;NA;NA;Core needle biopsy;NA;NA;21;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;4231;0:LIVING;da9c10ea-c13f-4d88-8b94-a0cbc106d036;050e66bb-438a-49d5-a005-7967a006b3f0;TCGA-BH-A0W5.60F59595-928B-43BB-978F-9E5B48539EFA.pdf;Negative;NA;Left;NA;NO;NA;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Other;BH;7;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A0W7;TCGA-BH-A0W7-01;49;M0;N0 (i-);Stage I;6th;T1c;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-17996;869;NA;0;558;44.78;0:DiseaseFree;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;segmental mastectomy;2/15/11;3048;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2008;NO;NA;0;0;2;NA;NA;NA;NA;NA;Core needle biopsy;NA;NA;130;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;4478;0:LIVING;9f80649b-a249-4fb5-97ad-059a30e13fea;e61873d5-bfd2-4fcc-9f9e-ca80779d36b7;TCGA-BH-A0W7.DCDEE014-3447-4DA3-A14F-48C6AED053D2.pdf;Negative;NA;Left Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Other;BH;43;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A0WA;TCGA-BH-A0WA-01;82;M0;N0 (i-);Stage I;6th;T1c;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-30025;724;NA;0;372;23.03;0:DiseaseFree;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;segmental mastectomy;2/16/11;6060;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;No;No;C50.9;1/03/8575;C50.9;Negative;NA;YES;2008;NO;NA;0;NA;3;NA;NA;NA;NA;NA;Fine needle aspiration biopsy;NA;NA;77;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;BRCA;2303;0:LIVING;786e8dbe-442e-4551-87b3-b4c333b04dd4;8ef7ad6f-a6e4-405c-b20e-d547985bd9d6;TCGA-BH-A0WA.87E28DAE-5012-4A16-BE27-A9F0F3F30F5B.pdf;Negative;NA;Right Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Other;BH;2566666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A18F;TCGA-BH-A18F-01;50;M0;N0;Stage IIA;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-18594;114;NA;0;268;32.88;0:DiseaseFree;NA;NA;3 Point Scale;Positive;70-79%;NOT HISPANIC OR LATINO;needle localized segmental mastectomy;6/1/11;2284;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;3;YES;2010;NO;YES;0;NA;1;NA;Peri (6-12 months since last menstrual period);NA;NA;NA;Core needle biopsy;NA;NA;41;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;3288;0:LIVING;bfd49783-1767-469b-9d79-7822301c5efc;adbf4056-e7d4-4282-8771-f2d6029386ab;TCGA-BH-A18F.771497E1-473E-421A-A149-CFA58E95B728.pdf;Negative;NA;Right Lower Outer Quadrant;NA;NO;NA;3+;NA;3 Point Scale;Positive;40-49%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Other;BH;1333333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A18G;TCGA-BH-A18G-01;81;M0;N0;Stage IA;NA;T1c;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-29820;78;NA;0;61;4.89;0:DiseaseFree;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;right segmental mastectomy;6/1/11;710;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.5;1/03/8500;C50.5;Negative;NA;YES;2010;NO;YES;0;NA;3;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NA;1136;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;489;0:LIVING;747083ff-0703-431b-aad4-f2adff739516;3b999df5-526b-4270-a29d-a627eb64c727;TCGA-BH-A18G.7C92F144-4A84-4D9E-8A35-C059FD082150.pdf;Negative;NA;Right;NA;NO;NA;NA;NA;NA;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Other;BH;3786666667;NA;Breast
brca_tcga_pub2015;TCGA-BH-A18H;TCGA-BH-A18H-01;63;M0;N0;Stage IA;7th;T1b;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-23065;16;NA;0;0;21.42;0:DiseaseFree;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;segmental mastectomy;6/6/11;2630;NA;NA;NA;NA;NA;Equivocal;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;Yes;C50.9;1/03/8500;C50.9;Positive;NA;YES;2010;NO;YES;0;NA;2;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;YES;31;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;2142;0:LIVING;878f975b-94fd-4d69-b7e7-1ed3ac2ee438;9321161b-d568-4d38-aed3-956786a06329;TCGA-BH-A18H.DF536409-601F-489B-9F8A-A2B372BF9999.pdf;Negative;NA;Right Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Other;BH;1033333333;NA;Breast
brca_tcga_pub2015;TCGA-BH-A18I;TCGA-BH-A18I-01;53;cM0 (i+);N1a;Stage IIA;7th;T1c;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-19489;80;NA;0;220;35.91;0:DiseaseFree;NA;H score;NA;Positive;NA;NOT HISPANIC OR LATINO;segmental mastectomy;6/7/11;1460;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.2;1/03/8500;C50.2;Positive;NA;YES;2010;NO;YES;1;1;3;Negative;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NA;25;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;3591;0:LIVING;9c1ceb7d-6fed-4c2f-a89a-bf3c5b15ca58;f7622b8a-b57c-42f0-bad1-c85edd41f034;TCGA-BH-A18I.01E8D241-C303-47FA-B484-B800D580B34C.pdf;Positive;NA;Left Upper Outer Quadrant;NA;NO;NA;NA;H score;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;Modified radical mastectomy;NA;Other;BH;833333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A18J;TCGA-BH-A18J-01;56;M1;N2;Stage IV;5th;T4b;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-20678;3948;612;0;NA;NA;NA;NA;NA;NA;Positive;40-49%;NOT HISPANIC OR LATINO;NA;6/8/11;2358;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2000;NO;NA;NA;NA;NA;NA;NA;Bone;NA;YES;NA;NA;NA;57;NA;NA;NA;Positive;NA;Negative;NA;Negative;NA;NA;Positive;NA;VERDADERO;IDC;2011;1:DECEASED;cc074b7f-d3b2-4880-902e-bf10e667b665;044f9b74-9a16-432e-acac-78c399c001bc;TCGA-BH-A18J.589BC4DD-0079-4106-A2E6-9A48E9BD7DE2.pdf;Negative;NA;Right;NA;NO;NA;NA;NA;NA;Positive;30-39%;WHITE;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Modified Radical Mastectomy;BH;1933333333;WITH TUMOR;Breast
brca_tcga_pub2015;TCGA-BH-A18L;TCGA-BH-A18L-01;50;M0;N1mi;Stage IIIA;6th;T3;NA;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;NA;-18519;2669;811;0;NA;NA;NA;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;total mastectomy and sentinel node biopsy;6/9/11;5814;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2003;NO;YES;1;1;3;NA;NA;NA;NA;NO;Core needle biopsy;NA;NA;33;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;MDLC;2664;1:DECEASED;9ddc3e7b-8b54-4a83-8335-8053940f56c1;796e565c-3841-425a-bdfb-569776d7c9ac;TCGA-BH-A18L.E4DF4771-074D-4870-A0BF-AF62724C5A86.pdf;Negative;NA;Left Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Other;BH;11;NA;Breast
brca_tcga_pub2015;TCGA-BH-A18M;TCGA-BH-A18M-01;39;M0;N1;Stage IIIA;5th;T3;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-14532;3629;2207;0;NA;NA;NA;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;6/15/11;1771;NA;NA;NA;NA;NA;Positive;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.3;1/03/8500;C50.3;Positive;NA;YES;2001;NO;YES;4;4;6;NA;NA;NA;NA;NO;Core needle biopsy;NA;NA;14;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;BRCA;725;1:DECEASED;f63722c1-a0bb-4bf9-8a10-1d76a8e1a0ba;6a914b5f-5bc2-4152-b80e-fcc864a415b0;TCGA-BH-A18M.4F67B7BE-68C1-40E1-8276-2D26B46C744D.pdf;Negative;NA;Left Upper Inner Quadrant;NA;NO;NA;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Modified Radical Mastectomy;BH;466666667;NA;Breast
brca_tcga_pub2015;TCGA-BH-A18N;TCGA-BH-A18N-01;88;M0;N1b;Stage IIA;NA;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-32404;3374;1148;0;NA;NA;NA;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;6/15/11;1399;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2001;NO;YES;2;2;26;NA;NA;NA;NA;NO;Fine needle aspiration biopsy;NA;NA;30;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;3771;1:DECEASED;665dd3d3-779c-4abd-b5d7-13342340451d;dba36215-670e-400f-864e-a46702d49240;TCGA-BH-A18N.60E8A9CF-3E2D-4E36-947D-448BA27C6561.pdf;Negative;NA;Left;NA;NO;NA;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;BH;1;NA;Breast
brca_tcga_pub2015;TCGA-BH-A18P;TCGA-BH-A18P-01;60;M0;N0;Stage I;6th;T1;NA;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;NA;-22222;2639;921;0;NA;NA;NA;NA;NA;NA;Positive;<10%;NA;NA;6/22/11;1673;NA;NA;NA;NA;NA;Positive;10-19%;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.3;1/03/8500;C50.3;Positive;1;YES;2003;NO;YES;0;NA;2;NA;NA;NA;NA;NA;Fine needle aspiration biopsy;NA;NA;239;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;MDLC;3026;1:DECEASED;557cb0a3-6f1b-4faf-8296-0a15c24158f9;0d0546ad-8a51-4802-a173-96fbe5ebb124;TCGA-BH-A18P.D24BB508-6E9A-4CF7-93C6-975E79F6E86D.pdf;Negative;NA;Left Lower Inner Quadrant;NA;NO;NA;NA;NA;NA;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Simple Mastectomy;BH;7966666667;WITH TUMOR;Breast
brca_tcga_pub2015;TCGA-BH-A18Q;TCGA-BH-A18Q-01;56;M0;N1b;Stage IIB;NA;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-20675;3417;1692;0;NA;NA;NA;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;6/24/11;7399;NA;NA;NA;NA;NA;Negative;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.8;1/03/8500;C50.8;Positive;NA;YES;2001;NO;YES;2;2;25;NA;NA;NA;NA;NA;Core needle biopsy;NA;NA;65;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;5558;1:DECEASED;db4bc6aa-2e7d-4bcb-8519-a455f624d33b;f225775e-e46f-4d1d-8b13-042e9776dd72;TCGA-BH-A18Q.BB4C7377-F10C-48D2-A8AA-6D5B43FEB108.pdf;Negative;NA;Left;NA;NO;NA;NA;NA;NA;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;BH;2166666667;NA;Breast
brca_tcga_pub2015;TCGA-BH-A18R;TCGA-BH-A18R-01;50;M0;N1;Stage IIA;NA;T2b;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-18524;3571;1142;0;NA;NA;NA;NA;NA;NA;Indeterminate;20-29%;NOT HISPANIC OR LATINO;NA;7/3/11;2866;NA;NA;NA;NA;NA;Positive;NA;3;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;NA;YES;2001;NO;YES;10;NA;15;NA;NA;NA;NA;NO;Incisional Biopsy;NA;NA;21;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;3752;1:DECEASED;f6e1ec78-5ad9-4879-9b7e-262d17b166ad;518be2c7-fba5-47b1-8c8b-fef812fa74a4;TCGA-BH-A18R.46DE21ED-1E08-4095-9B68-88D10AC74673.pdf;Negative;NA;Right Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Modified Radical Mastectomy;BH;7;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A18S;TCGA-BH-A18S-01;79;M0;N0;Stage I;6th;T1c;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-28974;2695;2009;0;NA;NA;NA;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;total mastectomy;7/2/11;1516;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Mucinous Carcinoma;NA;No;No;C50.3;1/03/8523;C50.3;Negative;NA;YES;2003;NO;YES;0;NA;2;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NA;18;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;BRCA;66;1:DECEASED;433427a1-bacf-4381-91ba-5fec8a0953f9;ce3a4469-8d19-4661-9c48-1baf6e84f49c;TCGA-BH-A18S.E89670CB-575A-4B67-AF79-1C730B9B86D4.pdf;Negative;NA;Right Lower Inner Quadrant;NA;NO;NA;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Other;BH;6;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A18T;TCGA-BH-A18T-01;70;M0;N0;Stage IIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-25674;2737;224;0;NA;NA;NA;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;segmental mastectomy;7/2/11;6652;NA;NA;NA;NA;NA;Negative;NA;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;NA;YES;2003;NO;NA;NA;NA;NA;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Fine needle aspiration biopsy;NA;NA;54;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;736;1:DECEASED;30ec8b1f-28c4-4f46-8a1b-a8d51e558c7d;50233285-5aef-412a-a225-3ed14eaa69d8;TCGA-BH-A18T.B8FF655E-47AB-4BB0-B119-1402A335126A.pdf;Negative;NA;Right Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Other;BH;18;WITH TUMOR;Breast
brca_tcga_pub2015;TCGA-BH-A18U;TCGA-BH-A18U-01;72;M0;N2a;Stage IIIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-26426;2697;1563;0;NA;NA;NA;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;total mastectomy;7/2/11;6182;NA;NA;NA;NA;NA;NA;NA;3;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.4;1/03/8500;C50.4;Positive;NA;YES;2003;NO;YES;9;NA;16;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NA;73;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;5135;1:DECEASED;233b02f3-c4f0-4a67-9db5-e68d5cdaccb6;79763193-268d-49e7-b94c-5cb95f7271b6;TCGA-BH-A18U.2616F70D-3E15-45BA-8907-65694595F726.pdf;Negative;NA;Left;NA;NO;NA;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Other;BH;2433333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A18V;TCGA-BH-A18V-01;48;M0;N1b;Stage IIB;5th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-17682;3621;1556;0;NA;NA;NA;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;Modified radical mastectomy with left breast biopsy;7/2/11;7015;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.4;1/03/8500;C50.4;Negative;NA;YES;2001;NO;YES;0;NA;25;NA;NA;Other, specify;axilaary node negative but intrammary node positive;YES;Core needle biopsy;NA;NA;151;NA;NA;NA;Negative;NA;NA;NA;Negative;NA;NA;Negative;NA;VERDADERO;IDC;5112;1:DECEASED;6b960b58-28e1-41c6-bd6e-7e669c6aa4ef;2923c735-34a1-4db6-a248-1c5de2241dd4;TCGA-BH-A18V.3C1C2CED-A1CF-48FC-BCB2-658D74E1982B.pdf;Negative;NA;Right;NA;NO;NA;NA;NA;NA;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Other;BH;5;NA;Breast
brca_tcga_pub2015;TCGA-BH-A1EN;TCGA-BH-A1EN-01;78;M0;NX;Stage IIA;5th;T2;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-28724;4343;2127;0;NA;NA;NA;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;right segmental mastectomy;9/3/11;6267;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;NA;YES;1999;NO;NA;NA;NA;NA;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Excisional Biopsy;NA;NA;42;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;BRCA;6988;1:DECEASED;858652b8-c4c2-41d8-be32-fdc88e1a7bb0;bea52276-596c-479e-981d-ca9132742098;TCGA-BH-A1EN.809F294F-8C48-4719-866B-7169FB1CE24D.pdf;Negative;NA;Right;NA;NO;NA;NA;NA;NA;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;BH;14;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A1EO;TCGA-BH-A1EO-01;68;M0;N1;Stage IIA;5th;T1c;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-25136;4330;2798;0;NA;NA;NA;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;right segmental mastectomy witrh axillary node dissection;9/6/11;2619;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Mixed Histology (please specify);ductal and lobular features;No;No;C50.9;1/03/8522;C50.9;Negative;NA;YES;1999;NO;YES;1;NA;15;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Excisional Biopsy;NA;NA;33;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;BRCA;9192;1:DECEASED;4510295e-8aa7-4ef1-b2b7-91cc902f8200;9d501ca9-f50d-45fc-bcc3-fee15f9771cd;TCGA-BH-A1EO.A2B755DD-00C4-4349-8E11-C1196EBC91D3.pdf;NA;NA;Right;NA;NO;NA;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;BH;11;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A1ES;TCGA-BH-A1ES-01;35;M0;N1a;Stage IIB;5th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-13138;4242;3462;0;NA;NA;NA;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;total mastectomy with rigth axillary lymph node and sentinel lymph node dissection;9/6/11;;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;1999;NO;YES;1;NA;4;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Tumor resection;NA;NA;;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;11373;1:DECEASED;51ccbf1b-7cae-44ba-991a-11eda8b8c404;aa1037f4-1414-4e05-b11a-c558a23b7e62;TCGA-BH-A1ES.9B2253AB-2C41-4E7A-9178-B690FFD9FF78.pdf;NA;NA;Right Upper Inner Quadrant;NA;NO;NA;NA;NA;NA;Positive;NA;WHITE;NA;YES;2;Primary;Female;Matched;NA;NA;NA;NA;Other;BH;;WITH TUMOR;Breast
brca_tcga_pub2015;TCGA-BH-A1ES;TCGA-BH-A1ES-06;35;M0;N1a;Stage IIB;5th;T2;NA;Invasive Breast Carcinoma;NA;NA;-13138;;3462;0;NA;NA;NA;NA;NA;NA;NA;NA;NOT HISPANIC OR LATINO;NA;9/6/11;5056;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;1999;NA;YES;1;NA;4;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NA;Tumor resection;NA;NA;30;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;;BRCA;11373;1:DECEASED;51ccbf1b-7cae-44ba-991a-11eda8b8c404;NA;NA;NA;NA;NA;NA;NO;NA;NA;NA;NA;NA;NA;WHITE;NA;YES;2;Metastasis;Female;Matched;NA;NA;NA;NA;NA;NA;1;WITH TUMOR;NA
brca_tcga_pub2015;TCGA-BH-A1ET;TCGA-BH-A1ET-01;55;M0;N0;Stage I;5th;T1;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-20425;4137;2520;0;NA;NA;NA;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;Left segmental mastectomy with left axillary lymph node dissection;9/7/11;892;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;1999;NO;YES;1;NA;19;NA;NA;NA;NA;NA;Fine needle aspiration biopsy;NA;NA;20;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;8279;1:DECEASED;8986a141-eae7-4157-b695-02cc6fc3b071;2190d984-3941-41d4-b6de-d0aa76f3570d;TCGA-BH-A1ET.E66D3DF8-1605-4EFD-AAFA-74F82366FD16.pdf;NA;NA;Left;NA;NO;NA;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;BH;666666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A1EU;TCGA-BH-A1EU-01;83;M0;N0;Stage I;5th;T1;NA;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;NA;-30339;4106;1286;0;NA;NA;NA;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;Right segmental mastectomy;9/7/11;1179;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;1999;NO;NO;NA;NA;NA;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Fine needle aspiration biopsy;NA;NA;16;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;MDLC;4225;1:DECEASED;a1093598-d3a8-4ffe-83fc-bc7d1faff7e5;73af0f78-cc37-43ff-8f46-524a9ba80eda;TCGA-BH-A1EU.FF6BC87F-029E-4565-A35A-6FB968F8EABA.pdf;NA;NA;Right;NA;NO;NA;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;NA;BH;533333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A1EV;TCGA-BH-A1EV-01;45;M0;N1b;Stage IIIA;5th;T3;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-16504;4103;365;0;NA;NA;NA;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;9/7/11;4189;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;NA;YES;1999;NO;YES;3;NA;10;NA;NA;NA;NA;NA;Fine needle aspiration biopsy;NA;NA;76;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;1199;1:DECEASED;417dea5f-f68e-4dab-940e-43ae8c67e5e6;29ac24fb-0065-47f8-b044-f4a66fad2394;TCGA-BH-A1EV.16DEA43F-4A61-44E3-854F-6B6575B45628.pdf;NA;NA;Left;NA;NO;NA;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Modified Radical Mastectomy;BH;25;WITH TUMOR;Breast
brca_tcga_pub2015;TCGA-BH-A1EW;TCGA-BH-A1EW-01;38;M0;N1b;Stage IIA;5th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-14090;4230;1694;0;NA;NA;NA;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;Left segmental mastectomy with level 1 and level 2 axillary dissection;9/7/11;3453;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;1999;NO;YES;1;NA;16;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NA;Core needle biopsy;NA;NA;12;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;5565;1:DECEASED;9d166970-07c8-4ca3-9cfa-ed0049df9ecc;50463a25-4292-4bc7-926a-341493e68242;TCGA-BH-A1EW.56EFCA58-2328-4C5C-9618-981447E76B12.pdf;NA;NA;Left Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;BH;4;WITH TUMOR;Breast
brca_tcga_pub2015;TCGA-BH-A1EX;TCGA-BH-A1EX-01;67;M0;N1b;Stage IIB;5th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-24544;3752;1508;0;NA;NA;NA;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;Right segmental mastectomy with sentinel lymph node and axillary lymph node biopsy;9/7/11;2258;NA;NA;NA;NA;NA;Negative;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;NA;YES;2000;NO;YES;2;NA;24;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NA;20;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;4954;1:DECEASED;7b892055-c59d-4550-8688-ad039790af3d;f713031b-b8ee-4195-91b1-ac9cf63d76a4;TCGA-BH-A1EX.FA86A743-EA67-4554-ABA2-BB8C1DBDB0B1.pdf;NA;NA;Right Lower Inner Quadrant;NA;NO;NA;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;BH;666666667;WITH TUMOR;Breast
brca_tcga_pub2015;TCGA-BH-A1EY;TCGA-BH-A1EY-01;79;M0;N0;Stage IIA;5th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-28940;3840;538;0;NA;13.01;1:Recurred/Progressed;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;9/7/11;3632;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2000;NO;YES;0;NA;12;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NA;33;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;1767;1:DECEASED;0741b5db-4405-42ba-b63a-c6ee4f341480;14193a12-5601-4f0c-90aa-ecd24d6ac41b;TCGA-BH-A1EY.2ED10396-96FF-4705-93AE-82FB9A80EC28.pdf;NA;NA;Left Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Modified Radical Mastectomy;BH;11;WITH TUMOR;Breast
brca_tcga_pub2015;TCGA-BH-A1F0;TCGA-BH-A1F0-01;80;M0;N1c;Stage IIA;5th;T1a;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-29335;3879;785;0;NA;NA;NA;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;9/7/11;288;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2000;NO;YES;1;NA;9;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Fine needle aspiration biopsy;NA;NA;26;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;2579;1:DECEASED;21ef1730-e5a7-47ce-b419-d000bb59ae15;f754aa5f-49c8-4e8b-a1fe-f370f807499a;TCGA-BH-A1F0.E2EE2397-0F8A-4A71-9B3C-0007F7D00500.pdf;NA;NA;Left;NA;NO;NA;NA;NA;NA;Indeterminate;NA;WHITE;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Modified Radical Mastectomy;BH;866666667;WITH TUMOR;Breast
brca_tcga_pub2015;TCGA-BH-A1F2;TCGA-BH-A1F2-01;53;M0;N1b;Stage IIIB;5th;T4b;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-19701;4147;959;0;NA;NA;NA;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;9/7/11;4715;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8541;C50.9;Positive;NA;YES;1999;NO;YES;6;NA;19;NA;NA;NA;NA;NA;Core needle biopsy;NA;NA;42;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;315;1:DECEASED;6a2972e3-cca9-47e5-aac0-b770f2399eeb;e5c171ac-f700-439c-9e44-6cfed2c9cea7;TCGA-BH-A1F2.FA781D93-C180-4453-BF95-B2D01B6CDB5C.pdf;NA;NA;Left;NA;NO;NA;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Modified Radical Mastectomy;BH;14;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A1F5;TCGA-BH-A1F5-01;62;M0;N1a;Stage IIA;5th;T1c;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-22842;3091;2712;0;NA;NA;NA;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;9/7/11;1457;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;Yes;C50.9;1/03/8500;C50.9;Negative;NA;YES;2002;NO;YES;1;NA;4;NA;NA;NA;NA;NA;Core needle biopsy;NA;NA;28;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;8909;1:DECEASED;e663954c-05a8-479a-a623-400c1eb5efc6;5cd62b0e-902e-492c-843d-5d8aa6964dc5;TCGA-BH-A1F5.F70DE761-F081-4F4C-AD22-9A166CF78CA8.pdf;NA;NA;Right;NA;NO;NA;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;NA;BH;933333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A1F6;TCGA-BH-A1F6-01;51;MX;N2a;NA;NA;T4d;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-18691;5230;2965;0;NA;NA;NA;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;9/7/11;5787;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;1996;NO;YES;6;NA;6;NA;NA;NA;NA;NA;Core needle biopsy;NA;NA;51;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;974;1:DECEASED;ad18820b-a804-49c0-ba8a-86c09fa6bce2;e5a9fa79-2d0f-4cda-9fea-baab86f78b8e;TCGA-BH-A1F6.7E9B0BE7-121E-423F-AA37-445BA922FC13.pdf;NA;NA;Left;NA;NO;NA;NA;NA;NA;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Modified Radical Mastectomy;BH;17;NA;Breast
brca_tcga_pub2015;TCGA-BH-A1F8;TCGA-BH-A1F8-01;90;M0;N2;Stage IIIB;5th;T4b;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-32871;4301;763;0;NA;NA;NA;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;9/7/11;9971;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;NA;YES;1999;NO;YES;12;NA;13;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NA;117;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;2507;1:DECEASED;ee554215-bea2-4268-aaf9-784e68cdb969;7e598a8a-9fb8-4c2d-94e7-ae1921addcd1;TCGA-BH-A1F8.BAA6AA92-69C5-454B-A550-246E7DB1EBE3.pdf;NA;NA;Left;NA;NO;NA;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Modified Radical Mastectomy;BH;39;WITH TUMOR;Breast
brca_tcga_pub2015;TCGA-BH-A1FC;TCGA-BH-A1FC-01;78;M0;N1b;Stage IIA;5th;T1c;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-28706;4456;3472;0;NA;NA;NA;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;localized segmental mastectomy with axillary node dissection;9/8/11;4675;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Medullary Carcinoma;NA;No;No;C50.9;1/03/8510;C50.9;Negative;NA;YES;1998;NO;YES;1;NA;23;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Fine needle aspiration biopsy;NA;NA;85;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;BRCA;11406;1:DECEASED;b97bf89a-7a85-4eef-ae7e-f787aead1f0a;3ad0093a-e57a-450a-b0ef-942c9b67a586;TCGA-BH-A1FC.7B1B31D2-0CC5-4EE6-8AF3-16DF726BE13F.pdf;NA;NA;Right Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Negative;NA;BLACK OR AFRICAN AMERICAN;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;BH;2833333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A1FE;TCGA-BH-A1FE-01;31;M0;N1;Stage IIB;5th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-11650;4456;2273;0;NA;NA;NA;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;9/8/11;1298;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;1998;NO;YES;1;NA;12;NA;NA;NA;NA;NA;Core needle biopsy;NA;NA;21;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;7467;1:DECEASED;4aa68586-6331-4795-b40c-859386640df6;3de73049-e6e7-4ed7-be98-bf174fd37c89;TCGA-BH-A1FE.098BAFB4-94D0-4FC8-B938-D8A410BD8FC1.pdf;NA;NA;Left;NA;NO;NA;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Modified Radical Mastectomy;BH;7;WITH TUMOR;Breast
brca_tcga_pub2015;TCGA-BH-A1FG;TCGA-BH-A1FG-01;88;M0;NX;Stage I;5th;T1c;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-32295;4460;3736;0;NA;NA;NA;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;segmental mastectomy;9/8/11;1163;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;1998;NO;NA;NA;NA;NA;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Excisional Biopsy;NA;NA;16;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;12273;1:DECEASED;d4e7426c-9739-4585-9114-e564b13c7c02;33f49b4e-924e-4590-8afa-e17403602137;TCGA-BH-A1FG.49927626-EB84-4A79-8073-67818722123A.pdf;NA;NA;Left;NA;NO;NA;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;BH;533333333;NA;Breast
brca_tcga_pub2015;TCGA-BH-A1FH;TCGA-BH-A1FH-01;47;M1;N1b;Stage IV;5th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-17172;4670;1034;0;NA;NA;NA;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;9/8/11;222;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;1998;NO;YES;8;NA;13;NA;NA;Bone;NA;YES;Core needle biopsy;NA;NA;8;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;3397;1:DECEASED;1783cac1-253a-40af-a9ac-48dfb20e1ab8;f0785dc2-a43e-4b59-a21c-ab55c490d441;TCGA-BH-A1FH.501C3E1B-573B-4A5A-A0ED-3CD15432E6FF.pdf;NA;NA;Left Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Modified Radical Mastectomy;BH;266666667;WITH TUMOR;Breast
brca_tcga_pub2015;TCGA-BH-A1FJ;TCGA-BH-A1FJ-01;66;M0;N1b;Stage IIIA;5th;T3;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-24262;4574;1927;0;NA;NA;NA;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;9/8/11;1001;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;1998;NO;YES;6;NA;35;NA;NA;NA;NA;NA;Core needle biopsy;NA;NA;24;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;BRCA;633;1:DECEASED;f6581eee-61b9-43d4-ab0d-ce5ce3ba1c74;72367269-4151-4e1f-8636-ff91396ba46c;TCGA-BH-A1FJ.8169BE67-03C8-4F4D-9A60-200705B795AE.pdf;NA;NA;Right Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Modified Radical Mastectomy;BH;833333333;NA;Breast
brca_tcga_pub2015;TCGA-BH-A1FL;TCGA-BH-A1FL-01;69;M0;N1b;Stage IIB;5th;T2;NA;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;NA;-25558;4572;1673;0;NA;NA;NA;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;needle directed right breast biopsy with left segmental mastectomy with axillary lymph node dissection;9/8/11;908;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;1998;NO;YES;4;NA;22;NA;NA;NA;NA;NA;Fine needle aspiration biopsy;NA;NA;26;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;MDLC;5496;1:DECEASED;14d1d84e-99e1-41ad-8892-3b4da3d4f948;6adbf536-e89b-4148-8ed6-9b9117f78c64;TCGA-BH-A1FL.032B81C5-F936-448E-A352-C186DF160B7C.pdf;NA;NA;Left Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;BH;866666667;WITH TUMOR;Breast
brca_tcga_pub2015;TCGA-BH-A1FM;TCGA-BH-A1FM-01;44;M0;N2;Stage IIIA;5th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-16289;4753;1388;0;NA;NA;NA;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;9/8/11;5273;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;1998;NO;YES;8;NA;10;NA;NA;NA;NA;NA;Core needle biopsy;NA;NA;40;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;456;1:DECEASED;7eb18190-5a41-4637-9783-f81bbde499e4;cf2b65de-c6a1-4ebc-a62a-c652ce17d2d0;TCGA-BH-A1FM.DA6A0EC9-6E20-4E4A-9B7F-A32EFF7627AD.pdf;NA;NA;Right Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Modified Radical Mastectomy;BH;1333333333;NA;Breast
brca_tcga_pub2015;TCGA-BH-A1FN;TCGA-BH-A1FN-01;34;M0;N0;Stage IIA;5th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-12525;4838;2192;0;NA;NA;NA;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;segmental mastectomy with axillary lymph node dissection;9/8/11;5352;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;1997;NO;YES;0;NA;29;NA;NA;NA;NA;NA;Fine needle aspiration biopsy;NA;NA;92;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;7201;1:DECEASED;6dd0dd7b-62ff-4fd1-a99a-b265f1a91dca;ae08dbd6-548a-469c-ba12-b6a87515bce7;TCGA-BH-A1FN.26F47A4F-B501-4C33-9D49-2039E98DBF26.pdf;NA;NA;Right Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;BH;3066666667;WITH TUMOR;Breast
brca_tcga_pub2015;TCGA-BH-A1FR;TCGA-BH-A1FR-01;73;M0;N1a;Stage IIIB;5th;T4b;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-26684;4876;1642;0;NA;NA;NA;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;segmental mastectomy with excision of mass on chest wall and axillary node dissection;9/8/11;5;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Other, specify;NA;No;No;C50.9;1/03/8523;C50.9;NA;NA;YES;1997;NO;YES;4;NA;10;NA;NA;NA;NA;NA;Core needle biopsy;NA;NA;20;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;BRCA;5394;1:DECEASED;bf3b1481-ae31-4406-b084-b6cc1d7163e3;0fc347ae-7ad9-4987-887a-d37fe871d6c2;TCGA-BH-A1FR.B6E6765F-14BC-4D3D-9266-EF8065354070.pdf;NA;NA;Right Upper Inner Quadrant;NA;NO;NA;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;BH;666666667;WITH TUMOR;Breast
brca_tcga_pub2015;TCGA-BH-A1FU;TCGA-BH-A1FU-01;44;M0;N0;Stage IA;5th;T1c;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-16174;5041;1688;0;NA;NA;NA;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;9/8/11;641;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;1997;NO;YES;0;NA;5;NA;NA;NA;NA;NA;Fine needle aspiration biopsy;NA;NA;40;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;BRCA;5545;1:DECEASED;c348a9b3-c901-4384-a222-144387bac0c5;438152c8-2d26-4b35-9f68-a4b6c473916e;TCGA-BH-A1FU.58B02C83-2AF7-4978-A3F7-A8B9E0D914A1.pdf;NA;NA;Right Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Modified Radical Mastectomy;BH;1333333333;WITH TUMOR;Breast
brca_tcga_pub2015;TCGA-BH-A201;TCGA-BH-A201-01;64;M0;N0;Stage IA;7th;T1;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-23423;86;NA;0;210;28.12;0:DiseaseFree;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;segmental mastectomy with sentinel lymph node biopsy and wire localization;9/8/11;1268;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2011;NO;YES;0;NA;2;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NA;16;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;2812;0:LIVING;3bf81a9f-abb4-4495-a514-fd3865e13a03;7893162b-3d19-4c54-86ee-aa4884d84e8a;TCGA-BH-A201.6AE92F6F-E29D-43B6-AF1E-F15720C1AAE8.pdf;NA;NA;Left;NA;NO;NA;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;BH;533333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A202;TCGA-BH-A202-01;60;M0;N0;Stage II;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-22052;62;NA;0;22;26.12;0:DiseaseFree;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;segmental mastectomy with sentinel lymph node biopsy;9/8/11;2689;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;NA;YES;2011;NO;YES;0;NA;4;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NA;26;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;2612;0:LIVING;e7a00d67-2c26-4d1f-bd17-35f659e88bc1;8fa798fe-f032-4d77-b362-06261db78e6d;TCGA-BH-A202.57323AE5-3EFE-4492-8522-D9A6DB3F1BE0.pdf;NA;NA;Left;NA;NO;NA;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Other;BH;866666667;NA;Breast
brca_tcga_pub2015;TCGA-BH-A203;TCGA-BH-A203-01;78;M0;N1b;Stage IIB;5th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-28609;5418;1174;0;NA;NA;NA;NA;NA;NA;NA;NA;NOT HISPANIC OR LATINO;NA;9/8/11;3623;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;1996;NO;YES;35;NA;39;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;NA;NA;NA;54;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;3857;1:DECEASED;b3264748-947a-43aa-b227-b294fbcc8447;002997ef-3b93-443a-80a3-bae63e129d99;TCGA-BH-A203.3EBBE51B-6D17-4A77-AAE1-E0424CEA56DB.pdf;NA;NA;Right;NA;NO;NA;NA;NA;NA;NA;NA;WHITE;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Lumpectomy;BH;18;WITH TUMOR;Breast
brca_tcga_pub2015;TCGA-BH-A204;TCGA-BH-A204-01;80;M0;N1b;Stage IIB;5th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-29529;5538;2534;0;NA;NA;NA;NA;NA;NA;NA;NA;NOT HISPANIC OR LATINO;NA;9/8/11;2346;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;1996;NO;YES;2;NA;16;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Fine needle aspiration biopsy;NA;NA;33;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;8325;1:DECEASED;05135396-df5c-49db-b34e-f4add5b65a2b;a28d9c46-4774-4167-8c1e-ee95436c7b2e;TCGA-BH-A204.531B1E8E-9936-42E0-B49B-39C61DD4E943.pdf;NA;NA;Left;NA;NO;NA;NA;NA;NA;NA;NA;WHITE;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Modified Radical Mastectomy;BH;11;NA;Breast
brca_tcga_pub2015;TCGA-BH-A208;TCGA-BH-A208-01;48;M0;N1b;Stage IIB;5th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-17715;5893;1759;0;NA;NA;NA;NA;NA;NA;NA;NA;NOT HISPANIC OR LATINO;NA;9/8/11;1644;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;1995;NO;YES;3;NA;15;NA;NA;NA;NA;NA;Core needle biopsy;NA;NA;51;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;5779;1:DECEASED;ddcbdac6-9e43-4146-a611-d033125eba14;723e0934-327e-46f2-94f0-20a65da1ea0e;TCGA-BH-A208.4F943D12-E769-45F3-86BE-75193786DD4E.pdf;NA;NA;Left;NA;NO;NA;NA;NA;NA;NA;NA;WHITE;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Lumpectomy;BH;17;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A209;TCGA-BH-A209-01;77;M0;N0;Stage I;5th;T1c;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-28403;5392;3959;0;NA;NA;NA;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;9/8/11;3066;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Medullary Carcinoma;NA;No;No;C50.9;1/03/8510;C50.9;NA;NA;YES;1996;NO;YES;0;NA;12;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Fine needle aspiration biopsy;NA;NA;76;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;BRCA;13006;1:DECEASED;5258294f-ef5b-4091-9183-6bcc545d54b2;fbf64fdd-6787-4647-b0cd-860acc8abce6;TCGA-BH-A209.E28150CE-E9B6-4C3F-B867-F9A75E2648DC.pdf;NA;NA;Left Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;NA;BLACK OR AFRICAN AMERICAN;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Lumpectomy;BH;2533333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A28O;TCGA-BH-A28O-01;50;M0;N3;Stage IIIC;7th;T3a;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-18501;163;NA;0;324;36.79;0:DiseaseFree;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;Segmental mastectomy;7/2/12;3;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Negative;NA;YES;2010;NO;YES;14;NA;14;NA;NA;NA;NA;NO;Fine needle aspiration biopsy;NA;NO;18;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;ILC;3679;0:LIVING;84B7CCF2-8AB3-4B21-96DE-800D231BC072;405B2B8F-7E2E-4D80-89BE-299DA48374EF;TCGA-BH-A28O.12A869FC-7578-4506-BB23-7C25597834EA.pdf;Negative;NA;Right Lower Outer Quadrant;NA;YES;NA;NA;NA;NA;Positive;NA;WHITE;NA;NO;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Other;BH;6;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A28Q;TCGA-BH-A28Q-01;46;M0;N1a;Stage IIB;7th;T2;NA;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;NA;-16882;223;NA;0;196;36.76;0:DiseaseFree;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;9/29/11;1605;NA;NA;NA;NA;NA;Indeterminate;NA;NA;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Negative;NA;YES;2010;NO;YES;2;NA;18;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NA;Fine needle aspiration biopsy;NA;NA;19;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;MDLC;3676;0:LIVING;32861b48-83f5-43a3-bb54-45215ad2c5d6;9864f875-05af-4336-b532-a283e4dfeed6;TCGA-BH-A28Q.9D040C65-C225-4D41-BA4C-6BB21EC1CD32.pdf;NA;NA;Right;NA;NO;NA;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Modified Radical Mastectomy;BH;633333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A42T;TCGA-BH-A42T-01;75;M0;N0 (i+);Stage IIA;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-27731;80;NA;0;30;NA;NA;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;9/28/12;4010;NA;NA;NA;NA;NA;Equivocal;NA;2;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Positive;NA;YES;2012;NO;YES;NA;1;2;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NA;31;NO;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;ILC;1051;1:DECEASED;10C829EC-FD66-49C4-8AFE-AD3AE567372C;312A82EE-9236-4282-B5EB-EE6063BABF5A;TCGA-BH-A42T.3FFD87C3-1E75-4A8E-AA26-BF7995E42245.pdf;Negative;NO;Left;NA;YES;NA;NA;NA;NA;Positive;NA;BLACK OR AFRICAN AMERICAN;NO;NO;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Simple Mastectomy;BH;1033333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-BH-A42U;TCGA-BH-A42U-01;80;M0;N0;Stage IIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-29330;3080;NA;0;3324;110.51;0:DiseaseFree;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;10/1/12;0;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Negative;NA;YES;2004;NO;YES;NA;NA;1;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NA;9;NO;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;ILC;11051;0:LIVING;2DC1CEC9-925A-417F-9E21-3C2143E711B4;CEE987EF-2EB6-4CDD-8094-331DE8EC38CA;TCGA-BH-A42U.25F791D8-27D6-4DC6-8D96-5D5CF68A5F13.pdf;Negative;NO;Right;NA;YES;NA;NA;NA;NA;Negative;NA;BLACK OR AFRICAN AMERICAN;NO;NO;1;Primary;Female;Matched;NA;NA;NA;NA;Simple Mastectomy;BH;3;NA;Breast
brca_tcga_pub2015;TCGA-BH-A42V;TCGA-BH-A42V-01;41;M0;N1mi;Stage IB;7th;T1c;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-15158;197;NA;0;272;20.86;0:DiseaseFree;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;1/17/13;894;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2012;NO;YES;1;NA;3;Negative;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NA;Core needle biopsy;NA;NA;39;NO;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;2086;0:LIVING;57CF380D-AB52-467F-B9AE-740B2F84C820;2CF478D5-5400-4724-BF36-89BF1DF26284;TCGA-BH-A42V.5BB5CEFD-CC07-4451-A774-25FB146067C7.pdf;Positive;NO;Left Lower Outer Quadrant;NA;YES;NA;NA;NA;NA;Positive;NA;BLACK OR AFRICAN AMERICAN;NO;NO;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;Other;Reexcision of segmental mastectomy;Modified Radical Mastectomy;BH;13;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-C8-A12K;TCGA-C8-A12K-01;80;M0;N1;Stage IIB;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-29463;57;NA;0;0;0;0:DiseaseFree;NA;NA;NA;NA;NA;NOT HISPANIC OR LATINO;Pateys surgery;4/12/11;4856;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;2010;NO;NA;1;NA;7;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Other method, specify:;Patey's Surgery;NO;88;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;0;0:LIVING;6b923e30-2ddc-407f-91b1-c202f1373fbb;aa21df77-6622-405a-821a-1122f9c93159;TCGA-C8-A12K.149E102C-FE01-4FC0-8410-CD9743CAFA15.pdf;Negative;NA;Right Upper Inner Quadrant;NA;YES;NA;NA;NA;NA;NA;NA;ASIAN;NA;NO;1;Primary;Female;Matched;Other (specify);Pateys surgery;NA;NA;Other;C8;3;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-C8-A12L;TCGA-C8-A12L-01;67;M0;N0 (i-);Stage IIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-24710;62;NA;0;0;11.93;0:DiseaseFree;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;Patey's Surgery;4/12/11;6096;NA;NA;NA;NA;NA;NA;NA;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;2010;NO;NA;NA;NA;3;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Other method, specify:;Patey's Suregery;NA;68;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;1193;0:LIVING;441919eb-8c9f-478c-bda3-8de4f8295e8a;e3cf8f8c-8fe6-45e2-b786-7db5590c08cb;TCGA-C8-A12L.150DD5CB-1CA0-4110-95A7-6476B5B6FC24.pdf;Negative;NA;Right;NA;YES;NA;NA;NA;NA;Negative;NA;ASIAN;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Other;C8;2266666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-C8-A12M;TCGA-C8-A12M-01;70;M0;N0 (i-);Stage IIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-25811;57;NA;0;0;11.76;0:DiseaseFree;NA;Allred Score 8;NA;Positive;NA;NOT HISPANIC OR LATINO;Patey's Surgery;4/12/11;4491;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2010;NO;NA;NA;NA;10;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Other method, specify:;Patey's Surgery;NA;52;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;1176;0:LIVING;dd0f8e5a-383d-4f03-bb71-0e115d4e442c;4874e4e2-c067-490d-9d99-8d3ca194b0a4;TCGA-C8-A12M.76F67AA2-4E17-48F5-810B-E4F4338902DC.pdf;Negative;NA;Left;NA;YES;NA;NA;NA;NA;Negative;NA;ASIAN;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Other;C8;1733333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-C8-A12N;TCGA-C8-A12N-01;58;M0;N0 (i-);Stage IIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-21428;57;NA;0;0;11.76;0:DiseaseFree;NA;Allred Score 8;NA;Positive;NA;NOT HISPANIC OR LATINO;Patey's Surgery;4/12/11;757;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2010;NO;NA;NA;NA;10;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Other method, specify:;Patey's Surgery;NA;18;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;1176;0:LIVING;b8a615f9-d19b-4b09-8ec8-0674e5c648cd;3f2c52a6-d79d-407d-9c71-11a58ab4e129;TCGA-C8-A12N.A845013D-BF15-42FB-8BFE-FCE206E943FE.pdf;Negative;NA;Right;NA;YES;NA;NA;Allread Score 8;NA;Positive;NA;ASIAN;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Other;C8;6;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-C8-A12O;TCGA-C8-A12O-01;50;M0;N0 (i-);Stage IIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-18506;57;NA;0;0;12.65;0:DiseaseFree;NA;Allred Score 7;NA;Positive;NA;NOT HISPANIC OR LATINO;Patey's Surgery;4/13/11;3342;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2010;NO;NA;NA;NA;10;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NA;Other method, specify:;Patey's Surgery;NA;33;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;1265;0:LIVING;83f26720-007c-42c9-a7de-7484bf8afa89;2c66d45a-c014-4fbe-9ff2-4ca17ec59ba9;TCGA-C8-A12O.273152AA-7B4C-4AE5-9231-1A3160058C74.pdf;Negative;NA;Left;NA;YES;NA;NA;Allred Score 7;NA;Positive;NA;ASIAN;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Other;C8;11;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-C8-A12P;TCGA-C8-A12P-01;55;M0;N1;Stage IIB;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-20332;57;NA;0;0;11.76;0:DiseaseFree;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;Patey's Surgery;4/13/11;3385;NA;NA;NA;NA;NA;NA;NA;3;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;NA;YES;2010;NO;NA;NA;NA;8;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Other method, specify:;Patey's Surgery;NA;123;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;1176;0:LIVING;abdc76db-f85e-4337-a57e-6d098789da03;0d5aa7a3-3488-4339-b8f1-e4971912e2bc;TCGA-C8-A12P.F04324BB-F0B1-4948-9189-7833646029F1.pdf;Negative;NA;Left;NA;YES;NA;NA;NA;NA;Negative;NA;ASIAN;NA;NO;1;Primary;Female;Matched;NA;NA;NA;NA;Other;C8;41;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-C8-A12Q;TCGA-C8-A12Q-01;78;M0;N2;Stage IIIA;NA;T1;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-28733;57;NA;0;2;NA;NA;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;Patey's Surgery;4/13/11;4088;NA;NA;NA;NA;NA;NA;NA;3;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;NA;YES;2010;NO;NA;NA;NA;7;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Other method, specify:;Patey's Surgery;NA;82;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;1265;1:DECEASED;a824b3bd-34d5-4cc1-a92f-f9d6ac0f1814;8867f07e-0993-4c9a-96df-18e24801ba80;TCGA-C8-A12Q.90AF32F0-5684-4D5B-B619-2B12DA3823C6.pdf;Negative;NA;Left;NA;YES;NA;NA;NA;NA;Negative;NA;ASIAN;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Other;C8;2733333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-C8-A12T;TCGA-C8-A12T-01;43;M0;N0;Stage IIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;;51;NA;0;0;0;0:DiseaseFree;NA;Allred Score 6;NA;Positive;NA;NOT HISPANIC OR LATINO;Patey's Surgery;4/11/11;2311;NA;NA;NA;NA;NA;NA;NA;3;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;NA;YES;2010;NO;YES;0;NA;5;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Other method, specify:;Patey's Surgery;NO;132;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;0;0:LIVING;71229981-97c2-4ae1-a130-fe5de336b37d;ea0b870f-324e-4d12-be78-1737ef7f80b5;TCGA-C8-A12T.4D751232-CD64-468E-AEBF-46F94FB6281F.pdf;Negative;NA;Left;NA;YES;NA;NA;Allred Score 8;NA;Positive;NA;ASIAN;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Other;C8;44;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-C8-A12U;TCGA-C8-A12U-01;46;M0;N1;Stage IIB;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-17045;57;NA;0;0;12.65;0:DiseaseFree;NA;Allred Score 5;NA;Positive;NA;NOT HISPANIC OR LATINO;Patey's Surgery;4/13/11;5344;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2010;NO;YES;NA;NA;7;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Other method, specify:;Patey's Surgery;NA;39;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;1265;0:LIVING;97b5f490-1cd9-4833-b903-5f4c6e45670d;c514a893-e085-4a67-b386-b61c3b63a22c;TCGA-C8-A12U.B6428344-2D68-404B-AD9F-CA6E0B0552B2.pdf;Negative;NA;Right;NA;YES;NA;NA;Allred Score 3;NA;Positive;NA;ASIAN;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Other;C8;13;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-C8-A12V;TCGA-C8-A12V-01;55;M0;N0;Stage IIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-20346;57;NA;0;0;12.65;0:DiseaseFree;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;Patey's Surgery;3/22/11;27;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2010;NO;YES;0;NA;5;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Other method, specify:;Patey's Surgery;NA;23;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;1265;0:LIVING;7e1673f8-5758-4963-8804-d5e39f06205b;905de5ec-787c-471d-964b-9db587003602;TCGA-C8-A12V.8ED8A37B-C885-4333-AC5D-EA73A5A81173.pdf;NA;NA;Right;NA;YES;NA;NA;NA;NA;Negative;NA;ASIAN;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Other;C8;766666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-C8-A12W;TCGA-C8-A12W-01;49;M0;N1;Stage IIIB;6th;T4;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-18140;57;NA;0;7;12.65;0:DiseaseFree;NA;Allred Score 7;NA;Positive;NA;NOT HISPANIC OR LATINO;Patey's Surgery;4/13/11;3504;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2010;NO;YES;NA;NA;7;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NA;Other method, specify:;Patey's Surgery;NA;36;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;BRCA;1265;0:LIVING;6adca853-1b09-47ff-814c-47b732a76d96;ded3862e-9e2f-468a-8a40-d90363a2742e;TCGA-C8-A12W.8A64D890-ABEF-4AF2-8915-D17DA89B8FC5.pdf;Negative;NA;Left;NA;YES;NA;NA;Allred Score 6;NA;Positive;NA;ASIAN;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Other;C8;12;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-C8-A12X;TCGA-C8-A12X-01;62;M0;N1;Stage IIB;6th;T2;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-22889;57;NA;0;0;12.65;0:DiseaseFree;NA;Allred Score 8;NA;Positive;NA;NOT HISPANIC OR LATINO;Patey's Surgery;4/13/11;2971;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Mucinous Carcinoma;NA;No;No;C50.9;1/03/8480;C50.9;Negative;NA;YES;2010;NO;YES;NA;NA;6;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Other method, specify:;Patey's Surgery;NA;45;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;BRCA;1265;0:LIVING;65cde5d5-1efc-4e30-b1bd-a93598794f2c;4ab470ca-b87c-448e-b4c6-48db22e39a39;TCGA-C8-A12X.B3FCE052-931C-4798-A188-F04A2178A5F6.pdf;Negative;NA;Left;NA;YES;NA;NA;Allred Score 7;NA;Positive;NA;ASIAN;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Other;C8;1533333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-C8-A12Y;TCGA-C8-A12Y-01;44;M0;N1;Stage IIB;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;;57;NA;0;0;48.49;0:DiseaseFree;NA;NA;NA;NA;NA;NOT HISPANIC OR LATINO;Patey's Surgery;4/13/11;2329;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;2010;NO;YES;NA;NA;9;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Other method, specify:;Patey's Surgery;NA;22;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;4849;0:LIVING;298a1710-deb4-4064-a0f2-da32d43aa217;d9de9f71-2b39-4d21-9c93-8e199080c011;TCGA-C8-A12Y.28E368DA-56B9-4BB1-99C3-7FF2CEC964CF.pdf;Negative;NA;Left;NA;YES;NA;NA;NA;NA;NA;NA;ASIAN;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Other;C8;733333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-C8-A12Z;TCGA-C8-A12Z-01;45;M0;N1;Stage IIB;6th;T2;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-16508;69;NA;0;12;12.55;0:DiseaseFree;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;Patey's Surgery;4/13/11;2697;NA;NA;NA;NA;NA;NA;NA;3;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;NA;YES;2010;NO;YES;2;NA;2;Negative;Peri (6-12 months since last menstrual period);NA;NA;NO;Core needle biopsy;NA;NA;42;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;BRCA;1255;0:LIVING;42621dfa-abfd-4c7d-8bc5-a02a09d1c2b4;238ffa7f-eecf-4f46-8831-efa0d23fa66c;TCGA-C8-A12Z.89B312D1-9FDD-4756-9C15-5442B428F75A.pdf;Negative;NA;Right;NA;YES;NA;NA;NA;NA;Negative;NA;ASIAN;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Other;C8;14;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-C8-A130;TCGA-C8-A130-01;52;M0;N2;Stage IIIA;6th;T3;NA;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;NA;-19117;89;NA;0;4;12.16;0:DiseaseFree;NA;Allred Score 7;NA;Positive;NA;NOT HISPANIC OR LATINO;Patey's Surgery;4/13/11;5081;NA;NA;NA;NA;NA;NA;NA;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;2010;NO;YES;NA;NA;8;NA;Peri (6-12 months since last menstrual period);NA;NA;NO;Core needle biopsy;NA;NA;29;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;MDLC;1216;0:LIVING;8cf54607-01ce-42b0-9bd9-8627edd9f3b7;3bea8456-da16-4691-a260-5c94a83e2860;TCGA-C8-A130.3E24D3A0-9741-4635-89DB-EED4BA3F6AAA.pdf;Negative;NA;Left;NA;YES;NA;NA;Allred Score 7;NA;Positive;NA;ASIAN;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Other;C8;966666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-C8-A131;TCGA-C8-A131-01;82;M0;N2;Stage IIIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-29966;163;NA;0;14;13.5;0:DiseaseFree;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;Patey's Surgery;4/15/11;2303;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2010;NO;YES;4;NA;8;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;NA;51;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;135;0:LIVING;c49e3b18-fd88-48f4-8b01-300692ceb367;8ba927e8-83e7-43d8-ba16-00d45a0f0484;TCGA-C8-A131.65C73797-1A8F-474D-94F6-45A2878B2C45.pdf;Negative;NA;Left;NA;YES;NA;NA;NA;NA;Negative;NA;ASIAN;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Other;C8;1733333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-C8-A132;TCGA-C8-A132-01;56;M0;N1;Stage IIB;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-20471;162;NA;0;13;12.58;0:DiseaseFree;NA;Allred Score 8;NA;Positive;NA;NOT HISPANIC OR LATINO;Modified Radical Masectomy;4/15/11;1483;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;2010;NO;YES;1;NA;4;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;NA;47;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;1258;0:LIVING;89e867de-d30e-4bfc-a453-0a76309dabd5;5de50617-0a03-45b7-8ffd-bcf3a0680d6b;TCGA-C8-A132.175224E6-3A06-4799-B695-704C254A847C.pdf;Negative;NA;Left;NA;YES;NA;NA;Allred Score 7;NA;Positive;NA;ASIAN;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Other;C8;1566666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-C8-A133;TCGA-C8-A133-01;65;M0;N1;Stage IIIA;6th;T3;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-23922;119;NA;0;0;0;0:DiseaseFree;NA;Allred Score 8;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;4/15/11;53;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Other, specify;NA;No;No;C50.9;1/03/8523;C50.9;NA;NA;YES;2010;NO;YES;NA;NA;26;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Other method, specify:;Modified Radical Masectomy;NA;19;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;BRCA;0;0:LIVING;b8b6cebc-26dc-43ae-a94a-20da6018f7ae;bc05cd4d-188f-4634-b6e4-c72a3683afed;TCGA-C8-A133.C47488B4-0E7E-46FB-91C6-0BEA58695974.pdf;Negative;NA;Right;NA;YES;NA;NA;Allred Score 8;NA;Positive;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;C8;633333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-C8-A134;TCGA-C8-A134-01;52;M0;N0;Stage IIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-19010;162;NA;0;14;12.58;0:DiseaseFree;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;Modified Radical Masectomy;4/15/11;4432;NA;NA;NA;NA;NA;NA;NA;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;2010;NO;NA;NA;NA;7;NA;Peri (6-12 months since last menstrual period);NA;NA;NA;Core needle biopsy;NA;NA;77;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;1258;0:LIVING;f1692f4b-ce1b-4fc5-ac55-1022ecae0d1e;e20c3a54-2fe7-4e5e-a41c-ad4efeb97f76;TCGA-C8-A134.CA8DFAB4-FC1F-45F9-B98A-9AF06A01DB28.pdf;Negative;NA;Left;NA;YES;NA;NA;NA;NA;Negative;NA;ASIAN;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Other;C8;26;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-C8-A135;TCGA-C8-A135-01;64;M0;N1;Stage IIB;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-23667;162;NA;0;13;12.91;0:DiseaseFree;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;4/15/11;2977;NA;NA;NA;NA;NA;NA;NA;3;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;NA;YES;2010;NO;YES;1;NA;3;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;NA;43;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;1291;0:LIVING;33cea538-4c3f-470a-972d-257c43241ab4;ddfbecf6-37e3-4015-bb24-125ccdd60d25;TCGA-C8-A135.7045ECC9-72B3-4AD3-A6C6-4F8C6914EAA1.pdf;Negative;NA;Left;NA;YES;NA;NA;NA;NA;Negative;NA;ASIAN;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;C8;1433333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-C8-A137;TCGA-C8-A137-01;34;M0;N1;Stage IIB;6th;T2;NA;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;NA;-12729;102;NA;0;34;4.47;1:Recurred/Progressed;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;4/15/11;2233;NA;NA;NA;NA;NA;NA;NA;3;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;NA;YES;2010;NO;YES;NA;NA;2;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Core needle biopsy;NA;NA;40;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;MDLC;1245;0:LIVING;03ab1e9f-4918-404d-b178-3a4fd929c5e8;69f11430-f6f2-46bd-ba02-f09cec02e168;TCGA-C8-A137.140F8918-739F-498A-9A17-B307E40E6060.pdf;Negative;NA;Left;NA;YES;NA;NA;NA;NA;Negative;NA;ASIAN;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;C8;1333333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-C8-A138;TCGA-C8-A138-01;54;M0;N2;Stage IIIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-20053;93;NA;0;7;12.48;0:DiseaseFree;NA;Allred Score 5;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;4/15/11;3556;NA;NA;NA;NA;NA;NA;NA;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;2010;NO;YES;NA;NA;2;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;NA;41;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;1248;0:LIVING;b6c286c6-2755-419b-87d3-59c7feda9653;f386bdc5-6530-400d-9f82-db2c96449a70;TCGA-C8-A138.3584F6CE-F9ED-441C-8714-BDF67C141CD6.pdf;Negative;NA;Left;NA;YES;NA;NA;NA;NA;Negative;NA;ASIAN;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;C8;1366666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-C8-A1HE;TCGA-C8-A1HE-01;59;M0;N0;Stage IIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;;109;NA;0;0;12.32;0:DiseaseFree;NA;Allred Score 7;NA;Positive;NA;NOT HISPANIC OR LATINO;Patey's Surgery;5/24/11;1178;NA;NA;NA;NA;NA;NA;NA;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;2010;NO;YES;NA;NA;5;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Other method, specify:;Patey's Surgery;NO;45;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;1232;0:LIVING;b26d41cd-393b-4cd4-8925-a9488f7de576;f2eac3ac-cb30-4d6d-a85a-4ea1ad3e7301;TCGA-C8-A1HE.DDB31719-1D2F-4502-B80E-544B684DC16F.pdf;Negative;NA;Right;NA;YES;NA;NA;Allred Score 4;NA;Positive;NA;ASIAN;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Other;C8;15;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-C8-A1HF;TCGA-C8-A1HF-01;48;M0;N0;Stage IIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;;109;NA;0;0;10.91;0:DiseaseFree;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;Patey's Surgery;5/24/11;2475;NA;NA;NA;NA;NA;NA;NA;3;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;NA;YES;2010;NO;YES;NA;NA;12;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Other method, specify:;Patey's Surgery;NO;22;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;1091;0:LIVING;a2453bcb-90f2-4505-949d-a89cf4bfc9b8;f2a49aa7-b756-4eaa-a6fd-00f56c7e7851;TCGA-C8-A1HF.40B07BB9-2CDB-463A-8773-771017E73DBC.pdf;Negative;NA;Left;NA;YES;NA;NA;Allred Score 3;NA;Positive;NA;ASIAN;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Other;C8;733333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-C8-A1HG;TCGA-C8-A1HG-01;50;M0;N0;Stage IIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;;122;NA;0;0;11.33;0:DiseaseFree;NA;Allred Score 8;NA;Positive;NA;NOT HISPANIC OR LATINO;Patey's Surgery;5/24/11;3587;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2010;NO;NO;NA;NA;NA;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Other method, specify:;Patey's Surgery;NO;34;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;1133;0:LIVING;0c23c380-363c-474d-b64c-b47f612a8225;bed56886-f4fe-4917-b32a-18b3d3f47c24;TCGA-C8-A1HG.0813A175-83ED-4F6E-AD7D-FB4135CFF34C.pdf;Negative;NA;Right;NA;YES;NA;NA;Allred Score 7;NA;Positive;NA;ASIAN;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Other;C8;1133333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-C8-A1HI;TCGA-C8-A1HI-01;40;M0;N2;Stage IIIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;;120;NA;0;0;11.27;0:DiseaseFree;NA;Allred Score 8;NA;Positive;NA;NOT HISPANIC OR LATINO;Patey's Surgery;6/1/11;2579;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;Yes;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2010;NO;YES;NA;NA;6;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Other method, specify:;Patey's Surgery;NA;28;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;1127;0:LIVING;444374f8-9282-439c-af00-0f828edcbff3;f0471d79-d107-4809-976e-fe5b231f0e9d;TCGA-C8-A1HI.04EF4A48-80E1-4567-BB61-2B542F715266.pdf;Negative;NA;Right;NA;YES;NA;NA;Allred Score 6;NA;Positive;NA;ASIAN;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Other;C8;933333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-C8-A1HJ;TCGA-C8-A1HJ-01;53;M0;N0;Stage IIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-19629;121;NA;0;5;0.16;0:DiseaseFree;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;Patey's Surgery;6/1/11;5135;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2010;NO;YES;NA;NA;10;NA;Peri (6-12 months since last menstrual period);NA;NA;NO;Tumor resection;NA;NA;99;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;16;0:LIVING;a855c228-a263-44df-87a0-cbc32187e3f5;e11024c2-709d-4e47-a9f3-45894a27f2bb;TCGA-C8-A1HJ.11F98715-1482-4D7D-9102-E362634806A7.pdf;Negative;NA;Right;NA;YES;NA;NA;NA;NA;Negative;NA;ASIAN;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Other;C8;33;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-C8-A1HK;TCGA-C8-A1HK-01;53;M0;N1;Stage IIB;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;;116;NA;0;7;12.02;0:DiseaseFree;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;Patey's Surgery;6/1/11;5180;NA;NA;NA;NA;NA;NA;NA;3;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;NA;YES;2010;NO;YES;NA;NA;8;NA;Peri (6-12 months since last menstrual period);NA;NA;NO;Other method, specify:;Patey's Surgery;NA;48;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;1202;0:LIVING;52c35691-efca-42f5-a03e-02c9f872275c;ca263104-9c70-4b9f-95d1-7a886587eebd;TCGA-C8-A1HK.4D1B4A09-FB4E-45EC-895B-2941D18AED18.pdf;Negative;NA;Right;NA;YES;NA;NA;NA;NA;Negative;NA;ASIAN;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Other;C8;16;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-C8-A1HL;TCGA-C8-A1HL-01;38;M0;N1;Stage IIIA;6th;T3;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;;94;NA;0;2;10.41;0:DiseaseFree;NA;Allred Score 8;NA;Positive;NA;NOT HISPANIC OR LATINO;Patey's Surgery;6/2/11;2376;NA;NA;NA;NA;NA;NA;NA;2;NA;NA;Other, specify;NA;No;Yes;C50.9;1/03/8480;C50.9;Equivocal;NA;YES;2010;NO;YES;NA;NA;9;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Other method, specify:;Patey's Surgery;NA;24;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;BRCA;1041;0:LIVING;a8a199c9-d781-4e6c-af8c-c85d60c7cd40;fa3f34b7-5f69-41f8-9384-42af0260d7ec;TCGA-C8-A1HL.ACA6B606-681C-427F-8923-77BAA7390795.pdf;Negative;NA;Left;NA;YES;NA;NA;NA;NA;Negative;NA;ASIAN;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Other;C8;8;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-C8-A1HM;TCGA-C8-A1HM-01;74;M0;N0;Stage IIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-27063;100;NA;0;6;12.32;0:DiseaseFree;NA;Allred Score 8;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;6/2/11;5116;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2010;NO;NO;NA;NA;NA;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;NA;250;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;1232;0:LIVING;8b525ec6-d24b-49d4-bfcb-b354de4dae7c;e3118dbe-9f93-45b0-81d3-2e64f06b7c74;TCGA-C8-A1HM.4DAF6DB8-5429-4B39-B103-D4317166D05B.pdf;Negative;NA;Left;NA;YES;NA;NA;Allred Score 5;NA;Positive;NA;ASIAN;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;C8;8333333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-C8-A1HN;TCGA-C8-A1HN-01;56;M0;N0;Stage IIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-20712;88;NA;0;2;12.94;0:DiseaseFree;NA;Allred Score 8;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;6/2/11;4360;NA;NA;NA;NA;NA;NA;NA;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;2010;NO;NO;NA;NA;NA;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;NA;38;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;1294;0:LIVING;86a18ae0-dfb1-49c3-b5c4-67ec331d6e40;fc3fe505-f138-426f-87d3-c7ae138be02d;TCGA-C8-A1HN.4C7445ED-B346-4DD7-8AFA-2E95E65364BF.pdf;Negative;NA;Left;NA;YES;NA;NA;Allred Score 3;NA;Positive;NA;ASIAN;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;C8;1266666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-C8-A1HO;TCGA-C8-A1HO-01;34;M0;N3;Stage IIIC;6th;T3;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-12715;52;NA;0;0;12.32;0:DiseaseFree;NA;Allred Score 7;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;7/12/11;3198;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2010;NO;NO;NA;NA;NA;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NA;Tumor resection;NA;NA;23;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;1232;0:LIVING;b3354b72-2637-4edc-9a95-e55801d3ac13;6e7092aa-e92c-4d9b-8ed1-f8c32f39fe80;TCGA-C8-A1HO.24B1FA5C-7D84-4CE5-B094-2358ECE73C10.pdf;Negative;NA;Left Upper Inner Quadrant;NA;YES;NA;NA;Allred Score 5;NA;Positive;NA;ASIAN;NA;NO;1;Primary;Female;Matched;NA;NA;NA;NA;NA;C8;766666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-C8-A26V;TCGA-C8-A26V-01;47;M0;N2;Stage IIIA;6th;T3;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-17468;143;NA;0;9;20.24;0:DiseaseFree;NA;Allred Score 8;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;7/21/11;1835;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2010;NO;NO;NA;NA;NA;NA;Peri (6-12 months since last menstrual period);NA;NA;NA;Other method, specify:;Modified Radical Masectomy;NA;61;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;2024;0:LIVING;89414e79-7f89-42d9-8228-101b5bf2f31f;4a299407-b9dc-4500-b6b1-27a474ab4c4a;TCGA-C8-A26V.929AB6C9-58B0-4E37-A2B4-9FC1F9099437.pdf;Negative;NA;Right;NA;YES;NA;NA;Allred Score 8;NA;Positive;NA;ASIAN;NA;NO;1;Primary;Female;Matched;NA;NA;NA;NA;Modified Radical Mastectomy;C8;2033333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-C8-A26W;TCGA-C8-A26W-01;58;M0;N1;Stage IIB;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-21391;142;NA;0;7;12.52;0:DiseaseFree;NA;Allred Score 8;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;7/21/11;3238;NA;NA;NA;NA;NA;NA;NA;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;2010;NO;NO;NA;NA;NA;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Tumor resection;NA;NA;42;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;1252;0:LIVING;ff0f875f-113a-4c0f-8c0a-4259cd496e6d;317b72a8-0332-4db8-b9d1-9a26d9907a24;TCGA-C8-A26W.0F1DC8BC-5987-4C50-9A34-79FFC1D2BA30.pdf;Negative;NA;Left Upper Outer Quadrant;NA;YES;NA;NA;Allred Score 8;NA;Positive;NA;ASIAN;NA;NO;1;Primary;Female;Matched;NA;NA;NA;NA;Modified Radical Mastectomy;C8;14;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-C8-A26X;TCGA-C8-A26X-01;58;M0;N1;Stage IIA;6th;T1;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-21463;136;NA;0;11;12.35;0:DiseaseFree;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;7/21/11;3564;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2010;NO;NO;NA;NA;NA;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Tumor resection;NA;NA;51;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;1235;0:LIVING;70ab4f23-23c4-409f-a5cc-18a010c3a24e;01aeb34a-75e4-446d-97ae-6e32c47158ad;TCGA-C8-A26X.8C845114-BBC6-45F2-9135-7E8298E24422.pdf;Negative;NA;Right Upper Outer Quadrant;NA;YES;NA;NA;NA;NA;Negative;NA;ASIAN;NA;NO;1;Primary;Female;Matched;NA;NA;NA;NA;Modified Radical Mastectomy;C8;17;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-C8-A26Y;TCGA-C8-A26Y-01;90;M0;N0;Stage IIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-32872;134;NA;0;13;12.94;0:DiseaseFree;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;7/21/11;5880;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2010;NO;NO;NA;NA;NA;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Tumor resection;NA;NA;599;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;1294;0:LIVING;4d51159f-ab2f-40e3-a363-847c3654431e;de71b625-2b73-43a7-9bc0-89d6a13d0d52;TCGA-C8-A26Y.B660432A-A67B-40CC-89F8-80648DB8AE98.pdf;Negative;NA;Left Upper Outer Quadrant;NA;YES;NA;NA;NA;NA;Negative;NA;ASIAN;NA;NO;1;Primary;Female;Matched;NA;NA;NA;NA;Modified Radical Mastectomy;C8;1996666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-C8-A26Z;TCGA-C8-A26Z-01;59;M0;N0;Stage IIA;6th;T2;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;;125;NA;0;4;15.44;0:DiseaseFree;NA;Allred Score 8;NA;Positive;NA;NOT HISPANIC OR LATINO;Patey's Surgery;7/21/11;5299;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2010;NO;NO;NA;NA;NA;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Other method, specify:;Patey's Surgery;NA;42;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;BRCA;1544;0:LIVING;dc11b1c7-1f00-4813-b4b5-ecf776b2eb37;5da663cd-e223-41ec-8b2f-796c141ec677;TCGA-C8-A26Z.5E21E07E-BD5F-4AC7-985A-178416D756E2.pdf;Negative;NA;Right Upper Inner Quadrant;NA;YES;NA;NA;Allred Score 4;NA;Positive;NA;ASIAN;NA;NO;1;Primary;Female;Matched;NA;NA;NA;NA;Other;C8;14;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-C8-A273;TCGA-C8-A273-01;29;M0;N1;Stage IIB;6th;T2;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;;168;NA;0;6;16.85;0:DiseaseFree;NA;Allred Score 8;NA;Positive;NA;NOT HISPANIC OR LATINO;Patey's Surgery;7/21/11;2254;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2010;NO;YES;2;NA;7;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NA;Other method, specify:;Patey's Surgery;NA;21;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;BRCA;1685;0:LIVING;5a5f0f48-2b13-4e78-b130-901b85d9a7f3;4bdb6c69-67b3-406b-9ac6-9cca2c15f52f;TCGA-C8-A273.EAB9E75C-2795-4D83-9806-5019DC14256E.pdf;Negative;NA;Right Upper Inner Quadrant;NA;YES;NA;NA;Allred Score 5;NA;Positive;NA;ASIAN;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Other;C8;7;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-C8-A274;TCGA-C8-A274-01;63;M0;N0;Stage IIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;NA;-23337;163;NA;0;1;16.69;0:DiseaseFree;NA;Allred Score 8;NA;Positive;NA;NOT HISPANIC OR LATINO;Patey's Surgery;7/21/11;4187;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2010;NO;NO;NA;NA;NA;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Other method, specify:;Patey's Surgery;NA;151;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;MDLC;1669;0:LIVING;dbcad60f-86c7-41e3-b0ae-baa39c9f83dd;7a3cd962-7512-4797-864a-cf374b5cb385;TCGA-C8-A274.A7FAA4F2-1846-48CF-9FB5-15E98430F6CE.pdf;Negative;NA;Right;NA;YES;NA;NA;Allred Score 7;NA;Positive;NA;ASIAN;NA;NO;1;Primary;Female;Matched;NA;NA;NA;NA;Other;C8;5033333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-C8-A275;TCGA-C8-A275-01;56;M0;N1;Stage IIA;6th;T1;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-20774;169;NA;0;1;0.03;0:DiseaseFree;NA;NA;NA;NA;NA;NOT HISPANIC OR LATINO;Patey's Surgery;7/21/11;2019;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;2010;NO;NO;NA;NA;NA;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Tumor resection;NA;NA;97;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;3;0:LIVING;ce887e90-0660-4f44-a3a4-b3b894cb7eda;17f2ecdd-59bb-4251-a1b3-2e0a461ea070;TCGA-C8-A275.BDE9E2A9-09E9-49BC-AFBE-BD32916972DC.pdf;Negative;NA;Left Upper Outer Quadrant;NA;YES;NA;NA;NA;NA;NA;NA;ASIAN;NA;NO;1;Primary;Female;Matched;NA;NA;NA;NA;Other;C8;3233333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-C8-A278;TCGA-C8-A278-01;61;M0;N2;Stage IIIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-22598;163;NA;0;9;9.76;0:DiseaseFree;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;Patey's Surgery;7/21/11;1661;NA;NA;NA;NA;NA;NA;NA;3;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;NA;YES;2010;NO;NO;NA;NA;NA;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Other method, specify:;Patey's Surgery;NA;24;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;976;0:LIVING;65077db7-dd59-4362-9d28-d5a9154e9be0;112649f5-133d-4c45-a66f-4fe9a70bd5b7;TCGA-C8-A278.4F3E197A-9731-427C-A2AB-2D506A1C717B.pdf;Negative;NA;Left;NA;YES;NA;NA;NA;NA;Negative;NA;ASIAN;NA;NO;1;Primary;Female;Matched;NA;NA;NA;NA;Other;C8;8;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-C8-A27A;TCGA-C8-A27A-01;48;M0;N1;Stage IIB;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-17779;435;NA;0;371;24.54;0:DiseaseFree;NA;Allred Score 7;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;7/21/11;3008;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2010;NO;NO;NA;NA;NA;NA;Peri (6-12 months since last menstrual period);NA;NA;NA;Tumor resection;NA;NA;19;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;2454;0:LIVING;3b1f7e48-216d-47de-ba79-db350f52bff0;b692cb10-ff2f-456b-a2c0-706b608d4e7e;TCGA-C8-A27A.4CC1413A-5D03-4BE4-91E5-80B578CE7DFA.pdf;Negative;NA;Right Upper Outer Quadrant;NA;YES;NA;NA;NA;NA;Positive;NA;ASIAN;NA;NO;1;Primary;Female;Matched;NA;NA;NA;NA;Modified Radical Mastectomy;C8;633333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-C8-A27B;TCGA-C8-A27B-01;48;M0;N0;Stage IIB;6th;T3;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-17763;93;NA;0;30;14.42;0:DiseaseFree;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;7/21/11;7389;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2011;NO;NO;NA;NA;NA;NA;Peri (6-12 months since last menstrual period);NA;NA;NA;Tumor resection;NA;NA;123;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;1442;0:LIVING;f0d8a1fe-e313-44f1-99cc-b965cbeeff0e;67d804d7-b6a5-4a70-92cd-f93195d928a4;TCGA-C8-A27B.CD43BA31-A5C6-4C0C-AA07-3171332776CC.pdf;Negative;NA;Left;NA;YES;NA;NA;NA;NA;Negative;NA;ASIAN;NA;NO;1;Primary;Female;Matched;NA;NA;NA;NA;Modified Radical Mastectomy;C8;4066666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-C8-A3M7;TCGA-C8-A3M7-01;60;M0;N0;Stage IIIB;7th;T4b;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-22096;401;NA;0;1;33.97;1:Recurred/Progressed;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;3/6/12;1781;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Negative;NA;YES;2010;NO;YES;0;NA;6;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Tumor resection;NA;NO;119;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;ILC;3397;1:DECEASED;959FF069-8A49-4C9B-85C2-5291CAC0ACFF;668220CE-7E03-4CCF-99F9-99127DDF9806;TCGA-C8-A3M7.953ADB1E-77C9-4721-B624-F9CCF040575F.pdf;Negative;NA;Left Upper Inner Quadrant;NA;YES;NA;NA;NA;NA;Negative;NA;ASIAN;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;C8;4;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-C8-A3M8;TCGA-C8-A3M8-01;68;M0;N0;Stage IA;7th;T1c;NA;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;NA;-24877;264;NA;0;7;12.94;0:DiseaseFree;NA;Allred;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;3/6/12;2516;NA;NA;NA;NA;NA;NA;NA;3;NA;Dako;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Positive;NA;YES;2011;NO;YES;NA;NA;NA;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Tumor resection;NA;NO;44;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;MDLC;1294;0:LIVING;C1E704D6-A33B-4891-90BD-992B0040C075;122305ED-CA1E-431F-A332-0AC3409CDED2;TCGA-C8-A3M8.25CD89AC-052F-4B9F-AE1C-B0824A7A5145.pdf;Negative;NA;Right Upper Outer Quadrant;NA;YES;NA;NA;Allred;NA;Positive;NA;ASIAN;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;C8;1466666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-D8-A13Y;TCGA-D8-A13Y-01;52;M0;N0;Stage IA;NA;T1c;manual counting;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-19028;184;NA;0;264;56.77;0:DiseaseFree;NA;10-75%;NA;Positive;70-79%;NOT HISPANIC OR LATINO;NA;2/23/11;9470;NA;NA;NA;NA;NA;NA;NA;1;Hecep Test TM DAKO;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2010;NO;NA;0;NA;6;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NO;59;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;5677;0:LIVING;17f275c1-a0d4-487d-8f02-ea279584b4cd;0dcfd67b-64b2-4333-af18-a2638dd82952;TCGA-D8-A13Y.0CF5DE3C-272C-4127-8047-4359D1278181.pdf;Negative;NA;Right Upper Outer Quadrant;NA;YES;manual counting;NA;10-75%;NA;Positive;70-79%;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;D8;1966666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-D8-A13Z;TCGA-D8-A13Z-01;51;M0;N2a;NA;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-18942;214;NA;0;210;20.86;0:DiseaseFree;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;2/27/11;4986;NA;NA;NA;NA;NA;NA;NA;1;NA;Hercep Test  TM Dako;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2010;NO;YES;9;NA;11;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Fine needle aspiration biopsy;NA;NA;70;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;2086;0:LIVING;5a17dcd9-5ced-4a69-8069-23c7fd0649d1;8caec376-1f90-4802-947f-b893c370f219;TCGA-D8-A13Z.8EFA6C19-2FA1-4F23-AF7B-15681E8E930A.pdf;Negative;NA;Right Lower Outer Quadrant;NA;YES;NA;NA;NA;NA;Negative;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;D8;2333333333;NA;Breast
brca_tcga_pub2015;TCGA-D8-A140;TCGA-D8-A140-01;62;M0;N1a;Stage IIB;7th;T2;manual counting;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-22900;204;NA;0;27;13.24;0:DiseaseFree;NA;>75%;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;2/26/11;2323;NA;NA;NA;NA;NA;NA;NA;3;Hercep Test TM DAKO;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;NA;YES;2010;NO;YES;1;NA;15;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NO;75;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;1324;0:LIVING;2585edbd-3488-4100-a4ab-a161252a31ee;660954c6-51ed-4b74-8eb0-65c282da3971;TCGA-D8-A140.D78476E6-799F-4DED-A219-CBFE2DE3C77B.pdf;Negative;NA;Left Upper Outer Quadrant|Left;NA;YES;manual counting;NA;<10%;NA;Positive;<10%;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;D8;25;NA;Breast
brca_tcga_pub2015;TCGA-D8-A141;TCGA-D8-A141-01;40;M0;N1;NA;7th;T1c;manual counting;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-14626;205;NA;0;113;20.57;0:DiseaseFree;NA;>75%;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;2/27/11;490;NA;NA;NA;NA;NA;NA;NA;1;NA;Hercep Test  TM Dako;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2010;NO;YES;1;NA;15;NA;Indeterminate (neither Pre or Postmenopausal);NA;NA;NA;Fine needle aspiration biopsy;NA;NA;16;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;2057;0:LIVING;42f6f503-4cf6-4a8e-b5fe-b44bccf6b38b;be0c070b-a114-4bae-9409-33f216bbfd4f;TCGA-D8-A141.AA6F84C8-D0B4-446F-A8A7-8CE7F9D07ECF.pdf;Negative;NA;Right;NA;YES;manual counting;NA;>75%;NA;Positive;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;D8;533333333;NA;Breast
brca_tcga_pub2015;TCGA-D8-A142;TCGA-D8-A142-01;74;M0;N0;Stage IIB;7th;T3;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-27313;212;NA;0;61;13.96;0:DiseaseFree;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;2/25/11;5222;NA;NA;NA;NA;NA;Negative;NA;2;NA;FISH;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;2010;NO;YES;0;NA;14;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NO;66;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;1396;0:LIVING;ccb22ecc-6e18-44b8-ad48-6ab51314b16e;530315de-d048-40f6-b0cc-3c7fb9875e46;TCGA-D8-A142.7D2C880F-6897-44A0-9470-5A5B5429A9C0.pdf;Negative;NA;Left Lower Outer Quadrant|Left;NA;YES;NA;NA;NA;NA;Negative;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;D8;22;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-D8-A143;TCGA-D8-A143-01;51;M0;N0;Stage IIA;7th;T2;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-18984;211;NA;0;172;14.16;0:DiseaseFree;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;2/25/11;5356;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2010;NO;YES;0;NA;11;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NO;38;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;BRCA;1416;0:LIVING;1c40b84e-a0e3-429f-a48c-21566cf881c0;1bab00ca-778e-48ac-ac59-ce2b99d84403;TCGA-D8-A143.F8C2F3EF-FA73-4FF8-9A4E-7F557E68D560.pdf;Negative;NA;Left Lower Inner Quadrant;NA;YES;NA;NA;NA;NA;Negative;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;D8;1266666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-D8-A145;TCGA-D8-A145-01;80;M0;N1a;Stage IIA;7th;T1c;manual counting;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-29280;191;NA;0;49;13.47;0:DiseaseFree;NA;>75%;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;2/25/11;845;NA;NA;NA;NA;NA;Negative;NA;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;2010;NO;YES;1;NA;7;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NO;31;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;1347;0:LIVING;4958c36f-1dc7-4f14-9dec-36e14107dbe3;429d3dc6-452e-48fc-9dce-e418317a77d3;TCGA-D8-A145.1D26CB97-536A-4D10-A593-73C3A846BB13.pdf;Negative;NA;Right Upper Inner Quadrant|Right;NA;YES;manual counting;NA;NA;NA;Positive;<10%;WHITE;NA;NO;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Simple Mastectomy;D8;1033333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-D8-A146;TCGA-D8-A146-01;57;MX;N0;Stage IIA;7th;T2;manual counting;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-20861;221;NA;0;344;21.12;0:DiseaseFree;NA;>75%;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;3/30/11;1640;NA;NA;NA;NA;NA;NA;NA;1;DAKO Hercep Test TM;NA;Infiltrating Ductal Carcinoma;NA;Yes;Yes;C50.9;1/03/8500;C50.9;Negative;NA;YES;2010;NO;YES;0;NA;11;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Fine needle aspiration biopsy;NA;NO;29;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;2112;0:LIVING;03da7a65-fa2f-42cb-a709-5fe8736f21d3;e8232960-f69e-4491-9cf0-ed7bdcf20031;TCGA-D8-A146.79749F5D-329A-400D-8511-C4CF479C1FCC.pdf;Negative;NA;Right Upper Outer Quadrant|Right;NA;YES;manual counting;NA;>75%;NA;Positive;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;D8;966666667;NA;Breast
brca_tcga_pub2015;TCGA-D8-A147;TCGA-D8-A147-01;45;M0;N0;NA;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-16736;163;NA;0;2;19.19;0:DiseaseFree;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;2/27/11;5742;NA;NA;NA;NA;NA;NA;NA;NA;Hercep Test  TM Dako;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2010;NO;YES;0;NA;1;NA;Indeterminate (neither Pre or Postmenopausal);NA;NA;NA;Tumor resection;NA;NA;107;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;1919;0:LIVING;fc18d029-9be2-4fa0-9aef-6d647dc55f0b;f984e167-e005-438d-ac04-d4825043b128;TCGA-D8-A147.380639A2-E89C-4495-8168-82120617129F.pdf;Negative;NA;Right Lower Outer Quadrant;NA;YES;NA;NA;NA;NA;Negative;NA;WHITE;NA;NO;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Lumpectomy;D8;3566666667;NA;Breast
brca_tcga_pub2015;TCGA-D8-A1J8;TCGA-D8-A1J8-01;77;M0;N1a;Stage IIB;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-28444;272;NA;0;256;14.16;0:DiseaseFree;NA;NA;NA;Positive;70-79%;NOT HISPANIC OR LATINO;NA;3/23/11;8977;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2010;NO;NA;3;NA;16;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Fine needle aspiration biopsy;NA;NA;604;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;1416;0:LIVING;62d70067-ff77-4f95-8b69-f537abaf74ce;781d285c-5b2a-4d42-b35e-3840d954070b;TCGA-D8-A1J8.E8E799F8-158D-4AEC-8F86-D40F132C071C.pdf;Negative;NA;Right Upper Outer Quadrant;NA;YES;NA;NA;NA;NA;Positive;70-79%;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;D8;2016666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-D8-A1J9;TCGA-D8-A1J9-01;48;M0;N0;Stage IA;7th;T1c;manual counting;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-17879;211;NA;0;248;17.48;0:DiseaseFree;NA;10-75%;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;3/29/11;3573;NA;NA;NA;NA;NA;NA;NA;3;Hecep Test TM DAKO;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;NA;YES;2010;NO;NA;0;NA;6;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Fine needle aspiration biopsy;NA;NA;139;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;1748;0:LIVING;d5e9a403-88ce-40fc-bb85-80cf3f8ff6bc;ed00a16b-6b8e-44e4-998a-ae4dcca5a93c;TCGA-D8-A1J9.D80E9389-AAD8-4EEB-9DE0-5DE57B5E5F6B.pdf;Negative;NA;Left Upper Outer Quadrant;NA;YES;manual counting;NA;0;NA;Negative;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;D8;4633333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-D8-A1JA;TCGA-D8-A1JA-01;60;M0;NX;NA;7th;T4b;manual counting;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-21918;194;NA;0;18;14.16;1:Recurred/Progressed;NA;NA;NA;Negative;<10%;NOT HISPANIC OR LATINO;NA;3/29/11;2448;NA;NA;NA;NA;NA;NA;NA;3;Hecep Test TM DAKO;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;NA;YES;2010;NO;NO;NA;NA;NA;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Other method, specify:;intraoperative examination;NO;770;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;1649;0:LIVING;9ced0c70-c46c-4f98-8f48-840defe4b8b1;4584c7e2-8011-4231-a5e6-26a264f6d1b1;TCGA-D8-A1JA.51A2B7B5-0CDD-427D-BC82-5498810B2641.pdf;Negative;NA;Left Upper Outer Quadrant;NA;YES;manual counting;NA;0;NA;Negative;NA;WHITE;NA;NO;1;Primary;Female;Matched;No axillary staging;NA;NA;NA;Modified Radical Mastectomy;D8;2566666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-D8-A1JB;TCGA-D8-A1JB-01;54;M0;N1a;Stage IIB;7th;T2;manual counting;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;NA;-19822;232;NA;0;365;55.45;0:DiseaseFree;NA;>75%;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;3/29/11;338;NA;NA;NA;not amplified;Path Vysion HER2 DNA Probe Kit;Positive;NA;2;Hecep Test TM DAKO;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;2010;NO;YES;1;NA;8;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Fine needle aspiration biopsy;NA;NO;31;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;MDLC;5545;0:LIVING;dd96a9c7-899c-47cd-a0f9-b149ed07a5d6;940d64bd-8c96-476f-84f9-678d1ed3500f;TCGA-D8-A1JB.27376503-A55C-4905-A885-632440EFCED2.pdf;Negative;NA;Right Upper Outer Quadrant;NA;YES;manual counting;NA;10-75%;NA;Positive;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;D8;1033333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-D8-A1JC;TCGA-D8-A1JC-01;59;M0;N2a;Stage IIIA;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-21898;201;NA;0;178;15.77;0:DiseaseFree;NA;>75%;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;3/29/11;3667;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2010;NO;YES;4;NA;11;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Other method, specify:;intraoperative examination;NO;67;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;1577;0:LIVING;02e6f999-24f2-4ad2-9b92-df3ee2b082e5;3182e60d-be44-4f03-ba0c-431e0c1f1d5e;TCGA-D8-A1JC.B4DB830F-BFA4-47F5-94C7-D95984315866.pdf;Negative;NA;Left Upper Outer Quadrant;NA;YES;NA;NA;>75%;NA;Positive;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;D8;2233333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-D8-A1JD;TCGA-D8-A1JD-01;41;M0;N1a;Stage IIB;7th;T2;manual counting;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-15166;230;NA;0;273;18.13;0:DiseaseFree;NA;>75%;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;3/29/11;4688;NA;NA;NA;NA;NA;NA;NA;1;Hecep Test TM DAKO;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2010;NO;NA;3;0;14;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NA;Core needle biopsy;NA;NA;84;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;1813;0:LIVING;530ad151-703d-4638-851f-0b5111ff318b;50111388-1058-413a-ac2a-3fd4f84091aa;TCGA-D8-A1JD.332880ED-FE4E-4EE4-9E96-0A61BFCCA27E.pdf;Negative;NA;Left Upper Outer Quadrant;NA;YES;manual counting;NA;10-75%;NA;Positive;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;D8;28;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-D8-A1JE;TCGA-D8-A1JE-01;62;M0;N1a;Stage IIA;7th;T1c;manual counting;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-22683;238;NA;0;57;18.89;0:DiseaseFree;NA;>75%;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;3/28/11;6207;NA;NA;NA;NA;NA;NA;NA;1;Hecep Test TM DAKO;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2010;NO;YES;3;NA;10;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Fine needle aspiration biopsy;NA;NO;29;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;1889;0:LIVING;115bc72c-116f-40c1-be9b-e3dd7650efae;0d7511fd-b57f-4bba-abc2-38b24ba4a15a;TCGA-D8-A1JE.746C603E-FB1F-40D7-BEAF-20ACE27D6C21.pdf;Negative;NA;Left Upper Outer Quadrant;NA;YES;manual counting;NA;10-75%;NA;Positive;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;D8;966666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-D8-A1JF;TCGA-D8-A1JF-01;79;M0;N2a;Stage IIIA;7th;T1c;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-29199;203;NA;0;96;12.02;0:DiseaseFree;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;3/28/11;4140;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2010;NO;YES;8;NA;25;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Other method, specify:;intraoperative examination;NO;38;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;1202;0:LIVING;dcd5e079-813a-4c1a-b320-0931468d2bbc;f642ec37-b771-4b55-a133-a54f3b54ac99;TCGA-D8-A1JF.03724E51-8430-414F-B483-2CB92D6A878F.pdf;Negative;NA;Left Upper Outer Quadrant;NA;YES;NA;NA;NA;NA;Negative;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;D8;1233333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-D8-A1JG;TCGA-D8-A1JG-01;62;M0;N0;Stage IIA;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-22878;215;NA;0;187;52.96;0:DiseaseFree;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;3/28/11;2687;NA;NA;NA;not amplified;NA;Negative;NA;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;2010;NO;YES;0;NA;1;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Other method, specify:;intraoperative examination;NO;108;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;5296;0:LIVING;7f2a63e6-64d5-4be1-9814-e8416fc9e688;9bd5963e-d8f4-4eed-b32b-2eedb00db268;TCGA-D8-A1JG.E1907A10-207B-41F1-8B8B-24D5B551BD05.pdf;Negative;NA;Right Upper Outer Quadrant;NA;YES;NA;NA;NA;NA;Negative;NA;WHITE;NA;NO;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Lumpectomy;D8;36;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-D8-A1JH;TCGA-D8-A1JH-01;56;M0;N0;Stage IA;7th;T1c;manual counting;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-20497;263;NA;0;284;13.99;0:DiseaseFree;NA;>75%;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;3/28/11;1;NA;NA;NA;NA;NA;NA;NA;1;Hecep Test TM DAKO;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2010;NO;YES;NA;NA;9;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Fine needle aspiration biopsy;NA;NA;23;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;1399;0:LIVING;4d1bf9e6-5837-4aed-b568-92f014ed5a4b;8d84c9f4-6f19-42a6-9f55-8b4ccafc6117;TCGA-D8-A1JH.49C79E09-2F69-4089-BFB1-53197DA09A46.pdf;Negative;NA;Right Lower Outer Quadrant;NA;YES;manual counting;NA;>75%;NA;Positive;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;D8;766666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-D8-A1JI;TCGA-D8-A1JI-01;54;MX;N1a;Stage IIA;7th;T1c;manual counting;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-20072;226;NA;0;21;18.96;0:DiseaseFree;NA;>75%;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;3/30/11;3900;NA;NA;NA;NA;NA;NA;NA;NA;DAKOHercepTest TM;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2010;NO;YES;2;NA;22;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Fine needle aspiration biopsy;NA;NO;30;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;1896;0:LIVING;baf2afc8-f16c-488f-947c-efc9083c6bef;5a4c0145-86eb-40ae-9983-adb13652a9a2;TCGA-D8-A1JI.EF2DC6FB-F026-4025-B148-DF07194914AB.pdf;Negative;NA;Right Upper Outer Quadrant;NA;YES;manual counting;NA;>75%;NA;Positive;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;D8;1;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-D8-A1JJ;TCGA-D8-A1JJ-01;54;M0;N0;Stage IIA;7th;T2;manual counting;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;NA;-19966;260;NA;0;274;20.07;0:DiseaseFree;NA;>75%;NA;Positive;NA;NOT HISPANIC OR LATINO;breast conserving therapy;3/29/11;4374;NA;NA;NA;NA;NA;NA;NA;1;DAKOHercepTest TM;10-75%;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2010;NO;YES;0;NA;1;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NA;58;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;MDLC;2007;0:LIVING;f7ab565c-83b5-4988-b9be-8a46f65dca8c;ae28fd1e-2445-47ad-8c01-1b47d6396694;TCGA-D8-A1JJ.3F1DA529-4967-462D-8966-E634D66EB3E1.pdf;Negative;NA;Right Upper Inner Quadrant;NA;YES;manual counting;NA;10-75%;NA;Positive;NA;WHITE;NA;NO;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Other;D8;1933333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-D8-A1JK;TCGA-D8-A1JK-01;90;M0;N0;Stage IIA;7th;T2;manual counting;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-32872;261;NA;0;109;20.11;0:DiseaseFree;NA;0;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;3/29/11;4906;NA;NA;NA;NA;NA;NA;NA;1;DAKOHercepTest TM;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2010;NO;YES;0;NA;13;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Fine needle aspiration biopsy;NA;NA;163;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;2011;0:LIVING;56203436-8634-4fd0-96b5-ba6be9d87857;eae4c66c-03a5-4663-a484-a01612602409;TCGA-D8-A1JK.1841FEE0-EC36-4EC4-8B5E-6D340C80735B.pdf;Negative;NA;Left Upper Inner Quadrant|Left Upper Outer Quadrant;NA;YES;manual counting;NA;NA;NA;Positive;<10%;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;D8;5466666667;NA;Breast
brca_tcga_pub2015;TCGA-D8-A1JL;TCGA-D8-A1JL-01;72;M0;N0;Stage IIA;7th;T2;manual counting;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-26484;264;NA;0;265;20.07;0:DiseaseFree;NA;0;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;3/29/11;3656;NA;NA;NA;NA;NA;NA;NA;1;DAKOHercepTest TM;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2010;NO;YES;0;NA;11;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Fine needle aspiration biopsy;NA;NA;88;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;2007;0:LIVING;aa4244a8-0454-4247-a1c3-357fd51746fa;b32287fb-5ff5-4f5f-a9dc-0c0d514351b4;TCGA-D8-A1JL.156DF753-DB3A-4934-9618-1E18CE46C845.pdf;Negative;NA;Left Lower Inner Quadrant;NA;YES;manual counting;NA;0;NA;Negative;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;D8;2933333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-D8-A1JN;TCGA-D8-A1JN-01;80;MX;N3a;Stage IIIC;7th;T3;manual counting;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-29331;273;NA;0;217;20.37;0:DiseaseFree;NA;>75%;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;3/29/11;1263;NA;HER2 amplification - negative;NA;NA;PathVision HER2 DNA Probe Kit;Negative;NA;NA;DAKOHercepTest TM;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Indeterminate;NA;YES;2010;NO;YES;11;NA;13;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Incisional Biopsy;NA;NA;116;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;ILC;2037;0:LIVING;28911b97-42bf-4189-9961-522fc0aeebc6;80265a56-75ca-479d-b92b-4fdaeb18ed17;TCGA-D8-A1JN.021DF0B3-A535-4AD4-9545-1B9A7BC3E1E6.pdf;Negative;NA;Left;NA;YES;manual counting;NA;NA;NA;Positive;<10%;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;D8;3833333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-D8-A1JP;TCGA-D8-A1JP-01;73;M0;N0;Stage IA;7th;T1c;manual counting;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-26862;292;NA;0;167;20.99;0:DiseaseFree;NA;>75%;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;3/29/11;4267;NA;NA;NA;NA;NA;NA;NA;1;DAKOHercepTest TM;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2010;NO;YES;NA;NA;1;Negative;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Fine needle aspiration biopsy;NA;NA;97;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;2099;0:LIVING;752f4773-5a12-4485-a1f6-896e148ddf4d;bdc13064-e554-4a1e-9037-03187bcb3507;TCGA-D8-A1JP.1B61F1C1-8B19-4D9C-B6B9-87EEE350A472.pdf;Negative;NA;Left Upper Inner Quadrant;NA;YES;manual counting;NA;NA;NA;Positive;<10%;WHITE;NA;NO;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;Mastectomy NOS;NA;Lumpectomy;D8;3233333333;NA;Breast
brca_tcga_pub2015;TCGA-D8-A1JS;TCGA-D8-A1JS-01;77;M0;N0;Stage IA;7th;T1c;manual counting;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-28178;212;NA;0;105;12.19;0:DiseaseFree;NA;>75%;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;3/28/11;619;NA;NA;NA;NA;NA;NA;NA;1;Hecep Test TM DAKO;NA;Other, specify;NA;No;No;C50.9;1/03/8503;C50.9;Negative;NA;YES;2010;NO;YES;0;NA;13;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Other method, specify:;intraoperative examination;NO;16;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;BRCA;1219;0:LIVING;0d03055c-186b-418a-b614-e2035757bc3b;aa5103b4-c25d-4ca4-847b-a1ece4c14aff;TCGA-D8-A1JS.0EA57ABF-E3DA-4862-BAB8-A6E36408AC42.pdf;Negative;NA;Right Upper Outer Quadrant;NA;YES;manual counting;NA;>75%;NA;Positive;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Lumpectomy;D8;533333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-D8-A1JT;TCGA-D8-A1JT-01;70;M0;N0;Stage IIA;7th;T2;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-25677;250;NA;0;123;13.3;0:DiseaseFree;NA;NA;NA;Positive;70-79%;NOT HISPANIC OR LATINO;NA;3/28/11;4147;NA;NA;NA;not amplified;NA;Negative;NA;2;NA;NA;Other, specify;NA;No;No;C50.9;1/03/8523;C50.9;Equivocal;NA;YES;2010;NO;YES;0;NA;15;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Fine needle aspiration biopsy;NA;NO;30;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;BRCA;133;0:LIVING;cd781589-3820-45a2-906b-8d60cd02f3ef;f5678056-2dc2-4f1c-87e9-4fba6c78b460;TCGA-D8-A1JT.72AF26A2-FAD0-42FD-A63C-6E8E2597B84E.pdf;Negative;NA;Left Lower Outer Quadrant;NA;YES;NA;NA;NA;NA;Positive;70-79%;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;D8;1;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-D8-A1JU;TCGA-D8-A1JU-01;51;M0;N0;Stage IA;7th;T1c;manual counting;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;NA;-18733;295;NA;0;106;14.68;0:DiseaseFree;NA;>75%;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;3/28/11;1035;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2010;NO;YES;0;NA;1;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NA;9;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;MDLC;1468;0:LIVING;af2a8e2f-2ae1-48bc-bba5-0e2c077c4e48;a56aa062-cc7f-4ceb-96d6-2a6c251fc9b5;TCGA-D8-A1JU.B5074D1A-C617-414F-B349-6096F59E122D.pdf;Negative;NA;Left Upper Outer Quadrant;NA;YES;manual counting;NA;>75%;NA;Positive;NA;WHITE;NA;NO;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Simple Mastectomy;D8;3;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-D8-A1X5;TCGA-D8-A1X5-01;81;MX;N3a;Stage IIIC;7th;T2;manual counting;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;NA;-29734;197;NA;0;171;18.56;0:DiseaseFree;NA;>75%;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;6/9/11;6310;NA;NA;NA;NA;NA;NA;NA;3;Hercep Test  TM Dako;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;NA;YES;2010;NO;YES;14;NA;16;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Fine needle aspiration biopsy;NA;NA;39;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;MDLC;1856;0:LIVING;eb93df3d-9e25-4e4c-9a5d-350f296e5acf;ae5c9a58-e3ae-420f-8f72-1e4ffdd3df24;TCGA-D8-A1X5.449F70F0-DFE1-40F9-879D-43283CFAF525.pdf;Negative;NA;Right Upper Outer Quadrant|Right Lower Inner Quadrant|Right Lower Outer Quadrant;NA;YES;manual counting;NA;10-75%;NA;Positive;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;D8;13;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-D8-A1X6;TCGA-D8-A1X6-01;80;MX;N2a;Stage IIIA;7th;T3;manual counting;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;NA;-29256;173;NA;0;236;17.77;0:DiseaseFree;NA;>75%;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;6/9/11;3619;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2010;NO;YES;5;NA;7;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Fine needle aspiration biopsy;NA;NA;40;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;MDLC;1777;0:LIVING;42e47f3a-dff7-41e4-8f84-146d97e8ab72;63963cdd-909a-47d8-bae5-965aa9d1cb99;TCGA-D8-A1X6.880A4D38-40C5-46C3-8EE7-36539DD64773.pdf;Negative;NA;Left Upper Inner Quadrant|Left Upper Outer Quadrant;NA;YES;manual counting;NA;>75%;NA;Positive;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;D8;13;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-D8-A1X7;TCGA-D8-A1X7-01;40;MX;N0;Stage IIA;7th;T2;manual counting;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-14858;141;NA;0;85;16.72;0:DiseaseFree;NA;>75%;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;6/9/11;853;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Other, specify;NA;No;No;C50.9;1/03/8503;C50.9;Negative;NA;YES;2010;NO;YES;0;NA;3;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Fine needle aspiration biopsy;NA;NA;23;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;BRCA;1672;0:LIVING;cdab777e-62de-4d51-92af-b6eb089c111f;70d8df1b-251c-4b3d-9de8-c20facd4cad8;TCGA-D8-A1X7.D3EA3547-7E53-442E-A957-B2DD7EBAFBB9.pdf;Negative;NA;Right Upper Outer Quadrant;NA;YES;manual counting;NA;>75%;NA;Positive;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Simple Mastectomy;D8;766666667;NA;Breast
brca_tcga_pub2015;TCGA-D8-A1X8;TCGA-D8-A1X8-01;62;M0;N2a;Stage IIIA;7th;T1c;% IHC;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-22995;225;NA;0;272;25.72;0:DiseaseFree;NA;>75%;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;5/16/11;1153;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Negative;NA;YES;2010;NO;YES;9;0;11;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Fine needle aspiration biopsy;NA;NO;20;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;ILC;2572;0:LIVING;8624354c-af25-423c-9c71-48a5dd821097;b4402906-2bfa-4b75-b479-4e660556fbe5;TCGA-D8-A1X8.5F1C3B85-5E5C-428B-8779-3A5878DCE1F2.pdf;Negative;NA;Left Lower Outer Quadrant;NA;YES;%IHC;2+;>75%;4 Point Scale;Indeterminate;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;D8;666666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-D8-A1X9;TCGA-D8-A1X9-01;66;M0;N1a;Stage IIB;7th;T2;% IHC;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-24417;399;NA;0;380;23.88;0:DiseaseFree;NA;>75%;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;5/16/11;2815;NA;NA;NA;not amplified;NA;Negative;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Indeterminate;NA;YES;2010;NO;YES;3;0;23;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;NO;77;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;2388;0:LIVING;34a74805-300c-4773-ab59-2085fcc2e6cc;eee3738e-89d5-41be-8f9d-564e46b4e065;TCGA-D8-A1X9.E69CF3E3-4799-4892-87E9-4291B14A1B9C.pdf;NA;NA;Left Lower Outer Quadrant;NA;YES;%IHC;NA;>75%;NA;Positive;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;D8;26;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-D8-A1XA;TCGA-D8-A1XA-01;64;M0;N0;Stage IA;7th;T1c;% IHC;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;NA;-23387;218;NA;0;274;27.56;0:DiseaseFree;NA;>75%;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;5/18/11;8612;NA;NA;NA;NA;NA;NA;NA;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;2010;NO;YES;0;0;1;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Other method, specify:;intraoperative examination;NO;22;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;MDLC;2756;0:LIVING;739cb132-51e9-41be-8064-311a13da0d74;4068463b-8568-4bdb-8db0-19390ec0c7f8;TCGA-D8-A1XA.9320030D-5E19-4BEE-99DA-366B6762DED1.pdf;Negative;NA;Left Upper Outer Quadrant;NA;YES;%IHC;NA;>75%;NA;Positive;NA;WHITE;NA;NO;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Lumpectomy;D8;766666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-D8-A1XB;TCGA-D8-A1XB-01;62;M0;N1a;Stage IIB;7th;T2;% IHC;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-22976;251;NA;0;201;18.13;0:DiseaseFree;NA;>75%;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;5/16/11;2170;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2010;NO;YES;1;0;10;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;NO;27;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;1813;0:LIVING;d2694b09-7844-4496-865c-5d3d8cd03330;5faa442d-a995-48aa-a52c-a7efe6f56cab;TCGA-D8-A1XB.B7367E27-2A40-4E8F-8975-D5665E6506D9.pdf;Negative;NA;Right Upper Outer Quadrant;NA;YES;%IHC;NA;>75%;NA;Positive;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;D8;9;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-D8-A1XC;TCGA-D8-A1XC-01;85;M0;N1a;Stage IIIB;7th;T4b;% IHC;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-31220;215;NA;0;81;NA;NA;NA;>75%;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;5/16/11;566;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Mucinous Carcinoma;NA;No;No;C50.9;1/03/8480;C50.9;Negative;NA;YES;2010;NO;YES;1;0;20;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Other method, specify:;intraoperative examination;NO;29;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;BRCA;1239;1:DECEASED;ee14e049-b891-4dda-a730-8ce99bd93baf;7fb4bff6-4385-4503-9016-f9b620af3f8c;TCGA-D8-A1XC.E5D2E429-C41C-47E2-96CB-F3B6F412499B.pdf;Negative;NA;Right Upper Inner Quadrant;NA;YES;%IHC;NA;>75%;NA;Positive;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;D8;966666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-D8-A1XF;TCGA-D8-A1XF-01;45;M0;N0;Stage IIA;7th;T2;% IHC;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-16787;170;NA;0;97;15.21;0:DiseaseFree;NA;>75%;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;5/16/11;6723;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2010;NO;YES;0;0;8;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Other method, specify:;intraoperative examination;NO;34;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;1521;0:LIVING;6f6afd31-b5dd-48ab-b18f-6390ba18a5f0;3b675bbd-b18e-4b72-b3c3-30527a9c157a;TCGA-D8-A1XF.FCBB54EB-6FBF-4DC4-B4D5-DB533687FA58.pdf;NA;NA;Left Upper Outer Quadrant;NA;YES;%IHC;NA;>75%;NA;Positive;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;D8;1133333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-D8-A1XG;TCGA-D8-A1XG-01;86;M0;N1a;Stage IIIB;7th;T4b;% IHC;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-31748;169;NA;0;75;14.72;0:DiseaseFree;NA;10-75%;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;5/16/11;1533;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2010;NO;YES;2;0;2;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Other method, specify:;intraoperative examination;YES;25;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;1472;0:LIVING;de531604-bd1a-49df-96c2-6de3ae703f1d;be145e7b-25ee-409a-8c9c-5e17c9b6c5aa;TCGA-D8-A1XG.AA869507-1B46-4812-8EC5-A4E01C588E6E.pdf;Negative;NA;Right Upper Inner Quadrant;NA;YES;NA;NA;NA;NA;Negative;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;D8;833333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-D8-A1XJ;TCGA-D8-A1XJ-01;76;MX;N1a;Stage IIIA;7th;T3;manual counting;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-27967;295;NA;0;352;21.81;0:DiseaseFree;NA;>75%;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;6/9/11;3525;NA;NA;NA;NA;NA;NA;NA;3;Hercep Test  TM Dako;NA;Other, specify;NA;No;No;C50.9;1/03/8523;C50.9;Positive;NA;YES;2010;NO;YES;2;NA;43;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Fine needle aspiration biopsy;NA;NA;70;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;BRCA;2181;0:LIVING;cc510968-fe52-4109-a79f-74f216b48c78;989450c7-cf32-4ed9-a74e-259a9be428ac;TCGA-D8-A1XJ.EEA126DE-A667-4373-9DC5-96B55E4ABF07.pdf;Negative;NA;Left Upper Outer Quadrant|Left Lower Outer Quadrant;NA;YES;manual counting;NA;10-75%;NA;Positive;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;D8;2366666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-D8-A1XK;TCGA-D8-A1XK-01;55;MX;N1a;Stage IIB;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-20092;275;NA;0;326;14.49;0:DiseaseFree;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;6/9/11;6388;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2010;NO;YES;3;NA;18;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Fine needle aspiration biopsy;NA;NA;885;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;1449;0:LIVING;97943d87-fed7-4f14-a0a7-c5bfee64c392;41af42ec-7521-4783-916e-2c982eef0f98;TCGA-D8-A1XK.B3DB4F9E-C91B-4913-93E8-F18FF22CBA7C.pdf;Negative;NA;Left Lower Inner Quadrant;NA;YES;NA;NA;NA;NA;Negative;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;D8;2956666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-D8-A1XL;TCGA-D8-A1XL-01;34;MX;N1a;Stage IIB;7th;T2;manual counting;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-12668;282;NA;0;319;19.91;0:DiseaseFree;NA;>75%;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;6/9/11;5466;NA;NA;NA;NA;NA;Negative;NA;2;HercepTest TM Dako;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;2010;NO;YES;2;NA;13;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Fine needle aspiration biopsy;NA;NA;91;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;1991;0:LIVING;2b19a6b4-7a17-4452-b4aa-6fc18adc0c3c;e5053de2-2a3b-4559-a166-35df5386d644;TCGA-D8-A1XL.762963FB-3D8C-4616-8C8C-0CD3E45FD243.pdf;Negative;NA;Left Upper Outer Quadrant;NA;YES;manual counting;NA;>75%;NA;Positive;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Lumpectomy;D8;3066666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-D8-A1XM;TCGA-D8-A1XM-01;57;M0;N0;Stage IA;7th;T1c;% IHC;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;NA;-21056;189;NA;0;218;17.67;0:DiseaseFree;NA;>75%;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;5/16/11;1667;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2010;NO;YES;0;0;1;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Fine needle aspiration biopsy;NA;NO;42;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;MDLC;1767;0:LIVING;92529232-8504-4541-b7e2-4df8f497c413;086eac10-6ea8-4cc4-a6e5-91f051e50c54;TCGA-D8-A1XM.7E48315C-3717-40DB-8773-71D070AFC47B.pdf;Negative;NA;Right Upper Inner Quadrant;NA;YES;%IHC;NA;>75%;NA;Positive;NA;WHITE;NA;NO;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Lumpectomy;D8;14;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-D8-A1XO;TCGA-D8-A1XO-01;56;M0;N1a;Stage IIB;7th;T2;% IHC;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-20606;193;NA;0;242;55.26;0:DiseaseFree;NA;>75%;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;5/16/11;2323;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Negative;NA;YES;2010;NO;YES;1;0;10;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;NO;12;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;ILC;5526;0:LIVING;6a186809-3422-41d0-83d2-867145830936;633ef184-2257-4cbd-90e8-64e92d91abb2;TCGA-D8-A1XO.9AAB53EC-89A0-4878-BB9D-D96BC56B54C4.pdf;Negative;NA;Left Lower Outer Quadrant;NA;YES;%IHC;NA;>75%;NA;Positive;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;D8;4;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-D8-A1XQ;TCGA-D8-A1XQ-01;69;M0;N0;Stage IIA;7th;T2;% IHC;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-25345;158;NA;0;177;16.39;0:DiseaseFree;NA;0;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;5/16/11;3387;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2010;NO;YES;0;0;7;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;NO;676;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;1639;0:LIVING;3886b4fb-ba22-4a50-b11a-a6893951f170;93324982-7cfa-477c-88a0-b6eef61f6ca2;TCGA-D8-A1XQ.33B6269D-1D59-4184-A786-2BEB73F6D3A8.pdf;Negative;NA;Right Upper Outer Quadrant;NA;YES;NA;NA;NA;NA;Negative;<10%;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;D8;2246666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-D8-A1XR;TCGA-D8-A1XR-01;56;M0;N1a;Stage IIB;7th;T2;% IHC;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-20488;162;NA;0;168;15.83;0:DiseaseFree;NA;>75%;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;5/16/11;2173;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2010;NO;YES;2;0;7;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;NO;21;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;1583;0:LIVING;70f34c5c-3671-44c8-9469-99f9786efec1;a582257d-4bf7-416b-a465-29a3220bc8c3;TCGA-D8-A1XR.D9A0E659-99BC-4704-AC85-E63098BA731D.pdf;Negative;NA;Right Upper Outer Quadrant;NA;YES;%IHC;NA;>75%;NA;Positive;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;D8;7;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-D8-A1XS;TCGA-D8-A1XS-01;48;M0;N3a;Stage IIIC;7th;T2;% IHC;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-17708;164;NA;0;50;16.29;0:DiseaseFree;NA;>75%;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;5/16/11;2212;NA;NA;NA;NA;NA;NA;NA;3;NA;NA;Other, specify;NA;No;No;C50.9;1/03/8507;C50.9;Positive;NA;YES;2010;NO;YES;25;0;28;NA;NA;NA;NA;NO;Core needle biopsy;NA;NO;15;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;BRCA;1629;0:LIVING;1026e0bf-5640-4fa5-b65f-4f11e8e76b18;ef5821f3-677a-4bd3-9d99-d9cdd533cdb5;TCGA-D8-A1XS.6C97C157-05A0-45CE-91E9-3DC8946EFEDE.pdf;Negative;NA;Left Upper Outer Quadrant;NA;YES;%IHC;NA;>75%;NA;Positive;NA;WHITE;NA;NO;1;Primary;Male;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;D8;5;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-D8-A1XT;TCGA-D8-A1XT-01;61;M0;N1a;Stage IIA;7th;T1c;% IHC;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-22448;144;NA;0;193;16.62;0:DiseaseFree;NA;0;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;5/16/11;3942;NA;NA;NA;NA;NA;NA;NA;3;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;NA;YES;2010;NO;YES;3;0;10;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Fine needle aspiration biopsy;NA;NO;39;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;1662;0:LIVING;64975923-d032-4182-8565-59fc37127d8d;b58f47b2-c3ce-49a2-9bd2-f4c2cbda734c;TCGA-D8-A1XT.99050E48-8DFE-4405-B8D8-7649CE2C9CFF.pdf;Negative;NA;Right Upper Outer Quadrant;NA;YES;%IHC;NA;0;NA;Negative;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;D8;13;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-D8-A1XU;TCGA-D8-A1XU-01;56;M0;N0;Stage IA;7th;T1c;% IHC;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-20715;102;NA;0;150;12.98;0:DiseaseFree;NA;>75%;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;5/16/11;9465;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2010;NO;YES;0;0;1;Negative;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;NO;23;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;1298;0:LIVING;332148f5-f070-4c20-8eb1-4d8c0673aa52;4fbe5e67-d18a-48d5-bd88-19a2f4c01c8d;TCGA-D8-A1XU.845F8FCF-CF3C-4CEF-B673-A57DE626939C.pdf;Negative;NA;Left Upper Outer Quadrant;NA;YES;%IHC;NA;10-75%;NA;Positive;NA;WHITE;NA;NO;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Modified Radical Mastectomy;D8;766666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-D8-A1XV;TCGA-D8-A1XV-01;84;M0;N0;Stage IIA;7th;T2;% IHC;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-30830;103;NA;0;147;15.14;0:DiseaseFree;NA;>75%;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;5/16/11;342;NA;NA;NA;not amplified;NA;Negative;NA;2;NA;NA;Mucinous Carcinoma;NA;No;No;C50.9;1/03/8480;C50.9;Equivocal;NA;YES;2010;NO;YES;0;0;1;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Fine needle aspiration biopsy;NA;NO;24;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;BRCA;1514;0:LIVING;87b85935-a058-44ad-8fb6-8511130eaffe;a9d130f4-84e6-4f3c-982f-69971b5b7a46;TCGA-D8-A1XV.D3AC6B8A-CC8F-475C-BD2E-A869BD07D94C.pdf;Negative;NA;Right Lower Inner Quadrant;NA;YES;%IHC;NA;>75%;NA;Positive;NA;WHITE;NA;NO;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Modified Radical Mastectomy;D8;8;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-D8-A1XW;TCGA-D8-A1XW-01;53;M0;N0;Stage IIA;7th;T2;% IHC;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-19478;76;NA;0;118;43;0:DiseaseFree;NA;0;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;5/16/11;3797;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2011;NO;YES;0;0;1;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Fine needle aspiration biopsy;NA;NO;77;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;43;0:LIVING;887b9e5b-99db-44ac-9c30-c0dc6877b41c;48c16c0d-085f-4266-b729-13bfd7aa9dab;TCGA-D8-A1XW.BD71F606-58BC-46B9-8A03-CB25D5BECA96.pdf;Negative;NA;Left Upper Inner Quadrant;NA;YES;NA;NA;NA;NA;Positive;<10%;WHITE;NA;NO;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Modified Radical Mastectomy;D8;2566666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-D8-A1XY;TCGA-D8-A1XY-01;74;MX;N0;Stage IIA;7th;T2;manual counting;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-27106;135;NA;0;81;16.52;0:DiseaseFree;NA;>75%;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;6/9/11;3139;NA;NA;NA;NA;NA;NA;NA;3;HerceptTest TM Dako;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;NA;YES;2010;NO;YES;0;NA;3;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Fine needle aspiration biopsy;NA;NA;33;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;1652;0:LIVING;0130d616-885e-4a6c-9d03-2f17dd692a05;c216cce6-3e13-466e-942d-348f9f803ab2;TCGA-D8-A1XY.9D1EDFE8-FA4E-4F6C-99E9-1FEB12175D6C.pdf;NA;NA;Left Upper Outer Quadrant;NA;YES;manual counting;NA;>75%;NA;Positive;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Simple Mastectomy;D8;11;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-D8-A1XZ;TCGA-D8-A1XZ-01;81;MX;N2a;Stage IIIA;7th;T1c;manual counting;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-29916;98;NA;0;121;15.31;0:DiseaseFree;NA;>75%;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;6/9/11;3560;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2010;NO;YES;6;NA;14;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Fine needle aspiration biopsy;NA;NA;54;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;1531;0:LIVING;2c90d5e3-ac8c-4c86-a06f-42ccc064eb49;eadfbcf9-0058-4021-8dde-7296d441e42f;TCGA-D8-A1XZ.1D6EE39C-DE75-4595-943A-CF53873F96BF.pdf;Negative;NA;Right Lower Inner Quadrant;NA;YES;NA;NA;NA;NA;Negative;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;D8;18;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-D8-A1Y0;TCGA-D8-A1Y0-01;65;MX;N2a;Stage IIIA;7th;T1c;manual counting;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;NA;-24083;104;NA;0;167;15.51;0:DiseaseFree;NA;>75%;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;6/9/11;3854;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2010;NO;YES;9;NA;15;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Incisional Biopsy;NA;NA;57;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;MDLC;1551;0:LIVING;ced2c048-b047-43ff-b0e7-cd7ad480850c;92f1452b-54af-408f-98a8-cd76191f472b;TCGA-D8-A1Y0.53ED4388-8CD2-4925-81A9-9C4792C83566.pdf;NA;NA;Left;NA;YES;manual counting;NA;>75%;NA;Positive;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;D8;19;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-D8-A1Y1;TCGA-D8-A1Y1-01;80;MX;N1a;Stage IIIA;7th;T3;manual counting;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-29474;93;NA;0;116;NA;NA;NA;10-75%;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;6/9/11;5329;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2010;NO;YES;1;NA;22;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Fine needle aspiration biopsy;NA;NA;201;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;992;1:DECEASED;38a631a1-6875-4216-a335-ee93c90a86d6;4c7ed667-0015-48e5-a262-cabd54a35244;TCGA-D8-A1Y1.1B198706-8844-452A-8F5B-8880A239717C.pdf;NA;NA;Left Upper Inner Quadrant|Left Upper Outer Quadrant;NA;YES;manual counting;NA;>75%;NA;Positive;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;D8;6766666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-D8-A1Y2;TCGA-D8-A1Y2-01;71;MX;N0;Stage IIA;7th;T2;manual counting;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-26021;65;NA;0;73;14.22;0:DiseaseFree;NA;>75%;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;6/9/11;3094;NA;NA;NA;NA;NA;Negative;NA;2;Venten;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Indeterminate;NA;YES;2011;NO;YES;0;NA;7;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Fine needle aspiration biopsy;NA;NA;20;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;1422;0:LIVING;c7d7a770-23c0-4310-ab48-1f6152dc2849;4c6bdfb2-3438-4216-b76d-d87c386bfa96;TCGA-D8-A1Y2.4ACD42D6-9520-4DC6-BB40-9187A4D49981.pdf;Negative;NA;Right Lower Outer Quadrant;NA;YES;manual counting;NA;NA;NA;Positive;<10%;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;D8;666666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-D8-A1Y3;TCGA-D8-A1Y3-01;61;MX;N2a;Stage IIIA;7th;T2;manual counting;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-22317;62;NA;0;125;14.13;0:DiseaseFree;NA;>75%;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;6/9/11;6120;NA;NA;NA;NA;NA;Negative;NA;2;Venten;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Indeterminate;NA;YES;2011;NO;YES;5;NA;8;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Fine needle aspiration biopsy;NA;NA;47;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;1413;0:LIVING;632984bd-dc81-42b6-b024-476cfd0bb2ae;9ae58006-9650-4494-991a-6ee217331740;TCGA-D8-A1Y3.E8D4229D-5049-4991-BDE0-AFC2CBC1827E.pdf;Negative;NA;Right Upper Outer Quadrant;NA;YES;manual counting;NA;>75%;NA;Positive;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;D8;1566666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-D8-A27E;TCGA-D8-A27E-01;66;M0;N0;Stage IA;7th;T1c;manual counting;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-24315;204;NA;0;182;17.41;0:DiseaseFree;NA;>75%;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;7/21/11;1;NA;NA;NA;NA;NA;NA;NA;1;Hercep Test  TM Dako;NA;Other, specify;NA;No;No;C50.9;1/03/8523;C50.9;Negative;NA;YES;2010;NO;YES;0;NA;1;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Fine needle aspiration biopsy;NA;NO;9;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;BRCA;1741;0:LIVING;680f23a9-fcce-493e-b908-27c1ad202e4c;0190a751-0a1f-4911-b5dd-26964b7fa5a5;TCGA-D8-A27E.36F6CB19-17FE-47FA-BFCA-3846578C028B.pdf;Negative;NA;Left Upper Inner Quadrant;NA;YES;NA;NA;NA;NA;Positive;<10%;WHITE;NA;NO;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;NA;D8;3;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-D8-A27F;TCGA-D8-A27F-01;40;M0;N0;Stage IIA;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-14731;166;NA;0;106;16.03;0:DiseaseFree;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;7/18/11;6698;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2010;NO;YES;0;0;11;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Other method, specify:;intraoperative examination;NO;48;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;1603;0:LIVING;1549dc64-3dab-43fc-96e9-b07d520957e1;7e9145f7-ccff-4132-b2b7-9b992eebebf4;TCGA-D8-A27F.976C6F9E-DDCB-42F4-BD2C-A4D715396B47.pdf;Negative;NA;Right Upper Outer Quadrant;NA;YES;NA;NA;NA;NA;Negative;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;D8;16;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-D8-A27G;TCGA-D8-A27G-01;75;M0;N0;Stage IIA;7th;T2;manual counting;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-27521;156;NA;0;210;13.44;0:DiseaseFree;NA;>75%;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;7/18/11;1084;NA;NA;NA;not amplified;NA;Negative;NA;2;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Equivocal;NA;YES;2010;NO;YES;0;0;31;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;NO;817;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;ILC;1344;0:LIVING;6f6e7356-3521-4674-8eec-ad01340d4b8e;e11babda-c07c-4406-85ed-0b1d45985017;TCGA-D8-A27G.F8B8EEB1-0603-4181-9BD3-209143024EF8.pdf;Negative;NA;Left Lower Outer Quadrant;NA;YES;manual counting;NA;>75%;NA;Positive;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;D8;2716666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-D8-A27H;TCGA-D8-A27H-01;72;M0;N0;Stage IIA;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-26588;84;NA;0;19;13.04;0:DiseaseFree;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;7/18/11;4824;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2011;NO;YES;NA;NA;1;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Other method, specify:;intraoperative examination;NO;104;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;1304;0:LIVING;0dca98b0-f43e-45b6-9a02-00092c78678c;b7542984-1410-45e6-b936-8333ff902eb4;TCGA-D8-A27H.52D7E980-806C-499D-9DB9-40E1D651D9EB.pdf;Negative;NA;Right Upper Outer Quadrant;NA;YES;NA;NA;NA;NA;Negative;NA;WHITE;NA;NO;1;Primary;Female;Matched;No axillary staging;NA;NA;NA;Modified Radical Mastectomy;D8;35;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-D8-A27I;TCGA-D8-A27I-01;58;M0;N2a;Stage IIIA;7th;T1c;manual counting;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-21327;132;NA;0;186;14.42;0:DiseaseFree;NA;>75%;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;7/18/11;458;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Negative;NA;YES;2010;NO;YES;4;0;10;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;NO;33;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;ILC;1442;0:LIVING;9c55032f-4db7-4026-ae83-8d060dd8e3fe;be694dea-a16a-4841-9588-89bba1b37dc6;TCGA-D8-A27I.FAB622C2-3E45-4E72-AA36-9530BB830993.pdf;Negative;NA;Right Upper Outer Quadrant;NA;YES;manual counting;NA;>75%;NA;Positive;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;D8;11;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-D8-A27K;TCGA-D8-A27K-01;47;M0;N1a;Stage IIB;7th;T2;manual counting;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;NA;-17426;77;NA;0;119;48;0:DiseaseFree;NA;>75%;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;7/18/11;1153;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2011;NO;YES;2;NA;17;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Fine needle aspiration biopsy;NA;NO;23;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;MDLC;48;0:LIVING;7f97971b-2818-4e4b-9c9e-7c0246f9484c;9e163b4c-d624-4c71-9d68-8f002aee6fec;TCGA-D8-A27K.6B2ADF84-5CEA-430A-87DD-5C2EC24C6E90.pdf;Negative;NA;Left Upper Inner Quadrant;NA;YES;manual counting;NA;>75%;NA;Positive;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;D8;766666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-D8-A27L;TCGA-D8-A27L-01;49;M0;N2a;Stage IIIA;7th;T1c;manual counting;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-18025;84;NA;0;126;16.39;0:DiseaseFree;NA;>75%;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;7/18/11;1113;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2011;NO;YES;2;NA;16;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;NO;29;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;1639;0:LIVING;6020d1b4-ee20-4cc9-82a3-340b5e3122f1;29ba933a-c5f0-4637-b741-ee9739f02cd2;TCGA-D8-A27L.1281F503-C256-4DFF-A3BD-BD5E51CE4249.pdf;Negative;NA;Right Upper Inner Quadrant;NA;YES;manual counting;NA;>75%;NA;Positive;NA;WHITE;NA;NO;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Modified Radical Mastectomy;D8;966666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-D8-A27M;TCGA-D8-A27M-01;59;M0;N0;Stage IA;7th;T1c;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-21910;83;NA;0;145;13.47;0:DiseaseFree;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;7/17/11;2982;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2011;NO;YES;NA;NA;1;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Fine needle aspiration biopsy;NA;NO;68;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;1347;0:LIVING;ae65baeb-6b78-492a-8c63-bb7e93e83dc2;d4371446-8326-4e35-9e86-d8a48393efae;TCGA-D8-A27M.85045216-10EC-473C-96A9-268E71D2B566.pdf;Negative;NA;Left Upper Outer Quadrant;NA;YES;NA;NA;NA;NA;Negative;NA;WHITE;NA;NO;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Modified Radical Mastectomy;D8;2266666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-D8-A27N;TCGA-D8-A27N-01;36;M0;N2a;Stage IIIA;7th;T2;manual counting;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-13243;75;NA;0;146;17.05;0:DiseaseFree;NA;>75%;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;7/18/11;2527;NA;NA;NA;NA;NA;NA;NA;3;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;NA;YES;2011;NO;YES;4;0;19;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Core needle biopsy;NA;NO;37;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;1705;0:LIVING;d5be2ab3-f748-480d-954b-385cf01b4c81;4f69c5f3-4e8c-4b71-a5fe-3179412c17e6;TCGA-D8-A27N.69007BC0-E1DF-4E68-BA6A-352F6A12F233.pdf;Negative;NA;Right Upper Outer Quadrant;NA;YES;manual counting;NA;10-75%;NA;Positive;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;D8;1233333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-D8-A27P;TCGA-D8-A27P-01;64;M0;N0;Stage IA;7th;T1c;manual counting;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-23576;37;NA;0;23;1.61;0:DiseaseFree;NA;>75%;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;7/18/11;485;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2011;NO;YES;0;NA;1;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Other method, specify:;intraoperative examination;NO;19;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;161;0:LIVING;c54d5507-bba5-4a1e-8885-3c3b1eed13c1;6fe6d586-3b5d-4cd4-acb8-5691936441b9;TCGA-D8-A27P.ACC0A0E7-218F-4112-AC74-9F5D5A512DD3.pdf;Negative;NA;Right Upper Inner Quadrant;NA;YES;manual counting;NA;>75%;NA;Positive;NA;WHITE;NA;NO;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Modified Radical Mastectomy;D8;633333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-D8-A27R;TCGA-D8-A27R-01;41;M0;N3a;Stage IIIC;7th;T2;manual counting;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;polisomy;-15122;50;NA;0;29;10.09;0:DiseaseFree;NA;>75%;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;7/18/11;3549;NA;NA;NA;not amplified;NA;Negative;NA;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;2011;NO;YES;11;NA;11;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;NO;27;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;1009;0:LIVING;0b23b5fe-6c7e-4297-bc55-f93fcb830ac4;b10e80e2-6ded-42f8-beab-b436e0286be1;TCGA-D8-A27R.5E997487-9A03-4723-B1E6-FA0B557D8FDF.pdf;Negative;NA;Right Upper Outer Quadrant;NA;YES;manual counting;NA;>75%;NA;Positive;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;D8;9;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-D8-A27T;TCGA-D8-A27T-01;53;M0;N3a;Stage IIIC;7th;T2;manual counting;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-19591;68;NA;0;136;13.07;0:DiseaseFree;NA;>75%;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;7/21/11;1924;NA;NA;NA;NA;NA;NA;NA;1;Venten;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Negative;NA;YES;2011;NO;YES;12;NA;12;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;NO;19;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;ILC;1307;0:LIVING;27c1c094-690b-4973-8900-a797ad88f98c;0f6ed829-a59b-48b7-a2ca-3aa9db40e4c2;TCGA-D8-A27T.15237FF6-A56E-4E05-B81D-B87E91B59917.pdf;Negative;NA;Right Upper Outer Quadrant|Right Lower Outer Quadrant;NA;YES;manual counting;NA;>75%;NA;Positive;NA;WHITE;NA;NO;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Simple Mastectomy;D8;633333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-D8-A27V;TCGA-D8-A27V-01;62;M0;N0;Stage IIA;7th;T2;manual counting;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-22958;51;NA;0;73;12.52;0:DiseaseFree;NA;>75%;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;7/21/11;3774;NA;NA;NA;NA;NA;NA;NA;1;Venten;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Negative;NA;YES;2011;NO;YES;0;NA;2;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Fine needle aspiration biopsy;NA;NO;166;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;ILC;1252;0:LIVING;AD6D26AB-6568-40DB-BFB0-394D40E801CF;D32E480B-D1EE-4BAE-AF15-8B5B94C1CC8A;TCGA-D8-A27V.E5011BD1-E1DE-4A47-BF3C-66BA1E0B84DC.pdf;Negative;NA;Right Upper Outer Quadrant|Right Lower Outer Quadrant;NA;YES;NA;NA;NA;NA;Positive;<10%;WHITE;NA;NO;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Simple Mastectomy;D8;5533333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-D8-A27W;TCGA-D8-A27W-01;55;M0;N0;Stage IIIB;7th;T4b;manual counting;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-20173;43;NA;0;15;12.25;0:DiseaseFree;NA;>75%;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;7/21/11;4452;NA;NA;NA;NA;Path Vysion HER2 DNA Probe Kit;Positive;NA;2;Venten;NA;Mucinous Carcinoma;NA;No;No;C50.9;1/03/8480;C50.9;Equivocal;NA;YES;2011;NO;YES;0;NA;12;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Fine needle aspiration biopsy;NA;NO;22;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;BRCA;1225;0:LIVING;bfa3dbc0-361c-400e-8c10-0aca7049fce9;e1c492c0-cf81-445d-8aa2-a8e8068ead1d;TCGA-D8-A27W.292571E3-D500-4337-B435-834B504F3109.pdf;Negative;NA;Right;NA;YES;manual counting;NA;>75%;NA;Positive;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;D8;733333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-D8-A3Z5;TCGA-D8-A3Z5-01;54;M0;N3a;Stage IIIC;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-19846;418;NA;0;441;33.34;0:DiseaseFree;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;7/3/12;1265;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Negative;NA;YES;2011;NO;YES;19;NA;21;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;NO;14;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;ILC;3334;0:LIVING;77E25AE8-82EC-4DEA-8E62-1176F27E47BA;BA0B6F0B-4E90-40B5-A47B-44ED4EB5DDE2;TCGA-D8-A3Z5.B16B3335-492B-471B-AEFE-2350EA558BFC.pdf;Negative;NA;Right;NA;YES;NA;NA;NA;NA;Positive;NA;WHITE;NA;NO;1;Primary;Female;Matched;Other (specify);mastectomy with TLND;NA;NA;Simple Mastectomy;D8;466666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-D8-A3Z6;TCGA-D8-A3Z6-01;56;M0;N3a;Stage IIIC;7th;T3;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-20629;160;NA;0;185;18.5;0:DiseaseFree;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;7/3/12;2634;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Negative;NA;YES;2011;NO;YES;19;NA;22;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;NO;24;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;ILC;185;0:LIVING;A6E5F869-1182-4F81-B4BB-CF55261C8F3F;287B037A-C32A-49F0-BED6-7674D2E26574;TCGA-D8-A3Z6.A8F63D86-37DF-472E-AF29-FB734EAB7E5C.pdf;Negative;NA;Left;NA;YES;NA;NA;NA;NA;Positive;NA;WHITE;NA;NO;1;Primary;Female;Matched;Other (specify);mastectomy with TLND;NA;NA;Modified Radical Mastectomy;D8;8;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-D8-A4Z1;TCGA-D8-A4Z1-01;68;M0;N0;Stage IA;7th;T1c;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-25097;114;NA;0;223;21.65;0:DiseaseFree;NA;NA;NA;Positive;70-79%;NOT HISPANIC OR LATINO;NA;2/1/13;31;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Negative;NA;YES;2012;NO;YES;0;NA;1;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NO;19;NO;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;ILC;2165;0:LIVING;80419545-4E5D-4BAF-8948-F84589B5EF3E;D36BAC7B-872B-44A8-8C7F-8CB850B49603;TCGA-D8-A4Z1.D77DF136-6F63-48B7-8187-6F8F98CC1F44.pdf;Negative;YES;Right|Right Upper Inner Quadrant;NA;YES;NA;NA;NA;NA;Positive;10-19%;WHITE;NO;NO;1;Primary;Female;Matched;No axillary staging;NA;NA;NA;Simple Mastectomy;D8;633333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E2-A105;TCGA-E2-A105-01;79;M0;N0 (i-);Stage IIA;6th;T2;Allred score 3 + 2 = 5;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-28855;1171;NA;0;1163;42.97;0:DiseaseFree;NA;Allred score 5;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;2/11/11;1353;NA;NA;NA;NA;NA;NA;70-79%;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;2007;NO;NA;0;NA;1;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NO;53;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;4297;0:LIVING;b0bcb829-cee0-4247-bb75-093a5bea89ee;daf94b80-d57a-4525-be1d-6ca0f83204e3;TCGA-E2-A105.252A2D12-EC16-459E-8486-7814FF39E6C2.pdf;Negative;NA;Left Upper Inner Quadrant;NA;NO;Allred score 3 + 2 = 5;NA;Allred score 5;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Lumpectomy;E2;1766666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E2-A107;TCGA-E2-A107-01;54;M0;N2a;Stage IIIA;6th;T3;Allred score 5+3=8;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-20065;715;NA;0;763;34.4;0:DiseaseFree;NA;Allred score 8;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;2/11/11;3303;NA;NA;1.2;NA;NA;Negative;NA;2;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Equivocal;NA;YES;2008;NO;NA;4;NA;27;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NO;23;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;ILC;344;0:LIVING;eff2360e-399a-4167-ab2b-798e27bef739;22848a4a-ed0d-4efb-850f-a49f11cd77ec;TCGA-E2-A107.BA87D188-A3B3-4A6F-B3AF-1FEB25B9E357.pdf;Negative;NA;Right Upper Inner Quadrant;NA;NO;Allred score 0+0=0;NA;Allred score 0;NA;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Simple Mastectomy;E2;766666667;WITH TUMOR;Breast
brca_tcga_pub2015;TCGA-E2-A108;TCGA-E2-A108-01;64;M0;N2a;Stage IIIA;6th;T2;Allred score 7 (outside facility);Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-23530;596;NA;0;124;27.5;0:DiseaseFree;NA;Allred score 7 (per outside facility);NA;Positive;NA;NOT HISPANIC OR LATINO;NA;2/11/11;338;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2009;NO;NA;4;NA;27;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NA;69;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;BRCA;275;0:LIVING;4f04bd10-9902-4a23-b15d-4f4409d79499;24e9d23a-1340-4074-9268-ca85896569cf;TCGA-E2-A108.DDBEE56C-F8E8-4A7D-8CF6-E0D63EE53FC4.pdf;Negative;NA;Right Upper Outer Quadrant;NA;NO;Allred score 7 per outside facility report;NA;Allred score 7 per outside facility report;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Lumpectomy;E2;23;NA;Breast
brca_tcga_pub2015;TCGA-E2-A109;TCGA-E2-A109-01;64;M0;N0 (i-);Stage IIA;6th;T2;Allred score 5+3=8;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-23521;1155;NA;0;1172;46.55;0:DiseaseFree;NA;Allred score 8;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;2/11/11;4427;NA;NA;1.46;NA;NA;Negative;50-59%;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;2007;NO;NA;0;NA;6;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NO;70;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;4655;0:LIVING;f0787165-6f58-4d67-b510-928eea2c4882;710eae35-a21d-4939-8414-d2af4ea02fdd;TCGA-E2-A109.089E0FB9-6B45-4E3E-843E-EC98D39863F6.pdf;Negative;NA;Right Upper Outer Quadrant;NA;NO;Allred score 0+0=0;NA;Allred score 0;NA;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Simple Mastectomy;E2;2333333333;NA;Breast
brca_tcga_pub2015;TCGA-E2-A10A;TCGA-E2-A10A-01;41;M0;N0 (i-);Stage IIB;6th;T3;Allred score 4+3=7;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-15085;1096;NA;0;352;3.02;1:Recurred/Progressed;NA;Allred score 7;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;2/11/11;2109;NA;NA;1.21;NA;NA;Negative;40-49%;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;NA;YES;2007;NO;NA;0;0;3;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NA;Core needle biopsy;NA;NO;21;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;4037;0:LIVING;4da7abaf-ac7a-41c0-8033-5780a398545c;0c8615d8-e7a2-465a-8de3-961734941c16;TCGA-E2-A10A.AA1BACC4-0B3D-4E2E-865E-24B570DA4E74.pdf;Negative;NA;Left Upper Outer Quadrant;NA;NO;Allred score 5+3=8;NA;Allred score 8;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Simple Mastectomy;E2;7;WITH TUMOR;Breast
brca_tcga_pub2015;TCGA-E2-A10B;TCGA-E2-A10B-01;67;M0;N1a;Stage IIB;6th;T2;Allred score 5+3= 8;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-24577;1065;NA;0;748;6.41;1:Recurred/Progressed;NA;Allred score 8;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;2/22/11;2365;NA;NA;1.11;NA;NA;Negative;10-19%;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;2007;NO;NA;2;0;28;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NO;36;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;3748;0:LIVING;f801aeed-dc43-49d7-a319-84c8851979d9;5f5cddc0-71d3-4bf4-a67c-66550596cf8d;TCGA-E2-A10B.5DAC95DD-5DA6-475B-AC14-5C79FC2F30A6.pdf;Close;NA;Left Lower Outer Quadrant;NA;NO;Allred score 5+3= 8;NA;Allred score 8;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Lumpectomy;E2;12;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E2-A10C;TCGA-E2-A10C-01;54;M0;N1a;Stage IIB;6th;T2;Allred score 5+3=8;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-19849;995;NA;0;854;40.08;0:DiseaseFree;NA;Allred score 8;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;2/11/11;5337;NA;NA;NA;NA;NA;NA;<10%;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2008;NO;NA;1;NA;13;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NO;290;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;4008;0:LIVING;9ac44381-5d43-4f63-aa3f-7703bfc923c9;afed1e5d-c6c1-4d95-9e57-d82f6a823543;TCGA-E2-A10C.E8A61AAC-BFF5-4341-B051-EDD87515ECDC.pdf;Negative;NA;Left Upper Outer Quadrant;NA;NO;Allred score 3+3=6;NA;Allred score 6;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Lumpectomy;E2;9633333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E2-A10E;TCGA-E2-A10E-01;64;M0;N1a;Stage IIA;6th;T1c;Allred score 5+3=8;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-23684;869;NA;0;418;28.42;0:DiseaseFree;NA;Allred score 8;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;2/11/11;1522;NA;NA;1.07;NA;NA;Negative;40-49%;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;2008;NO;NA;2;NA;21;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NO;20;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;2842;0:LIVING;dc15a8ae-991e-421c-bc70-70e94f79dd17;30ce2884-2ce3-4d6a-b758-17a554d6238c;TCGA-E2-A10E.CFB8EE09-41D3-4A39-A4AE-4CDEC84BB9BC.pdf;Negative;NA;Left;NA;NO;Allred score 3+2=5;NA;Allred score 5;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Simple Mastectomy;E2;666666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E2-A10F;TCGA-E2-A10F-01;47;M0;N0 (i-);Stage IIA;6th;T2;Allred score 5+3=8;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-17257;801;NA;0;360;28.84;0:DiseaseFree;NA;Allred score 8;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;2/11/11;1319;NA;NA;1.05;NA;NA;Negative;20-29%;2;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Equivocal;NA;YES;2008;NO;NA;0;NA;2;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NA;Core needle biopsy;NA;NO;21;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;ILC;2884;0:LIVING;8e159b50-8136-42d4-b9c7-d579a74e4931;2666d91b-06ca-4987-84a1-4002befc4d8a;TCGA-E2-A10F.71C82089-E070-4C7B-B15B-0492DECCB3BF.pdf;Negative;NA;Left Upper Outer Quadrant;NA;NO;Allred score 5+3=8;NA;Allred score 8;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Lumpectomy;E2;7;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E2-A14N;TCGA-E2-A14N-01;37;M0;N1;Stage IIB;6th;T2;Allred score 0+0 = 0;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-13743;1240;NA;0;1350;47.11;0:DiseaseFree;NA;Allred score = 0;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;5/31/11;848;NA;NA;NA;NA;NA;NA;<10%;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2007;NO;YES;1;NA;38;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Tumor resection;NA;NO;56;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;4711;0:LIVING;752ad011-79e0-494f-9868-98bf6feb28f8;caa51a8b-eadc-4d87-b0f8-f6ffc17723b5;TCGA-E2-A14N.C972EC08-E1AE-4FCB-B8A1-15000306CDE7.pdf;Negative;NA;Right Upper Inner Quadrant;NA;NO;Allred score 0+0 = 0;NA;Allred score = 0;NA;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Simple Mastectomy;E2;1866666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E2-A14O;TCGA-E2-A14O-01;76;M0;N1a;Stage IIIA;6th;T3;Allred score 5+3 = 8;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-27837;1064;NA;0;1173;44.65;0:DiseaseFree;NA;Allred score = 8;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;3/31/11;7348;NA;NA;1.65;NA;NA;Negative;50-59%;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;2008;NO;YES;2;NA;18;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Tumor resection;NA;NO;38;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;4465;0:LIVING;fb356957-f620-4d99-b675-1355a1d9f932;565c78a9-ae5b-49ba-b5fa-4c26250e174a;TCGA-E2-A14O.42E9A561-B052-412E-B0FD-563DC097C3C5.pdf;Negative;NA;Left Upper Outer Quadrant;NA;NO;Allred score 5+2 = 7;NA;Allred score = 7;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Modified Radical Mastectomy;E2;1266666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E2-A14P;TCGA-E2-A14P-01;79;M0;N3;Stage IIIC;6th;T2;Allred score 0+0 = 0;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-28923;965;NA;0;487;40.93;0:DiseaseFree;NA;Allred score = 0;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;3/31/11;2736;NA;NA;NA;NA;NA;NA;90-99%;3;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;NA;YES;2008;NO;YES;10;NA;24;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Tumor resection;NA;NO;60;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;4093;0:LIVING;e4fc0909-f284-4471-866d-d8967b6adcbc;58bfe278-a80f-4722-b286-4d966214d244;TCGA-E2-A14P.FD8CDFD9-6DCF-4CE1-9BB1-A7FF568EE53C.pdf;Negative;NA;Right Upper Outer Quadrant;NA;NO;Allred score 0+0 = 0;NA;Allred score = 0;NA;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Lumpectomy;E2;2;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E2-A14Q;TCGA-E2-A14Q-01;50;M0;N1mi;Stage IIB;6th;T2;Allred score 5+3 = 8;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-18507;960;NA;0;974;38.21;0:DiseaseFree;NA;Allred score = 8;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;3/31/11;1835;NA;NA;NA;NA;NA;NA;<10%;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2008;NO;YES;1;NA;7;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Tumor resection;NA;NO;26;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;3821;0:LIVING;303a1d77-a37a-4966-a4a4-9981d99ba1b4;10f2905c-6bac-4050-9327-926c5c4de29f;TCGA-E2-A14Q.42A1A073-69B4-4A66-A998-BE4366E0C89C.pdf;Negative;NA;Left Upper Outer Quadrant;NA;NO;Allred score 5+3 = 8;NA;Allred score = 8;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Lumpectomy;E2;833333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E2-A14R;TCGA-E2-A14R-01;62;M0;N0;Stage IIA;6th;T2;Allred score 0+0 = 0;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-22686;910;NA;0;845;31.9;1:Recurred/Progressed;NA;Allred score = 0;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;4/6/11;7127;NA;NA;NA;NA;NA;NA;<10%;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2008;NO;YES;0;NA;8;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Tumor resection;NA;NO;99;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;3857;0:LIVING;4fba3deb-db94-44b5-a0f2-a575d270779e;26c43e7a-753c-483b-9ec3-7240efce6c4e;TCGA-E2-A14R.0B6DCA80-3108-4D25-B095-3EC704598B23.pdf;Negative;NA;Left;NA;NO;Allred score 0+0 = 0;NA;Allred score = 0;NA;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Lumpectomy;E2;33;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E2-A14S;TCGA-E2-A14S-01;65;M0;N0;Stage I;6th;T1c;Allred score 5+3 = 8;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-23878;827;NA;0;834;33.15;0:DiseaseFree;NA;Allred score = 8;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;4/6/11;2502;NA;NA;1.04;NA;NA;Negative;NA;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;2008;NO;YES;0;NA;2;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Tumor resection;NA;NO;26;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;3315;0:LIVING;c2b104ee-f914-4e79-9e1b-56bf88157472;2b795cb0-4f14-4312-b96b-4adfbf9f4124;TCGA-E2-A14S.810B3936-DFF0-420C-BD6C-8D4990B8F536.pdf;Negative;NA;Left Lower Outer Quadrant;NA;NO;Allred score 4+3 = 7;NA;Allred score = 7;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Lumpectomy;E2;866666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E2-A14T;TCGA-E2-A14T-01;52;M0;N0;Stage IIA;6th;T2;Allred score 5+3 = 8;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-19237;792;NA;0;890;75.92;0:DiseaseFree;NA;Allred score = 8;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;4/6/11;4914;NA;NA;1.29;NA;NA;Negative;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2008;NO;YES;0;NA;7;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Tumor resection;NA;NO;31;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;BRCA;7592;0:LIVING;e0929c47-cff3-4518-a188-8764af01073a;aeea59ad-9570-41c9-9244-348e1c8350fd;TCGA-E2-A14T.6C8B56C1-330B-4116-8B60-7A81A1983277.pdf;Negative;NA;Left Upper Inner Quadrant;NA;NO;Allred score 2+2 = 4;NA;Allred score = 4;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Simple Mastectomy;E2;1033333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E2-A14U;TCGA-E2-A14U-01;74;M0;N0;Stage I;6th;T1c;Allred score 5+3 = 8;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-27389;796;NA;0;838;43.3;0:DiseaseFree;NA;Allred score = 8;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;4/6/11;0;NA;NA;1.04;NA;NA;Negative;40-49%;2;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Equivocal;NA;YES;2008;NO;YES;0;NA;8;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Tumor resection;NA;NO;14;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;ILC;433;0:LIVING;23B7AAEA-1119-4B10-AA1A-0AE255D2F2A6;06239773-A7E3-4262-9B5F-0105E3B1467A;TCGA-E2-A14U.7E0F430B-B96B-49B1-B4C1-88C1F3A855A7.pdf;Negative;NA;Right Upper Outer Quadrant;NA;NO;Allred score 5+3 = 8;NA;Allred score = 8;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;Other (specify);Sentinel lymph node dissection;NA;NA;Lumpectomy;E2;466666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E2-A14V;TCGA-E2-A14V-01;53;M0;N1;Stage IIB;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-19643;722;NA;0;748;34.23;0:DiseaseFree;NA;NA;3 Point Scale;Positive;NA;NOT HISPANIC OR LATINO;NA;4/6/11;3800;NA;NA;NA;NA;NA;NA;90-99%;3;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;NA;YES;2008;NO;YES;3;NA;24;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Tumor resection;NA;NO;70;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;3423;0:LIVING;3144f1fb-4342-4079-bfe8-940da4bfd88e;78910f0b-59f1-4b4b-a7de-a6cf2402a097;TCGA-E2-A14V.DC8FD7C7-A908-4B90-860F-04984244167C.pdf;Negative;NA;Left Lower Inner Quadrant;NA;NO;NA;NA;NA;3 Point Scale;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Lumpectomy;E2;2366666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E2-A14W;TCGA-E2-A14W-01;78;M0;N0;Stage IIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-28664;716;NA;0;834;32;0:DiseaseFree;NA;NA;3 Point Scale;Positive;NA;NOT HISPANIC OR LATINO;NA;4/25/11;3133;NA;NA;NA;NA;NA;Positive;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;2008;NO;YES;0;NA;5;NA;NA;NA;NA;NO;Tumor resection;NA;NO;83;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;32;0:LIVING;eadb0562-2165-4adb-ad58-018e73f82780;b4c869f2-6910-4d41-ae52-b08b378bf681;TCGA-E2-A14W.9ECD3DA1-25A4-4325-9B3B-6D7C12283C37.pdf;Negative;NA;Left Upper Outer Quadrant;NA;NO;NA;NA;NA;3 Point Scale;Positive;NA;WHITE;NA;YES;1;Primary;Male;Matched;Sentinel node biopsy alone;NA;NA;NA;Simple Mastectomy;E2;2766666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E2-A14X;TCGA-E2-A14X-01;55;M0;N2;Stage IIIA;6th;T2;Allred score 0+0 = 0;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-20105;652;NA;0;692;31.93;0:DiseaseFree;NA;Allred score = 0;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;4/6/11;3320;NA;NA;NA;NA;NA;NA;<10%;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2009;NO;YES;5;NA;21;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Tumor resection;NA;NO;23;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;3193;0:LIVING;60df7543-6da5-4c75-943b-5800c1e08234;a7cc9298-d6f1-48ef-a93a-9c75fc0cb800;TCGA-E2-A14X.734305A3-5EC4-4DE4-B263-91A49082F146.pdf;Negative;NA;Right Upper Outer Quadrant;NA;NO;Allred score 0+0 = 0;NA;Allred score = 0;NA;Negative;NA;BLACK OR AFRICAN AMERICAN;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Lumpectomy;E2;766666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E2-A14Y;TCGA-E2-A14Y-01;35;M0;N0;Stage IIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-13004;597;NA;0;688;69.28;0:DiseaseFree;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;4/6/11;2263;NA;NA;NA;NA;NA;Positive;NA;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;2009;NO;YES;0;NA;5;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Tumor resection;NA;NO;27;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;6928;0:LIVING;a0576d44-9add-429b-9eeb-f7b234b7385f;1fa2d526-b5d5-47e0-87d1-6ac17add8a0b;TCGA-E2-A14Y.957AC7B0-D613-4F97-BBBC-930EB95EE2E4.pdf;Negative;NA;Right;NA;NO;NA;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Simple Mastectomy;E2;9;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E2-A14Z;TCGA-E2-A14Z-01;64;M0;N0;Stage I;6th;T1c;Allred score 5+3 = 8;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;NA;-23682;519;NA;0;518;6.18;1:Recurred/Progressed;NA;Allred score = 8;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;4/6/11;4779;NA;NA;NA;NA;NA;NA;<10%;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2009;NO;YES;0;NA;1;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Tumor resection;NA;NO;48;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;MDLC;185;1:DECEASED;d7ce6b79-f7c0-481e-9dbd-6273f01c9786;b9ae712b-823b-4ff8-bd1b-2eab4a2b5790;TCGA-E2-A14Z.750D4149-BD70-4D7C-B915-9694BD1EC760.pdf;Negative;NA;Left Upper Outer Quadrant;NA;NO;Allred score 5+3 = 8;NA;Allred score = 8;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Lumpectomy;E2;16;WITH TUMOR;Breast
brca_tcga_pub2015;TCGA-E2-A150;TCGA-E2-A150-01;48;M0;N0;Stage IIA;6th;T2;Allred score 0+0 = 0;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-17580;506;NA;0;591;63.57;0:DiseaseFree;NA;Allred score = 0;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;4/6/11;6710;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2009;NO;YES;0;NA;2;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Tumor resection;NA;NO;38;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;BRCA;6357;0:LIVING;4ac693e9-10f3-46b3-9d46-df3af7b0d259;209bcf2c-dac4-48e4-b47c-5a4c8e8797b9;TCGA-E2-A150.5173DB84-EE23-4973-A244-4BB1D79325C9.pdf;Negative;NA;Left Upper Outer Quadrant;NA;NO;Allred score 0+0 = 0;NA;Allred score = 0;NA;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Lumpectomy;E2;1266666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E2-A152;TCGA-E2-A152-01;56;M0;N0;Stage I;6th;T1c;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-20705;484;NA;0;588;31.73;1:Recurred/Progressed;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;4/6/11;6421;NA;NA;NA;NA;NA;NA;NA;3;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;NA;YES;2009;NO;YES;0;NA;3;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Tumor resection;NA;NO;101;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;6991;0:LIVING;a8015490-9740-45c9-8bd2-eb6d1beefc2e;0ef32921-bb7a-4055-a6ed-e8ced5f824e4;TCGA-E2-A152.46EE72F9-2F59-413F-8278-7A073760F095.pdf;Negative;NA;Right Upper Inner Quadrant;NA;NO;NA;NA;NA;NA;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Lumpectomy;E2;34;WITH TUMOR;Breast
brca_tcga_pub2015;TCGA-E2-A153;TCGA-E2-A153-01;51;M0;N1a;Stage IIB;6th;T2;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-18875;475;NA;0;586;23.23;0:DiseaseFree;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;4/7/11;1942;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2009;NO;YES;3;NA;15;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Tumor resection;NA;NO;20;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;BRCA;2323;0:LIVING;be9bf36a-12e1-4386-addf-1686dc8b49de;6526e884-ca7a-4f10-9cb8-fe8fa90f1dbb;TCGA-E2-A153.06D417E8-68C2-408C-8ABC-B3042566C976.pdf;Negative;NA;Left;NA;NO;NA;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Modified Radical Mastectomy;E2;666666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E2-A154;TCGA-E2-A154-01;68;M0;N0;Stage I;6th;T1c;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-24999;461;NA;0;325;19.42;0:DiseaseFree;NA;NA;3 Point Scale;Positive;90-99%;NOT HISPANIC OR LATINO;NA;4/7/11;3826;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2009;NO;YES;0;NA;2;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Tumor resection;NA;NO;36;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;1942;0:LIVING;24e39609-9645-43e5-960b-db5446eaea65;093150bc-9ea8-4729-8693-32fe1d9690d2;TCGA-E2-A154.8F8DCA87-B27A-429C-952A-186F8D4502AE.pdf;Negative;NA;Left Upper Outer Quadrant;NA;NO;NA;NA;NA;3 Point Scale;Positive;90-99%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Lumpectomy;E2;12;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E2-A155;TCGA-E2-A155-01;58;M0;N1a;Stage IIB;6th;T2;NA;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;NA;-21348;457;NA;0;553;21.02;0:DiseaseFree;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;4/7/11;2209;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2009;NO;YES;2;NA;15;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Tumor resection;NA;NO;50;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;MDLC;2102;0:LIVING;01f50abf-fc15-446e-9d07-edeecc545a32;6ae685e1-cd02-4c07-839d-0f2507077955;TCGA-E2-A155.C3E398CE-1918-4107-948C-6579B1DA1F77.pdf;Negative;NA;Left Upper Inner Quadrant|Left Lower Inner Quadrant;NA;NO;NA;NA;NA;NA;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;E2;1666666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E2-A156;TCGA-E2-A156-01;61;M0;N0;Stage I;6th;T1c;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-22422;447;NA;0;481;23.85;0:DiseaseFree;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;4/7/11;482;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2009;NO;YES;0;NA;3;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Tumor resection;NA;NO;22;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;2385;0:LIVING;f05d314c-5ec5-4e2a-b785-9a702716f111;9d39f2cf-84b5-45ba-8c40-0a42d8f303b7;TCGA-E2-A156.EF28484E-82C7-4988-A6E0-DDDA555652EA.pdf;Negative;NA;Left;NA;NO;NA;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Lumpectomy;E2;733333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E2-A158;TCGA-E2-A158-01;43;M0;N1mi;Stage IIA;6th;T1c;Allred score 0+0 = 0;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-15903;436;NA;0;450;14.78;0:DiseaseFree;NA;Allred score = 0;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;4/7/11;4764;NA;NA;NA;NA;NA;NA;<10%;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;Yes;C50.9;1/03/8500;C50.9;Negative;NA;YES;2009;NO;YES;1;NA;2;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Tumor resection;NA;NO;74;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;1478;0:LIVING;a6edb6ca-ae9f-4da7-8ebe-92d83d2987fb;5ce91cce-a4ac-45e1-bc3e-737494a67769;TCGA-E2-A158.1CEBF20D-767A-4A19-AA41-B9EAFCF05176.pdf;Negative;NA;Left Upper Inner Quadrant|Left Upper Outer Quadrant;NA;NO;Allred score 0+0 = 0;NA;Allred score = 0;NA;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Simple Mastectomy;E2;2466666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E2-A159;TCGA-E2-A159-01;50;M0;N0;Stage IIA;6th;T2;Allred score 0+0 = 0;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-18621;434;NA;0;515;25.03;0:DiseaseFree;NA;Allred score = 0;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;4/7/11;3468;NA;NA;NA;NA;NA;Negative;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;2009;NO;YES;0;NA;4;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Tumor resection;NA;NO;126;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;2503;0:LIVING;d7308344-5bab-4073-bb4f-4d8cd8d7bd17;601e0a1b-309d-41c2-a7ba-a2282db846fa;TCGA-E2-A159.7CA117DA-5D1C-4F8B-8330-5C58FE05DE36.pdf;Negative;NA;Left Lower Outer Quadrant;NA;NO;Allred score 0+0 = 0;NA;Allred score = 0;NA;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Lumpectomy;E2;42;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E2-A15A;TCGA-E2-A15A-01;45;M0;N3a;Stage IIIC;6th;T2;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-16750;426;NA;0;502;23.32;0:DiseaseFree;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;4/7/11;4767;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2009;NO;YES;13;NA;19;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Tumor resection;NA;NO;40;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;BRCA;2332;0:LIVING;73ccc949-01b7-48d3-a7c4-c4bcd261672a;423305a8-f060-44da-a053-18dd8c2b172e;TCGA-E2-A15A.744919EA-D97A-41A1-B1F3-70A2F972D9A7.pdf;Negative;NA;Left;NA;NO;NA;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Simple Mastectomy;E2;1333333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E2-A15C;TCGA-E2-A15C-01;61;M0;N0;Stage I;6th;T1c;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-22583;393;NA;0;497;22.8;0:DiseaseFree;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;4/13/11;1347;NA;NA;1.02;NA;NA;Negative;20-29%;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;2009;NO;YES;0;NA;4;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Tumor resection;NA;NO;27;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;228;0:LIVING;da840a22-8d30-4682-bbd0-8fa87bd40528;31f45863-c419-4a07-896c-722b9724ce76;TCGA-E2-A15C.04FF2CF1-737B-4FD2-8A1D-F9B5488DE510.pdf;Negative;NA;Right Lower Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Lumpectomy;E2;9;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E2-A15D;TCGA-E2-A15D-01;47;M0;N0;Stage IIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-17224;393;NA;0;316;17.28;0:DiseaseFree;NA;Allred score = 8;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;4/13/11;2234;NA;NA;1.1;NA;NA;Negative;NA;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;2009;NO;YES;0;NA;4;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Tumor resection;NA;NO;29;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;1728;0:LIVING;c85f080a-1075-41df-959f-1b514a11b3c4;6c141702-104f-4ce1-ba82-1add65f07d7f;TCGA-E2-A15D.1FE4EB4C-FEF8-486A-B39D-6F9F023FDAC4.pdf;Negative;NA;Right;NA;NO;NA;NA;Allred score = 8;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Lumpectomy;E2;966666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E2-A15E;TCGA-E2-A15E-01;40;M0;N1a;Stage IIA;6th;T1c;Allred score 5+3 = 8;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-14894;387;NA;0;518;20.7;0:DiseaseFree;NA;Allred score = 8;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;4/25/11;2998;NA;NA;NA;NA;NA;Positive;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;2009;NO;YES;1;NA;9;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Tumor resection;NA;NO;27;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;207;0:LIVING;0a2a3529-f645-4967-9a58-89ee20b8bb62;9992eeb9-901b-4a32-badc-e9be7c9ba4ba;TCGA-E2-A15E.514D4C2E-8215-4770-9FC1-25F988232A85.pdf;Negative;NA;Left;NA;NO;Allred score 5+3 = 8;NA;Allred score = 8;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Lumpectomy;E2;9;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E2-A15F;TCGA-E2-A15F-01;64;M0;N0;Stage I;6th;T1c;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-23660;360;NA;0;469;21.62;0:DiseaseFree;NA;NA;3 Point Scale;Positive;90-99%;NOT HISPANIC OR LATINO;NA;4/13/11;2419;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;3;YES;2009;NO;YES;0;NA;3;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Tumor resection;NA;NO;19;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;2162;0:LIVING;ec77a23d-84f5-47e4-bf2a-fa1c03baf3db;996911f9-c9fe-48d8-aa35-5672610e72fb;TCGA-E2-A15F.19360B66-C514-4EE1-ACD7-08873828133E.pdf;Negative;NA;Left Upper Outer Quadrant;NA;NO;NA;3+;NA;3 Point Scale;Positive;90-99%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Lumpectomy;E2;633333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E2-A15G;TCGA-E2-A15G-01;76;M0;N0;Stage IIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;NA;-28013;358;NA;0;316;18.2;0:DiseaseFree;NA;Allred score = 8;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;4/13/11;763;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Mixed Histology (please specify);Invasive ductal and lobular carcinoma;No;No;C50.9;1/03/8522;C50.9;Negative;NA;YES;2009;NO;YES;0;NA;1;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Tumor resection;NA;NO;44;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;MDLC;182;0:LIVING;271e8024-a008-4bf0-9f6e-177f60096b1b;d6dcbd76-1146-4535-afd6-9a9c0e3c56a9;TCGA-E2-A15G.DD9FDF3B-29CA-4D11-8615-E2EEB5D601D1.pdf;Negative;NA;Left Upper Outer Quadrant;NA;NO;NA;NA;Allred score = 8;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Lumpectomy;E2;1466666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E2-A15H;TCGA-E2-A15H-01;38;M0;N1mi;Stage IIA;6th;T1c;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-13985;357;NA;0;42;12.91;0:DiseaseFree;NA;Allred Score = 7;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;4/13/11;1888;NA;NA;NA;NA;NA;Positive;NA;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;2009;NO;YES;1;NA;4;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Tumor resection;NA;NO;26;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;1291;0:LIVING;5580b21a-2cdb-4777-ad79-6e06654144f5;7cb99442-005b-4611-94f9-03af195ec7e3;TCGA-E2-A15H.E4D1A7DC-62B1-44D8-A747-5A19842C6F69.pdf;Negative;NA;Right Upper Outer Quadrant;NA;NO;NA;NA;Allred score = 8;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Lumpectomy;E2;866666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E2-A15I;TCGA-E2-A15I-01;44;M0;N0;Stage IIA;6th;T2;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-16163;344;NA;0;411;55.58;0:DiseaseFree;NA;NA;3 Point Scale;Positive;90-99%;NOT HISPANIC OR LATINO;NA;4/13/11;1498;NA;NA;1.04;NA;NA;Negative;NA;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;2009;NO;YES;0;NA;4;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Tumor resection;NA;NO;119;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;BRCA;5558;0:LIVING;64089c20-939f-48b4-ae8b-904ad0597145;c2f00c0c-9ad9-4c1d-912c-52eacedcba12;TCGA-E2-A15I.FE41053B-16F4-46B0-B243-571F4D5A1665.pdf;Negative;NA;Left Upper Outer Quadrant|Left Lower Outer Quadrant;NA;NO;NA;NA;NA;3 Point Scale;Positive;90-99%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Simple Mastectomy;E2;4;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E2-A15K;TCGA-E2-A15K-01;58;M0;N1a;Stage IIB;7th;T2;Allred score 5+3 = 8;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-21514;309;NA;0;34;9.03;0:DiseaseFree;NA;Allred score = 8;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;4/13/11;1946;NA;NA;0.9;NA;NA;Negative;10-19%;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;2010;NO;YES;2;NA;17;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Tumor resection;NA;NO;37;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;903;0:LIVING;17c1d42c-cb84-4655-a4cd-b54bae17ecaf;3a36b403-ea38-49f9-9c28-710c5d141164;TCGA-E2-A15K.2BAC50DA-016F-4B5C-B8D1-DE75377EF0C7.pdf;Negative;NA;Right Upper Outer Quadrant;NA;NO;Allred score 2+2 = 4;NA;Allred score = 4;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Lumpectomy;E2;1233333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E2-A15L;TCGA-E2-A15L-01;65;M0;N0;Stage IIA;7th;T2;Allred score 5+3 = 8;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-23845;289;NA;0;331;20.57;0:DiseaseFree;NA;Allred score = 8;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;4/13/11;1145;NA;NA;0.9;NA;NA;Negative;30-39%;2;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Equivocal;NA;YES;2010;NO;YES;0;NA;3;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Tumor resection;NA;NO;31;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;ILC;2057;0:LIVING;37242f5a-25ae-4b1f-9ce6-09ce1dc92539;66cd1bec-0b4d-4212-ab3f-548ffcfa7dd8;TCGA-E2-A15L.C04B3267-9833-44D6-8C3D-45D7F829C38C.pdf;Negative;NA;Right;NA;NO;Allred score 5+3 = 8;NA;Allred score = 8;NA;Positive;NA;BLACK OR AFRICAN AMERICAN;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Simple Mastectomy;E2;1033333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E2-A15M;TCGA-E2-A15M-01;66;M0;N0;Stage IIA;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-24266;287;NA;0;235;NA;NA;NA;Allred score = 8;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;4/14/11;2774;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Negative;NA;YES;2010;NO;YES;0;NA;5;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Tumor resection;NA;NO;59;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;ILC;1104;1:DECEASED;59be60a3-e0f6-4d63-b98c-574ef92428c4;0177791d-d02d-4433-81ae-458a93fdd60f;TCGA-E2-A15M.51601F8B-BA50-42C4-B0C9-B3581F80CD2C.pdf;Negative;NA;Right Lower Outer Quadrant;NA;NO;NA;NA;Allred score = 8;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Lumpectomy;E2;1966666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E2-A15O;TCGA-E2-A15O-01;89;M0;NX;Stage I;7th;T1c;Allred score 5+2 = 7;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-32583;273;NA;0;396;39.75;1:Recurred/Progressed;NA;Allred score = 7;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;4/14/11;2935;NA;NA;0.9;NA;NA;Negative;10-19%;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;Yes;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;2010;NO;NO;NA;NA;NA;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Tumor resection;NA;NO;32;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;5076;0:LIVING;eafa45a4-2fd1-4fa3-860c-9d52ed382b7d;cd17957d-1e5c-4874-8070-890c1d692a0b;TCGA-E2-A15O.AA4B6E2D-7503-4E51-BEA4-632CC994770A.pdf;Negative;NA;Left Upper Inner Quadrant;NA;NO;Allred score 4+3 = 7;NA;Allred score = 7;NA;Positive;NA;BLACK OR AFRICAN AMERICAN;NA;YES;1;Primary;Female;Matched;No axillary staging;NA;NA;NA;Lumpectomy;E2;1066666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E2-A15P;TCGA-E2-A15P-01;61;M0;N0;Stage IA;7th;T1c;Allred score 5+3 = 8;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;NA;-22524;269;NA;0;315;19.55;0:DiseaseFree;NA;Allred score = 8;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;4/14/11;1936;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2010;NO;YES;0;NA;2;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Tumor resection;NA;NO;41;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;MDLC;1955;0:LIVING;a1674d7b-787a-45c4-bf16-1b7d0efce207;62ce9f85-13d7-445b-a32a-11f6001617e4;TCGA-E2-A15P.8C7442C0-540C-4023-BBFA-8482935259A7.pdf;Negative;NA;Right Upper Outer Quadrant;NA;NO;Allred score 2+2 = 4;NA;Allred score = 4;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Lumpectomy;E2;1366666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E2-A15R;TCGA-E2-A15R-01;64;M0;N1a;Stage IIA;7th;T1c;Allred score 5+3 = 8;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;1.9;-23570;247;NA;0;330;56.9;0:DiseaseFree;NA;Allred score = 8;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;4/14/11;3571;NA;NA;1.3;2.4;NA;Negative;NA;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;2010;NO;YES;3;NA;4;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Tumor resection;NA;NO;33;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;MDLC;569;0:LIVING;33b7bf50-53f4-4839-aa83-9665f85671d8;7295d5c2-d7bc-4d35-bdcb-17c4ec5e5de0;TCGA-E2-A15R.0F708C6E-0262-46EE-8ED2-67E791D5C379.pdf;Negative;NA;Right Upper Outer Quadrant;NA;NO;Allred score 2+2 = 4;NA;Allred score = 4;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Lumpectomy;E2;11;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E2-A15S;TCGA-E2-A15S-01;34;M0;N1;Stage IIB;7th;T2;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-12671;247;NA;0;274;14.06;0:DiseaseFree;NA;Allred score = 7;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;4/14/11;4632;NA;NA;NA;NA;NA;Negative;NA;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;2010;NO;YES;1;NA;17;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Tumor resection;NA;NO;41;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;BRCA;1406;0:LIVING;0f7ab21b-1fd0-45e0-9a47-17c4691eb84f;0ac12a02-8fe3-4c1b-a885-848aa924a339;TCGA-E2-A15S.AF740239-D3E2-4C74-844E-0F5AD1A905ED.pdf;Negative;NA;Left Upper Inner Quadrant|Left Upper Outer Quadrant;NA;NO;NA;NA;Allred score = 2;NA;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Simple Mastectomy;E2;1366666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E2-A15T;TCGA-E2-A15T-01;65;M0;N0;Stage IIA;7th;T2;Allred score 5+3 = 8;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-24054;162;NA;0;267;51.35;0:DiseaseFree;NA;Allred score = 8;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;4/14/11;1639;NA;NA;1.3;NA;NA;Negative;NA;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;2010;NO;YES;0;NA;2;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Tumor resection;NA;NO;39;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;BRCA;5135;0:LIVING;e68ebfd4-3688-4caa-9e38-7764f9258c30;2dc5d195-dede-4511-9415-c7bd3070bbd3;TCGA-E2-A15T.8FEBDA40-59FF-4E76-A9B1-F46BAB7C3E4A.pdf;Negative;NA;Left Upper Outer Quadrant;NA;NO;Allred score 2+3 = 5;NA;Allred score = 5;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Simple Mastectomy;E2;13;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E2-A1AZ;TCGA-E2-A1AZ-01;63;M0;N1a;Stage IIB;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-23230;2527;NA;0;1965;76.51;0:DiseaseFree;NA;NA;3 Point Scale;Negative;NA;HISPANIC OR LATINO;NA;4/25/11;2665;NA;NA;0.42;NA;NA;Negative;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Indeterminate;NA;YES;2004;NO;YES;1;NA;3;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Tumor resection;NA;NO;45;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;7651;0:LIVING;89128dba-403f-4a96-bb3b-23ed0d5e2147;758fc615-957e-4bd0-a0c6-bcd23eb7d167;TCGA-E2-A1AZ.4E233F7D-035A-44A0-A5B6-6248357EB7B2.pdf;Negative;NA;Left Upper Inner Quadrant;NA;NO;NA;NA;NA;3 Point Scale;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Lumpectomy;E2;15;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E2-A1B0;TCGA-E2-A1B0-01;50;M0;N2;Stage IIIA;6th;T2;Allred score 0+0 = 0;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-18346;1315;NA;0;1271;53.58;0:DiseaseFree;NA;Allred score = 0;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;4/25/11;2357;NA;NA;NA;NA;NA;NA;90-99%;3;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;NA;YES;2007;NO;YES;6;NA;28;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Tumor resection;NA;NO;31;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;5358;0:LIVING;996bd3f0-d767-4eff-9c82-99fcb5a3006a;06479cfc-c43c-43f5-9d2f-44b3adc45d84;TCGA-E2-A1B0.9C3987A7-D474-4717-8DCE-4AF1AE03ED84.pdf;Negative;NA;Left Upper Outer Quadrant;NA;NO;Allred score 0+0 = 0;NA;Allred score = 0;NA;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Modified Radical Mastectomy;E2;1033333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E2-A1B1;TCGA-E2-A1B1-01;45;M0;N1;Stage IIB;6th;T2;Allred score 3+2 = 5;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-16603;1268;NA;0;1361;87.16;0:DiseaseFree;NA;Allred score = 5;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;4/25/11;269;NA;NA;15.12;NA;NA;Positive;70-79%;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;2007;NO;YES;1;NA;6;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Tumor resection;NA;NO;16;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;BRCA;8716;0:LIVING;8a0ef221-8070-43fc-9d98-def90abe4871;1cb37b69-c0a9-4b5c-baf5-4107d0e029ad;TCGA-E2-A1B1.431AE1CB-9605-45E3-B6C3-5253B24655D6.pdf;Negative;NA;Left Upper Outer Quadrant;NA;NO;Allred score 2+2 = 4;NA;Allred score = 4;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Lumpectomy;E2;533333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E2-A1B4;TCGA-E2-A1B4-01;74;M0;N2a;Stage IIIA;6th;T1c;Allred score 5+3 = 8;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-27241;798;NA;0;911;NA;NA;NA;Allred score = 8;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;4/25/11;302;NA;NA;NA;NA;NA;NA;10-19%;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2008;NO;YES;3;NA;4;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Tumor resection;NA;NO;30;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;3298;1:DECEASED;dbb2da92-99dd-400c-bc05-e87d7273656c;0edb299d-861a-4141-9d5c-132d8c970547;TCGA-E2-A1B4.2F35A09A-7EB3-484C-9738-664C8914C116.pdf;Negative;NA;Left Upper Inner Quadrant;NA;NO;Allred score 5+3 = 8;NA;Allred score = 8;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Lumpectomy;E2;1;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E2-A1B5;TCGA-E2-A1B5-01;46;M0;N0;Stage IIA;6th;T2;Allred score 5+3 = 8;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-17039;783;NA;0;774;32.33;0:DiseaseFree;NA;Allred score = 8;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;4/25/11;291;NA;NA;NA;NA;NA;NA;<10%;NA;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Negative;NA;YES;2008;NO;YES;0;NA;5;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Tumor resection;NA;NO;21;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;ILC;3233;0:LIVING;7241b3d4-31ee-4fd2-a4a5-35a9d5f37d6a;5b01ed81-2119-4797-9be9-67bc21abc7d9;TCGA-E2-A1B5.EDD254CA-0EC6-42F8-B213-C2D386AB11F4.pdf;Negative;NA;Left;NA;NO;Allred score 2+3 = 5;NA;Allred score = 5;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Lumpectomy;E2;7;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E2-A1B6;TCGA-E2-A1B6-01;44;M0;N0;Stage IIA;6th;T2;Allred score 0+0 = 0;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-16370;729;NA;0;338;28.48;0:DiseaseFree;NA;Allred score = 0;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;4/25/11;2;NA;NA;1.03;NA;NA;Negative;10-19%;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;2008;NO;YES;0;NA;5;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Tumor resection;NA;NO;17;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;2848;0:LIVING;e0b1bcd2-1139-44b9-98b3-67bcf92bcc39;402aa07d-b3c1-48a6-bf27-36917a30c33d;TCGA-E2-A1B6.539FF792-534D-401D-87A6-B3B7C2BC2EFC.pdf;Negative;NA;Left;NA;NO;Allred score 0+0 = 0;NA;Allred score = 0;NA;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Simple Mastectomy;E2;566666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E2-A1BC;TCGA-E2-A1BC-01;63;M0;N0;Stage IA;7th;T1c;NA;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;NA;-23168;275;NA;0;297;16.46;0:DiseaseFree;NA;NA;3 Point Scale;Positive;NA;NA;NA;4/25/11;1381;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;Yes;C50.9;1/03/8524;C50.9;Negative;NA;YES;2010;NO;YES;0;NA;4;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Tumor resection;NA;NO;28;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;MDLC;1646;0:LIVING;d8492ebd-3d94-4a4b-8de7-386526691cc2;83ec5738-3a27-4100-83f2-8b30ae3b2fb7;TCGA-E2-A1BC.817D4725-01FE-4148-A8FC-3431F28D5CD8.pdf;Positive;NA;Right;NA;NO;NA;NA;NA;3 Point Scale;Positive;NA;NA;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Simple Mastectomy;E2;933333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E2-A1BD;TCGA-E2-A1BD-01;53;M0;N0;Stage IIA;7th;T2;Allred score 5+3 = 8;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-19627;260;NA;0;317;37.22;0:DiseaseFree;NA;Allred score = 8;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;4/25/11;4632;NA;NA;1;NA;NA;Negative;10-19%;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;2010;NO;YES;0;NA;1;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Tumor resection;NA;NO;32;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;3722;0:LIVING;0e1d0d46-7a7b-4538-95dd-b9fc20a15aec;1ddc4c86-029f-49b5-893c-a218240d3fa4;TCGA-E2-A1BD.DF746E32-AD2F-49CB-9AA6-4F8494C16B20.pdf;Negative;NA;Right Upper Outer Quadrant;NA;NO;Allred score 5+3 = 8;NA;Allred score = 8;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Lumpectomy;E2;1066666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E2-A1IE;TCGA-E2-A1IE-01;61;M0;N1;Stage IIB;6th;T2;allred score 5 + 3 = 8;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-22510;938;NA;0;983;59.46;1:Recurred/Progressed;NA;allred score = 8;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;4/26/11;2631;NA;NA;1.05;NA;NA;Negative;20-29%;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;2008;NO;YES;1;NA;3;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Tumor resection;NA;NO;25;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;776;0:LIVING;2d0d7ff4-7866-4ae1-9cf1-a3c7f4cbe48d;6bbd477d-699c-4988-a27b-0c3233b595eb;TCGA-E2-A1IE.95443906-A63B-4E07-8C4A-ED0A918B88F8.pdf;Negative;NA;Right;NA;NO;allred score 3 + 3 = 6;NA;allred score = 6;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Lumpectomy;E2;866666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E2-A1IF;TCGA-E2-A1IF-01;74;M0;N0;Stage I;6th;T1c;allred score 5+3=8;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-27341;932;NA;0;956;37.39;0:DiseaseFree;NA;allred scrore = 8;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;4/28/11;1180;NA;NA;NA;NA;NA;NA;<10%;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2008;NO;YES;0;NA;4;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Tumor resection;NA;NO;20;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;3739;0:LIVING;718db047-9f32-48c4-98c9-515218441bca;5b62628a-b301-4d60-9213-396e3fc5a3ed;TCGA-E2-A1IF.9E2EF2C8-A60D-443D-99B6-205B7053175A.pdf;Negative;NA;Left Upper Outer Quadrant;NA;NO;allred score 4+2=6;NA;allred score = 6;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Lumpectomy;E2;666666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E2-A1IG;TCGA-E2-A1IG-01;45;M0;N1mi;Stage IIB;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-16757;679;NA;0;755;70.3;0:DiseaseFree;NA;NA;3 Point Scale;Positive;NA;NOT HISPANIC OR LATINO;NA;4/28/11;1263;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2009;NO;YES;1;NA;3;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Tumor resection;NA;NO;36;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;703;0:LIVING;bc0bc70f-c6cf-4dbc-9dc3-8b7bc5f381a4;5e429dd7-787c-4e7d-b672-b000b7b57929;TCGA-E2-A1IG.ECD02213-B048-4776-B09B-982FE1260F80.pdf;Negative;NA;Right Upper Inner Quadrant;NA;NO;NA;NA;NA;3 Point Scale;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Simple Mastectomy;E2;12;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E2-A1IH;TCGA-E2-A1IH-01;80;M0;N0;Stage I;6th;T1c;allred score 5+3=8;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-29444;883;NA;0;658;33.71;0:DiseaseFree;NA;allred score = 8;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;4/28/11;3813;NA;NA;NA;NA;NA;NA;20-29%;2;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Equivocal;NA;YES;2008;NO;YES;0;NA;2;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Tumor resection;NA;NO;54;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;ILC;3371;0:LIVING;ec0155ab-1b14-498d-8fa9-9f63e3ccb990;118fd65d-0b94-4663-a2a3-1f53b278711b;TCGA-E2-A1IH.12DAEBF2-CDBF-4D90-9C74-2A2AEF1E8433.pdf;Negative;NA;Right Upper Inner Quadrant;NA;NO;allred score 5+3+8;NA;allred score = 8;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Lumpectomy;E2;18;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E2-A1II;TCGA-E2-A1II-01;51;M0;N0;Stage I;6th;T1c;allred score 0 + 0 = 0;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-18788;854;NA;0;850;33.67;0:DiseaseFree;NA;allred score = 0;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;4/28/11;5139;NA;NA;NA;NA;NA;NA;<10%;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2008;NO;YES;0;NA;5;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Tumor resection;NA;NO;23;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;3367;0:LIVING;0fe1419e-a005-407c-8ae7-15c4c1579539;e70a8d1b-f29d-412f-8c90-85862a2b75ad;TCGA-E2-A1II.4F2A288E-8162-4579-BCD2-0FF31B0EEB3C.pdf;Negative;NA;Left;NA;NO;allred score 2+2 = 4;NA;allred score = 4;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Lumpectomy;E2;766666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E2-A1IJ;TCGA-E2-A1IJ-01;57;M0;N0;Stage I;6th;T1c;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-20956;707;NA;0;725;28.42;0:DiseaseFree;NA;NA;3 Point Scale;Positive;90-99%;NOT HISPANIC OR LATINO;NA;4/29/11;1163;NA;NA;1.2;NA;NA;Negative;NA;2;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Equivocal;NA;YES;2009;NO;YES;0;NA;3;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Tumor resection;NA;NO;16;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;ILC;2842;0:LIVING;b09643c2-ded5-4346-b3c5-90a48f88a02e;0c61c676-2a72-4dbe-8dcb-284bd112570c;TCGA-E2-A1IJ.35F7D0D1-BA21-4135-B444-6B10EAF66F25.pdf;Negative;NA;Right Upper Outer Quadrant;NA;NO;NA;NA;NA;3 Point Scale;Positive;90-99%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Lumpectomy;E2;533333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E2-A1IK;TCGA-E2-A1IK-01;71;M0;N1mi;Stage IIA;6th;T1c;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-26052;423;NA;0;519;59.13;0:DiseaseFree;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;5/17/11;0;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2009;NO;YES;1;NA;6;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Tumor resection;NA;NO;14;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;BRCA;5913;0:LIVING;becedbfd-b2aa-4dde-b7f4-29e6f59ec32c;e2da00f3-fdb9-4ab4-964a-6828568e2e6e;TCGA-E2-A1IK.FE54D4DC-C35E-44D2-B8B5-0B631AE0F89D.pdf;Negative;NA;Left;NA;NO;NA;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Lumpectomy;E2;466666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E2-A1IL;TCGA-E2-A1IL-01;78;M0;N1a;Stage IIA;6th;T1c;allred score 5+3=8;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-28495;417;NA;0;14;3.88;0:DiseaseFree;NA;allred score = 8;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;4/29/11;1685;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Negative;NA;YES;2009;NO;YES;1;NA;4;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Tumor resection;NA;NO;18;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;ILC;388;0:LIVING;b63391a0-73f8-4544-9e94-f6529245ca2a;a63690bb-5761-47d7-854e-7be44d9b0b3a;TCGA-E2-A1IL.E0CCE6AD-38A6-446C-ACF7-358C1DFC59F8.pdf;Negative;NA;Left Upper Outer Quadrant;NA;NO;allred score 4 + 3 = 7;NA;allred score = 7;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Lumpectomy;E2;6;NA;Breast
brca_tcga_pub2015;TCGA-E2-A1IN;TCGA-E2-A1IN-01;60;M0;N0;Stage I;7th;T1c;allred score 5+3=8;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-22199;368;NA;0;392;22.17;0:DiseaseFree;NA;allred score = 8;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;4/29/11;4490;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2010;NO;YES;0;NA;2;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Tumor resection;NA;NO;156;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;2217;0:LIVING;f43d622f-eed5-4933-adc6-ae9ad1e33028;24153fe0-2c47-456a-b344-874a0e28de4d;TCGA-E2-A1IN.CC0B1145-B242-45BD-A946-B14BA5A9E923.pdf;Negative;NA;Right;NA;NO;allred score 5+3+8;NA;allred score = 8;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Lumpectomy;E2;52;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E2-A1IO;TCGA-E2-A1IO-01;37;M0;N0;Stage I;6th;T1c;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-13671;416;NA;0;498;60.94;0:DiseaseFree;NA;NA;3 Point Scale;Positive;NA;NOT HISPANIC OR LATINO;NA;4/29/11;4112;NA;NA;1.1;NA;NA;Negative;30-39%;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;2009;NO;YES;0;NA;1;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Core needle biopsy;NA;NO;14;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;6094;0:LIVING;71fc8941-4cfb-47ea-a533-873d38f8c95c;de6d4267-c1cb-4761-a539-5f83368735af;TCGA-E2-A1IO.A9D36308-DAEF-48B9-A4EC-6B9B24EE3DC2.pdf;Negative;NA;Right;NA;NO;NA;NA;NA;3 Point Scale;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Lumpectomy;E2;466666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E2-A1IU;TCGA-E2-A1IU-01;60;M0;N0 (mol+);Stage IA;7th;T1c;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-22279;136;NA;0;127;11.07;0:DiseaseFree;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;4/29/11;515;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2010;NO;YES;0;NA;11;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Tumor resection;NA;NO;18;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;1107;0:LIVING;001cef41-ff86-4d3f-a140-a647ac4b10a1;92058c44-a484-4e08-b1fe-dfe2f03a0aa1;TCGA-E2-A1IU.ACE20EC5-2822-4F50-949E-E194C59F0FCD.pdf;Negative;NA;Right Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Simple Mastectomy;E2;633333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E2-A1L6;TCGA-E2-A1L6-01;44;M0;N1mi;Stage IIA;6th;T1c;allred score 5 + 3 = 8;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-16403;1325;NA;0;1312;54.14;0:DiseaseFree;NA;allred score = 8;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;6/7/11;1288;NA;NA;NA;NA;NA;NA;40-49%;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2007;NO;YES;1;NA;6;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Tumor resection;NA;NO;19;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;BRCA;5414;0:LIVING;2e32f31f-9817-4935-b259-96c59936ee33;5854b639-f677-4ee3-9d68-61b1cdd5a647;TCGA-E2-A1L6.F23523C7-B6E9-4205-BD36-D76E9EE9C453.pdf;Negative;NA;Left Upper Outer Quadrant;NA;NO;allred score 5 + 3 = 8;NA;allred score =  8;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Simple Mastectomy;E2;633333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E2-A1L7;TCGA-E2-A1L7-01;40;M0;N2;Stage IIIA;6th;T2;Allred score 1+1 = 2;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-14854;548;NA;0;633;53.19;1:Recurred/Progressed;NA;Allred score = 2;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;6/1/11;4586;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2009;NO;YES;7;NA;20;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Tumor resection;NA;NO;65;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;6032;0:LIVING;791c5768-f0f5-4ab6-86eb-998e5c4b49e3;09b414c4-a314-43c5-823a-d91442b6b02b;TCGA-E2-A1L7.E78526AB-D72D-4407-B7E1-2255BB5B2F68.pdf;Negative;NA;Right Upper Outer Quadrant;NA;NO;Allred score 0+0 = 0;NA;Allred score = 0;NA;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;E2;2166666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E2-A1L8;TCGA-E2-A1L8-01;52;M0;N1a;Stage IIB;6th;T2;allred score 5 + 3 = 8;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-19187;912;NA;0;1015;73.59;0:DiseaseFree;NA;allred score = 8;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;6/7/11;1645;NA;NA;1.1;NA;NA;Negative;40-49%;2;NA;NA;Infiltrating Lobular Carcinoma;NA;No;Yes;C50.9;1/03/8520;C50.9;Equivocal;NA;YES;2008;NO;YES;2;NA;13;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Tumor resection;NA;NO;25;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;ILC;7359;0:LIVING;eebad74f-5961-4e91-b0eb-157a2f6f952b;91657171-7e5e-4a81-9201-d0b2d5806c04;TCGA-E2-A1L8.9AA68C63-2C14-430A-85C0-5A92F7FCCD36.pdf;Negative;NA;Left Upper Outer Quadrant;NA;NO;allred score 4 + 3 = 7;NA;allred score = 7;NA;Positive;NA;BLACK OR AFRICAN AMERICAN;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Simple Mastectomy;E2;833333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E2-A1L9;TCGA-E2-A1L9-01;40;M0;N1mi;Stage IIA;6th;T1c;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-14868;465;NA;0;388;19.65;0:DiseaseFree;NA;allred score = 7;3 Point Scale;Positive;80-89%;NOT HISPANIC OR LATINO;NA;6/7/11;944;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2009;NO;YES;1;NA;2;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Tumor resection;NA;NO;20;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;1965;0:LIVING;5ea18514-51ad-4844-abea-15e82f0b10c9;644c9a14-09da-4382-a6d1-dce67f25a4ff;TCGA-E2-A1L9.97B6C43B-4C7D-49FC-BA49-00D2DF41827D.pdf;Negative;NA;Right;NA;NO;NA;NA;allred score = 7;3 Point Scale;Positive;80-89%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Lumpectomy;E2;666666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E2-A1LA;TCGA-E2-A1LA-01;59;M0;N1a;Stage IIA;6th;T1c;allred score 5 + 3 = 8;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-21773;581;NA;0;463;24.57;0:DiseaseFree;NA;allred score = 8;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;6/1/11;3391;NA;NA;1.15;NA;NA;Negative;NA;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;2009;NO;YES;1;NA;35;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Tumor resection;NA;NO;68;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;2457;0:LIVING;ce9e0309-9756-42d2-ae94-d91264a79498;cef6023a-2fbf-44ee-a9b3-df78707bd85a;TCGA-E2-A1LA.8F401B38-8D91-4F75-ADE5-52521EAA7DFE.pdf;Negative;NA;Right Upper Inner Quadrant;NA;NO;allred score 5 +3 = 8;NA;allred score = 8;NA;Positive;NA;NA;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Simple Mastectomy;E2;2266666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E2-A1LB;TCGA-E2-A1LB-01;41;M0;N1;Stage IIB;6th;T2;Allred score 0+0 = 0;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-15283;909;NA;0;972;75.76;0:DiseaseFree;NA;Allred score = 0;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;6/7/11;1072;NA;NA;NA;NA;NA;NA;90-99%;3;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;NA;YES;2008;NO;YES;2;NA;25;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Tumor resection;NA;NO;35;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;7576;0:LIVING;fa176764-a76f-44c7-b97a-cd6d21e052be;26f9a1ab-fa60-47f3-ac29-96acaa68fb4a;TCGA-E2-A1LB.A868EC86-9CB6-445E-B961-5D4C57263548.pdf;Negative;NA;Right Upper Outer Quadrant;NA;NO;Allred score 0+0 = 0;NA;Allred score = 0;NA;Negative;NA;BLACK OR AFRICAN AMERICAN;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Lumpectomy;E2;1166666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E2-A1LE;TCGA-E2-A1LE-01;71;M0;N3a;Stage IIIC;6th;T2;Allred score 0+0 = 0;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-26239;986;879;0;NA;11.86;1:Recurred/Progressed;NA;Allred score = 0;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;6/7/11;4304;NA;NA;NA;NA;NA;NA;90-99%;3;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;NA;YES;2008;NO;YES;27;NA;28;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Tumor resection;NA;NO;62;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;2888;1:DECEASED;7317E605-93BA-49A9-8743-20613B02767A;CA3A64DA-CEBC-4451-AD48-5FDB6B9C26CC;TCGA-E2-A1LE.42E3E8C1-D18A-4457-B2F0-FE49F4C027D7.pdf;Negative;NA;Right Upper Inner Quadrant|Right Lower Inner Quadrant;NA;NO;Allred score 0+0 = 0;NA;Allred score = 0;NA;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Simple Mastectomy;E2;2066666667;WITH TUMOR;Breast
brca_tcga_pub2015;TCGA-E2-A1LG;TCGA-E2-A1LG-01;50;M0;N0;Stage IIA;7th;T2;Allred score 0+0 = 0;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-18492;252;NA;0;350;50.03;0:DiseaseFree;NA;Allred score = 0;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;6/3/11;5605;NA;NA;1.1;NA;NA;Negative;60-69%;2;NA;NA;Infiltrating Lobular Carcinoma;NA;No;Yes;C50.9;1/03/8520;C50.9;Equivocal;NA;YES;2010;NO;YES;0;NA;19;NA;Peri (6-12 months since last menstrual period);NA;NA;NO;Tumor resection;NA;NO;106;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;BRCA;5003;0:LIVING;ef4cbd38-bc79-4d60-a715-647edd2ebe9e;b462982a-4dd0-425e-bce3-0eb8f5527264;TCGA-E2-A1LG.08A790DE-B01D-4140-BB1C-B4844291D71E.pdf;Negative;NA;Left Upper Outer Quadrant;NA;NO;Allred score 0+0 = 0;NA;Allred score = 0;NA;Negative;NA;BLACK OR AFRICAN AMERICAN;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;E2;36;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E2-A1LH;TCGA-E2-A1LH-01;59;M0;N0;Stage I;5th;T1c;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-21628;2998;NA;0;2876;106.67;0:DiseaseFree;NA;NA;3 Point Scale;Negative;NA;NOT HISPANIC OR LATINO;NA;6/3/11;1889;NA;NA;NA;NA;NA;NA;NA;NA;NA;ACIS;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2002;NO;YES;0;NA;2;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Tumor resection;NA;NO;137;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;10667;0:LIVING;d8ecba6a-9fff-4993-a799-9a8d2aea524e;c236908e-4814-409b-9fcc-2bedf60aa168;TCGA-E2-A1LH.DAB174BB-862D-49BE-9BA4-9C11C4489305.pdf;Negative;NA;Right;NA;NO;NA;NA;NA;3 Point Scale;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Lumpectomy;E2;4566666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E2-A1LI;TCGA-E2-A1LI-01;57;M0;N1;Stage IIB;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-21064;2815;NA;0;2750;102.53;0:DiseaseFree;NA;NA;3 Point Scale;Negative;NA;NOT HISPANIC OR LATINO;NA;6/3/11;4015;NA;NA;1.21;NA;NA;Negative;NA;NA;NA;ACIS;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;2003;NO;YES;0;NA;2;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Tumor resection;NA;NO;16;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;10253;0:LIVING;3558dec7-eae3-4a41-a217-266c6a4535fb;55a21e0c-e8a7-43bf-8b28-0e06211114d7;TCGA-E2-A1LI.B3A319BE-2230-43E2-91E5-A3B3C76B85BA.pdf;Close;NA;Left Upper Outer Quadrant;NA;NO;NA;NA;NA;3 Point Scale;Negative;NA;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Lumpectomy;E2;533333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E2-A1LK;TCGA-E2-A1LK-01;84;M0;N3a;Stage IIIC;6th;T4b;Allred score 0+0 = 0;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-30757;1051;266;0;NA;5.09;1:Recurred/Progressed;NA;Allred score = 0;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;6/3/11;3805;NA;NA;1.41;NA;NA;Negative;80-89%;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;2008;NO;YES;11;NA;15;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Tumor resection;NA;NO;33;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;874;1:DECEASED;1d27253f-b036-44e7-a04d-8da5bbf57419;cc937913-802f-48cd-a490-e6b90f007c5d;TCGA-E2-A1LK.6CC4E6EF-6664-448E-933E-FFA9117C7ABF.pdf;Negative;NA;Left Upper Outer Quadrant|Left Lower Outer Quadrant;NA;NO;Allred score 0+0 = 0;NA;Allred score = 0;NA;Negative;NA;BLACK OR AFRICAN AMERICAN;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;E2;11;WITH TUMOR;Breast
brca_tcga_pub2015;TCGA-E2-A1LL;TCGA-E2-A1LL-01;73;MX;N2a;Stage IIIA;6th;T3;Allred score 0+0 = 0;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-27028;988;NA;0;1014;42.81;1:Recurred/Progressed;NA;Allred score = 0;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;6/3/11;3672;NA;NA;NA;NA;NA;NA;<10%;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2008;NO;YES;5;NA;44;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Tumor resection;NA;NO;30;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;BRCA;43;0:LIVING;2a84997d-ccee-4f46-bea2-752534f26416;e57574e4-7e01-4e61-bd29-ee4ec63dddd6;TCGA-E2-A1LL.3327975F-94BE-460E-9900-E063340927BE.pdf;Negative;NA;Left Upper Outer Quadrant;NA;NO;Allred score 0+0 = 0;NA;Allred score = 0;NA;Negative;NA;BLACK OR AFRICAN AMERICAN;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Simple Mastectomy;E2;1;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E2-A2P5;TCGA-E2-A2P5-01;78;M0;N3;Stage IIIC;7th;T2;Allred score = 8;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-28621;219;NA;0;326;19.61;1:Recurred/Progressed;NA;Allred score = 8;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;12/19/11;6636;NA;NA;1;NA;NA;Negative;NA;NA;NA;NA;Infiltrating Lobular Carcinoma;NA;No;Yes;C50.9;1/03/8520;C50.9;NA;NA;YES;2011;NO;YES;21;NA;25;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;NO;65;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;ILC;2697;1:DECEASED;F0DE67FF-8967-4FCE-9C12-0E07193285CD;CD8AC496-CD1B-426F-8E17-8F15BA8E94D1;TCGA-E2-A2P5.85E91C9F-9F61-4A25-B4D9-1BCBC7108F5E.pdf;Negative;NA;Left;NA;NO;Allred score = 8;NA;Allred score = 8;NA;Positive;NA;BLACK OR AFRICAN AMERICAN;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;E2;2166666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E2-A2P6;TCGA-E2-A2P6-01;77;M0;N1;Stage IIB;7th;T2;Allread score 5+3 = 8;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-28411;174;NA;0;168;34.53;0:DiseaseFree;NA;Allred score = 8;NA;Positive;NA;HISPANIC OR LATINO;NA;12/19/11;1405;NA;NA;NA;NA;NA;Negative;NA;NA;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;NA;NA;YES;2011;NO;YES;1;NA;5;Negative;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;NO;106;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;ILC;3453;0:LIVING;F83B866B-0B2E-4BBA-9367-BE6DCCF56232;3BC62725-AD6D-4685-BC50-0F1127363D90;TCGA-E2-A2P6.E6A21CE6-841D-4D9B-A563-80B9BAF6E682.pdf;Positive;NA;Left Upper Outer Quadrant;NA;NO;Allred score 2+2 = 4;NA;Allred score = 4;NA;Positive;NA;NA;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;Modified radical mastectomy;NA;Lumpectomy;E2;3533333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E2-A3DX;TCGA-E2-A3DX-01;43;M0;N3;Stage IIIC;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-15969;142;NA;0;217;43.53;0:DiseaseFree;NA;Allred score = 7;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;1/17/12;199;NA;NA;7.1;NA;NA;Positive;NA;NA;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;NA;NA;YES;2011;NO;YES;25;NA;36;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Core needle biopsy;NA;NO;12;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;ILC;4353;0:LIVING;31427699-E27A-4035-8925-6D8D6900D097;796DF715-916F-46E4-9DA1-E19C94958E07;TCGA-E2-A3DX.3B7CA8ED-58E2-4609-BE41-46525D3732E7.pdf;Positive;NA;Right;NA;NO;NA;NA;Allred score = 8;NA;Positive;NA;WHITE;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;E2;4;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E2-A56Z;TCGA-E2-A56Z-01;69;M0;N1a;Stage IIB;7th;T2;Allred 8 = 5+3;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;2.2;-25282;254;NA;0;219;8.28;0:DiseaseFree;NA;Allred Score;NA;Positive;10-19%;NOT HISPANIC OR LATINO;NA;6/20/13;4799;200;NA;1.5;3.2;NA;Negative;10-19%;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;2012;NO;YES;1;NA;16;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NO;44;NO;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;828;0:LIVING;45C3975C-D333-4237-93F7-E12DC2451C38;EF196594-35DC-4BA9-8BEB-1EFE72D59E6A;TCGA-E2-A56Z.83AAF7BF-131D-4044-AD3B-670B838A23D6.pdf;Negative;YES;Right;NA;NO;Allred 5 = 2+3;NA;Allred Score;NA;Positive;<10%;BLACK OR AFRICAN AMERICAN;YES;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Lumpectomy;E2;1466666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E2-A570;TCGA-E2-A570-01;47;M0;N1mi;Stage IB;7th;T1c;Allred 7 = 5+2;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;2;-17456;416;NA;0;549;30.58;0:DiseaseFree;NA;Allred Score;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;6/21/13;1371;200;NA;1.1;2.2;NA;Negative;10-19%;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;2011;NO;YES;1;NA;7;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NA;Core needle biopsy;NA;NO;23;NO;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;3058;0:LIVING;CDD8C046-FD97-482A-A11F-2217B321C4D1;DA3319A2-F906-495C-B0DE-38CB8672E28F;TCGA-E2-A570.803922CD-3D37-47DC-8BDC-EF8F4779685A.pdf;Negative;YES;Right Lower Inner Quadrant;NA;NO;Allred 8 = 5+3;NA;Allred Score;NA;Positive;NA;BLACK OR AFRICAN AMERICAN;NO;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Simple Mastectomy;E2;766666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E2-A573;TCGA-E2-A573-01;48;M0;N0;Stage IA;7th;T1c;Allred 0 = 0+0;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;1.8;-17689;595;NA;0;677;34.89;0:DiseaseFree;NA;Allred Score;NA;Negative;NA;NOT HISPANIC OR LATINO;Partial Mastectomy;6/20/13;3000;200;NA;1.3;2.3;NA;Negative;10-19%;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;2011;NO;YES;0;NA;4;NA;Peri (6-12 months since last menstrual period);NA;NA;NA;Core needle biopsy;NA;NO;44;NO;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;3489;0:LIVING;6429C443-8AC3-407F-BB9C-66420B904BBF;8E324F79-8FBF-4D12-94D2-7B5A978425FC;TCGA-E2-A573.14EB270E-0AAB-4C12-8D71-ED79076C2E93.pdf;Negative;YES;Right Upper Outer Quadrant;NA;NO;Allred 0 = 0+0;NA;Allred Score;NA;Negative;NA;BLACK OR AFRICAN AMERICAN;YES;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Other;E2;15;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E2-A574;TCGA-E2-A574-01;44;M0;N0;Stage IIA;7th;T2;Allred 0 = 0+0;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;2.8;-16195;429;NA;0;605;38.73;0:DiseaseFree;NA;Allred Score;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;6/20/13;6276;200;NA;1;2.8;NA;Negative;10-19%;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;2011;NO;YES;0;NA;4;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NA;Core needle biopsy;NA;NO;80;NO;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;3873;0:LIVING;029CE650-5E5A-4100-8596-CD94300E7EF5;CC3A7053-34F6-412F-85B8-DE4C8B481D7E;TCGA-E2-A574.F3FAB505-03FF-4FAA-ABB6-96AD20F47871.pdf;Negative;YES;Left;NA;NO;Allred 0 = 0+0;NA;Allred Score;NA;Negative;NA;BLACK OR AFRICAN AMERICAN;YES;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Lumpectomy;E2;27;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E9-A1N3;TCGA-E9-A1N3-01;70;M0;N2;Stage IIIA;7th;T1c;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-25714;65;NA;0;0;34.79;0:DiseaseFree;NA;NA;NA;NA;NA;NOT HISPANIC OR LATINO;NA;5/26/11;779;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Mixed Histology (please specify);Infiltrating ductal and lobular carcinoma;No;No;C50.9;1/03/8522;C50.9;NA;NA;YES;2010;NO;YES;7;NA;7;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Tumor resection;NA;NO;27;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;3479;0:LIVING;03c143e0-d8a1-4d60-a4a3-df0501fc6b6e;a3ac21e2-b92b-4597-a870-8444ddc6b4d6;TCGA-E9-A1N3.4F50E811-0743-440B-9094-6BA0F40BD734.pdf;Negative;NA;Right Upper Inner Quadrant;NA;YES;NA;NA;NA;NA;NA;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;E9;866666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E9-A1N4;TCGA-E9-A1N4-01;41;M0;N2;Stage IIIA;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-15055;65;NA;0;5;32.85;0:DiseaseFree;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;5/26/11;1888;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Mixed Histology (please specify);Infiltrating ductal and lobular carcinoma;No;No;C50.9;1/03/8520;C50.9;Positive;NA;YES;2010;NO;YES;4;0;7;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Tumor resection;NA;NO;18;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;3285;0:LIVING;69a68fbc-e43d-4652-85ee-693211bded47;8d122839-4167-48b2-9f3a-7ff7c3f134d8;TCGA-E9-A1N4.64B91C7E-E6D8-4952-B49F-0F5D57332994.pdf;Negative;NA;Left Upper Inner Quadrant;NA;YES;NA;NA;NA;NA;Positive;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;NA;E9;6;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E9-A1N5;TCGA-E9-A1N5-01;45;M0;N1;Stage IIB;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-16736;63;NA;0;0;36.79;0:DiseaseFree;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;6/23/11;1846;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Mixed Histology (please specify);Infiltrating ductal and lobular carcinoma;No;No;C50.9;1/03/8522;C50.9;Positive;NA;YES;2010;NO;YES;2;0;11;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Tumor resection;NA;NO;28;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;3679;0:LIVING;f954de05-1b44-4087-8933-6cc72d81028d;cc07e1f1-e1e7-4335-ab8b-b7bebef1669f;TCGA-E9-A1N5.224A51C8-8EEB-424C-AD88-44C4321050EA.pdf;Negative;NA;Left Upper Outer Quadrant;NA;YES;NA;NA;NA;NA;Positive;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;NA;E9;933333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E9-A1N8;TCGA-E9-A1N8-01;48;M0;N0;Stage IIA;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-17652;66;NA;0;0;34.13;0:DiseaseFree;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;6/23/11;7276;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2010;NO;YES;0;0;8;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Tumor resection;NA;NO;31;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;3413;0:LIVING;ac075bc0-1b59-4557-beea-541694faee03;28e05d2f-0559-425a-accf-d5b4c1152548;TCGA-E9-A1N8.4F15F8D6-9F34-4A61-A006-E5E7A2E68207.pdf;Negative;NA;Right Upper Outer Quadrant;NA;YES;NA;NA;NA;NA;NA;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;NA;E9;1033333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E9-A1N9;TCGA-E9-A1N9-01;58;M0;N0;Stage IIA;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-21228;44;NA;0;0;36.17;0:DiseaseFree;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;6/23/11;4243;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Mixed Histology (please specify);Infiltrating ductal and lobular carcinoma;No;No;C50.9;1/03/8522;C50.9;Positive;NA;YES;2011;NO;YES;0;0;8;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Tumor resection;NA;YES;44;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;3617;0:LIVING;994ca1f5-ad10-44ec-aa21-71fc2940653b;3c2bed9f-2ab5-4623-b631-99e394d7723d;TCGA-E9-A1N9.39D6D1DE-2CAE-470F-836B-926242F46E67.pdf;Negative;NA;Right Lower Outer Quadrant;NA;YES;NA;NA;NA;NA;Positive;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;NA;E9;1466666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E9-A1NA;TCGA-E9-A1NA-01;58;M0;N0;Stage IIA;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-21397;42;NA;0;0;36.53;0:DiseaseFree;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;6/23/11;3875;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Mixed Histology (please specify);Infiltrating ductal and lobular carcinoma;No;No;C50.9;1/03/8522;C50.9;Positive;NA;YES;2011;NO;YES;0;0;11;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Tumor resection;NA;YES;84;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;3653;0:LIVING;af577366-0258-49e7-b6af-e70056c081a4;e2ef6df2-c375-4c59-ae1b-c8cca22a8387;TCGA-E9-A1NA.595BB256-2F3D-493A-AA90-022BE0CC995F.pdf;Negative;NA;Left Lower Outer Quadrant;NA;YES;NA;NA;NA;NA;Positive;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;NA;E9;28;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E9-A1ND;TCGA-E9-A1ND-01;75;M0;N1;Stage IIB;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-27400;37;NA;0;0;41.59;0:DiseaseFree;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;6/23/11;1313;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;NA;YES;2011;NO;YES;1;0;11;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Tumor resection;NA;YES;77;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;4159;0:LIVING;f06f09f3-8133-4a92-ac86-fbe64295e0d8;b41b1f04-226e-466c-b5e1-f61e45ad3210;TCGA-E9-A1ND.AC26EE69-27D8-4523-917A-68573F5F614E.pdf;Negative;NA;Left Upper Outer Quadrant;NA;YES;NA;NA;NA;NA;Negative;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;NA;E9;2566666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E9-A1NE;TCGA-E9-A1NE-01;28;M0;N1;Stage IIB;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-10564;31;NA;0;0;35.74;0:DiseaseFree;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;6/23/11;132;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8522;C50.9;Negative;NA;YES;2011;NO;YES;1;0;2;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Tumor resection;NA;YES;40;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;3574;0:LIVING;3d676bba-154b-4d22-ab59-d4d4da051b94;0ca24149-4cc4-4ad1-b448-4cc33fef851e;TCGA-E9-A1NE.CF6E29A2-FAE6-45BB-B625-33877887A89E.pdf;Negative;NA;Right Lower Outer Quadrant;NA;YES;NA;NA;NA;NA;Positive;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;NA;E9;1333333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E9-A1NF;TCGA-E9-A1NF-01;60;M0;N0;Stage IIA;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-21981;31;NA;0;0;2.96;1:Recurred/Progressed;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;6/23/11;4963;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Mixed Histology (please specify);Infiltrating ductal and lobular carcinoma;No;No;C50.9;1/03/8522;C50.9;Negative;NA;YES;2011;NO;YES;0;0;9;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Tumor resection;NA;YES;47;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;3522;1:DECEASED;a8b1f6e7-2bcf-460d-b1c6-1792a9801119;0c30cd0e-a2d2-42b0-9ca9-8297de64e4a8;TCGA-E9-A1NF.740CF6E1-C742-47DC-8057-9D73AF4D6171.pdf;Negative;NA;Right Upper Outer Quadrant;NA;YES;NA;NA;NA;NA;Positive;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;NA;E9;1566666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E9-A1NG;TCGA-E9-A1NG-01;62;M0;N0;Stage IIA;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-22896;30;NA;0;0;NA;NA;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;6/23/11;874;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2011;NO;YES;0;0;5;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Tumor resection;NA;YES;22;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;2582;1:DECEASED;659b0170-e914-45ff-aa55-fcb8d3dc7b8a;7adf414b-c3f7-4e2c-aa80-81d3edd9764e;TCGA-E9-A1NG.73953A70-DAC0-443A-AC04-28BDA8D5F673.pdf;Negative;NA;Right Upper Outer Quadrant;NA;YES;NA;NA;NA;NA;Positive;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;NA;E9;733333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E9-A1NH;TCGA-E9-A1NH-01;71;M0;N1;Stage IIB;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-26221;30;NA;0;0;18.92;0:DiseaseFree;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;6/23/11;1230;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2011;NO;YES;3;0;5;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Tumor resection;NA;YES;19;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;1892;0:LIVING;b2aac45b-2073-4c7a-adb9-769a4fdcc111;fb0b2d84-d982-4d3a-9803-36420f2e7e46;TCGA-E9-A1NH.A6248687-C0C0-4DEF-9D92-196CBDB5CBDE.pdf;Negative;NA;Left Upper Inner Quadrant;NA;YES;NA;NA;NA;NA;Positive;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;E9;633333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E9-A1NI;TCGA-E9-A1NI-01;51;M0;N0;Stage IIA;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-18985;21;NA;0;-7;9.86;0:DiseaseFree;NA;NA;NA;Positive;NA;NOT HISPANIC OR LATINO;NA;6/23/11;3954;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Mixed Histology (please specify);Infiltrating ductal and lobular carcinoma;No;No;C50.9;1/03/8522;C50.9;Negative;NA;YES;2011;NO;YES;0;0;4;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Tumor resection;NA;YES;121;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;986;0:LIVING;c65b835a-2d38-4250-a173-0780d2c2cf58;558c43ad-12ad-42dd-94b2-80a607465fcb;TCGA-E9-A1NI.3F4F5A98-F6EA-46D5-95E8-6797D419328A.pdf;Negative;NA;Left Upper Outer Quadrant;NA;YES;NA;NA;NA;NA;Positive;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;NA;E9;4033333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E9-A1QZ;TCGA-E9-A1QZ-01;61;M0;N0;Stage IIA;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-22397;58;NA;0;0;24.8;0:DiseaseFree;NA;NA;NA;NA;NA;NOT HISPANIC OR LATINO;NA;7/28/11;1040;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;2011;NO;YES;0;NA;19;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Tumor resection;NA;NA;13;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;248;0:LIVING;b6b932ce-6856-4d94-9e6c-16dfbe51906f;ec76e770-ba6b-4294-a992-993183640ff8;TCGA-E9-A1QZ.864BB34A-1008-480C-A3B5-A2C616E95C49.pdf;Negative;NA;Left Lower Inner Quadrant;NA;YES;NA;NA;NA;NA;NA;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;NA;E9;433333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E9-A1R0;TCGA-E9-A1R0-01;58;M0;N1;Stage IIA;7th;T1c;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-21394;44;NA;0;0;28.25;0:DiseaseFree;NA;NA;NA;NA;NA;NOT HISPANIC OR LATINO;NA;7/28/11;970;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;2011;NO;YES;1;NA;12;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Tumor resection;NA;NA;22;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;2825;0:LIVING;f2da1d3f-f226-4c99-a97e-9b26f67d7a5d;e61781e7-6c4e-4a6f-8f8d-22896b1243ca;TCGA-E9-A1R0.DD0ADC20-2059-435E-9EB4-351C87D7CBEB.pdf;NA;NA;Left Upper Outer Quadrant;NA;YES;NA;NA;NA;NA;NA;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;NA;E9;733333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E9-A1R2;TCGA-E9-A1R2-01;51;MX;N3;Stage IIIC;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;74;-18936;64;NA;0;19;34.92;0:DiseaseFree;NA;Two-tier;NA;Positive;90-99%;NOT HISPANIC OR LATINO;NA;7/28/11;3226;NA;NA;NA;114;NA;Negative;90-99%;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;4;YES;2011;NO;YES;17;NA;19;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;NO;51;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;3492;0:LIVING;8631969d-4ac6-4fe1-9db3-d47db604494a;92b16015-e552-48e3-a095-0197b99b52a8;TCGA-E9-A1R2.5B9C0E4A-3958-4ECF-B8B2-E758E04E7722.pdf;Positive;NA;Left Upper Outer Quadrant;NA;YES;NA;NA;Two-tier;NA;Negative;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Lumpectomy;E9;17;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E9-A1R3;TCGA-E9-A1R3-01;70;M0;N3;Stage IIIC;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-25693;80;NA;0;64;2.56;0:DiseaseFree;NA;NA;NA;NA;NA;NOT HISPANIC OR LATINO;NA;7/28/11;3326;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;2010;NO;YES;10;NA;10;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;NO;23;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;256;0:LIVING;4922cddc-575c-4b8a-8245-ce5f6876760c;27c9fa1c-e5e1-40d3-8d25-81f10d27d984;TCGA-E9-A1R3.BE186852-8596-4CDB-B5C4-AA5838C15B5F.pdf;Negative;NA;Right Upper Outer Quadrant;NA;YES;NA;NA;NA;NA;NA;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;E9;766666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E9-A1R4;TCGA-E9-A1R4-01;66;M0;N0;Stage IA;7th;T1c;NA;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;NA;-24181;45;NA;0;29;6.11;0:DiseaseFree;NA;NA;NA;NA;NA;NOT HISPANIC OR LATINO;NA;7/28/11;3172;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;2011;NO;YES;0;NA;10;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Other method, specify:;Lumpectomy;NO;102;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;MDLC;611;0:LIVING;b7a4df9a-4e25-4550-9c10-338ca1921c2f;ea78a749-5aee-44e6-9592-b2e20eeb7ff9;TCGA-E9-A1R4.AA095896-8217-4BEE-97EC-BC79F5C395BA.pdf;Negative;NA;Left Upper Outer Quadrant;NA;YES;NA;NA;NA;NA;NA;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;NA;E9;3433333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E9-A1R5;TCGA-E9-A1R5-01;63;M0;N0;Stage IA;7th;T1c;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-23116;58;NA;0;42;3.02;0:DiseaseFree;NA;NA;NA;NA;NA;NOT HISPANIC OR LATINO;NA;7/28/11;2577;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;2011;NO;YES;0;NA;10;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Cytology (e.g. Peritoneal or pleural fluid);NA;NO;34;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;302;0:LIVING;23c21dea-3713-408f-ba56-f7c586e9f206;9f6511cf-f17a-48b9-8e58-9c251bd5e8f4;TCGA-E9-A1R5.141B770B-22DD-4C87-AFF7-04D85FC9C74A.pdf;Negative;NA;Right Upper Outer Quadrant;NA;YES;NA;NA;NA;NA;NA;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Lumpectomy;E9;1133333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E9-A1R6;TCGA-E9-A1R6-01;63;M0;N0;Stage IIA;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-23347;100;NA;0;84;11.14;0:DiseaseFree;NA;NA;NA;NA;NA;NOT HISPANIC OR LATINO;NA;7/28/11;4507;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;2010;NO;YES;0;NA;10;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Cytology (e.g. Peritoneal or pleural fluid);NA;NO;28;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;1114;0:LIVING;4842bac3-abaa-4900-871f-f2c3ba6457f5;061e539b-4cde-4e37-bbcf-30937ce689c9;TCGA-E9-A1R6.8A865E33-082A-454F-A6DF-89E994206E65.pdf;Negative;NA;Right Upper Outer Quadrant;NA;YES;NA;NA;NA;NA;NA;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Lumpectomy;E9;933333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E9-A1R7;TCGA-E9-A1R7-01;64;M0;N0;Stage IIA;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-23397;51;NA;0;34;48.19;0:DiseaseFree;NA;NA;NA;NA;NA;NOT HISPANIC OR LATINO;NA;7/28/11;3827;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;2011;NO;YES;0;NA;10;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Cytology (e.g. Peritoneal or pleural fluid);NA;NO;51;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;4819;0:LIVING;2680da86-c977-4611-b75f-df015283c023;8d9f2037-1c1f-4c73-a993-dc4c2aa67d30;TCGA-E9-A1R7.FA19C3C4-E13B-464B-84CC-3AF7E83D5B9C.pdf;Negative;NA;Right Upper Outer Quadrant;NA;YES;NA;NA;NA;NA;NA;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Lumpectomy;E9;17;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E9-A1RB;TCGA-E9-A1RB-01;40;M0;N0;Stage IIA;7th;T2;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-14755;39;NA;0;21;NA;NA;NA;NA;NA;NA;NA;NOT HISPANIC OR LATINO;NA;7/28/11;6044;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;2011;NO;YES;0;0;10;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Cytology (e.g. Peritoneal or pleural fluid);NA;NO;22;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;BRCA;3206;1:DECEASED;94b95984-b2fb-4e42-8887-45e7086c3179;43993e01-588a-40de-80ec-72c1a66fe70b;TCGA-E9-A1RB.3BE8EA29-3C5F-4339-9CE7-98994B545848.pdf;Negative;NA;Left Upper Inner Quadrant;NA;YES;NA;NA;NA;NA;NA;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;E9;733333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E9-A1RC;TCGA-E9-A1RC-01;56;M0;N3;Stage IIIC;7th;T4b;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-20795;1246;NA;0;1224;40.21;0:DiseaseFree;NA;NA;NA;NA;NA;NOT HISPANIC OR LATINO;NA;7/28/11;2996;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Mixed Histology (please specify);Infiltrating ductal and lobular carcinoma;No;No;C50.9;1/03/8522;C50.9;NA;NA;YES;2007;NO;YES;10;0;10;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Cytology (e.g. Peritoneal or pleural fluid);NA;NO;39;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;4021;0:LIVING;5cdae21d-eee5-478f-932a-0f51fcf5f031;9eaa7f15-8a97-4a49-9e93-b5790a1fade0;TCGA-E9-A1RC.D10A419F-B161-4998-97DE-45DF70F4E212.pdf;Negative;NA;Right Upper Outer Quadrant;NA;YES;NA;NA;NA;NA;NA;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;E9;1266666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E9-A1RD;TCGA-E9-A1RD-01;67;M0;N0;Stage IIA;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-24719;38;NA;0;20;1.12;0:DiseaseFree;NA;NA;NA;NA;NA;NOT HISPANIC OR LATINO;NA;7/28/11;2262;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;2011;NO;YES;0;NA;10;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Cytology (e.g. Peritoneal or pleural fluid);NA;NO;19;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;112;0:LIVING;5fe3c51f-65e2-4da6-8924-a6fae17c022d;d19fe184-84a8-4a49-a4d4-75891670da4d;TCGA-E9-A1RD.EDDEB48B-B712-40B0-9DE5-9F5B5791AF4D.pdf;Negative;NA;Right Lower Inner Quadrant;NA;YES;NA;NA;NA;NA;NA;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;E9;633333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E9-A1RE;TCGA-E9-A1RE-01;74;M0;N2;Stage IIIA;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-27392;65;NA;0;47;46.62;0:DiseaseFree;NA;NA;NA;NA;NA;NOT HISPANIC OR LATINO;NA;7/28/11;5125;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;2011;NO;YES;9;NA;10;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Cytology (e.g. Peritoneal or pleural fluid);NA;NO;48;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;4662;0:LIVING;24046547-d038-4616-b190-52ac93f4965f;d2d7f976-2330-47aa-b1b3-947b3182b0b0;TCGA-E9-A1RE.80831A1A-95BD-4ECD-B7D9-6DDCD5313B25.pdf;Negative;NA;Left Upper Outer Quadrant;NA;YES;NA;NA;NA;NA;NA;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;E9;16;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E9-A1RF;TCGA-E9-A1RF-01;68;M0;N2;Stage IIIA;7th;T2;NA;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;NA;-25119;56;NA;0;38;6.57;0:DiseaseFree;NA;NA;NA;NA;NA;NOT HISPANIC OR LATINO;NA;8/2/11;4068;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;2011;NO;YES;5;NA;10;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Cytology (e.g. Peritoneal or pleural fluid);NA;NO;120;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;MDLC;657;0:LIVING;c694615c-b1c6-499c-8058-995633ebf948;ca0d78dc-c860-4835-ad07-052f176804a4;TCGA-E9-A1RF.50F3690C-2082-4590-A923-656C5F226FAE.pdf;Negative;NA;Left Upper Outer Quadrant;NA;YES;NA;NA;NA;NA;NA;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;E9;4;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E9-A1RH;TCGA-E9-A1RH-01;63;M0;N0;Stage IIA;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-23224;32;NA;0;14;46.55;0:DiseaseFree;NA;NA;NA;NA;NA;NOT HISPANIC OR LATINO;NA;8/2/11;4291;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;2011;NO;YES;0;NA;10;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Cytology (e.g. Peritoneal or pleural fluid);NA;NO;77;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;4655;0:LIVING;408cb583-6dc3-4698-8bd2-e284042bd5ef;6b1bb382-0103-4207-a0e8-871aa6aae81c;TCGA-E9-A1RH.FA93BDAA-B56E-4217-9022-4EBE6009FCF7.pdf;Negative;NA;Right Lower Outer Quadrant;NA;YES;NA;NA;NA;NA;NA;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Lumpectomy;E9;2566666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E9-A1RI;TCGA-E9-A1RI-01;43;M0;N2;Stage IIIA;7th;T1c;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-15942;64;NA;0;48;47.6;0:DiseaseFree;NA;NA;NA;NA;NA;NOT HISPANIC OR LATINO;NA;7/28/11;1189;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Mixed Histology (please specify);Infiltrating ductal and lobular carcinoma;No;No;C50.9;1/03/8522;C50.9;NA;NA;YES;2011;NO;YES;5;NA;10;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Cytology (e.g. Peritoneal or pleural fluid);NA;NO;13;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;476;0:LIVING;dd3bfb26-b534-4917-9c4d-9fe7b6477762;7423f6fa-4f31-46b1-a391-b5fc45833c2b;TCGA-E9-A1RI.91303D10-CC36-47CF-BF14-E1DCE0157D1C.pdf;Negative;NA;Left Upper Outer Quadrant;NA;YES;NA;NA;NA;NA;NA;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;E9;433333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E9-A226;TCGA-E9-A226-01;45;M0;N2;Stage IIIA;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-16511;48;NA;0;16;25.95;1:Recurred/Progressed;NA;NA;NA;NA;NA;NOT HISPANIC OR LATINO;NA;8/3/11;2557;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;2011;NO;YES;6;NA;10;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Cytology (e.g. Peritoneal or pleural fluid);NA;NO;28;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;3443;1:DECEASED;dd67408e-46ba-4573-9415-d4814e9f84de;c1adf54e-8248-4b44-a9a1-e883fcc4f702;TCGA-E9-A226.7C8F01DC-9CD9-4D61-9032-BC9F28A687EE.pdf;Negative;NA;Left Lower Inner Quadrant;NA;YES;NA;NA;NA;NA;NA;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;E9;933333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E9-A227;TCGA-E9-A227-01;42;M0;N1;Stage IIB;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-15602;66;NA;0;24;32.03;0:DiseaseFree;NA;Two-tier;NA;Positive;90-99%;NOT HISPANIC OR LATINO;NA;7/28/11;506;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;4;YES;2011;NO;YES;1;NA;17;Negative;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Core needle biopsy;NA;NO;15;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;3203;0:LIVING;89a8da07-4487-47c6-8d3c-442a87e4f632;409b906a-5e2c-4ce6-bc85-20a59fa383f4;TCGA-E9-A227.13CA22BB-5EA5-46C9-82D3-77867122D1B4.pdf;Positive;NA;Left Upper Outer Quadrant;NA;YES;NA;4+;Two-tier;NA;Positive;80-89%;WHITE;NA;NO;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;Other;Re-excision of original lumpectomy site;Lumpectomy;E9;5;WITH TUMOR;Breast
brca_tcga_pub2015;TCGA-E9-A228;TCGA-E9-A228-01;58;M0;N1;Stage IIB;7th;T2;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-21294;42;NA;0;0;42.21;0:DiseaseFree;NA;NA;NA;NA;NA;NOT HISPANIC OR LATINO;NA;8/2/11;1701;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;2011;NO;YES;2;NA;12;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Tumor resection;NA;NA;38;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;BRCA;4221;0:LIVING;b95eef8a-205f-4cf8-9d3c-ae51d406e1e0;6d129f34-7de2-4f8a-b150-e6111c5845cc;TCGA-E9-A228.B0E8F3C1-E996-4E70-9630-AC95AF6E4EDC.pdf;Negative;NA;Right Lower Inner Quadrant;NA;YES;NA;NA;NA;NA;NA;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;NA;E9;1266666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E9-A229;TCGA-E9-A229-01;37;M0;N0;Stage IA;7th;T1c;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-13817;56;NA;0;0;37.71;0:DiseaseFree;NA;NA;NA;NA;NA;NOT HISPANIC OR LATINO;NA;8/2/11;1635;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;2011;NO;YES;0;NA;14;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Tumor resection;NA;NA;14;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;3771;0:LIVING;cea9d8f9-e18c-4947-a461-5f712e3c1e6d;c3927b5c-d641-45e5-87ea-9cc18c7ec85e;TCGA-E9-A229.15FA41AE-3A0F-4112-828B-EE8687A6F158.pdf;Negative;NA;Right Lower Inner Quadrant;NA;YES;NA;NA;NA;NA;NA;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;NA;E9;466666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E9-A22A;TCGA-E9-A22A-01;74;M0;N0;Stage IIA;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-27288;59;NA;0;0;39.06;0:DiseaseFree;NA;NA;NA;Positive;10-19%;NOT HISPANIC OR LATINO;NA;8/2/11;3124;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2011;NO;YES;0;0;2;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Tumor resection;NA;YES;31;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;3906;0:LIVING;4aacbc42-5ac5-4339-b9fa-c6e812084837;0f0cca8e-770c-45df-a6cc-466cc9328637;TCGA-E9-A22A.BC3061B7-9C99-4270-84EE-B1306FA01AE2.pdf;Negative;NA;Right Lower Outer Quadrant;NA;YES;NA;NA;NA;NA;Negative;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;NA;E9;1033333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E9-A22B;TCGA-E9-A22B-01;71;M0;N0;Stage IA;7th;T1c;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-26278;59;NA;0;0;38.34;0:DiseaseFree;NA;NA;NA;Positive;10-19%;NOT HISPANIC OR LATINO;NA;8/2/11;2412;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Mixed Histology (please specify);Infiltrating ductal and lobular carcinoma;No;No;C50.9;1/03/8522;C50.9;Negative;NA;YES;2011;NO;YES;0;0;4;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Tumor resection;NA;YES;48;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;3834;0:LIVING;b956df1b-bc77-4bdb-a5bd-5dda7b4c8da7;3f1e9bda-addf-4e24-a92f-123085bf40bc;TCGA-E9-A22B.FC896EB8-1CEC-46A0-82E1-E3FBFAAB69F1.pdf;Negative;NA;Right Upper Outer Quadrant;NA;YES;NA;NA;NA;NA;Negative;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;NA;E9;16;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E9-A22D;TCGA-E9-A22D-01;38;M0;N0;Stage IIA;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-14115;52;NA;0;0;41;0:DiseaseFree;NA;NA;NA;Positive;10-19%;NOT HISPANIC OR LATINO;NA;8/2/11;2295;NA;NA;NA;NA;NA;NA;<10%;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;NA;YES;2011;NO;YES;0;0;10;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NA;Tumor resection;NA;YES;19;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;41;0:LIVING;cf0a3f38-5850-44e1-8574-808bd37d84a3;0d7c1a37-5da1-4257-a118-b7d0717f23da;TCGA-E9-A22D.ED60F792-A71B-4BAE-A536-5FF6D8C3DEAA.pdf;Negative;NA;Right Upper Outer Quadrant;NA;YES;NA;NA;NA;NA;Positive;<10%;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;E9;633333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E9-A22E;TCGA-E9-A22E-01;56;M0;N2;Stage IIIA;7th;T2;NA;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;NA;-20574;52;NA;0;0;41.69;0:DiseaseFree;NA;NA;NA;Positive;10-19%;NOT HISPANIC OR LATINO;NA;8/2/11;4323;NA;NA;NA;NA;NA;NA;<10%;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;NA;YES;2011;NO;YES;4;0;10;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Tumor resection;NA;YES;74;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;MDLC;4169;0:LIVING;64d4dfae-8d91-464b-adc3-80ba7caf54ae;147a9822-8704-4a7f-b856-9a659f4717b3;TCGA-E9-A22E.7788E7FD-B5A3-4B22-83CA-EA3FB5E826FC.pdf;Negative;NA;Right Upper Inner Quadrant;NA;YES;NA;NA;NA;NA;Positive;<10%;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;NA;E9;2466666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E9-A22G;TCGA-E9-A22G-01;47;M0;N0;Stage IIA;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-17300;45;NA;0;0;40.7;0:DiseaseFree;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;8/2/11;8768;NA;NA;NA;NA;NA;NA;<10%;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;NA;YES;2011;NO;YES;0;0;6;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Tumor resection;NA;YES;81;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;407;0:LIVING;56033839-35d5-4d72-8b8c-400cb345263d;55e28aaf-8025-4b46-97d3-96cdf512a609;TCGA-E9-A22G.E34F4BF0-A0C3-4C72-8E3A-F319D4CDDD5D.pdf;Negative;NA;Left Upper Outer Quadrant;NA;YES;NA;NA;NA;NA;Negative;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;NA;E9;27;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E9-A22H;TCGA-E9-A22H-01;42;M0;N1;Stage IIB;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-15504;38;NA;0;0;40.47;0:DiseaseFree;NA;NA;NA;Positive;<10%;NOT HISPANIC OR LATINO;NA;8/2/11;1039;NA;NA;NA;NA;NA;NA;<10%;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Positive;NA;YES;2011;NO;YES;1;0;8;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Tumor resection;NA;YES;22;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;4047;0:LIVING;161917b8-88ad-407b-ade6-d6b98478b359;9ff0477c-10cd-47d6-8d0d-4e763ea185a8;TCGA-E9-A22H.672E4D81-DA47-495C-A58B-BD2B4FEA2380.pdf;Negative;NA;Left Upper Outer Quadrant;NA;YES;NA;NA;NA;NA;Positive;10-19%;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;E9;733333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E9-A243;TCGA-E9-A243-01;52;M0;N0 (i-);Stage IIA;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-19035;94;NA;0;43;10.02;1:Recurred/Progressed;NA;NA;NA;NA;NA;NOT HISPANIC OR LATINO;NA;8/17/11;1011;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;2011;NO;YES;0;NA;10;NA;Peri (6-12 months since last menstrual period);NA;NA;NO;Cytology (e.g. Peritoneal or pleural fluid);NA;NO;56;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;2011;0:LIVING;d4a1ecdc-399c-4f82-aa7a-68a0c82ded3f;ae72a901-e7b7-41cf-8eeb-2a7fb51e14f0;TCGA-E9-A243.742A4812-9EB1-4348-996E-3F1AD7FA3E5D.pdf;Negative;NA;Right Upper Inner Quadrant;NA;YES;NA;NA;NA;NA;NA;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Lumpectomy;E9;19;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E9-A244;TCGA-E9-A244-01;54;M0;N0 (i-);Stage IIA;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-19778;58;NA;0;21;0.69;0:DiseaseFree;NA;NA;NA;NA;NA;NOT HISPANIC OR LATINO;NA;3/15/11;3765;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;2011;NO;YES;0;NA;10;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Cytology (e.g. Peritoneal or pleural fluid);NA;NO;72;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;69;0:LIVING;a4c59287-1ad5-46a5-8040-e591e6ce064f;51e96168-f2d8-4827-9910-66264b410b4c;TCGA-E9-A244.4158FEAB-066B-4500-8FD2-3F197438DFB5.pdf;Negative;NA;Left Upper Outer Quadrant;NA;YES;NA;NA;NA;NA;NA;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Lumpectomy;E9;24;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E9-A245;TCGA-E9-A245-01;47;M0;N1;Stage IIB;7th;T2;NA;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;NA;-17363;62;NA;0;26;NA;NA;NA;NA;NA;NA;NA;NOT HISPANIC OR LATINO;NA;3/16/11;345;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;2011;NO;YES;3;NA;10;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Cytology (e.g. Peritoneal or pleural fluid);NA;NO;16;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;MDLC;;1:DECEASED;8218119a-f68b-4ea7-9ee4-5e2edc2ae342;dc85267a-0ce1-439e-9ecf-e5a13ad06f26;TCGA-E9-A245.5F2A52E5-2844-4242-8CE4-A87DF9D9C97B.pdf;Negative;NA;Left Upper Outer Quadrant;NA;YES;NA;NA;NA;NA;NA;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Lumpectomy;E9;533333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E9-A247;TCGA-E9-A247-01;59;M0;N0 (i-);Stage IA;7th;T1c;NA;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;NA;-21562;49;NA;0;13;38.96;0:DiseaseFree;NA;NA;NA;NA;NA;NOT HISPANIC OR LATINO;NA;8/18/11;7006;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;2011;NO;YES;0;NA;10;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Other method, specify:;Lumpectomy;NA;36;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;MDLC;3896;0:LIVING;636b0a90-c8c2-4ad6-a77d-6cd428a826d1;c6f8aca1-259f-48ab-a470-a1afecb8a2a9;TCGA-E9-A247.61E73960-32B0-413E-AF1D-2EF4582293B3.pdf;Negative;NA;Left Upper Inner Quadrant;NA;YES;NA;NA;NA;NA;NA;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;NA;E9;12;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E9-A248;TCGA-E9-A248-01;51;M0;N0 (i-);Stage IIA;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-18684;52;NA;0;22;1.94;0:DiseaseFree;NA;NA;NA;NA;NA;NOT HISPANIC OR LATINO;NA;3/22/11;790;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;2011;NO;YES;0;NA;10;NA;Peri (6-12 months since last menstrual period);NA;NA;NO;Cytology (e.g. Peritoneal or pleural fluid);NA;NO;21;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;194;0:LIVING;539bbbed-43fb-4fef-9c67-6406f58b186a;02ec11f4-1d26-4d2f-babe-d576ebfff1c7;TCGA-E9-A248.8950E632-451D-4436-9AA2-740CB08237E8.pdf;Negative;NA;Right Upper Outer Quadrant;NA;YES;NA;NA;NA;NA;NA;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Lumpectomy;E9;7;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E9-A249;TCGA-E9-A249-01;45;M0;N0 (i-);Stage IIA;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-16689;59;NA;0;29;7.13;0:DiseaseFree;NA;NA;NA;NA;NA;NOT HISPANIC OR LATINO;NA;3/22/11;4018;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;2011;NO;YES;0;NA;10;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Cytology (e.g. Peritoneal or pleural fluid);NA;NO;12;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;713;0:LIVING;fb3607eb-858e-4ecd-8477-95140658c6d2;bf8eb507-a277-4f3a-a605-313cd37f18b4;TCGA-E9-A249.6272ED78-501A-4055-8C87-430F46F518AA.pdf;Negative;NA;Left Upper Outer Quadrant;NA;YES;NA;NA;NA;NA;NA;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Lumpectomy;E9;4;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E9-A24A;TCGA-E9-A24A-01;69;M0;N1;Stage IIA;7th;T1c;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-25370;41;NA;0;11;24.54;0:DiseaseFree;NA;NA;NA;NA;NA;NOT HISPANIC OR LATINO;NA;3/22/11;1266;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;2011;NO;YES;1;NA;10;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Other method, specify:;Lumpectomy;NO;25;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;2454;0:LIVING;9f3cc92b-fa22-478e-a2e4-6b4c8afb93d6;91202959-0b44-43ba-961c-58c9de842d76;TCGA-E9-A24A.392524F7-B570-4047-A439-71FC15642DC8.pdf;Negative;NA;Right Upper Outer Quadrant;NA;YES;NA;NA;NA;NA;NA;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;NA;E9;833333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E9-A295;TCGA-E9-A295-01;71;M0;N0 (i-);Stage IIA;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-25957;63;NA;0;22;12.32;0:DiseaseFree;NA;7;NA;Positive;80-89%;NOT HISPANIC OR LATINO;NA;9/12/11;4456;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Positive;NA;YES;2011;NO;YES;0;0;7;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Tumor resection;NA;YES;65;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;ILC;1232;0:LIVING;fec0da58-1047-44d2-b6d1-c18cceed43dc;3944bcd6-1a95-4297-8cf3-7e7d38b9390e;TCGA-E9-A295.A23D86FF-CCA9-42B2-B6AE-9E365AAC03C8.pdf;Negative;NA;Right Lower Outer Quadrant;NA;YES;NA;NA;7;NA;Positive;80-89%;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;E9;22;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E9-A2JS;TCGA-E9-A2JS-01;72;M0;N1;Stage IIB;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-26407;79;NA;0;13;17.21;1:Recurred/Progressed;NA;NA;NA;NA;NA;NOT HISPANIC OR LATINO;NA;12/20/11;6188;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;NA;NA;YES;2011;NO;YES;1;NA;10;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Cytology (e.g. Peritoneal or pleural fluid);NA;NO;46;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;ILC;297;1:DECEASED;4A831893-F4CA-4357-A756-B5E954E35DD7;C18A3E05-F8EE-454C-89B2-5659045BA68E;TCGA-E9-A2JS.1DFFCBD1-962D-4E9B-BEE1-726CABE3AA95.pdf;Negative;NA;Left Upper Outer Quadrant;NA;YES;NA;NA;NA;NA;NA;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Lumpectomy;E9;1566666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E9-A2JT;TCGA-E9-A2JT-01;63;M0;N0 (i-);Stage IIA;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-23318;94;NA;0;23;9.46;0:DiseaseFree;NA;NA;NA;NA;NA;NOT HISPANIC OR LATINO;NA;12/20/11;19;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;NA;NA;YES;2011;NO;YES;0;NA;10;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Cytology (e.g. Peritoneal or pleural fluid);NA;NO;16;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;ILC;946;0:LIVING;B35FBE19-0E6D-427E-B9BE-EE3527B5FCA6;5FCE29D3-4250-4696-B691-D4BC953C21CD;TCGA-E9-A2JT.C70325C1-54EB-41BF-B77C-D92FADA8D23E.pdf;Negative;NA;Left Upper Outer Quadrant;NA;YES;NA;NA;NA;NA;NA;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Lumpectomy;E9;533333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E9-A3Q9;TCGA-E9-A3Q9-01;78;M0;N3;Stage IIIC;7th;T3;NA;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;NA;-28715;198;NA;0;31;32.88;0:DiseaseFree;NA;8;NA;Positive;40-49%;NOT HISPANIC OR LATINO;NA;4/30/12;275;NA;NA;NA;NA;NA;NA;<10%;NA;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Indeterminate;NA;YES;2011;NO;YES;22;0;22;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Tumor resection;NA;YES;40;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;MDLC;3288;0:LIVING;E36E985D-2C44-4E14-854A-7DBCA4BB0304;5D1CB65A-7798-455D-8100-25871CEC5A47;TCGA-E9-A3Q9.FE3E1376-1527-42C0-8F5F-8849D0F2743B.pdf;Negative;NA;Right Lower Inner Quadrant;NA;YES;NA;NA;8;NA;Positive;40-49%;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;NA;E9;13;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E9-A3QA;TCGA-E9-A3QA-01;33;M0;N0 (i-);Stage IIA;7th;T2;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-12142;282;NA;0;19;30.16;0:DiseaseFree;NA;NA;NA;NA;NA;NOT HISPANIC OR LATINO;NA;4/30/12;908;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Medullary Carcinoma;NA;No;No;C50.9;1/03/8510;C50.9;NA;NA;YES;2011;NO;YES;0;NA;14;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Tumor resection;NA;NA;55;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;BRCA;3016;0:LIVING;F3CB557D-23E4-4FD1-81CA-DB1A3F56D56E;27E8B056-063F-4742-A591-B98FB9A948A5;TCGA-E9-A3QA.1F02AA5F-67B1-4BAF-A3A9-CA20BCD7FBAF.pdf;Negative;NA;Left Lower Inner Quadrant;NA;YES;NA;NA;NA;NA;NA;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;NA;E9;1833333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E9-A3X8;TCGA-E9-A3X8-01;48;M0;N1;Stage IIB;7th;T2;NA;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;NA;-17588;233;NA;0;23;30.42;0:DiseaseFree;NA;8;NA;Positive;20-29%;NOT HISPANIC OR LATINO;NA;8/24/12;767;NA;NA;NA;NA;NA;NA;<10%;NA;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Positive;NA;YES;2011;NO;YES;4;0;8;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Tumor resection;NA;YES;15;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;MDLC;3042;0:LIVING;95873E61-AFDB-496C-9F77-3F9BEB008CDA;C9E12D18-6092-499F-92AE-6FD6B16F2ACD;TCGA-E9-A3X8.00058FFD-35E6-4891-8B01-DAB3AE9EBF78.pdf;Negative;NA;Left Upper Outer Quadrant;NA;YES;NA;NA;8;NA;Positive;20-29%;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;E9;5;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E9-A54X;TCGA-E9-A54X-01;85;M0;N0 (i-);Stage IA;7th;T1b;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-31173;78;NA;0;0;23.88;0:DiseaseFree;NA;NA;NA;Positive;90-99%;NOT HISPANIC OR LATINO;NA;6/21/13;2207;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Mucinous Carcinoma;NA;No;No;C50.9;1/03/8480;C50.9;Negative;3;YES;2012;NO;YES;0;NA;2;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NO;27;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;BRCA;2388;0:LIVING;3DBC8D60-3A97-47B2-91D0-C18FB46B4365;076736E4-6B47-40F4-BBD6-3868DFD1B9C5;TCGA-E9-A54X.BCDA7E7B-396B-4809-A0B3-2BC2C22DC908.pdf;Negative;NA;Left|Left Upper Outer Quadrant;NA;YES;NA;3+;NA;NA;Positive;90-99%;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Lumpectomy;E9;9;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E9-A5UO;TCGA-E9-A5UO-01;41;M0;N0;Stage IIA;7th;T2;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-15050;98;NA;0;7;25.79;0:DiseaseFree;NA;NA;NA;NA;NA;NOT HISPANIC OR LATINO;Partial mastectomy;5/23/13;2246;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Mucinous Carcinoma;NA;No;No;C50.9;1/03/8480;C50.9;NA;NA;YES;2012;NO;YES;0;NA;10;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NA;Fine needle aspiration biopsy;NA;NO;31;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;BRCA;2579;0:LIVING;ED2617C3-5D3B-4688-9283-0F8A10E0B10D;ECE822AF-EA84-419B-99F1-6CE53E4C1E8A;TCGA-E9-A5UO.6C698240-6557-4F96-BF56-60792693920F.pdf;Negative;NA;Right Upper Outer Quadrant;NA;YES;NA;NA;NA;NA;NA;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Other;E9;1033333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-E9-A5UP;TCGA-E9-A5UP-01;63;M0;N0;Stage IIA;7th;T2;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-23371;85;NA;0;0;26.38;0:DiseaseFree;NA;NA;NA;NA;NA;NOT HISPANIC OR LATINO;NA;5/23/13;5951;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Other, specify;NA;No;No;C50.9;1/03/8503;C50.9;NA;NA;YES;2012;NO;YES;0;NA;10;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Tumor resection;NA;NO;25;NO;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;BRCA;2638;0:LIVING;A412B374-4D25-491F-B76F-DDAA989ACF59;D5DE71C5-B810-426D-A1F9-7F7FF07B775F;TCGA-E9-A5UP.B50AB6D5-3010-450E-9CCE-E9BFA0202736.pdf;Negative;NA;Left Upper Outer Quadrant;NA;YES;NA;NA;NA;NA;NA;NA;WHITE;NA;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;NA;E9;833333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-EW-A1IW;TCGA-EW-A1IW-01;80;MX;N1a;Stage IIB;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-29529;213;NA;0;252;12.19;0:DiseaseFree;NA;NA;3 Point Scale;Positive;90-99%;HISPANIC OR LATINO;total mastectomy;5/27/11;1756;NA;NA;NA;NA;NA;NA;90-99%;3;+ or -;CISH;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Positive;3;YES;2010;NO;YES;2;0;10;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;YES;74;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;ILC;1219;0:LIVING;5e2cbc56-97f9-4b94-ade2-a3f739bcc7be;bfd30c90-9b30-4e7b-96f5-1f1b2ce23f04;TCGA-EW-A1IW.D4194F52-3E15-4105-9A1A-1326CF128BF8.pdf;Negative;NA;Right Lower Inner Quadrant|Right Lower Outer Quadrant;NA;NO;NA;3+;NA;3 Point Scale;Positive;90-99%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Other;EW;2466666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-EW-A1IX;TCGA-EW-A1IX-01;48;MX;N1a;Stage IIA;6th;T1b;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-17597;1030;NA;0;1082;39.68;0:DiseaseFree;NA;NA;3 Point Scale;Positive;90-99%;HISPANIC OR LATINO;total mastectomy;6/10/11;676;NA;NA;NA;NA;NA;NA;<10%;NA;NA;NA;Other, specify;NA;No;No;C50.9;1/03/8524;C50.9;Negative;3;YES;2008;NO;YES;1;1;27;NA;Peri (6-12 months since last menstrual period);NA;NA;NO;Core needle biopsy;NA;YES;25;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;BRCA;3968;0:LIVING;e8614b7d-132e-4b4e-b1ae-df8bb4f2d4d4;142d082f-444c-4384-97c0-bbc78e228470;TCGA-EW-A1IX.3CF4FC36-70EF-4EA3-874C-4A514FCDB717.pdf;Negative;NA;Right Upper Outer Quadrant;NA;NO;NA;3+;NA;3 Point Scale;Positive;90-99%;ASIAN;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Other;EW;833333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-EW-A1IY;TCGA-EW-A1IY-01;38;MX;N0;Stage I;6th;T1c;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-14122;590;NA;0;258;8.48;0:DiseaseFree;NA;NA;3 Point Scale;Positive;90-99%;NOT HISPANIC OR LATINO;NA;5/10/11;644;NA;NA;NA;NA;NA;NA;<10%;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;3;YES;2009;NO;YES;0;0;6;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Core needle biopsy;NA;YES;30;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;848;0:LIVING;5ff12cbe-a3e0-4ce6-8452-12b984a1baaf;d728c743-10a6-4ac4-8725-61c0d2980057;TCGA-EW-A1IY.7C003A4F-DC30-43D0-AC61-ACE6BA118BEE.pdf;Negative;NA;Right Upper Inner Quadrant;NA;NO;NA;3+;NA;3 Point Scale;Positive;90-99%;ASIAN;NA;YES;1;Primary;Female;Matched;Other (specify);sentinel LN and one non sentinel LN;NA;NA;Lumpectomy;EW;1;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-EW-A1J1;TCGA-EW-A1J1-01;38;M0;N1a;Stage IIB;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-14122;214;NA;0;282;18.89;0:DiseaseFree;NA;NA;3 Point Scale;Positive;90-99%;HISPANIC OR LATINO;NA;5/11/11;2787;NA;NA;NA;NA;NA;NA;<10%;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;3;YES;2010;NO;YES;1;0;17;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Core needle biopsy;NA;YES;17;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;1889;0:LIVING;ed6cef77-1bd9-4e3b-b576-550a91e4253a;af9f631b-2857-48e2-8d77-34f66c1c6149;TCGA-EW-A1J1.E8B860F6-F3FD-4FDF-B467-8988646C2F00.pdf;Negative;NA;Right Upper Inner Quadrant;NA;NO;NA;3+;NA;3 Point Scale;Positive;90-99%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Lumpectomy;EW;566666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-EW-A1J2;TCGA-EW-A1J2-01;50;MX;N1mi;NA;7th;T1c;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-18558;51;NA;0;140;13.24;0:DiseaseFree;NA;NA;3 Point Scale;Positive;90-99%;NOT HISPANIC OR LATINO;total mastectomy;5/27/11;1378;NA;NA;NA;NA;NA;NA;<10%;NA;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Negative;3;YES;2010;NO;YES;1;1;21;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Core needle biopsy;NA;YES;27;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;ILC;1324;0:LIVING;a381275f-8858-4793-a8a2-0ca9db7274c8;2556d93d-9252-4248-a044-91deaa7f02df;TCGA-EW-A1J2.0046FACA-9E90-4BA9-B216-258A2A7A2EC6.pdf;Negative;NA;Right Lower Inner Quadrant;NA;NO;NA;3+;NA;3 Point Scale;Positive;90-99%;BLACK OR AFRICAN AMERICAN;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Other;EW;9;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-EW-A1J3;TCGA-EW-A1J3-01;61;M0;N0;Stage IA;7th;T1c;NA;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;NA;-22332;155;NA;0;252;16.56;0:DiseaseFree;NA;NA;3 Point Scale;Positive;90-99%;HISPANIC OR LATINO;TOTAL MASTECTOMY;5/18/11;1817;NA;NA;NA;NA;NA;NA;90-99%;3;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Positive;3;YES;2010;NO;YES;0;0;3;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;YES;26;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;MDLC;1656;0:LIVING;bb1de798-0c02-437e-b539-33cb556d3993;3e2102ac-0d18-4cf5-8617-863245e21b3f;TCGA-EW-A1J3.79C0D757-50BE-4375-AF69-E577629EE0CA.pdf;Negative;NA;Left Lower Outer Quadrant;NA;NO;NA;3+;NA;3 Point Scale;Positive;90-99%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Other;EW;866666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-EW-A1J6;TCGA-EW-A1J6-01;70;M0;N0 (i-);Stage I;6th;T1c;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-25830;528;NA;0;595;28.75;0:DiseaseFree;NA;NA;3 Point Scale;Positive;90-99%;HISPANIC OR LATINO;NA;5/11/11;9022;NA;NA;NA;NA;NA;NA;<10%;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;3;YES;2009;NO;YES;0;0;3;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;YES;30;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;2875;0:LIVING;87281a89-91d2-44f7-9f80-668567ad5c72;1e20ead6-a07f-4f0d-962a-a3a240722fb6;TCGA-EW-A1J6.F282122D-C129-4A8B-9A49-78D5267C37CA.pdf;Negative;NA;Right Upper Inner Quadrant;NA;NO;NA;3+;NA;3 Point Scale;Positive;90-99%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Lumpectomy;EW;1;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-EW-A1OV;TCGA-EW-A1OV-01;56;MX;N1mi;Stage IIB;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-20764;469;NA;0;523;25.92;0:DiseaseFree;NA;NA;3 Point Scale;Negative;<10%;HISPANIC OR LATINO;NA;5/27/11;3884;NA;NA;1.8;NA;NA;Negative;<10%;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2009;NO;YES;0;1;6;Negative;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;YES;83;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;2592;0:LIVING;ac68d219-5670-4ddd-8df6-8aa7ad59e5c7;684196da-0213-497f-b239-7b5e76b01d0e;TCGA-EW-A1OV.88E39E13-8ADC-481A-992E-610B3BEBCBD4.pdf;Close;NA;Right Lower Outer Quadrant;NA;NO;NA;NA;NA;3 Point Scale;Negative;<10%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;Modified radical mastectomy;NA;Lumpectomy;EW;2766666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-EW-A1OX;TCGA-EW-A1OX-01;43;MX;N0;Stage IIA;6th;T2;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-15837;550;NA;0;562;29.93;0:DiseaseFree;NA;NA;3 Point Scale;Positive;90-99%;HISPANIC OR LATINO;NA;5/18/11;924;NA;NA;NA;NA;NA;NA;<10%;NA;NA;NA;Mucinous Carcinoma;NA;No;No;C50.9;1/03/8523;C50.9;Negative;3;YES;2009;NO;YES;0;0;4;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Core needle biopsy;NA;YES;18;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;BRCA;2993;0:LIVING;5fc7ff35-d3f7-4687-8759-3542bd58e988;8ba7248f-69cd-4b16-8900-ad2feec2eab8;TCGA-EW-A1OX.4C40B309-3178-4E7E-A987-47698E5E364B.pdf;Negative;NA;Right Upper Inner Quadrant;NA;NO;NA;3+;NA;3 Point Scale;Positive;90-99%;WHITE;NA;YES;1;Primary;Female;Matched;Other (specify);sentinel + non sentinel;NA;NA;Lumpectomy;EW;6;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-EW-A1OY;TCGA-EW-A1OY-01;63;MX;N0;Stage IIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-23266;526;NA;0;593;29.83;0:DiseaseFree;NA;NA;3 Point Scale;Positive;90-99%;HISPANIC OR LATINO;NA;6/10/11;5930;NA;NA;NA;NA;NA;Negative;<10%;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;3;YES;2009;NO;YES;0;0;1;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;YES;57;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;2983;0:LIVING;53ff5893-7d5e-4bcb-be9c-665fa34b7824;22ebe36e-3c42-4ca0-a624-c4219074bab9;TCGA-EW-A1OY.76358109-41A0-4D5C-8894-F6A63A925961.pdf;Negative;NA;Left;NA;NO;NA;3+;NA;3 Point Scale;Positive;90-99%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Lumpectomy;EW;19;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-EW-A1OZ;TCGA-EW-A1OZ-01;56;M0;N0 (i-);Stage IIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;2;-20664;928;NA;0;941;40.37;0:DiseaseFree;NA;NA;3 Point Scale;Positive;90-99%;NOT HISPANIC OR LATINO;total mastectomy;5/11/11;6261;40;NA;2.2;NA;NA;Positive;20-29%;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;3;YES;2008;NO;YES;0;0;4;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;YES;50;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;4037;0:LIVING;8f912a40-3251-4e1f-ae65-1f93d71f9881;ac0612f6-3d84-44d5-a224-6cbe65531505;TCGA-EW-A1OZ.42DE8E2C-395D-4E9B-B7BC-6A0B2F9BD7CE.pdf;Negative;NA;Left Upper Outer Quadrant;NA;NO;NA;NA;NA;3 Point Scale;Negative;<10%;BLACK OR AFRICAN AMERICAN;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Other;EW;1666666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-EW-A1P0;TCGA-EW-A1P0-01;55;MX;N1b;Stage IIB;6th;T2;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-20107;1142;NA;0;1121;35.94;1:Recurred/Progressed;NA;NA;3 Point Scale;Positive;90-99%;NOT HISPANIC OR LATINO;NA;5/10/11;2439;NA;NA;NA;NA;NA;NA;<10%;NA;NA;NA;Other, specify;NA;No;No;C50.9;1/03/8523;C50.9;Negative;3;YES;2008;NO;YES;1;NA;21;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;YES;Core needle biopsy;NA;NO;22;NA;NA;3+;Positive;90-99%;NA;1+;Negative;<10%;1;Negative;<10%;VERDADERO;BRCA;411;0:LIVING;81e32f39-3aa0-468b-87ed-dd2eb6165ddf;f2b7091e-ed85-4546-8f11-307154153d31;TCGA-EW-A1P0.F9FB00C3-9F86-40AC-A5E8-08712CD5002B.pdf;Negative;NA;Left Upper Outer Quadrant;NA;NO;NA;NA;NA;3 Point Scale;Negative;<10%;WHITE;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;EW;733333333;WITH TUMOR;Breast
brca_tcga_pub2015;TCGA-EW-A1P3;TCGA-EW-A1P3-01;48;MX;N0;Stage IIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-17637;919;NA;0;987;52.92;0:DiseaseFree;NA;NA;3 Point Scale;Positive;90-99%;NOT HISPANIC OR LATINO;NA;6/10/11;2396;NA;NA;NA;NA;NA;NA;<10%;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;Yes;C50.9;1/03/8500;C50.9;Negative;3;YES;2008;NO;YES;0;0;4;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Core needle biopsy;NA;YES;19;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;5292;0:LIVING;1ff85ada-3cdd-4afb-b311-2c7befb52702;bbe1e6e5-7c52-44aa-940e-104f07751e11;TCGA-EW-A1P3.042304AE-706A-4033-A97F-3765A6AEC649.pdf;Negative;NA;Right Lower Outer Quadrant;NA;NO;NA;3+;NA;3 Point Scale;Positive;90-99%;WHITE;NA;YES;1;Primary;Female;Matched;Other (specify);SN+1 non sentinel node;NA;NA;Simple Mastectomy;EW;633333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-EW-A1P4;TCGA-EW-A1P4-01;43;M0;N0 (i-);Stage IIA;6th;T2;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-15989;525;NA;0;501;29.8;0:DiseaseFree;NA;NA;3 Point Scale;Negative;<10%;HISPANIC OR LATINO;NA;5/11/11;4697;NA;NA;NA;NA;NA;NA;<10%;NA;NA;NA;Medullary Carcinoma;NA;No;No;C50.9;1/03/8510;C50.9;Negative;NA;YES;2009;NO;YES;0;0;3;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Core needle biopsy;NA;YES;58;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;BRCA;298;0:LIVING;521e2140-ae5b-456f-8699-97398d009687;7a3b5790-35c8-473a-b952-bb603aca5aa1;TCGA-EW-A1P4.70C8D54A-9698-4275-BD96-A6EF2E26474B.pdf;Negative;NA;Left Upper Outer Quadrant;NA;NO;NA;NA;NA;3 Point Scale;Negative;<10%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Simple Mastectomy;EW;1933333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-EW-A1P5;TCGA-EW-A1P5-01;77;M0;N1a;Stage IIB;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-28177;325;NA;0;365;23.09;0:DiseaseFree;NA;NA;3 Point Scale;Positive;90-99%;NOT HISPANIC OR LATINO;NA;5/11/11;2559;NA;NA;1.12;NA;NA;Negative;<10%;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;3;YES;2010;NO;YES;3;0;40;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;YES;15;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;2309;0:LIVING;53d0af48-d7ea-42c9-8695-c614b89b415b;c5eb7bf2-fc4a-497e-ace9-c715fea47e5b;TCGA-EW-A1P5.82771A56-81CA-4414-949F-EFBCAE1C98D4.pdf;Negative;NA;Right Upper Outer Quadrant;NA;NO;NA;3+;NA;3 Point Scale;Positive;90-99%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Modified Radical Mastectomy;EW;5;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-EW-A1P6;TCGA-EW-A1P6-01;64;M0;N1a;Stage IIB;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-23485;249;NA;0;312;18.46;0:DiseaseFree;NA;NA;3 Point Scale;Positive;90-99%;HISPANIC OR LATINO;NA;5/19/11;919;NA;NA;NA;NA;NA;NA;<10%;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;3;YES;2010;NO;YES;2;0;25;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;YES;22;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;1846;0:LIVING;ee5744c0-a8dc-43f2-abdd-0b5529a3e9fb;174435cc-64d1-4d33-953c-1ada5df46ecd;TCGA-EW-A1P6.6FEAD496-58BA-42DC-A3F2-2F380EEB1588.pdf;Close;NA;Right Upper Outer Quadrant;NA;NO;NA;3+;NA;3 Point Scale;Positive;90-99%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Lumpectomy;EW;733333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-EW-A1P7;TCGA-EW-A1P7-01;59;M0;N0 (i-);Stage IIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-21750;604;NA;0;635;23.95;1:Recurred/Progressed;NA;NA;3 Point Scale;Negative;<10%;HISPANIC OR LATINO;NA;5/18/11;27;NA;NA;1.8;NA;NA;Negative;10-19%;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;2009;NO;YES;0;0;2;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;YES;30;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;3006;0:LIVING;01674b2c-5cf2-478f-84a1-f69c39f47bd4;3d164bd9-7416-47af-a102-29954e3efe2c;TCGA-EW-A1P7.8F35E936-E4DD-4E35-BD9B-6CB7974E2765.pdf;Negative;NA;Right Upper Outer Quadrant;NA;NO;NA;NA;NA;3 Point Scale;Negative;<10%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Lumpectomy;EW;1;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-EW-A1P8;TCGA-EW-A1P8-01;58;M0;N3b;Stage IIIC;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-21501;224;239;0;NA;6.8;1:Recurred/Progressed;NA;NA;3 Point Scale;Negative;<10%;NOT HISPANIC OR LATINO;NA;5/27/11;9462;NA;NA;NA;NA;NA;NA;<10%;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2010;NO;YES;14;NA;15;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);Lung|Bone|Liver|Other, specify;skin;YES;Fine needle aspiration biopsy;NA;NO;32;NA;NA;NA;Negative;<10%;NA;NA;Negative;<10%;NA;Negative;<10%;VERDADERO;IDC;785;1:DECEASED;359f12f9-5c41-48a4-85bc-fd7e307bf7d8;bf055644-7bca-43b6-8f5a-e21c42f7cf88;TCGA-EW-A1P8.6CB5A0ED-5569-4FDC-B651-758BFC6B59D8.pdf;Negative;NA;Left Upper Outer Quadrant;NA;NO;NA;NA;NA;3 Point Scale;Negative;<10%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Lumpectomy;EW;1066666667;WITH TUMOR;Breast
brca_tcga_pub2015;TCGA-EW-A1PA;TCGA-EW-A1PA-01;59;M0;N1a;Stage IIB;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-21837;220;NA;0;267;18.89;0:DiseaseFree;NA;NA;3 Point Scale;Positive;90-99%;HISPANIC OR LATINO;NA;5/11/11;3026;NA;NA;NA;NA;NA;NA;<10%;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;3;YES;2010;NO;YES;1;NA;13;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;NO;27;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;1889;0:LIVING;4cfef7f9-f1ee-401c-a2a3-c225d4adc3b6;50c357b1-a9fc-44e4-9a7b-937e6d74e081;TCGA-EW-A1PA.A68B2364-89DA-4DC7-9AA7-A08BBCC85025.pdf;Negative;NA;Left Upper Outer Quadrant;NA;NO;NA;3+;NA;3 Point Scale;Positive;90-99%;WHITE;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Lumpectomy;EW;9;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-EW-A1PB;TCGA-EW-A1PB-01;70;MX;N1a;Stage IIIA;6th;T3;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-25770;569;NA;0;608;19.97;0:DiseaseFree;NA;NA;3 Point Scale;Negative;<10%;NOT HISPANIC OR LATINO;NA;5/18/11;1579;NA;NA;NA;NA;NA;NA;<10%;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2009;NO;YES;2;NA;8;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NO;121;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;1997;0:LIVING;88db1340-e4bf-451a-87c0-6e9168296f5e;da9dc40b-0350-4b8c-8a7a-15100d5aeb90;TCGA-EW-A1PB.B3B6DE56-F40C-40BF-B6B3-2BC10F695F16.pdf;Negative;NA;Right Upper Outer Quadrant;NA;NO;NA;NA;NA;3 Point Scale;Negative;<10%;BLACK OR AFRICAN AMERICAN;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Simple Mastectomy;EW;4066666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-EW-A1PC;TCGA-EW-A1PC-01;66;MX;N0 (i-);Stage IIB;7th;T3;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-24434;146;NA;0;187;6.14;0:DiseaseFree;NA;NA;3 Point Scale;Positive;90-99%;NOT HISPANIC OR LATINO;NA;9/28/11;5900;NA;NA;NA;NA;NA;NA;<10%;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;3;YES;2011;NO;YES;0;0;2;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;YES;99;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;614;0:LIVING;F45210D3-9E66-4F5E-BEF1-5EE5547CC893;FB635F1D-5EE1-4E58-86EA-B1AADA2DE4BA;TCGA-EW-A1PC.4A0524B4-2A0B-4442-91B6-0E2FEA90CBC6.pdf;Negative;NA;Left;NA;NO;NA;3+;NA;3 Point Scale;Positive;50-59%;BLACK OR AFRICAN AMERICAN;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Modified Radical Mastectomy;EW;33;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-EW-A1PD;TCGA-EW-A1PD-01;61;M0;N1a;Stage IIA;7th;T1c;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-22536;112;NA;0;175;13.93;0:DiseaseFree;NA;NA;3 Point Scale;Positive;90-99%;HISPANIC OR LATINO;NA;5/18/11;3329;NA;NA;2.2;>6.0;NA;Positive;20-29%;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;3;YES;2010;NO;YES;2;NA;7;NA;NA;NA;NA;NO;Core needle biopsy;NA;NO;62;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;1393;0:LIVING;4dfc233b-ed03-4825-8089-e04cdee99996;9f52ae8b-7fe7-441c-9fb6-c55a9bd1a0d0;TCGA-EW-A1PD.B6D80CA9-F4DA-4DFB-80BF-08BEE17142BD.pdf;Negative;NA;Right;NA;NO;NA;3+;NA;3 Point Scale;Positive;90-99%;WHITE;NA;YES;1;Primary;Male;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Modified Radical Mastectomy;EW;2066666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-EW-A1PE;TCGA-EW-A1PE-01;56;M0;N1a;Stage IIA;7th;T1c;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-20694;44;NA;0;107;10.51;0:DiseaseFree;NA;NA;3 Point Scale;Positive;90-99%;HISPANIC OR LATINO;NA;5/27/11;1758;NA;NA;NA;NA;NA;NA;<10%;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8507;C50.9;Negative;3;YES;2011;NO;YES;1;NA;23;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;NA;NA;NO;28;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;BRCA;1051;0:LIVING;f3b86c02-09a5-4e97-aa7a-86f13f7cda4b;0bc7a0cb-2a16-4f63-8188-39fd4c20b8b3;TCGA-EW-A1PE.F59530A5-7370-4E77-9099-9F38B25A38EB.pdf;Negative;NA;Left Upper Outer Quadrant;NA;NO;NA;3+;NA;3 Point Scale;Positive;90-99%;WHITE;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Lumpectomy;EW;933333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-EW-A1PG;TCGA-EW-A1PG-01;53;MX;N1a;Stage IIB;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-19464;829;NA;0;876;34.53;0:DiseaseFree;NA;NA;3 Point Scale;Positive;90-99%;HISPANIC OR LATINO;NA;5/18/11;4;NA;NA;1.8;<4.0;NA;Negative;10-19%;2;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Equivocal;3;YES;2008;NO;YES;1;1;25;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;YES;8;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;ILC;3453;0:LIVING;da286247-e8bb-4941-a2af-2453fe61cd02;e216aa55-98fc-4d0d-a24e-cfa05778f973;TCGA-EW-A1PG.6197798C-6F04-470E-BA91-922548E2DFAF.pdf;Negative;NA;Left Lower Inner Quadrant|Left Lower Outer Quadrant;NA;NO;NA;3+;NA;3 Point Scale;Positive;90-99%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Modified Radical Mastectomy;EW;266666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-EW-A1PH;TCGA-EW-A1PH-01;52;M0;N1a;Stage IIA;7th;T1c;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-19073;77;NA;0;140;19.94;0:DiseaseFree;NA;NA;3 Point Scale;Negative;<10%;HISPANIC OR LATINO;NA;5/27/11;4664;NA;NA;NA;NA;NA;NA;<10%;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2010;NO;YES;1;0;10;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;YES;45;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;1994;0:LIVING;4da999a0-ef41-4a0b-b1d1-446b39cc855a;dd38ba60-656a-46f7-b22b-bcee3b6d2f19;TCGA-EW-A1PH.2E77693B-FAAD-4CCC-BD4F-3D2470C25143.pdf;Negative;NA;Right Upper Outer Quadrant;NA;NO;NA;NA;NA;3 Point Scale;Negative;<10%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Lumpectomy;EW;15;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-EW-A2FR;TCGA-EW-A2FR-01;59;MX;N3a;Stage IIIC;6th;T1b;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;2;-21628;1015;NA;0;1120;54.96;0:DiseaseFree;NA;NA;3 Point Scale;Negative;<10%;NOT HISPANIC OR LATINO;NA;10/12/11;742;40;NA;3;>6;ratio > 2.2 is positive;Positive;10-19%;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;1;YES;2008;NO;YES;19;NA;21;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;NO;44;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;5496;0:LIVING;AF97E043-88CB-4F99-8F8B-9BCBCCCDF842;061F9BB8-09F5-4788-B39D-35138A3AA019;TCGA-EW-A2FR.792A24F5-065E-4001-97F6-3F9BA121C65D.pdf;Negative;NA;Right Upper Outer Quadrant;NA;NO;NA;1+;NA;3 Point Scale;Negative;<10%;BLACK OR AFRICAN AMERICAN;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Lumpectomy;EW;1466666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-EW-A2FS;TCGA-EW-A2FS-01;41;MX;N1mi;Stage IIB;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-15302;1074;NA;0;1173;52.69;0:DiseaseFree;NA;NA;3 Point Scale;Positive;90-99%;NOT HISPANIC OR LATINO;NA;10/12/11;1908;NA;NA;NA;NA;NA;NA;<10%;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;3;YES;2008;NO;YES;1;NA;8;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Core needle biopsy;NA;YES;28;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;5269;0:LIVING;D34471A1-B367-4F8A-B35A-C5901C4F5503;D92B4202-25D2-40B1-A704-C6BCA0EB5BC3;TCGA-EW-A2FS.F273B11F-D3CE-4619-BEC2-15C110567503.pdf;Negative;NA;Left Upper Outer Quadrant;NA;NO;NA;1+;NA;3 Point Scale;Negative;<10%;BLACK OR AFRICAN AMERICAN;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Lumpectomy;EW;933333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-EW-A2FV;TCGA-EW-A2FV-01;39;MX;N3a;Stage IIIC;7th;T3;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-14316;133;NA;0;239;25.89;0:DiseaseFree;NA;NA;3 Point Scale;Positive;90-99%;HISPANIC OR LATINO;NA;10/5/11;1508;NA;NA;NA;NA;NA;NA;<10%;1;NA;NA;Other, specify;NA;No;No;C50.9;1/03/8507;C50.9;Negative;3;YES;2011;NO;NA;29;NA;32;Negative;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Excisional Biopsy;NA;NO;20;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;BRCA;2589;0:LIVING;F45AA0B2-F3DE-4DB5-9730-E5C6C4E2ED3A;DE8AE7A3-D96B-4B54-9373-8E63F3AC926B;TCGA-EW-A2FV.335BFEB5-6356-43A3-896D-50BF3830B59E.pdf;Negative;NA;Left Upper Inner Quadrant;NA;NO;NA;3+;NA;3 Point Scale;Positive;90-99%;WHITE;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;EW;666666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-EW-A2FW;TCGA-EW-A2FW-01;52;MX;N0 (i-);Stage IIA;7th;T2;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-19085;99;NA;0;191;22.08;0:DiseaseFree;NA;NA;3 Point Scale;Positive;90-99%;HISPANIC OR LATINO;NA;10/5/11;2122;NA;NA;NA;NA;NA;NA;<10%;1;NA;NA;Other, specify;NA;NA;No;C50.9;1/03/8503;C50.9;Negative;3;YES;2011;NO;YES;0;0;6;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;YES;19;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;BRCA;2208;0:LIVING;E6F527A2-38EB-457E-BB39-3C5B9C0BCBEC;7E728799-4C12-451A-AFA9-0B26996F5736;TCGA-EW-A2FW.0487E2B3-C03F-43A0-ABCB-B2BDBE0FF47E.pdf;Negative;NA;Right Upper Outer Quadrant;NA;NO;NA;3+;NA;3 Point Scale;Positive;90-99%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Lumpectomy;EW;633333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-EW-A3E8;TCGA-EW-A3E8-01;60;MX;N0;Stage IIB;7th;T3;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-21922;505;NA;0;647;34;0:DiseaseFree;NA;NA;NA;Positive;NA;HISPANIC OR LATINO;NA;2/8/13;997;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Negative;NA;YES;2011;NO;YES;0;NA;2;NA;NA;NA;NA;NA;Core needle biopsy;NA;NA;80;NO;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;ILC;34;0:LIVING;C0B7B798-3383-4A45-A455-9ECA5810739E;A896CC6D-91D8-4C63-B9C6-2B049E88B8B3;TCGA-EW-A3E8.E4ECB8AA-0ECC-47A5-B940-045A2C3D9A1A.pdf;Negative;YES;Left|Left Upper Outer Quadrant;NA;YES;NA;NA;NA;NA;Negative;NA;WHITE;YES;NO;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Simple Mastectomy;EW;2666666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-EW-A3U0;TCGA-EW-A3U0-01;61;M0;N1a;Stage IIIA;7th;T3;NA;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;NA;-22520;182;NA;0;229;17.48;0:DiseaseFree;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;partial left mastectomy;5/24/12;4676;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2011;NO;YES;1;NA;25;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;NO;113;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;MDLC;1748;0:LIVING;D9DC3B59-613D-469E-8B4F-6C5A557EB26A;549F03A5-3F91-4975-9EEB-AA062264A602;TCGA-EW-A3U0.8652E026-9C4D-4AB6-AADE-29DA3345892E.pdf;Negative;NA;Left;NA;YES;NA;NA;NA;NA;Negative;NA;BLACK OR AFRICAN AMERICAN;NA;NO;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Other;EW;3766666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-EW-A423;TCGA-EW-A423-01;75;MX;N0;Stage IIA;7th;T2;NA;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;NA;-27627;161;NA;0;309;17.51;0:DiseaseFree;NA;NA;NA;Positive;50-59%;HISPANIC OR LATINO;NA;1/4/13;6939;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Negative;NA;YES;2012;NO;YES;0;0;2;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NO;43;NO;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;MDLC;1751;0:LIVING;BDD08EC8-8892-4273-8F21-6FDE0F23C52D;4B4DDC10-5B37-42D2-BBF8-B0CAC95AE1B3;TCGA-EW-A423.0BB6CAC8-CE26-461F-A9FE-46E28E96A368.pdf;Negative;YES;Left Upper Inner Quadrant;NA;YES;NA;NA;NA;NA;Positive;<10%;WHITE;YES;NO;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Lumpectomy;EW;1433333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-GI-A2C8;TCGA-GI-A2C8-01;63;MX;N0;Stage IIIB;6th;T4b;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-23103;2429;NA;0;225;7.39;0:DiseaseFree;NA;NA;3 Point Scale;Positive;90-99%;NOT HISPANIC OR LATINO;NA;10/21/11;5576;NA;NA;NA;NA;NA;Negative;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;Yes;No;C50.9;1/03/8500;C50.9;Negative;3;YES;2004;NO;YES;0;NA;10;NA;NA;NA;NA;NO;NA;NA;NO;92;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;739;0:LIVING;33fe5833-d7a0-43d7-a03d-56985ea448a6;4a21e922-a294-43f0-89cb-862dabed4f8c;TCGA-GI-A2C8.4AABCBD1-DF12-45E1-9307-21D6CB0894A9.pdf;Negative;NA;Right;NA;NO;NA;2+;NA;3 Point Scale;Positive;<10%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Modified Radical Mastectomy;GI;3066666667;NA;Breast
brca_tcga_pub2015;TCGA-GI-A2C9;TCGA-GI-A2C9-01;58;MX;N0;Stage IIB;6th;T3;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-21534;2979;NA;0;711;109.79;0:DiseaseFree;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;10/21/11;5638;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2003;NO;YES;0;0;4;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;YES;113;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;BRCA;10979;0:LIVING;9F6BE944-83DE-42AB-8738-F0022F475E61;143FC27D-E119-48FF-A5EA-BD6AAFC0404E;TCGA-GI-A2C9.ADDE6090-5278-42D5-8E89-E0AB630A4C06.pdf;Negative;NA;Right;NA;NO;NA;NA;NA;NA;Negative;NA;BLACK OR AFRICAN AMERICAN;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Lumpectomy;GI;3766666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-GM-A2D9;TCGA-GM-A2D9-01;69;M0;N0 (i-);Stage I;6th;T1c;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;1.93;-25490;1910;1812;0;NA;44.38;1:Recurred/Progressed;NA;NA;3 Point Scale;Positive;90-99%;NOT HISPANIC OR LATINO;NA;9/28/11;1545;60;NA;1.16;2.23;NA;Negative;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;3;YES;2006;NO;YES;0;0;2;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);Bone;NA;YES;Core needle biopsy;NA;YES;347;NA;NA;NA;Positive;90-99%;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;5953;1:DECEASED;1133B8A9-6B11-4511-B70A-F200E3B8B5DB;07C938AD-70F7-418F-B6C9-EC6E4B1DAE66;TCGA-GM-A2D9.C690925E-38A2-48BC-8E2B-4EA383E27FE2.pdf;Negative;NA;Left Upper Inner Quadrant;NA;NO;NA;3+;NA;3 Point Scale;Positive;40-49%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Lumpectomy;GM;1156666667;WITH TUMOR;Breast
brca_tcga_pub2015;TCGA-GM-A2DA;TCGA-GM-A2DA-01;46;M0;N1b;Stage IIB;4th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;3.7;-16854;6583;NA;0;5909;214.72;1:Recurred/Progressed;NA;NA;NA;Positive;90-99%;NOT HISPANIC OR LATINO;NA;9/28/11;1413;60;NA;4.05;15;NA;Positive;90-99%;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;1993;NO;YES;2;0;13;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;YES;Fine needle aspiration biopsy;NA;NO;24;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;21659;1:DECEASED;C07B122E-AC50-4DB2-ADD2-5617A5D0E976;ED47A919-BE85-4D06-AEE3-87B6485498CC;TCGA-GM-A2DA.F3CD8E6E-B02F-4D5D-B895-6DF063F61603.pdf;Negative;NA;Right Upper Inner Quadrant|Right Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;50-59%;WHITE;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;GM;8;WITH TUMOR;Breast
brca_tcga_pub2015;TCGA-GM-A2DB;TCGA-GM-A2DB-01;62;M0;N0 (i-);Stage IIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;1.5;-22883;1644;NA;0;1616;79.04;0:DiseaseFree;NA;NA;NA;Negative;<10%;NOT HISPANIC OR LATINO;NA;9/28/11;2286;60;NA;1.11;1.67;NA;Negative;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2006;NO;YES;0;0;3;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;YES;103;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;7904;0:LIVING;6E6B7742-A562-490B-BB72-04A5653852E4;57557C6C-4927-449B-976E-127C0916763B;TCGA-GM-A2DB.5A315635-886B-459E-AF5D-079F66E859F0.pdf;Negative;NA;Left Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Negative;<10%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Lumpectomy;GM;3433333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-GM-A2DC;TCGA-GM-A2DC-01;57;M0;N1a;Stage IIA;6th;T1c;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;4.43;-21122;1820;NA;0;1628;83.28;0:DiseaseFree;NA;NA;NA;Positive;90-99%;NOT HISPANIC OR LATINO;NA;9/29/11;4130;60;NA;1.06;4.7;NA;Negative;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;2006;NO;YES;1;0;21;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;NO;17;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;8328;0:LIVING;DD43FFD9-DA18-4AD3-ABE7-6F443C76A717;25DE243D-F03E-496B-B5F0-3DD8E61303FE;TCGA-GM-A2DC.48CB011B-074A-424B-B2D2-E8A2397CF02E.pdf;Negative;NA;Right Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;90-99%;WHITE;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Lumpectomy;GM;566666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-GM-A2DD;TCGA-GM-A2DD-01;53;M0;N0 (i-);Stage I;6th;T1c;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;1.45;-19415;1490;NA;0;1309;74.97;0:DiseaseFree;NA;NA;NA;Negative;<10%;NOT HISPANIC OR LATINO;NA;9/29/11;1170;60;NA;1.11;1.62;NA;Negative;<10%;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;Yes;C50.9;1/03/8500;C50.9;Equivocal;NA;YES;2007;NO;YES;0;0;2;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;YES;45;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;7497;0:LIVING;B343BFE0-7C23-4C6A-8C84-9EE39DB2ECDA;C6514DEB-3214-4CEB-8DB6-46DACA13911F;TCGA-GM-A2DD.E7B75FEC-1706-42C1-8906-B17FE4440161.pdf;Negative;NA;Right;NA;NO;NA;NA;NA;NA;Negative;<10%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Simple Mastectomy;GM;15;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-GM-A2DF;TCGA-GM-A2DF-01;53;M0;N1a;Stage IIA;6th;T1c;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;1.4;-19614;1372;NA;0;1299;70.8;0:DiseaseFree;NA;NA;NA;Negative;<10%;NOT HISPANIC OR LATINO;NA;9/29/11;1934;60;NA;1.12;1.57;NA;Negative;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2007;NO;YES;1;0;32;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;NO;28;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;708;0:LIVING;D6F7AFC0-1558-43AD-ACB1-2B5311ED2264;66760E17-251D-4981-BB02-82C29B315080;TCGA-GM-A2DF.CA6B733A-6030-422C-9DE9-B9718CBB2FDC.pdf;Negative;NA;Left Lower Outer Quadrant;NA;NO;NA;NA;NA;NA;Negative;<10%;BLACK OR AFRICAN AMERICAN;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Lumpectomy;GM;933333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-GM-A2DH;TCGA-GM-A2DH-01;58;M0;N0 (i+);Stage I;6th;T1c;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;2.8;-21344;1464;NA;0;1286;72.04;0:DiseaseFree;NA;NA;NA;Negative;<10%;NOT HISPANIC OR LATINO;NA;9/29/11;2932;60;NA;1;2.8;NA;Negative;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2007;NO;YES;0;1;2;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;YES;115;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;7204;0:LIVING;5700C1B3-922A-4401-8AB8-89028908D696;1BE16830-BC94-422F-B925-26A772F1ED58;TCGA-GM-A2DH.C3243207-2190-4435-9AA9-39E3B913E316.pdf;Negative;NA;Right Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Negative;<10%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Simple Mastectomy;GM;3833333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-GM-A2DI;TCGA-GM-A2DI-01;52;M0;N0 (i+);Stage I;6th;T1c;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;3.33;-19030;2144;NA;0;1883;85.09;0:DiseaseFree;NA;NA;NA;Negative;<10%;NOT HISPANIC OR LATINO;NA;9/29/11;143;60;NA;1.06;3.53;NA;Negative;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;2005;NO;YES;0;1;9;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NO;Core needle biopsy;NA;YES;50;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;8509;0:LIVING;66FA504C-4AE4-49AC-9355-1E063776DC0D;554CD9E3-7BF0-4D5B-A389-D258A8F46073;TCGA-GM-A2DI.D437E9FF-5C09-4FD6-BB0B-0881CD4C50D7.pdf;Negative;NA;Left Upper Inner Quadrant;NA;NO;NA;NA;NA;NA;Negative;<10%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Simple Mastectomy;GM;1666666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-GM-A2DK;TCGA-GM-A2DK-01;58;M0;N0 (i-);Stage I;6th;T1c;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-21198;2109;NA;0;1896;86.89;0:DiseaseFree;NA;NA;NA;Positive;90-99%;NOT HISPANIC OR LATINO;NA;9/29/11;1815;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2005;NO;YES;0;0;1;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;YES;18;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;8689;0:LIVING;3A0775A0-61AE-43F2-B5F6-629A44355C2F;6407B3AB-D159-4700-8E6B-D460411643AC;TCGA-GM-A2DK.FBD7BD94-2870-431D-A519-DAF72A97845F.pdf;Negative;NA;Right Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Negative;<10%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Lumpectomy;GM;6;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-GM-A2DL;TCGA-GM-A2DL-01;50;M0;N0 (i-);Stage I;6th;T1c;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-18475;2723;NA;0;2763;115.6;0:DiseaseFree;NA;NA;NA;Positive;90-99%;NOT HISPANIC OR LATINO;NA;9/29/11;1835;NA;NA;NA;NA;NA;NA;<10%;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2003;NO;YES;0;0;2;NA;Peri (6-12 months since last menstrual period);NA;NA;NO;Core needle biopsy;NA;YES;40;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;1156;0:LIVING;A76774FE-7298-4D68-A2B2-C1BAD93F0C31;D6E981EE-1AFC-4F84-A3BE-E87E0D1460CD;TCGA-GM-A2DL.8CF4E53E-924F-4DC6-8748-BC8A1F7D5662.pdf;Negative;NA;Left Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;90-99%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Lumpectomy;GM;1333333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-GM-A2DM;TCGA-GM-A2DM-01;57;M0;N0 (i-);Stage IIA;6th;T2;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;-21160;2464;NA;0;2331;105.98;0:DiseaseFree;NA;NA;NA;Positive;40-49%;HISPANIC OR LATINO;NA;9/30/11;55;NA;NA;NA;NA;NA;NA;<10%;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2004;NO;YES;0;0;2;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;YES;19;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;BRCA;10598;0:LIVING;753D5D49-3B40-4737-9D4C-B1EC29CC2692;70C927BD-AB54-4E15-8521-5E3A5035DEA5;TCGA-GM-A2DM.18D46E96-4E16-4736-AACF-C6BF8AEC9368.pdf;Negative;NA;Right Lower Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;30-39%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Lumpectomy;GM;633333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-GM-A2DN;TCGA-GM-A2DN-01;58;M0;N0 (i-);Stage IIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-21288;2436;NA;0;2352;101.54;0:DiseaseFree;NA;NA;NA;Positive;90-99%;NOT HISPANIC OR LATINO;NA;9/30/11;649;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2004;NO;YES;0;0;9;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;YES;21;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;10154;0:LIVING;56BBD282-B88D-4730-9242-AB97D08DC83A;E46B29B9-C697-4739-B292-398674A5ADB9;TCGA-GM-A2DN.8829274B-EB82-4155-A458-CF9F0E60B36E.pdf;Negative;NA;Left Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;90-99%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Modified Radical Mastectomy;GM;7;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-GM-A2DO;TCGA-GM-A2DO-01;54;M0;N0 (i-);Stage I;6th;T1c;NA;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;NA;-19842;1932;NA;0;1623;85.28;0:DiseaseFree;NA;NA;NA;Positive;90-99%;NOT HISPANIC OR LATINO;NA;9/30/11;343;NA;NA;NA;NA;NA;NA;<10%;NA;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Negative;NA;YES;2006;NO;YES;0;0;3;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;YES;99;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;MDLC;8528;0:LIVING;5FD37868-4762-4109-9DCF-6FDBAB5B645D;B0763E0D-56A7-4953-AD36-C3B218C059B3;TCGA-GM-A2DO.100E842E-0ADD-4E58-B31B-0C67DC175787.pdf;Negative;NA;Right Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;90-99%;BLACK OR AFRICAN AMERICAN;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Lumpectomy;GM;33;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-GM-A3NW;TCGA-GM-A3NW-01;63;M0;N0 (i-);Stage IIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;1.57;-23041;3110;NA;0;2982;110.41;0:DiseaseFree;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;1/3/12;2472;60;NA;1.15;1.8;NA;Negative;30-39%;1;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Equivocal;NA;YES;2003;NO;YES;0;0;4;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;YES;68;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;ILC;11041;0:LIVING;6DDAEE34-46EB-490C-BD13-F0AB963C4322;0B6EE423-04A5-4426-B397-9669FEAE4C44;TCGA-GM-A3NW.00C6FB2B-A1C9-4310-B178-740313565A32.pdf;Negative;NA;Left Upper Inner Quadrant;NA;NO;NA;NA;NA;NA;Positive;20-29%;WHITE;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Simple Mastectomy;GM;2266666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-GM-A3NY;TCGA-GM-A3NY-01;72;M0;N1a;Stage IIB;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-26642;778;NA;0;743;38.17;0:DiseaseFree;NA;NA;NA;Positive;90-99%;NOT HISPANIC OR LATINO;NA;1/3/12;1117;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Negative;NA;YES;2009;NO;YES;1;0;13;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NO;Core needle biopsy;NA;NO;53;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;ILC;3817;0:LIVING;BD5374C9-7F36-457F-B66B-7CC7FF64224E;50BD5C91-6557-4456-92D3-AE40CF7A8B9D;TCGA-GM-A3NY.1659798C-9B6A-4DF9-A5B6-79AD2194DF11.pdf;Negative;NA;Left Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;20-29%;WHITE;NA;YES;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Lumpectomy;GM;18;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-GM-A3XG;TCGA-GM-A3XG-01;46;M0;N1a;Stage IIIA;6th;T3;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;1.67;-16948;899;NA;0;982;43.69;0:DiseaseFree;NA;NA;NA;Positive;90-99%;NOT HISPANIC OR LATINO;NA;10/1/12;0;60;NA;1.04;1.73;NA;Negative;NA;1;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Negative;NA;YES;2009;NO;YES;3;0;26;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NA;Core needle biopsy;NA;YES;5;NO;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;ILC;4369;0:LIVING;6F0FD68F-ED6A-4C9E-BE02-C97BA4950F76;A172DB3E-B6D5-4153-ADEC-9E772D6C1971;TCGA-GM-A3XG.E76B5204-99E5-42D0-AE7E-ED5525796CCB.pdf;Negative;YES;Right|Right Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;90-99%;WHITE;YES;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Modified Radical Mastectomy;GM;166666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-GM-A3XL;TCGA-GM-A3XL-01;49;M0;N0 (i-);Stage IIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-18171;1779;NA;0;1717;69.25;0:DiseaseFree;NA;NA;NA;Negative;<10%;NOT HISPANIC OR LATINO;NA;10/1/12;4806;NA;NA;0.99;NA;NA;Negative;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;2007;NO;YES;0;0;4;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;YES;77;NO;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;6925;0:LIVING;65CAC997-4D39-4501-85EC-4FCB328A8EB5;FED3A891-21BE-4196-B9EF-0BF7C8F976AA;TCGA-GM-A3XL.E8583D11-D6F7-41AC-8CD5-53437CBD8820.pdf;Negative;YES;Right|Right Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Negative;<10%;BLACK OR AFRICAN AMERICAN;YES;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Lumpectomy;GM;2566666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-GM-A3XN;TCGA-GM-A3XN-01;44;M0;N2a;Stage IIIA;6th;T1c;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;1.73;-16109;1627;NA;0;1641;66.33;0:DiseaseFree;NA;NA;NA;Positive;80-89%;NOT HISPANIC OR LATINO;NA;10/1/12;1675;60;NA;1.07;1.85;NA;Negative;NA;1;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Negative;NA;YES;2007;NO;YES;5;0;34;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Incisional Biopsy;NA;NO;16;NO;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;ILC;6633;0:LIVING;0930E97A-72EA-4BD5-B2F0-50C76AF695F3;281F2BE7-7FB2-46F2-9A4A-033DB48329A1;TCGA-GM-A3XN.E9A88E5B-4F50-4683-9C65-56CFCB15405E.pdf;Negative;YES;Left|Left Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;90-99%;WHITE;YES;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Lumpectomy;GM;533333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-GM-A4E0;TCGA-GM-A4E0-01;67;M0;N3a;Stage IIIC;6th;T3;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-24788;1871;NA;0;1753;71.98;0:DiseaseFree;NA;NA;NA;Positive;90-99%;NOT HISPANIC OR LATINO;NA;11/26/12;133;NA;NA;NA;NA;NA;Negative;NA;NA;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;NA;NA;YES;2007;NO;YES;10;1;22;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;YES;16;NO;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;ILC;7198;0:LIVING;6397D7BC-9CB1-4A84-81AD-76954E0A8CEE;EE6B71D0-3596-4669-B138-AF822C2C3C6B;TCGA-GM-A4E0.DB0291E6-E371-40F8-BDB3-0F85F015B3DE.pdf;Negative;YES;Left|Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;90-99%;WHITE;YES;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Modified Radical Mastectomy;GM;533333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-HN-A2NL;TCGA-HN-A2NL-01;56;M0;N0;Stage IIA;6th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-20483;;NA;0;79;2.6;0:DiseaseFree;NA;NA;NA;Negative;NA;NA;NA;5/30/14;9228;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Negative;NA;YES;;NO;YES;0;0;3;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Tumor resection;NA;YES;64;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;ILC;26;0:LIVING;124B693C-77DC-4FA8-B703-54E8B5054A92;DAEC3A82-E1F5-4D6F-87DD-90853E48BF29;TCGA-HN-A2NL.CC1EE9E0-BC1A-46ED-A262-7A2B9CC8BBB1.pdf;Negative;NA;Left Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Negative;NA;NA;NA;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Simple Mastectomy;HN;2133333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-JL-A3YW;TCGA-JL-A3YW-01;49;M0;N1;Stage IIB;7th;T2;NA;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;NA;;312;NA;0;360;11.83;0:DiseaseFree;NA;NA;3 Point Scale;Positive;30-39%;NOT HISPANIC OR LATINO;NA;11/8/12;1167;NA;NA;NA;NA;NA;NA;30-39%;1;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Positive;3;YES;2011;NO;YES;3;0;16;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Tumor resection;NA;NA;75;NO;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;MDLC;1183;0:LIVING;A2434F47-2168-47D0-9BBB-981071597843;CDE5B270-BEC9-40D4-9C59-29F93EF08293;TCGA-JL-A3YW.476488A9-3708-4B11-854A-C91B583C7804.pdf;Negative;NO;Left;NA;YES;NA;3+;NA;3 Point Scale;Positive;30-39%;ASIAN;NO;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;JL;2533333333;NA;Breast
brca_tcga_pub2015;TCGA-JL-A3YX;TCGA-JL-A3YX-01;46;M0;N0;Stage IIA;7th;T2;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;NA;;306;NA;0;352;11.56;0:DiseaseFree;NA;NA;3 Point Scale;Positive;30-39%;NOT HISPANIC OR LATINO;NA;11/8/12;2097;NA;NA;NA;NA;NA;NA;30-39%;3;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Positive;2;YES;2011;NO;YES;0;0;16;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Tumor resection;NA;NA;30;NO;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;BRCA;1156;0:LIVING;75F6E476-233A-409C-A3EF-0240BE569813;659EE487-4309-4D68-A9BC-9079EE87E4A9;TCGA-JL-A3YX.25782EF0-8786-446E-ADBA-21F489844237.pdf;Negative;NO;Left;NA;YES;NA;2+;NA;3 Point Scale;Positive;30-39%;ASIAN;NO;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;JL;1;NA;Breast
brca_tcga_pub2015;TCGA-LL-A440;TCGA-LL-A440-01;61;MX;N0 (i-);Stage IA;7th;T1c;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;46;-22497;32;NA;0;20;24.93;0:DiseaseFree;NA;NA;3 Point Scale;Positive;90-99%;NOT HISPANIC OR LATINO;NA;10/26/12;68;20;NA;1.7;79;NA;Negative;NA;2;NA;NA;Infiltrating Lobular Carcinoma;NA;No;Yes;C50.9;1/03/8520;C50.9;Equivocal;3;YES;2012;NO;YES;0;0;4;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;YES;8;NO;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;ILC;2493;0:LIVING;00B11CA8-8540-4A3D-B602-EC754B00230B;E0630A0D-D4AA-4C20-87EA-441EA60E6CFE;TCGA-LL-A440.5577BE88-72ED-43E5-9BB1-83D56C2EA346.pdf;Negative;NO;Left Upper Outer Quadrant;NA;YES;NA;3+;NA;3 Point Scale;Positive;90-99%;WHITE;NO;NO;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Simple Mastectomy;LL;266666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-LL-A441;TCGA-LL-A441-01;62;MX;N0;Stage IA;7th;T1c;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-22772;37;NA;0;91;32.72;0:DiseaseFree;NA;NA;3 Point Scale;Negative;NA;NOT HISPANIC OR LATINO;NA;11/5/12;1771;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2012;NO;YES;0;0;4;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;YES;59;NO;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;3272;0:LIVING;69FC24FC-CFE2-487A-935F-1A954B30B709;E3A1436E-8E38-4CB9-A913-0A50512DB5B3;TCGA-LL-A441.1FFDD2E3-02D5-4C38-B6E9-1261EB57835A.pdf;Negative;YES;Right Upper Outer Quadrant;NA;YES;NA;NA;NA;3 Point Scale;Negative;NA;BLACK OR AFRICAN AMERICAN;NO;NO;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Lumpectomy;LL;1966666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-LL-A50Y;TCGA-LL-A50Y-01;84;MX;N0;Stage IIA;7th;T2;NA;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;2.5;-30934;91;NA;0;210;25.03;0:DiseaseFree;NA;NA;3 Point Scale;Positive;90-99%;NOT HISPANIC OR LATINO;NA;3/8/13;849;167;NA;1;2.6;NA;Negative;NA;2;NA;NA;Infiltrating Lobular Carcinoma;NA;No;Yes;C50.9;1/03/8520;C50.9;Equivocal;NA;YES;2012;NO;YES;0;0;8;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;YES;29;NO;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;MDLC;2503;0:LIVING;91DA548B-5C64-49C3-A44A-1EF115F53311;CC10FEB5-CED7-4C1E-B429-C4AC77236765;TCGA-LL-A50Y.C3BD4B5F-0FB9-4B22-B8FE-9D689660B5E9.pdf;Negative;YES;Right Upper Outer Quadrant;NA;YES;NA;2+;NA;3 Point Scale;Positive;90-99%;WHITE;NO;NO;1;Primary;Female;Matched;Axillary lymph node dissection alone;NA;NA;NA;Modified Radical Mastectomy;LL;966666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-LL-A5YL;TCGA-LL-A5YL-01;64;MX;N1a;Stage IIB;7th;T2;NA;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;2.9;-23395;84;NA;0;169;17.05;0:DiseaseFree;NA;NA;3 Point Scale;Positive;90-99%;NOT HISPANIC OR LATINO;NA;6/3/13;1994;65;NA;0.9;2.6;NA;Negative;NA;3;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Positive;3;YES;2012;NO;YES;3;0;23;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NA;57;NO;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;MDLC;1705;0:LIVING;1D75E89D-4B01-443C-BE54-749C7A667BF4;E5C7EA3C-3AAA-4409-B10B-372F2F8E30F6;TCGA-LL-A5YL.17B51CA5-E325-4EA0-AFED-C6D0FD5A40EF.pdf;Negative;YES;Right|Right Upper Inner Quadrant;NA;YES;NA;NA;NA;3 Point Scale;Negative;<10%;WHITE;NO;NO;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Simple Mastectomy;LL;1933333333;NA;Breast
brca_tcga_pub2015;TCGA-LL-A5YM;TCGA-LL-A5YM-01;88;M0;NX;Stage IIIB;7th;T4b;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;54;-32478;131;NA;0;143;8.48;1:Recurred/Progressed;NA;NA;3 Point Scale;Positive;90-99%;NOT HISPANIC OR LATINO;partial mastectomy;6/3/13;4424;20;NA;3.2;172;NA;Positive;NA;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8541;C50.9;Equivocal;3;YES;2012;NO;NO;NA;NA;NA;Negative;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NA;23;NO;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;1531;0:LIVING;E9A12DF9-024E-4CBC-B6BF-E4E87485FA90;CF5FDA71-8FBA-43FC-91F3-E4BAA36571DD;TCGA-LL-A5YM.B169A5B5-27CD-48A6-A8D7-C14D3824A20A.pdf;Positive;NO;Left|Left Upper Inner Quadrant;NA;YES;NA;3+;NA;3 Point Scale;Positive;90-99%;BLACK OR AFRICAN AMERICAN;NO;NO;1;Primary;Female;Matched;No axillary staging;NA;Mastectomy NOS;NA;Other;LL;766666667;WITH TUMOR;Breast
brca_tcga_pub2015;TCGA-LL-A5YN;TCGA-LL-A5YN-01;46;M0;N0 (i-);Stage IIA;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;54;-16884;41;NA;0;111;14.68;0:DiseaseFree;NA;NA;3 Point Scale;Positive;90-99%;NOT HISPANIC OR LATINO;NA;5/20/13;1778;20;NA;3.2;172;NA;Positive;NA;2;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Equivocal;3;YES;2013;NO;YES;0;0;5;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NO;26;NO;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;1468;0:LIVING;EF1B3332-CD7F-41BB-A2D3-2538E7BECC5C;97AD1ECF-7643-461F-B9A2-1AC953825895;TCGA-LL-A5YN.4D4811FB-5BF1-4574-975B-1740602E43D8.pdf;Negative;YES;Right|Right Upper Inner Quadrant;NA;YES;NA;3+;NA;3 Point Scale;Positive;90-99%;BLACK OR AFRICAN AMERICAN;NO;NO;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Lumpectomy;LL;866666667;NA;Breast
brca_tcga_pub2015;TCGA-LL-A5YO;TCGA-LL-A5YO-01;50;MX;N0;Stage IA;7th;T1b;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-18354;47;NA;0;97;14.45;0:DiseaseFree;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;5/8/13;570;NA;NA;NA;NA;NA;NA;NA;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;Negative;NA;YES;2013;NO;YES;0;0;1;NA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);NA;NA;NA;Core needle biopsy;NA;YES;45;NO;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;1445;0:LIVING;B8AEFC48-4A6E-4254-A57F-5F688399B582;2B7230C7-0182-4417-9861-03672629D98D;TCGA-LL-A5YO.C5C5D704-2558-4D4B-937B-33BD91132882.pdf;Negative;YES;Left Upper Outer Quadrant;NA;YES;NA;NA;NA;NA;Negative;NA;BLACK OR AFRICAN AMERICAN;NO;NO;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Lumpectomy;LL;15;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-LL-A5YP;TCGA-LL-A5YP-01;49;M0;N1a;Stage IIB;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;35;-18041;29;NA;0;99;14.78;0:DiseaseFree;NA;NA;3 Point Scale;Positive;<10%;NOT HISPANIC OR LATINO;NA;5/20/13;5530;20;NA;3.4;118;NA;Positive;<10%;1;NA;NA;Infiltrating Ductal Carcinoma;NA;No;Yes;C50.9;1/03/8500;C50.9;Negative;3;YES;2013;NO;YES;2;NA;12;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NO;64;NO;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;FALSO;IDC;1478;0:LIVING;6D24E675-2FA4-4102-861F-7516650B3049;3DC0BC4F-6863-4297-8915-F29E1AA25D26;TCGA-LL-A5YP.B6B4DCFE-F044-44D6-BB90-EF71E6981E82.pdf;Negative;YES;Right|Right Lower Inner Quadrant;NA;YES;NA;NA;NA;3 Point Scale;Negative;<10%;BLACK OR AFRICAN AMERICAN;NO;NO;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Modified Radical Mastectomy;LL;2133333333;NA;Breast
brca_tcga_pub2015;TCGA-LQ-A4E4;TCGA-LQ-A4E4-01;73;MX;N1a;Stage IIIA;7th;T3;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;1.1;-26883;414;NA;0;484;22.37;1:Recurred/Progressed;NA;NA;3 Point Scale;Positive;90-99%;NOT HISPANIC OR LATINO;NA;12/5/12;1878;60;NA;1.05;1.1;NA;Negative;NA;NA;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;NA;1;YES;2011;NO;YES;3;0;26;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NO;69;NO;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;ILC;2789;0:LIVING;4F321D41-3255-46A4-AE0D-1CF39699E624;8C8D4BD4-3AA9-4AD1-9715-2376EE540A0C;TCGA-LQ-A4E4.C13D16C9-BAC7-4CA4-B062-D925466F9E2B.pdf;Positive;YES;Right Upper Outer Quadrant;NA;NO;NA;1+;NA;3 Point Scale;Positive;90-99%;WHITE;YES;YES;1;Primary;Female;Matched;Sentinel lymph node biopsy plus axillary dissection;NA;NA;NA;Modified Radical Mastectomy;LQ;23;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-MS-A51U;TCGA-MS-A51U-01;44;M0;N1;Stage IIB;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-16213;129;NA;0;85;22.37;0:DiseaseFree;NA;NA;NA;Positive;90-99%;NOT HISPANIC OR LATINO;NA;9/12/12;1797;NA;NA;NA;NA;NA;Negative;NA;NA;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Negative;NA;YES;2012;NO;YES;2;NA;18;NA;NA;NA;NA;NO;NA;NA;NA;13;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;ILC;2237;0:LIVING;910655DA-2C12-4572-96B7-DED616E69B4B;764A5732-0B44-4CBE-93F2-7B84FD7D81A1;TCGA-MS-A51U.58D54D1A-3A8D-40DD-A643-846CAF242494.pdf;Negative;NA;Left Upper Outer Quadrant|Left Lower Outer Quadrant|Left;NA;YES;NA;NA;NA;NA;Positive;20-29%;WHITE;NA;NO;1;Primary;Female;Matched;NA;NA;NA;NA;Modified Radical Mastectomy;MS;433333333;WITH TUMOR;Breast
brca_tcga_pub2015;TCGA-OL-A66H;TCGA-OL-A66H-01;;MX;N1mi;Stage IB;7th;T1c;NA;Invasive Breast Carcinoma;Invasive Breast Carcinoma;1.7;;441;NA;;NA;NA;0:DiseaseFree;NA;NA;NA;Positive;90-99%;NOT HISPANIC OR LATINO;NA;6/11/13;587;NA;NA;1.03;1.8;NA;Negative;NA;NA;NA;NA;Mucinous Carcinoma;NA;No;No;C50.9;1/03/8480;C50.9;NA;NA;YES;;NO;YES;NA;NA;1;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Fine needle aspiration biopsy;NA;NA;19;NO;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;BRCA;2669559786;0:LIVING;76BD9BB9-9A8B-4A90-BB7C-EAFE76472EE4;31E39E5F-AF9C-4F34-B065-8363CF9DF39C;TCGA-OL-A66H.3D84D02A-42B1-42E1-84FB-E9AE9381ABB4.pdf;Negative;NO;Right;NA;NO;NA;NA;NA;NA;Positive;80-89%;BLACK OR AFRICAN AMERICAN;YES;YES;1;Primary;Female;Matched;NA;NA;NA;NA;Lumpectomy;OL;7;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-OL-A66I;TCGA-OL-A66I-01;36;MX;N1mi;Stage IIA;6th;T1c;NA;Invasive Breast Carcinoma;Breast Invasive Ductal Carcinoma;NA;-13458;1715;NA;0;714;23.46;0:DiseaseFree;NA;NA;NA;Negative;NA;NOT HISPANIC OR LATINO;NA;6/11/13;4090;NA;NA;1.04;NA;NA;Negative;NA;NA;NA;NA;Infiltrating Ductal Carcinoma;NA;No;No;C50.9;1/03/8500;C50.9;NA;NA;YES;2008;NO;YES;0;NA;13;NA;NA;NA;NA;NA;Core needle biopsy;NA;NA;29;NO;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;IDC;2346;0:LIVING;35BD694D-1DD2-466F-AB27-03320614B40E;2B8C960A-3E9A-49BF-8329-7D322DA90326;TCGA-OL-A66I.800346FC-BC14-4A33-B10C-84224D908481.pdf;Negative;YES;Right Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Negative;NA;BLACK OR AFRICAN AMERICAN;YES;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Lumpectomy;OL;966666667;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-OL-A66J;TCGA-OL-A66J-01;80;MX;N0;Stage I;6th;T1c;NA;Invasive Breast Carcinoma;Breast Mixed Ductal and Lobular Carcinoma;NA;-29345;1645;NA;0;1658;65.57;0:DiseaseFree;NA;NA;NA;Positive;90-99%;NOT HISPANIC OR LATINO;NA;6/11/13;664;NA;NA;1.5;NA;NA;Negative;NA;NA;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;NA;NA;YES;2008;NO;YES;0;NA;4;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NA;52;NO;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;MDLC;6557;0:LIVING;96E1FC6D-693F-4F4F-B5F7-8D6E1C6C43F8;1889A2AF-AE25-41EC-8A6D-0EC5C5B852CB;TCGA-OL-A66J.D5DE4BB3-81AC-44CB-9336-060F324C7A2F.pdf;Negative;NO;Right Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;50-59%;WHITE;YES;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Lumpectomy;OL;1733333333;TUMOR FREE;Breast
brca_tcga_pub2015;TCGA-OL-A66K;TCGA-OL-A66K-01;72;MX;N0;Stage IIA;7th;T2;NA;Invasive Breast Carcinoma;Breast Invasive Lobular Carcinoma;NA;-26299;981;NA;0;1021;NA;NA;NA;NA;NA;Positive;70-79%;NOT HISPANIC OR LATINO;NA;6/11/13;1883;NA;NA;1.23;NA;NA;Negative;NA;2;NA;NA;Infiltrating Lobular Carcinoma;NA;No;No;C50.9;1/03/8520;C50.9;Equivocal;NA;YES;2010;NO;YES;NA;NA;2;NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);NA;NA;NA;Core needle biopsy;NA;NA;25;NO;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;VERDADERO;ILC;4189;1:DECEASED;2AB1B35B-9E56-475C-AC9B-15ED0A422683;796B90A8-99D6-4102-81A0-96C6954E9F26;TCGA-OL-A66K.8A19AA55-9B1F-4325-B730-068F928F1C13.pdf;Negative;NO;Right Upper Outer Quadrant;NA;NO;NA;NA;NA;NA;Positive;90-99%;WHITE;NO;YES;1;Primary;Female;Matched;Sentinel node biopsy alone;NA;NA;NA;Simple Mastectomy;OL;833333333;TUMOR FREE;Breast
